gulf chapter sample ballot - american association of · pdf file · 2012-09-17aug...

Gulf ChapterAmerican Association of

Clinical Endocrinologists

1st Annual Meeting

October 12, 2012

CHAPTER II: MEMBERSHIP

• Section 1. Eligibility. All members in good

standing of the American Association of

Clinical Endocrinologists (AACE) licensed to

practice medicine in the Gulf countries (Saudi

Arabia, Bahrain, Kuwait, United Arab

Emirates, Oman and Qatar) shall be eligible

for membership in the Chapter.

CHAPTER III: MEETINGS

• Section 1. Annual Meeting. The Chapter shall hold an annual meeting, open to all members and invited guests, at a time and place designated by the Chapter Board of Directors. The purpose of meeting shall be to elect Chapter Officers and Chapter Board of Directors members, present education programs, and to transact other business that may come before the Chapter.

• Section 4. Quorum. At any meeting of the membership of the Chapter, a majority of the members present and voting at such meeting shall constitute a quorum for the transaction of business.

CHAPTER IV: BOARD OF DIRECTORS

• Section 2. Composition. The Chapter Board of Directors shall consist of: the officers of the Chapter, four members of the Chapter at large, and one member appointed by the Chapter President.

•

• Section 3. Election and Term of Office. The Chapter Board of Directors shall be elected by the members of the Chapter present and voting at each annual meeting of the Chapter, and shall serve for three (3) years.

CHAPTER V: OFFICERS

• Section 1. Officers. The officers of the Chapter

shall consist of the President, President Elect, the

Secretary/Treasurer and the Immediate Past

President.

• Section 2. Election and Term of Office. The term

of office of shall be for one year and the Chapter

Officers shall be elected by the members of the

Chapter at an annual meeting.

Board of Director Nominees

1. Thamer Alessa, MD; Kuwait

2. Eman M Alfadhli, MD; KSA

3. Mohammed Hussein Al-

Ghamdi, MBChb,FRCPC,FACP

FACE; KSA

4. Naji Jameel Aljohani, MD; KSA

5. Juma M Alkaabi, MD FACE; UAE

6. Aishah Ali Alkhzaimi, MD, KSA

7. Mohamed Abdullah Al-Lamki,

MBChB, MSc, FRCP; Oman

8. Nasreen Abdulkarim Al-Sayed,

MD FACP; Bahrain

9. Salem Arifi Beshyah, MBBChMRCI MRCP (UK) FRCP PhD; UAE

10. Nabil Kamal Elnaggar, MD; KSA

11. Imad El-Din Ginawi El-Sadig, MD; UAE

12. Amin Ahmad Jayyousi, MD; Qatar

13. Satendra Kumar Multani, MD FACE; UAE

14. Huda Ezzeddin Mustafa, MD ECNU; UAE

15. Mahmoud Ali Zirie, MD FACE; Qatar

Secretary/Treasurer Nominees

1. Wiam Ibrahim Hussein, MD FACE FACP;

Bahrain

2. Khalid Faiq Mohammed Salih, MD FACE; UAE

Vice President Nominees

1. Ali Saeed Alzahrani, MD FACE; KSA

2. Ali Barnard Khalil MD, FACE; UAE

President Nominees

1. Fatma AlMarashi, MD FACE; UAE

2. Kamal A S Al-Shoumer, BSC, MB, DIC, PhD,

FRC FACE; Kuwait

3. Mahmoud Mohamed A Fikri, MBBCh, PhD;

UAE

4. Ahmed A K Hassoun, MD FACE; UAE

Candidate

Information

Submissions

*The following materials were submitted to AACE by the

candidate and appear in alphabetical order by position. Click on

the name to be directed to the appropriate candidate materials.

Board of Director

Candidates

1. Thamer Alessa, MD; Kuwait

2. Eman M Alfadhli, MD; KSA

3. Mohammed Hussein Al-Ghamdi, MBChb,FRCPC,FACP FACE;

KSA

4. Naji Jameel Aljohani, MD; KSA

5. Juma M Alkaabi, MD FACE; UAE

6. Aishah Ali Alkhzaimi, MD, KSA

7. Mohamed Abdullah Al-Lamki, MBChB, MSc, FRCP; Oman

8. Nasreen Abdulkarim Al-Sayed, MD FACP; Bahrain

9. Salem Arifi Beshyah, MBBCh MRCI MRCP (UK) FRCP PhD;

UAE

10. Nabil Kamal Elnaggar, MD; KSA

11. Imad El-Din Ginawi El-Sadig, MD; UAE

12. Amin Ahmad Jayyousi, MD; Qatar

13. Satendra Kumar Multani, MD FACE; UAE

14. Huda Ezzeddin Mustafa, MD ECNU; UAE

15. Mahmoud Ali Zirie, MD FACE; Qatar

Personal Statement Serving a role of a promoter of health and well being has always been my ambition, beginning in medical school, going through the journey of medical residency and fellowship in the United States and then taking the responsibility of a full time physician in Kuwait taking care of patients and engaging in social and scientific activities. I have learned the role of AACE and other similar scientific societies very early in my medical career and through the mentoring from great physicians and professors in the University of Miami, like Dr.Paul Jellinger, a past president of AACE, who taught me during my fellowship the importance of medical knowledge and how to share them to other colleagues. To be a part of such a very well known medical society, AACE, and be serving in the Gulf Chapter Board of Directors, is a promising goal and would love to fulfill it. I see any medical society like a bridge between clinical knowledge and clinical practice specially with using the well-‐known AACE excellent medical and scientific reputation. I see the role of the Gulf Chapter to be establishing this bridge by several ways:

1) Providing medical information for physicians 2) Conducting annual, or similar, scientific meetings to discuss medical

literature, medical updates and Gulf based research developments and presentations

3) Sharing the medical, clinical and research experience from AACE Faculty 4) Proving mentoring opportunities in the Gulf region for research and medical

experience 5) Periodic newsletters describing latest Endocrine news, like medical, legal,

research and even social activities 6) Promoting Endocrine science to medical student and young physicians

through encouraging attending the AACE annual and the Chapter meetings with a learning track specified to them plus the experience from AACE’s own Endocrine University®

7) Involving the public in promoting health by establishing ways to reach media outlets or by using social networking or through educational or social institutions

I believe the AACE Gulf Chapter, will serve a big role in the local Endocrine medical society and I would love to be a part of it.

1

Thamer M. Alessa, M.D.

Mail Address Contact Information P.O. Box 5975 Cell: (+965) 99877855 Safat, 13060 Email: [email protected] Kuwait Twitter : @thameralessa

EDUCATION July 2009–June 2011 Fellowship in Endocrinology, Diabetes and Metabolism at the J. Maxwell

McKenzie Fellowship Program. University of Miami/Jackson Memorial Hospital and the Miami VA Hospital – Florida/USA

Nov 2005–Nov 2008 Internal Medicine Residency Program at the University of Miami/Jackson

Memorial Hospital and the Miami VA Hospital – Florida/USA 2000–2003 Kuwait University – Faculty of Medicine

• B.M., B.Ch. Bachelor of Medicine and Surgery degree. 1996–2000 Kuwait University – Faculty of Medicine

• B.Med.Sc., Bachelor of Medical Sciences degree. EXPERIENCE Aug 2011 – Present Endocrine Division - Mubarak Al-Kabeer Hospital – State of Kuwait – Senior

Registrar Nov 2008–July 2009 Internal Medicine - Mubarak Al-Kabeer Hospital – State of Kuwait – Assistant

Registrar Aug 2004–Nov 2005 Internal Medicine - Mubarak Al-Kabeer Hospital – State of Kuwait – Assistant

Registrar Aug 2003–Aug 2004 Mubarak Al-Kabeer Hospital – State of Kuwait – Internship Jul 2001 Professional Exchange Clerkship, International Federation of Medical Students’

Associations (IFMSA) • General Surgery elective for 4 weeks at Virchow-Klinikum Hospital, Berlin,

Germany. RESEARCH & PUBLICATIONS June 2011 Poster Presentation at the Endocrine Society 93rd Annual Meeting in Boston,

Massachusetts with a title “High HDL-Cholesterol Is Common in Older Adults with Type 1 Diabetes (T1DM)” • Alessa T, Szeto A, Mendez A, Chacra W, Goldberg R. • Competed for the Presidential Poster Competition.

June 2010 Management of Diabetic Dyslipidemia: an update – Review Article

• Alessa T, Goldberg R. International Diabetes Monitor. 2010; 22(5):203-212.

2

Thamer M. Alessa, M.D.

June 2010 Poster Presentation at the Endocrine Society 92nd Annual Meeting in San Diego, California with a title “Pituitary Dysfunction in a Patient with Rosai−Dorfman Disease”. • Alessa T.

Aug 2006–2008 Inhaled Insulin Research Study – University of Miami – Miller School of Medicine

– Diabetes Research Institute • Joint Dr.Hernandez-Cassis in a research project towards studying the use of inhaled

insulin in patients with Type 1 diabetes. 2002 7th Annual Health Sciences Poster Day, Health Science Center. Faculty of Medicine

- Kuwait University • Alsuwaidan MT, Alessa TM, Almutawa FA. Assessing Personality Profiles Among

Physicians of Different Specialties in Kuwait. HONORS & AWARDS July 2010–June 2011 Chief Fellow, the J. Maxwell McKenzie Endocrinology, Diabetes and Metabolism

Fellowship Program. University of Miami/Jackson Memorial Hospital and the Miami VA Hospital – Florida/USA

2002 Kuwait Medical Students’ Association Outstanding Student Award

• Honored by Dr. Muhammad Al-Jarallah, Minister of Health. 2001 HRH the Emir of Kuwait’s Graduation Ceremony

• Honored by His Royal Highness for graduating in high standing. 2000 Kuwait Medical Students’ Association Outstanding Student Award

• Honored by the Dean of the Faculty of Medicine. 1997 Kuwait Medical Students’ Association Outstanding Student Award

• Honored by Vice-rector of Kuwait University. MEMBERSHIPS 2010–Present Endocrine Society 2009–Present American Thyroid Association 2006–Present American Association of Clinical Endocrinologists. 2003–Present Kuwait Medical Association. CERTIFICATIONS

• Educational Commission for Foreign Medical Graduates certification. • Medical Council of Canada Evaluating Examination. • American Board of Internal Medicine (ABIM) Certification Examination Aug 17th

2009. • The International Society for Clinical Densitometry (ISCD) Clinical Densitometry

Certification exam (CCD), June 2011.

My name is Eman Alfadhli, Assistant professor of Medicine, consultant

Endocrinologist and Vice Dean of Pharmacy Collage at Taibah University- Girls

section, Madinah, Saudi Arabia. I got a fellowship in Endocrinology and metabolism

from King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia in

2002. Then I worked as a Clinical Research fellow in islet transplantation program at

University of Alberta, Edmonton, Canada in 2004. In 2009, I served as a visiting

scientist and research scholar in Endocrinology and Metabolism at University of

California, Los Angeles, Harbour Medical Centre at United State of America.

I am honoured to be nominated for a position on the Board of Directors of the Gulf

Chapter of the American Association of Clinical Endocrinology. I believe strongly in

the goals of the Gulf Chapter: advocating for policies and actions that enhance the

science and practice of endocrinology; promoting the professional development of

endocrinologists through educational initiatives; and recognizing excellence in

endocrinology in the Gulf area.

AACE has been at the forefront of the profession in field of endocrinology. As a

Board member at the Gulf Chapter, I will work to make sure that AACE Gulf Chapter

be a leader in the Gulf region. I will work to maintain close collaboration with other

AACE chapters and other endocrinology organizations which is necessary for

successful policy formulation. AACE also serves an important function for the

continuing education and professional development of endocrinologists. This is

achieved in part by the stellar scientific value of the annual meeting program, the

other meetings, and courses that conducted by AACE. I would like to see Gulf

Chapter of AACE grow and expand in professional development. AACE is a

proactive in the continuing education of its membership. I believe the greatest asset

of AACE is its membership. In particular, I appreciate the variety of endocrinologists

from all areas, government, industry, and academia. I feel it is vital for AACE Gulf

Chapter to find ways to actively engage membership from different areas and I would

like to be a member of the Board Directors. Also I like to continue efforts to expand

membership with an emphasis on minorities, students, and early career

endocrinologists in all settings.

1

CURRICULUM VITAE

Dr. Eman Mohammed Alfadhli

2

Name : Eman Mohammed Al Fadhli, MD, MRCP, SBIM, ABIM, JBIM

Place of birth : Al Madinah Al-Monawara, Saudi Arabia

Marital status : Married

Present position : Assistant professor of Medicine at Taibah

University, Madinah

Al-Monawara

Vice Dean of the Pharmacy Collage at Taibah

University- girls section

Contact information: Mobile: 0555305170, Home: 04- 8443195

E – Mail: [email protected]. Wasel 7373 Ash shuraybat,

Ibraheem Bin Abbad Street

Unit No 1

Almadinah 42316-5353

Saudi Arabia

Education

Medical School : King Saud University, 1994

Internship : King Saud University, 1994 - 1995

Residency : Riyadh Armed Forces Hospital

Sept 1995- Sept 1999

Fellowship : Senior Registrar, Endocrinology

Riyadh Armed Forces Hospital

Oct 1999 – Sept 2000

Fellow in Endocrinology

King Faisal Specialist Hospital & Research Centre

3

Oct 2000 – December 2003

Clinical Research fellow in islet transplantation

and Endocrinology

University of Alberta, Edmonton, Canada

Jan 2004 – December 2004.

Visiting scientist and Research scholar in

Endocrinology and metabolism

University of California, Los Angeles, United State

December 2008 – November 2009

Past Positions :* Locum as a consultant endocrinologist at different

hospitals in Saudi Arabia:

- King Fahad medical City, Riyadh on 2005 and 2007

- King Fahad Hospital, Al-Madinah Al-Monwarha on

2008

- Royal commission Hospital, Jubail 2008.

- Royal commission Hospital, Yanbu 2010.

- National Guard Hospital, Riyadh on 2010.

* Acting Vice Dean of Medical Collage at Taibah

University, Madinah Monwarha

Feb 2007- June 2007

* Consultant Endocrinologist

King Fahad Hospital, Al-Madinah Al-Monwarha

Feb 2005 – until Nov 2005

Certifications

1. Membership of Royal College of Physicians (MRCP) of Internal Medicine, June

1999

2. Arab Board of Internal Medicine, February 2000

3. Jordanian Board of Internal Medicine, February 2000

4. Saudi Board of Internal Medicine, November 2000

4

5. Medical Council of Canada Evaluating Exam (MCCEE), February 2003

Presentations at Symposiums:

1- Recent Advances in Diabetes Management, at Islet transplantation

symposium with collaboration with City of Hope, King Faisal Specialist

Hospital & Research Center, Riyadh, Saudi Arabia, 2003.

2- Islet Cell Transplantation, at Endocrine update symposium, Riyadh, Saudi

Arabia, Military Hospital, March 30, 2005.

3- Islet Cell Transplantation, at Diabetes update symposium, Saudi Society of

Family & community Medicine, Al- Madinah, Saudi Arabia, May 11 2005.

4- Diabetes in pregnancy, at Saudi Society of Family & community Medicine,

Madinha, Saudi Arabia, March, 2006.

5- Islet Cell Transplantation, at Surgery Update Symposium, Madinha, Saudi

Arabia, April 3-5, 2006.

6- Advances in Diabetes Management, at First annual symposium of

diabetes, Taibah University, Madinha, Saudi Arabia, 15/1/2007.

7- Advances in Diabetes Management, at Taibha club for Diabetes &

Endocrinology, Madinha, Saudi Arabia, March 5, 2007.

8- Difficult case of Grave’s disease, at Taibha club for Diabetes &

Endocrinology, Madinha, Saudi Arabia, April 5, 2007.

5

9- Endocrine emergency, at Introduction to Emergency Nursing course at

King Fahad Hospital, Madinha, Saudi Arabia, 31/10/2007.

10- Adrenal incidentaloma, at Taibha club for Diabetes & Endocrinology,

Madinha, Saudi Arabia, November 12, 2007.

11- Diabetes in pregnancy, at Maternal and Child Health Care Course,

Madinha, Saudi Arabia, december, 2007.

12- Management of Diabetic Peripheral neuropathy, at Diabetic Foot mini-

Symposium, Taibah University, Madinha, Saudi Arabia, 2/3/2008.

13- Adrenal incidentaloma, at Update in Diabetes & Endocrinology

symposium, Madinha, Saudi Arabia, March 22, 2008.

14- Diabetes in pregnancy, at Update in Diabetes & Endocrinology

symposium, Madinha, Saudi Arabia, March 23, 2008.

15- Update in the management of Gestational Diabetes, at First International

Diabetes & Obesity Conference, Taif, Saudi Arabia, April 27-29, 2008.

16- Continuous glucose monitoring system, at First International Diabetes &

Obesity Conference, Taif, Saudi Arabia, April 27-29, 2008.

17- Diabetes and Pregnancy, at Diabetes Care Course, Madinha, Saudi Arabia,

May 21-22, 2008.

18- Insulin therapy, at Diabetes Care Course, Madinha, Saudi Arabia, May 21-

22, 2008.

19- Advances in Diabetes Management, at Jubail Hospital, Saudi Arabia,

15/8/2008.

20- Adrenal incidentaloma, at the Second Diabetes and Endocrinology

Conference, Jeddah, Saudi Arabia, August 26-27, 2008.

21- Diabetes in pregnancy, at the Second Diabetes and Endocrinology

Conference, Jeddah, Saudi Arabia, August 26-27, 2008.

6

22- Update in the management of Gestational Diabetes, at International

Diabetes Day, Madinha, Saudi Arabia, November 12, 2008.

23- Advances in Diabetes Management, at International Diabetes Day,


24- Initiation and Adjustment of insulin therapy for T2DM after failure of OHA,

at International Diabetes Day, Madinha, Saudi Arabia, November 12, 2008.

25- Update in the management of Gestational Diabetes, at Update in

Endocrine Disorders Symposium, Alula, Saudi Arabia, March 24-25, 2010.

26- Management of T2DM: Initiation and Adjustment, at Update in Endocrine

Disorders, Alula, Saudi Arabia, March 24-25, 2010.

27- Update in the management of Gestational Diabetes, at the Forth Jeddah

Update in Diabetes and Endocrinology Conference, Saudi Arabia, October

11-13, 2010.



29- Management of T2DM: Initiation and Adjustment, at Medical Therapy

Conference. Madinha, Saudi Arabia, February 24-25, 2010.

30- Management of T2DM: Initiation and Adjustment, at Diabetes

Management Course for Physicians, , King Fahad Medical City, Riyadh,

Saudi Arabia, March 12-16, 2011.

31- Islet Cell Transplantation, at Surgery Update Symposium, at Diabetes



32- Endocrine emergency, at First Aid course for Nurses at King Fahad

Hospital, Madinha, Saudi Arabia, 14/6/2011.

33- Management of T2DM: Initiation and Adjustment, at Recent Advances in

Medicine, Saudi Germani Hospital, Madinha, Saudi Arabia, September 20-

22, 2011.

7

34- Management of hyperglycemia in hospitals at Annual Regional Hajj

Symposium, King Fahad Hospital, Madinha, Saudi Arabia, October 4-5,

2011.

35- Hyperglycemic crises in Patients with Diabetes at First RCMC Emergency

Care Regional Symposium. Yanbu, Saudi Arabia, November 21-22, 2011.

36- Management of hyperglycemia in hospitals at Six Taif National Diabetic

Conference, Taif, Saudi Arabia, March 20-21, 2012.

37- Management of hyperglycemia in hospitals at First Update Internal

Medicine Conference, Madinha, Saudi Arabia, April 25-26, 2012.

8

Courses and Symposia

1- Royal Free Hospital course of Internal Medicine, London, 1998

2- BPR course of Internal Medicine, London, 1998

3- Medipass course of Internal Medicine, London, 1998

4- Adult Medicine course for MRCP II & Arab Board in Hammadi Hospital,

Riyadh – both written and clinical courses, September 1998 and February

1999 respectively.

5- Adult Medicine course for MRCP II and Arab Board in Al Qassim, 1997 and

1999

6- Basic ECG course at Riyadh Military Hospital, 1994

7- Advanced ECG course and arrhythmia course, 1998

8- Basic course in general ultrasound, 1997

9- 6th Advanced Medicine Symposium, Riyadh Armed Forces Hospital, 1996

10- 7th Advanced Medicine Symposium, Riyadh Armed Forces Hospital, 1998

11- 5th Saudi Gastroenterology Association Meeting, AlKhobar, November

1997 (attended and participated in a case report about “Primary

amyloidosis of the liver”

12- 2nd Acute Medicine Symposium, Riyadh Armed Forces Hospital, 1995

13- 3rd Acute Medicine Symposium, Riyadh Armed Forces Hospital, 1997

14- 4th Acute Medicine Symposium, Riyadh Armed Forces Hospital, 1999

15- 10th Saudi Neurosciences Symposium, King Faisal Sepcialist Hospital &

Research Centre, Riyadh, 2000

9

16- International Symposium on Osteoporosis, Security Forces Hospital,

Riyadh, 2002

17- Diabetes Care 2002 – working Together for Prevention and Control, King

Khalid Eye Specialist Hospital, Riyadh, 2002

18- Fundamental of conducting Research symposium, King Faisal Specialist

Hospital & Research Centre, Riyadh, 2002

19- 2nd Endocrine and Diabetes Update Symposium, King Khalid University

Hospital, Riyadh, 2002.

20- Personal Digital Assistants, May 29, 2004, University of Alberta, Edmonton,

Canada.

21- Endocrine Society annual meeting, June 16-19 2004, New Orleans, LA,

USA.

22- Ms Word (1) course, August 4, 2004, University of Alberta, Edmonton,

Canada.

23- Ms Word XP (2) course, September 20 4,2004, University of Alberta,

Edmonton, Canada.

24- Ms Excel (1) course, August 6, 2004, University of Alberta, Edmonton,

Canada.

25- Ms Excel (2) course, August 13, 2004, University of Alberta, Edmonton,

Canada.

26- Ms Power Point XP (1) course, September 22 4,2004, University of Alberta,

Edmonton, Canada.

27- The Canadian Diabetes Association (CDA)/Canadian Society of

Endocrinology and Metabolism (CSEM) Professional Conference and

Annual Meeting, October 27 - 30, 2004 Quebec City, Canada.

28- Endocrine update symposium, Riyadh, Saudi Arabia, Military Hospital,

March 30 2005.

10

29- Diabetes update symposium, Madinha, Saudi Arabia, Saudi Society of

Family & community Medicine, May 11 2005.

30- Update on diabetes symposium, Jeddah, Saudi Arabia, October 2006.

31- Surgery Update Symposium, Madinha, Saudi Arabia, April 2006.

32- First annual Madinah diabetes and metabolism conference, Madinha,

Saudi Arabia, June 2006.

33- Medical Education Workshop (1) Taibah University, Madinha, Saudi

Arabia, 17/6/2006

34- Medical Education Workshop (2) Taibah University, Madinha, Saudi

Arabia, 17/11/2006.

35- National symposium and workshop on liver disease, Madinha, Saudi

Arabia, 18-19/11/2006.

36- First annual symposium of diabetes, Taibah university, Madinha, Saudi

Arabia,15/1/2007.

37- Taibha club for Diabetes & Endocrinology, Madinha, Saudi Arabia, one

day in March, April, June & February, 2007.

38- Medical and surgical aspects of neuroendocrine disorders symposium,

King Faisal Specialist Hospital & Research Centre, Riyadh, 3-4/4/ 2007.

39- Infertility and reproductive endocrinology symposium, Madinha, Saudi

Arabia, 23/5/2007.

40- Evidence Based Medicine course, King Fahad Hospital, Madinha, Saudi

Arabia, 19- 22/5/2007.

41- Conference in Diabetes Economics – Vital Investments, Riyadh, Saudi

Arabia, 3-5/11/2007.

11

42- Maternal and Child Health Care Course, Madinha, Saudi Arabia, December

29, 2007.

43- 7th Clinical Research Professionals’ Course, Riyadh, Saudi Arabia, King

Faisal Specialist Hospital & Research Centre, Riyadh, 19-30/1/ 2008

44- Diabetic Foot mini-Symposium, Taibah University, Madinha, Saudi Arabia,

2/3/2008.

45- Symposium in Growth Hormone, Jeddah, Saudi Arabia, February 21 2008.

46- Symposium in Disorders of Vitamin D Deficiency, at King Fahad Medical

City, Riyadh, Saudi Arabia, February 27 2008.

47- Update in Diabetes & Endocrinology symposium, Madinha, Saudi Arabia,

March 22-23, 2008.

48- First International Diabetes & Obesity Conference, Taif, Saudi Arabia, April

27-29, 2008.

49- Accreditation for Healthcare Institutions workshop, Central Board of

Accreditation for Healthcare Institutions, Jeddah, May, 4-7 2008.

50- Diabetes Care Course, Madinha, Saudi Arabia, May 21-22, 2008.

51- The Second Diabetes and Endocrinology Conference, Jeddah, Saudi

Arabia, August 26-27, 2008.

52- International Diabetes Day, Madinha, Saudi Arabia, November 12, 2008.

53- Advances and management of thyroid and parathyroid diseases

symposium, Cedar- Sinai Medical Center, Los Angeles, California, United

State, March 14-15, 2009.

54- Annual Rachmiel Levine Diabetes and Obesity Symposium, City Of Hope,

Los Angeles, United State, March 18-21, 2009.

55- The 31st Symposium on Thyroid 2009, University of Southern California,

Los Angeles, California, United State, May 9, 2009.

12

56- Introductory Hands-On Thyroid Ultrasound Workshop, Washington, DC,

United State, June 9, 2009.

57- Endocrine society meeting for 2009, Washington, DC, United State, June

10-13, 2009.

58- Update in Endocrine Disorders Symposium, Alula, Saudi Arabia, March 24-

25, 2010.

59- First Taibah University Clinical Toxicology Workshop, at Taibah University,

Madinha, Saudi Arabia, May 5-6/2010.

60- The Forth Update in Diabetes and Endocrinology Conference, Jeddah,

Saudi Arabia, October 11-13, 2010.

61- EndNote workshop, Madinah, Taibah University, November 29-30 2010.

62- Electronic Education Course 1, at Taibah University, Madinha, Saudi

Arabia, 6/12/2010.

63- Electronic Education Course 2, at Taibah University, Madinha, Saudi

Arabia, 7-8/12/2010.



65- Medical Malpractice Conference, Medical & Legislative perspective 2011,

at Taibah University, Madinha, Saudi Arabia, 4-6/1/2011.

66- Management of T2DM: Initiation and Adjustment, at Medical Therapy

Conference. Madinha, Saudi Arabia, February 24-25, 2010.

67- The Essential Academic Leader, Jazan University, Saudi Arabia, March 5-6,

2011.

68- Management of T2DM: Initiation and Adjustment, at Diabetes



13

69- Islet Cell Transplantation, at Surgery Update Symposium, at Diabetes



70- Clinical Endocrinology: 2011, Massachusetts General Hospital, Harvard

Medical school, Boston, USA, April 6-10, 201.

71- AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course®, San

Diego, USA, April 11-12, 2011.

72- 20th Annual Meeting and Clinical Congress of the American Association

of Clinical Endocrinology: 2011, San Diego, USA, April 13-17, 2011.

73- Effective Communication workshop, at Taibah University, Madinha, Saudi

Arabia, 21-25/6/2011.

74- SPSS course, at Taibah University, Madinha, Saudi Arabia, 28-31/6/2011.

75- Workshop on How to become a successful trainer, at Taibah University,

Madinha, Saudi Arabia, 2-8/6/2011.

76- First Aid course for Nurses at King Fahad Hospital, Madinha, Saudi Arabia,

11-15/6/2011.

77- Recent Advances in Medicine, Saudi Germany Hospital, Madinha, Saudi

Arabia, September 20-22, 2011.

78- Annual Regional Hajj Symposium, King Fahad Hospital, Madinha, Saudi

Arabia, October 4-5, 2011.

79- . First RCMC Emergency Care Regional Symposium. Yanbu, Saudi Arabia,

November 21-22, 2011.

80- Third Saudi Pediatrics Endocrine Conference, Madinha, Saudi Arabia,

January 4-5, 2012.

81- Six Taif National Diabetic Conference, Taif, Saudi Arabia, March 20-21,

2012.

14

82- First Update Internal Medicine Conference, Madinha, Saudi Arabia, April

25-26, 2012.

Organization for Courses and Symposia:

1-Member of the Organizing Committee for Islet transplantation symposium with

collaboration with City of Hope, at King Faisal Specialist Hospital & Research

Center, Riyadh, Saudi Arabia, 2003.

2- Chairman of the Organizing Committee for Update in Diabetes &

Endocrinology symposium, Madinha, Saudi Arabia, March 22-23, 2008.

3- Chairman of the Organizing Committee for International Diabetes Day,


Awards:

- Best resident of Internal Medicine, Riyadh Armed Forces Hospital, 1996

- Award for obtaining annual Internal Medicine prize in Riyadh Armed Forces

Hospital for 2 years, 1997 & 1998

- Riyadh Armed Forces Hospital Award for achievement, 2000

15

- Riyadh Armed Forces Hospital Award for achievement, 2001

16

Member of:

- Chief of Taibha club for Diabetes & Endocrinology, Madinha, Saudi Arabia. - Board member of Saudi Society for Endocrinology & Metabolism

- Member of Endocrine Society.

- Member of American Association of Clinical Endocrinology.

- Member of the International Society for Clinical Densitometery (ISCD).

- Member of Diabetes Care Course.

- Member Taibah medical Doctors.

- Member Central Board for Accreditation of Health Institutes (CBAHI).

Peer- reviewer for:

- The Annals of Saudi Medicine Journal.

17

Papers:

1. Edmond A. Ryan, Breay W. Paty ,Peter A. Senior David Bigam, Eman Alfadhli,

Norman M. Kneteman, Jonathan Lakey and A.M. James Shapiro. Five year

follow-up after clinical islet transplantation, Diabetes, VOL. 54, JULY 2005.

2. Intesar Sultan, Eman Alfadhli, Lobnha Saber, and Nahid Abdulgani. Is type 2

diabetes mellitus a risk factor for vitamin D insufficiency, Journal of Taibah

University, Medical Science, 2007; 2 (1, 2): 30 - 41.

3. Hussein Raef, Eman Alfadhli, Alya Al Hajjaj, Siema Bakheet and Abdulrahman

Al-Nuaim. High rate of persistence/ recurrent disease among patient with

thyroid cancer: Factors affecting non-remession. Ann Saudi Med 28(4) July-

August 2008

4. Raef H, Malabu UH, Alfadhli E, Al-Hajjaj A, Al-Sobhi S, Rifai A, Al-Nuaim A.

Prognostic value of postoperative and post-ablative serum thyroglobulin

levels in patients with differentiated thyroid cancer. Niger J Med. 2008 Oct-

Dec;17(4):391-5.

5. Alfadhli E, Koh A, Albaker W, Bhargava R, Ackerman T, McDonald C, Ryan EA,

Shapiro AM, Senior PA. High prevalence of ovarian cysts in premenopausal

women receiving sirolimus and tacrolimus after clinical islet transplantation.

Transplant International, 2009 Jun; 22(6):622-5 .

6. Eman M Alfadhli. Secondary adrenal insufficiency and primary

antiphospholipid syndrome. Intern Med. 2009;48(22):1963-6.

7. Eman Alfadhli, Manal Ibrahim Hanafi, Intessar Sultan. Assessment of self-

reported cardoimetabolic risk awareness among physicians. Bulletin of

Alexandria Faculty of Medicine. 2009 Nov.

8. Eman Alfadhli. Cholesterol deposition around small joints of the hands in

familial hypercholesterolemia mimicking “Bouchard's and Heberden's nodes”

of osteoarthritis". Intern Med. 2010;49(15):1675-6.

9. Eman Alfadhli, Andrew G. Gianoukakis. Management of severe thyrotoxicosis

when gastrointestinal tract is compromised. Thyroid. March 2011, 21(3): 215-

220.

18

10- Eman Alfadhli, Allergy to insulin glargine. J Med Cases • 2011;2(1):4-6.

Abstracts:

10. E Alfadhli, M Ahmed, A Almahfouz, A Alarifi, H Raef, F Al Dayel and S Al

Sobhi. Vitamin D Deficiency (VDD) Associated with Primary

Hyperparathyroidism (PHPPT) Presenting With Giant Brown Tumors (BT)

Mimicking Primary Bone Malignancy (PBM). Presented at the Endocrine

Society 84th Annual Meeting, June 2002, San Francisco

11. E Alfadhli, M Ahmed, A Arifi, A Almahfouz, F AlDayal and S AlSobhi. (Poster)

Adrenalcortical Carcinoma (ACC): Long Term Remission. Presented at the

Endocrine Society 84th Annual Meeting, June 2002, San Francisco

12. H Raef, E Alfadhli, A Almahfouz. TB of the thyroid Gland Mimicking

Subacute thyroiditis. Presented at the Endocrine Society 84th Annual Meeting,

19-22 2002 June, San Francisco

13. E Alfadhli, M Ahmed, S Alsifri, A almahfouz, F AlDayel and S. Alsobhi.

Vagaries in the Presentation of Primary Hyperparathyroidism (PHPPT).

Presented at the Endocrine Society 84th Annual Meeting, June 2002, San

Francisco

14. E Alfadhli, A AlHajjaj, S Bakheet and H Raef. Succesful Ablation Rate of

Differentiated Thyroid Cancer at KFSH&RC Using I123 for Pretreatment Whole

Body Scan (WBS) and Factors Affecting Remission. Poster presentation at the

American Thyroid Association, Oct 2002.

15. Hussein Raef, Eman Alfadhli, Alya Al Hajjaj, Siema Bakheet and Abdulrahman

Al-Nuaim. Contributing Factors to the High Recurrence/Persistence Rate

among Patients with Differentiated Thyroid cancer in the Kingdom of Saudi

Arabia. Presented at the Endocrine Society’s 85th Annual Meeting,

Philadelphia, USA, 19-22 June 2003

16. Nora Kahtani, Abdullah Alarifi, Eman Alfadhli, Suzan Salam, Mohammed

Ahmed, and Saif al Sobhi. The Usefulness of T3/T4 ratio in Early Detection of

19

Subclinical Hypothyroidism. Presented at the 6th King Faisal Specialist

Hospital research annual day, 31 December 2003 - Riyadh. Also presented as

a poster at the Endocrine Society Annual Meeting, June 2004, New Orleans,

USA.

17. Abdulraof Almahfouz, Eman Alfadhli, Mohammed Ahmed, Hussein Raef and

Ali Alzahrani. Factors Predictive of Clinical Responses to Pioglitazone in

Uncontrolled Diabetic Patients. Presented at the 6th King Faisal Specialist

Hospital research annual day, 31 December 2003 - Riyadh.

18. Anthony Yin, Eman Alfadhli, Michelle Htun, Sandy Faulkner, Robert Dudley,

Laura Hull, Andrew Leung, Ronald Swerdloff and Christina Wang. Effect of

dietary fat on the pharmacokinetics of an oral formulation of testosterone

undecanoate (SEDDS) in hypogonadal men. Presented at the Endocrine

Society Annual Meeting, June 2010, San Diego, USA.

Referees:

- Entessar Sultan, MD. Professor of Medicine

Consultant Endocrinologist

Department of Medicine, Taibah University.

Jameat Road, Madinha.

Saudi Arabia. Po Box 344

- Ali S. Alzahrani, MD, FRCP, FACE, FACP.

Visiting Professor at Johns Hopkins University, Baltimore, USA

Consultant Endocrinologist


P.O. Box 3354, Riyadh 11211

Kingdom of Saudi Arabia

- Ronald S. Swerdloff, M.D. Professor of Medicine

David Geffen School of Medicine at UCLA

Chief Division of Endocrinology

Harbor-UCLA Medical Center

1000 W. Carson St. Box 446, Torrance, CA 90502

Phone: (310) 222-1867

Fax: (310) 533-0627

American Association of Clinical EndocrinologistsAmerican Association of Clinical EndocrinologistsAmerican Association of Clinical EndocrinologistsAmerican Association of Clinical Endocrinologists 245 Riverside Avenue • Suite 200 • Jacksonville, Florida 32202 • Phone: (904) 353-7878 • Fax: (904) 353-8185 • http://www.aace.com

Gulf Chapter of the American Association of Clinical Endocrinologists (Bahrain, Kuwait, Omar, Qatar, Kingdom of Saudi Arabia, United Arab Emirates)

1st Annual Meeting

October 12, 2012

Attn: Gulf AACE Chapter Members,

In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model,

the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates

Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the

Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This

meeting is open to all Gulf-AACE members and their invited guests.

If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and

return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your

nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate

statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173.

1 Name: Mohammed H AL-Ghamdi.FRCPC,FACE,FACP

Address: P O Box 20610

City: ALKHOBAR 31952

Country: Saudi Arabia 31952

Email: [email protected]

2 Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the

purposes of Chapter business? _x__ yes ___ no

3 Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

___ President

___ Vice President

___ Secretary

___ Treasurer

_x__ Board of Director Member

___ CV or bio-sketch included ___ Candidate statement included



1st Annual Meeting

October 12, 2012











1 Name: NAJI Jameel Aljohani PO BOX 59045 Riyadh 11525

Address: King Fahad Medical City

City: Riyadh

Country: Saudi Arabia



purposes of Chapter business? _*__ yes ___ no


___ President

___ Vice President

___ Secretary

___ Treasurer

_*__ Board of Director Member


Dr. Juma M Alkaabi BSc, MBChB, DTM&H, FRCP, FACP,FACE The Gulf Chapter of the American Association of Clinical Endocrinologist

Self-

Iam Associate Professor of Medicine at the Faculty of Medicine and Health Sciences, UAE University and consultant Internist, Endocrinologist at the two teaching hospitals (Tawam and Al-Ain). I provide comprehensive ambulatory setting and consultative service in General Internal Medicine, Endocrinology, Diabetes and Metabolism where, I deliver a modern clinical service,

.

I obtained the basic medical science degree from the University of St. Andrews Scotland in 1990 and the Medical Degree from University of Manchester- England in 1993. Subsequently I trained in Internal Medicine in the United Kingdom followed by Clinical Fellowship in Endocrinology and Metabolism at the University of Alberta- Edmonton- Canada where I spent two years and a half as clinical fellow at the department of Endocrinology and Metabolism and I was attached to the islet cell transplant unit.

I have significant inputs into the clinical healthcare system of the UAE through my membership of the Ministry of Health National Diabetes Committee. In the community, I made my speciality of diabetes reachable and understandable by the general population to direct involvement with national guidelines preparations and awareness campaigns. I have been active in contributing to the CME, public health awareness in the community. In addition, I have been successful in organising the Annual Diabetes Workshops in the Faculty of Medicine UAE University and have been a member of the scientific committee for many local conferences, workshops and scientific meetings. Why I am applying for the Board of Directors membership of the Gulf Chapter of the AACE?

This can be summarized in the following points;

1. I have been encouraged to apply. 2. To organize and facilitate high caliber scientific meetings in the Gulf States. 3. To encourage potential candidates to join the AACE and the Gulf Chapter of the AACE. 4. To facilitate regional collaboration in terms of dissemination and implementation of the

latest guidelines in clinical practice. 5. To encourage research; the Gulf Chapter of the AACE may play a major role in

encouraging more active clinical or basic science research in the region through the networking among the endocrinologist in the region.

For more information, kindly find the enclosed CV.

Many thanks.

Juma M Alkaabi

DR. JUMA AL-KAABI CV SEPTEMBER, 2012

1

CURRICULUM VITAE

DR. JUMA MUSABAH MOHAMMED AL-KAABI

ASSISTANT PROFESSOR AND CONSULTANT, INTERNAL

MEDICINE/ENDOCRINOLOGY-DIABETES & METABOLIC DISEASES

Nationality U.A.E. National. Professional address Faculty of Medicine and Health Sciences,

Department of Internal Medicine UAE University, PO Box 17666, Al Ain, United Arab Emirates. Telephone: +971 3 7137472 Fax: +971 3 7672995 E-mail: [email protected]

QUALIFICATIONS

BSc, MBChB, MRCP(UK), DTM&H, FRCP, FACP, FACE and a Canadian Clinical Fellowship in

Endocrinology and Metabolism.

CURRENT POSITION

Associate Professor of Medicine at the Faculty of Medicine and Health Sciences- UAE University,

Consultant, Internal Medicine/Endocrinology-Diabetes & Metabolic Diseases at Al Ain and Tawam

Hospitals.


2

GMC REGISTRATION NUMBER

4027081

HAAD LICENSE

GD 6505, Consultant Internal Medicine/Endocrinology-Diabetes & Metabolic Diseases.

FELLOWSHIP

The Royal College of Physicians of London and Edinburgh

The American College of Physicians

The American Association of Clinical Endocrinologists

LIST OF DEGREES

1985-1987 Scottish Highers Clydebank College Glasgow - Scotland.

1987-1990 Bachelor of Medical Sciences The University of St. Andrews- Scotland.

1990-1993 MBChB The University of Manchester-England.

April 1999 Diploma of Tropical Medicine and Hygiene (DTM&H), The University of London.

July 1999 Membership of The Royal College of Physicians MRCP(UK)

October 2005 Clinical Fellowship Program in Endocrinology and Metabolism - University of Alberta, Edmonton- Canada

March 2008


3

Fellowship of The Royal College of Physicians of Edinburgh

June 2008 Fellowship of the American College of Physicians

July 2008 Fellowship of the Royal College of Physicians of London

December 2008 Fellowship of the American College of Endocrinologists

MEMBERSHIP OR FELLOWSHIP OF PROFESSIONAL SOCIETIES

1. The General Medical Council of the U.K.

2. Royal College of Physicians of Edinburgh.

3. College of Physicians and Surgeons Province of Alberta.

4. The American College of Physicians (01274189) Membership.

5. The Endocrine Society - Membership (221494).

6. American Association of Clinical Endocrinologists (AACE).

7. American Diabetes Association.

8. The International Society for Clinical Densitometry.

9. FMHS Diabetes and Cardiovascular Research Priority Group.

10. The UAE National Diabetes Committee.

11. Member of the Scientific Committee of the Shaikh Hamdan bin Rashid Al Maktoum Award

for Medical Sciences.

12. Emirates Medical Association.

13. The Emirates Endocrine Club.


4

RECOGNITION AND AWARDS

1987-1990 Eight merit certificates in different medical science courses were awarded during Bachelor of

Medical Sciences studies at the University of St. Andrews-Scotland.

2000-2001 Elected by the medical students of College of Medicine, SQUH, Oman to be awarded Clinical Tutor

of the Year.

2008-2009 Elected by students and faculty to receive the FMHS Distinguished Teaching Award .

17 Nov. 2011

May 2012 Elected by students and faculty to receive the FMHS Distinguished

ADVISORY COMMITTEES

2010 and up-to-date Scientific Committee of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences Oct. 2011 PhD Advisory Committee Dec.2011 Fellowship Program at the UAE University. Jan. 2012


5

FULL LIST OF PUBLICATIONS IN PEER REVIEWED JOURNALS

1. T. E. Adrian, S. Gariballa, K. A. Parekh, S. A. Thomas, H. Saadi, Al Kaabi JM, N.

Nagelkerke, B. Gedulin and A. A. Young. Rectal taurocholate increases L cell and insulin

secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers.

Diabetologia Clinical and Experimental Diabetes and Metabolism (accepted).

2. Al-Kaabi JM, Al Neyadi M, Al Darei F, Al Mazrooei M, Al Yazedi J, Abdulle A. Terrestrial

snakebites in the South East of the Arabian Peninsula: Patient Characteristics, Clinical

Presentation, and Management. PLoSone Journal. Open Access Article URL;

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0024637

3. Al-Kaabi JM, Bayan Al-Dabbagh, Hussein Saadi, Salah Gariballa, Javed Yasin. Effect of

coffee consumption on the Glycemic index of Khalas dates tested in healthy and diabetic

subjects. Published in ClinicalTrials.gov Identifier: NCT01422668.

4. Al-Kaabi JM, Wheatley AD, Barss P, Al Shamsi M, Lababidi A, Mushtaq A. Carbon

monoxide poisoning in the United Arab Emirates. International Journal of Occupational and

Environmental Health, Vol 17, No 3 (2011).

5. Al-Kaabi JM, Al-Dabbagh B, Ahmad S, Saadi H, Gariballa S, Al Ghazali M. Glycemic

Indices of Five Varieties of Dates in Healthy and Diabetic Subjects. Nutrition Journal, May

2011, 10:59. Open Access Article URL: http://www.nutrition.com/content/10/1/59.

6. Hussein Saadi, Al-Kaabi JM, Mahmoud Benbarka, Ali Khalili, Wael Mahmeed, Nicolas

Nagelkerke, Alessandro Salustri, Leila Abdelwarthe, Elsadig Kazam, Awad Al Essa, Javed

Yasin, and Bayan Al-Dabbagha. Prevalence of Undiagnosed Diabetes and Quality of Care in

Diabetic Patients Followed at Primary and Tertiary Clinics in Abu Dhabi, United Arab

Emirates (Accepted in May 2011 for publication in the Journal of Rev Diabet Stud.).

7. Raffan E, Soos MA, Rocha N, Tuthill A, Thomsen AR, Hyden CS, Gregory JW, Hindmarsh

P, Dattani M, Cochran E, Al-Kaabi JM, Gorden P, Barroso I, Morling N, O'Rahilly S,


6

Semple RK. Founder effect in the Horn of Africa for an insulin receptor mutation that may

impair receptor recycling. Diabetologia. 2011 May; 54(5):1057-65.

8. Hussein Saadi, Nicolaas Nagelkerke, Al-Kaabi JM, Bachar Afandi, Fatima Al-Maskari,

Elsadig Kazam. Screening Strategy for Type 2 Diabetes in the United Arab Emirates. Asia-

Pacific Journal of Public Health; July 2010; 22(3)54-59.

9. Kamal S, Al-Kaabi JM, Ellis M, Gariballa S. Pulmonary nocardiosis masquerading as severe

community-acquired pneumonia. European Journal of Emergency Medicine Feb.2010

edition.

10. Al-Kaabi JM, Mushtaq A, Al-Maskari FN, Moussa NA, Gariballa S. Hypokalemic periodic

paralysis: a case series, review of the literature and update of management. Eur J Emerg

Med. 2010 Feb;17(1):45-7.

11. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N. Physical activity

and reported barriers to activity among type 2 diabetic patients in the United Arab Emirates.

Rev Diabet Stud. 2009 Winter;6(4):271-8.

12. Al-Kaabi JM, Thomas JT, Moussa NA. Transient Gestational Diabetes Insipidus: A case

report, review of the literature and update on the management. The Endocrinologist

18(6):270-272, Nov/Dec.2008.

13. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N. Assessment of

dietary practice among diabetic patients in the United Arab Emirates. Rev Diabet Stud. 2008

Summer;5(2):110-5.

14. Al-Kaabi JM, Lewanczuk RZ, Chik CL. Pericarditis with cardiac tamponade and addisonian

crisis as the presenting features of autoimmune polyglandular syndrome type II: a case

series. Endocr Pract. 2008 May-Jun;14(4):474-8.

15. Al-Kaabi JM, Ghazal-Aswad S, Sagle M. Babies as desired: Ethical arguments about gender

selection. Emirates Medical Journal (2007); 25(1): 1-5.

16. Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholls

MG, Kazam E, Algawi K, Al-Kaabi JM, Leduc C, Sabri S, El-Sadig M, Elkhumaidi S,

Agarwal M, Benedict S. Prevalence of diabetes mellitus and its complications in a


7

population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract.78

(2007) 369-377.

17. Nayar RC, Al-Kaabi JM, Ghorpade K. Primary Nasal Tuberculosis: A Case Report. Ear Nose

Throat J. 2004 Mar;83(3):188-91.

18. Woodhouse NJ, El-Shafie OT, Mehar A, Johnston WJ and Al-Kaabi JM. Spironolactone

Responsive Familial Hypertension: A Potentially High Prevalence of Mineralocorticoid

disease in Oman. Saudi Med J 2003; Vol. 24 (2):229-231.

19. Varghese JC, Al-Kaabi JM, Dabbagh K, Al-Rawas O. Simple Aspiration -Versus Intercostal

Tube Drainage in the Management of Spontaneous Pneumothorax: Case Report and Review

of the Literature. Oman Medical Journal (19), Nov 2002:47-51.

20. Al-Kaabi JM, Samir S. Hussein, Charles S. Bukheit , Nicholas J. Woodhouse, Omiema T.

Elshafie, Haddia Be

Treatment. Saudi Med J 2002 Sept; 23 (9):1049-53.

21. El-shafie O, Al-Kaabi JM , Bererhi H, Woodhouse NJ. Severe Osteoporosis in Childhood

Anorexia Nervosa : Dramatic Remineralisation of Bone and Vertebral Body Remodeling

During Recovery. Oman Medical Journal, Feb.2002 ; 18 (3): 19-21.

22. Al-Kaabi JM, Euan Scrimegeour, Andre Louon, Bazdawi M. Al-Riyami. Tetanus: A Clinical

Review. Saudi Med J 2001; Vol.22 (7): 606- 609.

23. Scrimegeour E, Gallagher M, Al-Kaabi JM. Venomous Snake-Bite and Use of Polyvalent

Snake Antivenom in Oman. Oman Medical Journal, Vol.18 (1) August 2001: 20-26.

PUBLICATIONS IN A NON-PEER REVIEWED JOURNALS:

1. Saadi H, Afandi B, Al-Kaabi JM. Prevalence of Diabetes Mellitus and its Complications in A

Population Based Sample in Al Ain, United Arab Emirates. Commentary in Health and

Diabetes; Jordan Arabic Magazine. July 2010.


8

ABSTRACTS, CONFERENCE PRESENTATIONS AND PROCEEDINGS

1. Al-Kaabi JM, Saadi H, Benbaraka M, Khalili A. Cardiovascular risk profile of diabetic

patients followed in primary and tertiary clinics in Abu Dhabi, United Arab Emirates.

Accepted for World Cardiology Congress (WCC) Annual Meeting, 19-21 April 2012; Dubai-

UAE.

2. Fakhra Al Darei, Juma Al Kaabi, Mariam Al Neyadi, Mariam Al Mazrooei, Jawaher Al

Yazedi, Abdishakur Abdulle. Terrestrial snakebites in the United Arab Emirates and Oman:

Patient characteristics, clinical presentation, and management.The Eighth International

Scientific Conference for Medical Students in the GCC Countries. Sultan Qaboos University

Muscat-Oman 28th Jan.-1st Feb.2012.

3. Al-Kaabi JM, Al-Dabbagh B, Saadi H, Gariballa S, Yasin J. Effect of coffee consumption on

the glycemic index of khalas dates tested in healthy and diabetic subjects. Presentation at the

Annual Endocrine Society Meeting, June 2011, Boston- USA.

4. Al-Kaabi JM, Al Neyadi M, Al Darei F, Al Mazrooei M, Al Yazedi J. Terrestrial snakebites

in South East Arabia: Presentation, Management and Complications. Biomedical Research

Day, 10th May, 2011, FMHS, UAE University.


indices of five types of dates in healthy and diabetic subjects. Oral presentation at the 16th

Annual Diabetes and its complications workshop, FMHS, 16th April 2011.


Indices of five varieties of dates tested in healthy and diabetic subjects. The 2nd SEHA

Annual Research Conference, 12th- 13th Dec, 2010, Abu Dhabi- UAE.

7. Adrian T, Saadi H, Gariballa S, Al-Kaabi JM, Nagelkerke N. Can Diabetes and Obesity be

treated through the rectum? The 46th EASD Annual Meeting of the European Association for

the Study of Diabetes, Stockholm, Sweden, Sept., 20-24th, 2010.


9

8. Saadi H, Nagelkerke N, Al-Kaabi JM, Afandi B, Al-Maskari F, Kazam E. Screening strategy

for type 2 diabetes mellitus in the UAE. Diabetes: Journal of the American Diabetes

Association; June, 2010 Volume 59 Supplement 1; 2367-PO: A620.

9. Adrian T, Gariballa S, Parekh KA, Thomas SA, Saadi H, Al-Kaabi JM, Nagelkerke N,

Gedulin B, Young AA. The Bile Acid Brake: A Novel Target for Treating Diabetes and

Obesity. Diabetes: Journal of the American Diabetes Association; June, 2010 Volume 59

Supplement 1; 602-P: A164.

10. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B. Prevalence of peripheral vascular disease

among diabetic patients attending the diabetes center at Tawam hospital-UAE. Diabetes:

Journal of the American Diabetes Association; June, 2010 Volume 59 Supplement 1; 2367-

PO: A620.

11. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B. Prevalence of peripheral vascular disease

among type 2 diabetic in Al Ain Medical District. 15th Annual Workshop on Diabetes and its

complications, FMHS, UAE University, Al Ain, UAE. 13th March, 2010.

12. Adrian T, Saadi H, Gariballa S, Al-Kaabi JM, Nagelkerke N. Release of Rectal Hormones

for Weight Loss and Improvement of Type II Diabetes Mellitus. FMHS, March, 2010.

13. Saadi H, Nagelkerke N, Al-Kaabi JM, Afandi B, Al-Maskari F, Elsadig K. Screening

strategy for type 2 diabetes mellitus in the UAE. 15th Annual Workshop on Diabetes and its

complications, FMHS, UAE University, Al Ain, UAE. 13th March, 2010.

14. Al-Kaabi JM, Al Neyadi M, Al Darei F, Al Mazrooei M, Al Yazedi J. Terrestrial snakebites

in South East Arabia: Presentation, Management and Complications. The 7th Scientific

Conference for Medical Students in the GCC countries, King Abdulaziz University, Jeddah,

Saudi Arabia. February, 2010.

15. Saadi H, Nagelkerke N, Al-Kaabi JM, Afandi B, Al-Maskari F, Kazam E. Screening Strategy

for Type 2 Diabetes in the United Arab Emirates. Global Health Conference, Al Ain, UAE. 4

January, 2010.

16. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, H Parker. Assessment of Physical Activity

in Diabetic Patients in United Arab Emirates. The Annual Meeting of the Endocrine Society;

Washington DC, USA. 10-13 June, 2009.


10

17. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B. Prevalence of peripheral diabetic

neuropathy and peripheral vascular disease among type 2 diabetic in Al-Ain district. 14th

Annual Workshop on Diabetes and its Complications, FMHS, UAE. 4th April, 2009.

18. Al-Maskari F, El-Sadig M, Al-Kaabi JM, Afandi B. Knowledge, attitude and practices of

diabetic patients in Al-Ain City, United Arab Emirates. The 90th Annual meeting of the

Endocrine Society, San Francisco, USA. 15-18 June, 2008.

19. Al-Kaabi JM, F Al-Maskari, H Saadi, B Afandi, H Parker. Assessment of physical activity

and dietary practices among diabetic patients. 13th Annual Workshop on Diabetes and its

Complications, FMHS, UAE University, Al Ain, UAE. 22 March, 2008.

20. Al-Kaabi JM, Lewanczuk RZ, Chik CL. Cardiac Tamponade and Addisonian crisis as the

presenting feature of Autoimmune Polyglandular Syndrome Type 2- A Case Series. The

Annual CDA Professional Conference, Edmonton, Canada. 20 October, 2005.

21. Al-Kaabi JM, F Al-Maskari, H Saadi, B Afandi, H Parker. Assessment of physical activity

and dietary practices among diabetic patients among diabetic patients. 13th Annual Workshop

on Diabetes and its Complications, FMHS, UAE University, Al Ain, UAE. 22 March, 2008.

22. Mclean M, Al-Kaabi JM.

board examinations: use of a MOCK examination. The 13th Ottawa International Medical

Education Conference on Clinical Competence. 5-8 March, 2008.

23. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, H Parker. Assessment of Physical Activity

and Dietary Practices among Diabetic Patients in Al-Ain District. The 1st International

Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Prague, Czech

Republic, 27 February 1 March, 2008.

24. Al-Kaabi JM, Al-Maskari F, Saadi H. Assessment of Physical Activity and Dietary Practices

among Diabetic Patients in Al-Ain District, UAE. Proceedings from the 8th Annual Scientific

Research Conference, Al Ain, UAE. 23-25 April, 2007.

25. Saadi H, Carruthers G, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholls G,

Kazam E, Algawi K, Al-Kaabi JM, Leduc C, Sabri S, El-Sadig M, Elkhumaidi S, Agarwal

M, Benedict S. National Survey of Diabetes and its Complications - A Pilot Study.

Proceedings from 8th Annual UAE University Research Conference, Al Ain, April, 2007.


11

26. Al-Maskari F, El-Sadig M, Al-Kaabi JM , Afandi B. Knowledge, Attitude and Practices of

Diabetic Patients in Al-Ain Medical District, UAE. Proceedings from 8th Annual University

Research Conference, Al Ain UAE. April, 2007.



Annual CDA Professional Conference, Edmonton, Canada. 20 October 2005.



Residents Poster Day, University of Alberta, Canada. 19 May 2005.

29. Al-BahraniA, Al-Kaabi JM. Dyslipidemia as predictor of abnormal glucose tolerance.

College of Medicine Poster Day, Sultan Qaboos University, Oman. 7th February 2000.

CONGRESSES, CONFERENCES, WORKSHOPS AND SEMINARS

7th Jan.2012 Invited speaker

Update on the Management of , Al Ain UAE.

24th Jan. 2012

Invited speaker at Cardiff University Postgraduate Diploma in Diabetes introductory lectures. The - Dubai, UAE.

15th of Feb. 2012 Conduction of the certifying examination for the Diabetic Educator course at Rashid Hospital- Dubai. I prepared 120 MCQ exam paper (2 sessions) covering the main topics of the course. Out of the 38 candidates enrolled in the course, 30 passed the exam and the department of medical education at the FMHS- UAE University issued the certificates.

19th - 20th Feb. 2012 Conducting and organizing the MRCP-PACES Examination at Al Ain Hospital. On Mond. The 20th of Feb. I was examiner for the whole day.


12

25th Feb.2012 Conducting and participating as an examiner in the one-day Mock-OSCE examination of the Internal Medicine residents preparing for the Board examination. There were 28 residents from various hospitals in the Emirates.

3rd March 2012

Invited chairman ed by multidisciplinary team from Tawam hospital looking after difficult pituitary cases requiring surgical intervention or radiation therapy, Al Ain UAE.

7th March 2012

Invited presenter edicine residents as part of their academic half day activity. Al Muwaji ambulatory Health Care Service Al Ain.

16th-17th March 2012 Invited chairman Center of Excellence in Ras Al Khaima- UAE.

18th -21st April 2012 Presenting research poster at the annual meeting of World Congress of Cardiology in Dubai. The abstract of the poster was accepted for publication incirculation Journal.

3rd-5th May 2012 Invited moderator for case based workshop with interactive sessions with the audience of the 2nd EUC (Emirates Societies United to Compact Diseases) conference, Dubai- UAE.

12th May 2012 Organizer, Chairman of the scientific Committee and speaker at the 17th annual diabetes/endocrine disorders conference at the FMHS.

12th May 2012 Speaker Update on the Management of Hypo-V th annual conference on Diabetes Mellitus and Endocrine Disorders, FMHS- Al Ain- UAE.

20th - 29th May 2012


13

Participant in the Ultrasound and FNA thyroid hand-on Course and attending the annual meeting of the American Association of the Clinical endocrinologists; Philadelphia USA.

24th June to the 5th July 2012 Examiner in the FIE OSCE Examination and Coordinator of the Clinical FIE Examination.

11th July 2012 Scientific Interview at Abu Dhabi TV dealing with diabetes during the fasting of the holy month of Ramadan (30 min.)

13th July 2012 Organizer, Chairman of the scientific Committee and speaker at the symposium Diabetes

Al Ain- UAE (4 CME activity).

13th July 2012 Speaker Review of the Guidelines- Al Ain- UAE.

4th Jan.2011 Scientific Interview at Sama Dubai TV with Prof. Ibrahim Galadari (30 min.)

21st Febraury 2011 Invited Examiner for the MRCP (UK) PACES Examinations, Al Ain hospital -UAE.

22 -24 March 2011 Attendance of the International Osteoporosis Foundation Conference Meeting. Valencia- Spain.

16th April 2011 Organizer, Chairman and Speaker at the 16th Annual Diabetes Workshop at the FMHS.

26th May 2011

at 1st Al Buraimi International Endocrine Conference, Buraimi- Sultanate of Oman.

4-8th June 2011 Attendance and poster presentation in the 93rd Annual Meeting of the Endocrine Society, Boston- USA.

12th -16th September Attendance of the Annual Meeting of the European Association for the Study of Diabetes (EASD); Lisbon- Portugal.


14

7th-8th Oct.2011 - UAE.

19th-22nd Oct.2011 Attendance of the annual meeting of the International Osteoporosis Foundation (IOF) Dubai- UAE.

29th Oct.2011 Member of the scientific committee in reviewing and updating the National Diabetes Practice Guidelines- UAE.

17th Nov.2011

3rd December 2011 Organizer and chair of the scientific committee of the IDF Congress Satellite Symposium at the FMHS, Al Ain- UAE.

Dec 4-8, 2011 Invited Chairman of a scientific session (Diabetes Education) at the World Diabetes Congress-IDF Meeting in Dubai-UAE.

21-22 January 2010 Participant in the Insulin Pump Therapy and Continuous Glucose Monitoring Workshop. Beirut, Lebanon.

17th February 2010 Chairperson G Ain, UAE.

13th March 2010 Organizer and a speaker in the 15th

14th March 2010 Attendance and a Chairman of a Scientific Session in the 1st Abu Dhabi Diabetes Congress, Abu Dhabi, UAE.

17th April 2010 Chairman of the Scientific Meeting

Ain, UAE.

April, 2010 Invited Speaker at Al-Noor Hospital-


15

28-30 April 2010 th Pan Arab , Syria.

3-7 May 2010 Attendance of the Amman, Jordan.

June, 2010 Examiner for the OSCE course for the Internal Medicine Residents held at the FMHS. 25th -29th June 2010 Attendance and presentation at the Annual Scientific meeting of the American Diabetes Association, Orlando- Florida, USA. 20th -24th Sept. 2010 Scientific Presentation and Attendance of the European Association for the Study of Diabetes, Stockholm-Sweden. 28th Sept. to 2nd Oct. 2010 Participant in the Board Review Course and the Endocrine Clinical Update by the Endocrine Society. Los Angeles USA. 25th - 27th Nov. 2010 Speaker abetes: The principles and the PDiabetes and Endocrinology 2010 Conference, Abu Dhabi- UAE. 12-13th Dec. 2010 Poster presenter S onference, Abu Dhabi- UAE. 14th -16th Dec. 2010 Member of the Scientific Committees and chairperson of the 6th Dubai International Conference for Medical Sciences and the Emirates Endocrine Congress 2010. Dubai- UAE. Chairman of in the Scientific Sessions. 18th Dec.2010 Speaker anagement of O - UAE. 20th & 21st Dec.2010 Official Delegate and Participant in the 2nd Workshop on Leadership in Health Research 2010, establishing Research Priorities in the UAE. Ministry of Health, Dubai- UAE.

American Association of Clinical Endocrinologists 245 Riverside Avenue Suite 200 Jacksonville, Florida 32202 Phone: (904) 353-7878 Fax: (904) 353-8185 http://www.aace.com


1st Annual Meeting October 12, 2012

Attn: Gulf AACE Chapter Members, In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model, the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This meeting is open to all Gulf-AACE members and their invited guests. If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173. Name: Dr. Aishah Ali Mohamed Ahmed Alkhzaimi Address:Jareer street, P.O.Box 28322, City: Riyadh Country: Saudi Arabia Email: [email protected] Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the purposes of Chapter business? yes Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

___ President ___ Vice President ___ Secretary ___ Treasurer __√√_ Board of Director Member √CV or bio-sketch included __√_ Candidate statement included



Dear Sir, AACE is well-known world wide of their excellent activities that attract the endocrinologists all over the world to attend and participate in. I have attended the meetings of AACE and they were very impressive along with their thyroid workshops. With every AACE meeting, there is always an appreciation of the role of other chapters of ACCE in different countries and their contributions in AACE are well recognized. I felt that we need to have a role too to participate and support AACE by having our Gulf Chapter of AACE. At the moment, I’m a board member in Saudi society of endocrinology and metabolism since March 2010 and I have been organizing many educational activities including latest international conference by Saudi society that is going to be held in November 2012. I have organized an endocrine course over 6 weeks for all the family physicians in the kingdom of Saudi Arabia in September 2011 and February 2012 beside , another endocrine teaching course for all the clinical fellows in September 2012. I have been attending all the board meetings of the Saudi society of endocrinology that is held monthly. I feel I have the energy, the motivation, the commitment to participate actively to serve the Gulf Chapter. For that reason, I would like to nominate myself as a board member in the Chapter. Sincerely, Dr.Aishah Alkhzaimi, MBBS, FRCPC Assistant professor of medicine Endocrinology Consultant King Saud University King Khalid University Hospital Tel: +966542763640

CURRICULUM VITAE PERSONAL DATA

Name: Aishah Ali Mohd Ahmed Ekhzaimy Date of birth: 15th January 1975Sex: Female Nationality: United Arab Emirates Address in UAE: P.O. Box 50340 Dubai United Arab Emirates Tel: 011 971 50 4897071/0542763640/0553433393 ( Riyadh) Email:[email protected]/[email protected] ACADEMIC QUALIFICATIONS Year School Place Achievements 2009 2007 2006 2005

MCC I and II American Board of Endocinology and Metabolism Royal College of Physicians and Surgeons of Canada Royal College of Physician and Surgeon of Canada

Canada Mcgill University, Canada Queen’sUniversity, Canada

Full MCC lisence American board of Endocrinology and Metabolism FRCPC, Subspecialty in Endocrinology and Metabolism FRCPC, Internal Medicine

2005

American Board of Internal medicine

American Board of Internal Medicine

2000

MCCE Exam Muscat,Oman MCCE

2000 Faculty Of Medicine, United Arab Emirates University University

United Arab Emirates

M.B.B.S (Bachelor Of Medicine & Bachelor Of Surgery)

1992 Fujairah Secondary School UAE High School Certificate

PROFESSIONAL EXPERIENCE

January 2010- current: Assistant professor, Internal medicine and Endocrinology consultant at King Saud University, KKUH, Riyadh, Saudi Arabia October 2009 – January 2010: 3 months of Locum as an endocrinology consultant at KFMC in Riyadh, SA June 2009- September 2009: Internal medicine and endocrinology consultant at Humber River Regional Hospital, Toronto, Ontario, canada August 2008- March 2009 Working as a consultant endocrinology/internal medicine at Fujairah Hospital, Ministry of Health January 2008-June 2008 Worked with Dr. S. Ezzat in clinical Endocrine oncology at University of Toronto February 2007-June 2008 Third year clinical training in thyroid cancer and endocrine oncology at Western Ontario University January 2005- January 2007 Residency training program as a clinical fellow in Endocrinology and metabolism at Mcgill University January 2002- December 2004 Residency training program in internal medicine at Queen’s university, Ontario November 2001- December 2001 Pre-assessment period of 2 months( PEAP) at Queen’s University, Ontario October 2000- October 2001 12 months of working experiences as a resident in internal medicine department in Al-Ain Hospital in UAE taking the 1st call responsibility to cover Emergency medicine unit, outpatient clinics and coronary care unit.

September 1999- September 2000 Internship year: mandatory rotations in different subspecialty to complete clinical skills requirement for MBBS including internal medicine and subspecialty rotations for 6 months, general surgery and surgical subspecialty rotations for 6 months in the university hospitals of UAE ( Al-Ain and Tawam hospitals). June 1998 Summer elective in general internal medicine and infectious disease in Cleveland hospital, Ohaio, USA for 2 months During these periods I gained considerable experience in the management of emergency cases and critically ill patients. I have been involved in the management of large number of diabetic patients and patients with different endocrinological and metabolic problems. I have performed lots of clinical skill procedures : arterial and venous canulation, central lines, endotracheal intubation, swan ganz catheterization ,chest tube insertion, thoracocentesis , paracentesis,bone marrow aspiration and biopsy. I have done many thyroid FNA s during my training and my practice with and without US guidance.

ADDITIONAL TRAINING AND SKILLS May 2008 Achieved the award of the president of AACE for the third place in “Power of prevention “ 5 k marathon in florida September 2007 Teaching Medical students at University of Western Ontario July 2006 A chief resident in endocrinology department at Mcgill Univesity June 2006 Participated in “ improving resident’s teaching skills” workshop at Mcgill University May 2006 Summer course in clinical epidemiology at Mcgill University February 2006 Teaching medical students at Mcgill University “ basic physiology of endocrinology” July 2004

Endocrinology elective for 4 weeks in Kingston General Hospital at Queen’s University with Dr. Houlden September 2003 Endorinology elective for 4 weeks at University of Toronto with Dr. R. Silver June 2000 and October 2002 BCLS and ACLS courses at Tawam hospital in UAE and Queen’s university in Canada Extensive involvement in teaching medical students and residents during the 5 years of residency training in Canada

ACADEMIC ACHIEVEMENTS AND PRESENTATIONS

1. Always the first in all the classes during elementary, primary and secondary school

2. Sheikh Hamad bin Saif Award Students Geniuses 3. Award for Mathematics Olympic Gulf in the secondary school 4. A project in diabetes mellitus complications, management plan, follow up and

compliance rate among diabetic patients. The study was conducted in peripheral health clinics in Al-Ain city in 1998

5. A project in breast cancer screening among females from 35 years and above in UAE in 1993

6. Presented at the serial clinical grand rounds at Queen’s university “ Intensive Glucose management in the ICU” in October 2004

7. Research at Mcgill university starting May2006 in Gestational Diabetes looking at the Percentage of return for post – partum OGTT screening among gestational DM women and the ways to improve the return

8. Presented a case of a novel mutation in the calcium-sensing receptor gene in a hypocalcemic patient with SLE at CSEM meeting in Toronto in October 2006 and in the combined round at Mcgill University

9. Sheikh Rashid awards in United Arab Emirates for the American and Canadian boards in Internal Medicine and Endocrinology in May 2008

PROFESSIONAL ORGANISATIONS

Associate member of American college of physician Member of Endocrine society Member of American Association of Clinical Endocrinology Associate member of American Thyroid Association Fellow of Royal college of physician of Canada Member of UAE Endcorine society Board member of Saudi Society of Endocrinology and Metabolism

COURSED AND MEETING ATTENDED

Attended many conferences in UAE during the internship Attended annual American college of physician meeting of internal medicine in April 2004 in New Orleans Attended cardiology and EKG course at Queen’s university in 2004 Attended the endocrine society CEU in Toronto in October 2005 Attended Harvard course of clinical endocrinology in Boston in April 2006 Attended the 88th annual endocrine society meeting in Boston in June 2006 Attended CDA and CSEM meeting in Toronto in October 2006 Attended the 89th annual endocrine society meeting in Toronto in June 2007 Attended AACE meeting in florida in May 2008. Attended Canadian Endocrine update in Hamilton and Osteoporosis clinical course in May 2008 Attended the 91st annual endocrine society meeing in June 2009 Attended the 92nd annual endocrine society meeting in june 2010 Attended the 93rd annual endocrine society meeting in june 2011 Attended the AACE annual meeting in San Diego in May 2011 Organized Endocrine course for Family physician in Riyadh, SA in September 2011 and February 2012- Organized Endocrine course for Clinical Fellows in Saudi Arabia in September 2012 Member of scientific committee of the 1st international conference of Saudi Society of Endocrinology and metabolism in November 2012 REFERENCES 1. Dr. P. Doran

Program director of Endocrinology program at Mcgill University 687 Pine Avenue West Montreal, Quebec H3A 1A1 Tel: 1514 934 1934 Fax: 1514 982 0825

2. Dr. Simon Wing Director, Division of Endocrinology and Metabolism, McGill University 687 Pine Avenue West Montreal, Quebec H3A 1A1 Tel: 1514 934 1934 Fax: 1514 982 0825

3. Dr. Mark Trifiro

Acting director of Endocrinology department at JGH Associate professor of internal medicine 3755 Cote. Ste . Catherine street Montreal, Quebec, H3T 1E2 Tel: 1514 3408260 X 5269

4. Dr. R. Morton

Professor, Department of medicine

Division of nephrology, Queen’s university Medical director, Peritoneal dialysis program, Kingston general hospital

5. Dr. S. Ezzat Department of endocrinology and metabolism, Mt. Sinai hospital Endocrine oncology, Princess Margret Hospital, Toronto Tel: 416 586 8505 email: [email protected]



1st Annual Meeting

October 12, 2012











1 Name: Dr Mohamed Abdullah Al-Lamki

Address: P O BOX 399

City: MUSCAT

Country: SULTANATE OF OMAN

Email: m [email protected]


purposes of Chapter business? __√_ yes ___ no


___ President

___ Vice President

___ Secretary

___ Treasurer

__√_ Board of Director Member

__√_ CV or bio-sketch included _√__ Candidate statement included

I propose by Candidancy as board member to facilitate and oversee the establishment /activities of the AACE –Gulf Chapter.

Personel details: Full name: Mohamed Abdullah Al-Lamki

Title: Doctor,Senior Consultant Endocrinologist &

Clinical Director Department of

Medicine,Royal Hospital,Oman.

MBchB.Msc ,FRCP(UK)

Biography text:

The biography should not exceed a maximum length of 150 words.

Please insert biography text here:Clincal Director in Department of Medicine at the

Royal Hospital,Muscat ,Oman. Training in Egypt and Glasgow,thereby returned to

Oman and headed the department of endocrinology ,mostly laying the foundation

for a multidisciplinary care, modules and pathway for electronic oriented clinical

standards of care. For the last 5years was involved and designed the National

Diabetes,Endocrine and Metabolic Center.I am now the Clinical Director in Medicine

and chairman to commission the National Center.Additional post, committee member

for the National Diabetes program in Oman,founding member of Gulf group for the

study of diabetes, and current vice-president of Diabetes Asia Study Group, and Ex –

President of Oman Diabetes Association.

Educational: Trained in Ein-Shams,Egypt: MBchB,Glasgow Uk for masters in

Endocrinology and MRCP,Became a Fellow and presently Examiner for the Paces –

Royal College -UK

Professional Experience; internal Medicine and Endocrinology,both covering diabetes

and general endocrinology-Utilization of pattern management in diabetes,and using

Glp-1 very early,prior to its release in the MENA region.

Academic and Professional achievements :the introduction of clinical modules-

electronic.The use Glp-1 and initiation of education for nurses, intregreted care system

using soft-ware and pattern management for diabetes care.

Profession Interest:Chronic disease Management system ,integrated in Clinical

practice.Neuroendocrine tumors,Diabetes and Hepatitis.



1st Annual Meeting

October 12, 2012











1 Name: NASREEN AL-SAYED, BMedSci,MD, FACP.

Address: ARABIAN GULF UNIVERSITY, COLLEGE OF MEDICINE & MEDICAL SCIENCES- ALJAWHARA

MEDICAL CENTER.

City: P.O. BOX 26671, MANAMA

Country: BAHRAIN

Email: [email protected] OR [email protected]


purposes of Chapter business? ___ yes ___ no


___ President

___ Vice President

___ Secretary

___ Treasurer

___ Board of Director Member

NASREEN AL-SAYED, BMedSci., MD, FACP.

I feel very honoured to have the opportunity to nominate myself for the “Board of Director Member”

position. I've been a member with AACE since 2009 and am very much excited for us to have AACE

chapter in the Gulf region. I feel this is a real opportunity to become more involved in AACE at the gulf

level. I am very much motivated to achieve the impossible and here is a chance for me to really help.

The Gulf AACE chapter will have a tremendous scientific impact on the Endocrinology field in the region

and Middle East. Knowing how prevalent diabetes and other common endocrinological disorders are in

the region, The Gulf AACE chapter will, no question, have a great influence in promoting scientific

awareness and guidance among Endocrinologists in the region.

I am currently working as a full time faculty staff at The Arabian Gulf University, College of Medicine

and Medical sciences and practicing as Endocrinologist and Lipidologist at the University Clinics at

Princess Aljawhara Medical Center which will eventually transform to King Abdulla Medical city in the

very near future in Bahrain.

I did Internal Medicine residency training at Sinai-Grace Hospital, Wayne State University, Detroit,

Michigan (USA) and Endocrinology fellowship at Cleveland Clinic Foundation (USA). In addition, I

recently had a Board Certification in Clinical Lipidology.

I have been very active in the field at professional as well as at community level. I am currently working

on several research papers pertaining to diabetes, lipids and endocrinological disorders through my post

with the University. In addition, I am chairing the scientific and event committee for the upcoming “First

Regional Diabetes Symposium in Bahrain”. I am active member in several Endocrine/Diabetes

organizations and societies such as American Diabetes Association, The Endocrine Society, National lipid

association and Fellow of American College of Physicians. At community level, I have attributed to

several community based lectures and awareness’s, several TV and radio interviews locally and

regionally and community health projects the latest being “The Diabetic Project for School Children” and

“The Metabolic Syndrome Network Project with Bahrain Ministry of Health”. I am one of the very few

Endocrinologists in the region and Middle East to hold board certification in clinical Lipidology and to

treat resistant cases of hypoparathyroidism with parathyroid hormone. I have good working relationships

with authorities in Bahrain Ministry of Health as well as the Endocrinologists in Bahrain and the gulf

region.

Because of all the benefits I have gotten from AACE, I feel it is only right that I do what I can to give

back to this organization. Running for “Board of Director Member” is the best way I can think of to say

“Thank you” to AACE.

Looking forward to your support,

Nasreen AL-Sayed, BMedSci., MD, FACP.

CURRICULUM VITAE

Dr. Nasreen AbdulKarim AlSayed M.D. FACP

Date of Birth : October 11, 1970

Place of Birth: Manama, Bahrain

Nationality : Bahraini

Mobile : +973- 33989330

Residence : +973-77173939 Email : [email protected]

Marital status: Married with three children

Qualifications: Secondary General Certificate of Education,

Ministry of Education, Bahrain, June, 1988

Ranked 6th over Bahrain with a score of 95%

Bachelor Degree of Basic Medical Sciences.

Arabian Gulf University, College of Medicine.

M.D. with Distinction (ranked second) from the Arabian Gulf

University College of Medicine.

Manama, Bahrain September 1988 to May 1995.

Golden Medal for the most prominent student.

American Board Certification in Internal Medicine

Board Certified, August, 2000. Re-certified 01/2011.

Endocrinology , Metabolism and Diabetes Fellowship Training,

Cleveland Clinic Foundation 2010-2011.

American Board Certification in Clinical Lipidology, 2011.

Elected as Fellow of American College of Physicians 07/2010.

.

Certification of training in Thyroid ultrasound and FNA.

Certified in Insulin Pump Therapy.

ECFMG Certificate, September 1996

Valid indefinitely.

Bahrain Medical License Examination Certificate.

Work Experience: July 1995 – June 1996

July 1996 – August 1996

Sept. 1996 – Dec. 1996

Jan 1997 – May 1997

July 1997 – June 2000

Jan 2001 – August 2002

Sept 2002 – February 2004

March 2004- Dec 2008

July 2010- June 2011

November 2011-August

2012

Internship in Salmaniya Medical

Center, Bahrain

Emergency rotation in Salmaniya

Medical Center, Bahrain

Radiology rotation in Salmaniya

Medical Center, Bahrain.

Internal Medicine resident in

Salmaniya Medical Center,

Bahrain.

Internal Medicine Resident in

Sinai-Grace Hospital, Wayne State

University, Detroit Medical

Center, U.S.A.

Internal Medicine Consultant at

American Mission Hospital,

Manama, Bahrain


Bahrain Specialist Hospital,

Manama, Bahrain.


Joslin Diabetes Center Affiliate

Manama, Bahrain.

Advanced fellowship training in

Endocrinology & Metabolism

Cleveland Clinic Foundation

Private Clinic in Alkindi Hospital

February 2012-current

September 2012

Senior lecturer, Arabian Gulf

University. Will be promoted to

Assistant Professor by February

2013.

Private Practice Princess

Aljawhara Medical Center,

affiliated with Arabian Gulf

University.

Research &

Conferences:

1. Nasreen Al-Sayed, Mona Areqat, Wassim Almawi,

"Association of comorbid Depression, Anxiety, Stress

Disorders in Bahraini type 2 diabetes patients.", a clinical

Research, Bahrain, “ Journal of Endocrinological Inve-

stigation”, 2008 Nov; 31(11):1020-4.

.

2. Wassim Almawi, Nareen AL-Sayed, Mona Areqat,

“Association of selective HLA class II susceptibility

Conferring and protective haplotypes with type 2

Diabetes in patients from Bahrain & Lebanon.

Published: “Clinical & Vaccine Immunology, Nov-2006

P-1296-1298, Vol.13. No.11.

3. Nasreen AL-Sayed, Robert Zimmerman, “ACE Inhibitors

better than ARBs In Reducing Albuminuria in Type 2

Diabetics”, Cleveland Clinic Foundation, Abstract presented

in Endocrine Society meeting 2011, in process for

publication in Endocrine practice.

4 Experience (7 years) in treating a Bahraini patient with a

resistant case of idiopathic hypoparathyroidism with

synthetic PTH, Collaboration with NIH, USA.

5 Al Sayed N, Farroq A, “Hepatic Encephalopathy in a

Patient with Non-Alcoholic Steatohepatitis-(NASH)”.

Poster presentation at American College of Physicians

(ACP) meeting, Traver city, Michigan September 1999.

6 Al Sayed N, Al-Room K, “The Prevalance of Bronchial

Asthma among children living in Industrial area in

Bahrain” Research in Arabian Gulf University, in March

1993.

7 Currently, enrolled in several ongoing research projects

in Diabetes, Lipidology and Endocrinology funded by

Arabian Gulf University.

8 Attended several workshops and conferences in Bahrain

and U.S.A. covering different displays including general

health care and medical education. A list of some of the

conferences:

1 Medical Education Conference and its Future

Prospectus, March 1995.

2 Hypertension Management Conference,

November, 1999 Ann Arbor, Michigan.

3 Treating Type 2 Diabetes in Culturally Diverse

Populations, (Conference)

August 2000 - Dearborn, Michigan.

4 New Directions in Myocardial Revascularization

Conference, September, 1999, Troy, Michigan.

6 Arab Health Diabetes Congress, Dubai, UAE.

Accredited by American Academy Of Continuing

Medical Education.2004.

7 The first International GGSD Conference, Arab

Health 2005, Dubai, UAE.

8 41th Annual Meeting of The European Association

for The Study of Diabetes, Sept. 2005

Athens, Greece.

9 Arab Health Diabetes Congress, Dubai, UAE

Accredited by American Academy of Continuing

Medical Education. 2006.

10 Invited as guest speaker at "Hypoparathyroidism

Conference" to share my experience in treating a

Case of Hypoparathyroidism with PTH.

April, 2006, June 2007, June 2008, USA.

11 Endocrinology Board Review, Cleveland Clinic

Foundation,October 2010.

12 Diabetes Day Symposium, Cleveland Clinic

Foundation, 2010,

13 Thyroid Ultrasound and FNA course, Cleveland

Foundation, September, 2010

14 The 20th Annual AACE congress,

April, 2011 San Diego.

15 AACE Thyroid Ultrasound and FNA course,

April, 2011, San Diego.

16 The Endocrine Society Annual meeting, Boston

2011.

17 The 21st Annual AACE congress, May 2012,

Philadelphia.

Extra Curricular

Activities &

Memberships:

Languages:

1. Member of National Lipid Association.

2. Member of Bahrain Medical Society.

3. Member of American Diabetes Association.

4. Member of American College of Physicians.

5. Member of American Association of Clinical

Endocrinologists.

6. Member of the Endocrine Society.

7. Member of Hospital Improvement Committee in

American Mission Hospital. (2001-2002)

8. Member in Radiology Committee in American Mission

Hospital. (2001-2002)

9. Member in Medical Record Committee in American

Mission Hospital. (2001-2002)

10. Member of HTH World wide (International Travel

Health Organization).

11. Member in Infection Control Committee in Bahrain

Specialist Hospital. (September 2002-February 2004).

12. Member in Medical Record Committee in Bahrain

Specialist Hospital. (September 2002-February 2004).

13.Scientific and Education Program Coordinator,

Joslin Diabetes Center Affiliate. Bahrain. (2004-2008)

14. Chairperson of the "Education Advisory Committee",

Joslin Diabetes Center Affiliate. Bahrain.(2004-2008).

15. Chair of Event Committee and CO-Chair of the program

committee of the upcoming “First Regional Diabetes

Symposium” that will be held in Bahrain, January 2013.

16.Several TV interviews locally and regionally pertaining

mainly to Diabetes and endocrinologic disorders

17. Several community based lectures and presentations

On Endocrinology & Diabetes.

Arabic (Fluent written and spoken)

English (Fluent written and spoken)




Attn: Gulf AACE Chapter Members, In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model, the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This meeting is open to all Gulf-AACE members and their invited guests. If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173. Name: Salem Arifi Beshyah Address: Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Karamah Street City: Abu Dhabi Country: United Arab Emirates Email: [email protected] Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the purposes of Chapter business? Yes Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

___ President ___ Vice President ___ Secretary ___ Treasurer X Board of Director Member Yes CV or bio-sketch included Yes Candidate statement included

SHORT BIOSCETCH AND STATEMENT

Dr. Salem A BESHYAH, MBBCh DIC PhD FRCP Consultant Endocrinologist, Endocrinology Division, Department of Medicine,

Sheikh Khalifa Medical City, Abu Dhabi, UAE. E-mail: [email protected] Tel: 00971505662723 Skype: Beshyah2010

Overview: Salem Beshyah qualified from the Medical School of Tripoli in 1981. He started his clinical training in Tripoli till 1985 when he moved to the UK. He obtained his MRCP (UK) and MRCPI during his introductory year in Scotland under the auspices of the Royal College of Physicians and Surgeons of Glasgow. He then trained as a clinical registrar in Leicester and Bedford (1987-1989). He did four-year clinical research fellowship in working on the clinical and metabolic consequences of hypopituitarism and growth hormone deficiency which was the subject of his PhD thesis. After further clinical training, he was appointed consultant physician in diabetes and endocrinology in Harlow, Essex UK for 10 years; Very keen on education and was the Royal College of Physicians Tutor for the last 3 years in Harlow. In 2006, he moved to his current post and has been very active in organizing CME local, national and regional activities. Why I am nominating myself for Board member of Gulf Chapter Interests: Wide clinical interests: I am a clinican with wide range range of interests who has been in practice for a good while of 16 years as a consultant endocrinologist. I have clinical interests covering thyroid disease, practical management of diabetes, diabetic foot and cardiovascular disorders in diabetes. My academic Interests: Cultural aspects of diabetes care, continuous medical education, translational Research. Contributions: Contributed as volunteer to many activities. Regular visitor to the relevant clinical units in Libya (Tripoli, Zawia, Sebha and Benghazi) to support, teach and examine. Founding member and Honorary Treasurer and Web master of the Libyan Association for Diabetes and Endocrinology; Contributed to the organization and conduct of the 4th ,5th ,6th ,7th and 8th “National Congress for Diabetes and Endocrinology” as a true non governmental activity. Personal skills: Skilled organizer of academic activities (see www.endodiablibya.org & www.excellenceincme.org), sponsorship negotiator, researcher and author (over 50 publications; 38 of which are medline), speaker (Arabic and English) and editor (3 years standing as the associate editor of Ibnosina Journal of Medicine and Biomedical Sciences see www.ijmbs.org). If elected, I will work with the president and other members of the board to see the Gulf Chapter as an effective trans-national body of experts that help the profession and patients in the fields care, education and research.

ـةتیرة ذایـس CURRICULUM VITAE

یـھـریفي بشم العالـسـ دكتور Doctor Salem Arifi BESHYAH

MBBCh DIC PhD FRCP

CONTACT DETAILS: Home: Villa 3, Street 1 (joining 25 and 23), Sector 23, Al Moshref, Zone 1, Abu Dhabi, UAE Work: Diabetes and Endocrine Division, Institute of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE Tel +971 50 5662723 Fax +971 2 6103420 E-mail: [email protected]

CURRICULUM VITAE I. PERSONAL DETAILS: Name: Salem Arifi BESHYAH Gender Male Date of birth: 18.6.1956 Marital status: Married, Three children (23, 21, 11) II. EDUCATION: 1971-1974 Suk El-Giuma Secondary School, Tripoli, Libya. 1974-1981 Faculty of Medicine, Tripoli University, Tripoli, Libya. 1989-1993 St Mary’s Hospital Medical School, Imperial College of Scence,

Technology and Medicine, University of London, UK III. QUALIFICATIONS: M.B., B.Ch. (1981) Faculty of Medicine, Tripoli University, Tripoli, Libya. M.R.C.P.I. (1987) Royal College of Physicians of Ireland, Dublin, Ireland. M.R.C.P. (U.K.) (1987) Royal Colleges of Physicians (UK). D.I.C. (1994) Imperial College of Science, Technology and Medicine London. Ph.D. (1994) St Mary’s Hospital Medical School, University of London,

London, UK F.R.C.P. (2000) Royal College of Physicians of London IV. DETAILS OF REGISTRATION: Limited Registration: 1st February 1986 Full registration No 3399932, 23rd March 1989 to date. Specialist Register: General Internal Medicine, 1st October 1996 and Diabetes and Endocrinology, 1st October 1996 UK Licence to Practice in any grade in above specialities= 3299933 UAE Licence to Practice as a consultant endocrinologist, SKMC, Abu Dhabi, UAE= GD9721 V. HOUNORS AND DISTINCTIONS: Secondary School: Grade: Excellent (the 9th at a nationwide exam) Medical School: Grade: Very Good (Second Class Honours); The second

top graduate on the final year.

VI. SENIOR POSTS: Current 17.9.2006 – Date Senior Consultant Endocrinologist, Division of Endocrinology, Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE I have joined 2 other senior endocrinologists. The services are focused at delivering high quality outpatients endocrine and diabetes services and high quality endocrine and diabetic consultations for inpatients under other specialities. I have 6 OPD clinics per week (3 endocrine and 3 diabetic) and 1:3 on second on-call for the specialty. In addition, I took on the role of coordinating the CME and Educational Activities for the centre, I have coordinated several CME programmes of 1-5 CM credits each. I was invited to lecture at several of Abu Dhabi medical institutions (Al Noor Hospital, ADNOC, Al-Ahlia and HAAD). I Key Note Lecturer for the 11th Al-Ain Diabetes Work Shop, Al-Ain, UAE) and was a member of the Medicine Update 2007 organizing committee and the Quality Improvement Committee, coordinated the MM activity and the Consultant’s Journal Club for the Department of Medicine. I have coordinated (jointly with Dr Asma Deeb) the excellence in Diabetes and Endocrinology and with Dr Assem Gharsaa The Excellence in Acute Medicine. Head, Division of Endocrinology: Dr. Mahmoud Benbarka, MD FACE 1.5.1996 – 8.9.2006 Consultant Physician in General Medicine, Diabetes and Endocrinology, Princess Alexandra Hospital, Harlow, Essex, UK. Clinical Audit Lead (1.1.1997 - 31.12.1999) Unit Training Director/Royal College Tutor (1.1.2003 - 31.8.2006) I initially started this job as a locum for 4 months (May to August, 1996) during

which I was appointed to the substantive post on the 26.July 1996. This is a full-time NHS post. The fixed sessions include 2 ward rounds and 4 OPD

clinics together with acute medical on call rota of 1:6 for the first 4 years, now 1:12. One of the OPD clinics is a medical/endocrine and the other three are diabetic clinics (on three different sites to meet the geographical needs of the district).

The medical/diabetic firm consists of four junior doctors (a Diabetes Specialist Registrar on North Thames Rotation, Staff Grade Doctor, a medical SHO on our 24 month rotation and a pre-registration House Physician), three Diabetes Specialist Nurses and a part time Diabetes Link Midwife, and two Clinical Assisstant sessions in Diabetes Care.

The diabetic care is delivered via the conventional diabetic clinics and by the three nurses following patients up in the community. A new Diabetes Education Centre is used for educational sessions, walk-in services and to see “out of clinic” consultations for urgent and high risk patients. All OPD diabetic clinic sessions are supported by dietary advise and chiropody services.

There is a close cooperation with the local medical opthalmology unit (Miss

Dierdre Flaye), and the vascular surgeon (Mr Refson). I have Combined Thyroid Clinic (1st Friday of the month) with the local thyroid surgeon (Miss Jenkins) and a Diabetic Ante-natal Clinic (Jointly with Mr Hartwell). I have established a close working relationship with Professor John P. Monson (Saint Bartholomew’s Hospital) for tertiary endocrine referrals and the Renal physicians in the surrounding hospitals for joint management of diabetic renal disease.

During this appointment I had been the Clinical Audit Lead and I ran an effective well attended programme. For three years. (1.1.1997-31.12.1999).

I was the Unit Training Director/Royal College Tutor. I run an active educational programme catering for the needs of the SHO’s preparing for the MRCP and other juniors. 1.1.2003-31.8.2006.

I am very keen on continuing education. I regularly lecture and lead workshops for GP and Practice Nurses in the locality and the region in addition to my commitments to teaching of medical students and Junior Doctors in Hospital VII. TRAINING POSTS AND EXPERIENCE (in reverse chronological order): 19.2.96 - 30.4.1996 Senior Registrar (Locum): In general medicine and diabetes/endocrinology at the Central Middlesex Hospital, London. This locum post included ward work, OPD clinics, acute medical on take (1:8) and teaching of medical students (from St Marys Hospital Medical School). The OPD cover included 1 diabetic, 1 endocrine and 1 general medical/new diabetic clinics. Consultants: Dr. S. McHardy-Young, MD FRCP Dr. A. Grenfell, MD FRCP 1.10.95 - 18.2.96 Short Locums in General Internal Medicine & Diabetes/Endocrinology: During this period I have took up short term appointments in general and geriatric medicine including a locum consultant physician in general medicine and diabetes/endocrinology working with Dr. Richard Paisey at Torbay Hospital, Torquy (5 weeks) and a locum registrar/senior registrar in medicine at the West Middlesex, Mayday, Chase Farm, Royal Free, Edgware General and Wexham Park hospitals. 29.5.95 to 13.9.95 Senior Registrar (Loum) In general medicine and diabetes/endocrinology at Guy's Hospital, London. This locum post included the cover for ward rounds, OPD clinics and acute medical on take (1:6). The OPD cover included 2 diabetic, 1 endocrine and 1 general medical clinics. I also support the metabolic ward staff in the care of walk-in diabetic patients and supervision of patients undergoing dynamic endocrine investigations.

Consultants: Dr. Robert Knight, FRCP Dr. Jacke K. Powrie, MD FRCP Dr. Brendan Hicks, MD FRCP 1.1.95 - 28.5.95 Senior Registrar (Temporary) In general internal medicine and diabetes/endocrinology at St. Mary's Hospital, London. The range of clinical duties cover ward rounds, OPD clinics and acute medical on take (1:5). The weekly OPD cover included 2 diabetic, 1 endocrine and 1 lipid clinics in addition to an alternate weekly attendance at the reproductive medicine clinic and doing a once monthly joint diabetic-renal clinic. Consultants: Professor Desmond G. Johnston, PhD FRCPath FRCP Dr. Robert S. Elkeles, MD FRCP Dr. Stephen Robinson, MA MD FRCP Professor Stephen Franks, MD FRCP 1.8.94 - 30.9.94 Consultant Physician in GIM/Diabetes & Endocrinology (Locum) In acute general medicine and diabetes/endocrinology at Hillingdon Hospital, Uxbridge, Middlesex. The duties include ward rounds, OPD clinics and acute medical on call rota of 1:5. 1.4.94 - 31.7.94 Medical Registrar/Senior Registrar (locums) In acute general medicine at several hospitals in and around London (Central Middlesex, West Middlesex, Wittington Hospitals in London and Medway Hospital, Kent). The duties included ward rounds, OPD clinics and resident acute medical on take including cover for the accident and emergency department and coronary care unit. 1.1.94 - 31.3.94 PhD Writing up Period Unit of Metabolic Medicine at St. Mary's Hospital Medical School, London. Thesis Title: “Clinical and Metabolic Studies on Hypopituitarism and Growth Hormone Treatment in Adults” Submitted to St Mary’s Hospital Medical School, Imperial College of Science, Technology and Medicine, University of London, London.

13.9.89 - 31.12.93 Clinical Research Fellow/Honorary Registrar Unit of Metabolic Medicine at St. Mary's Hospital Medical School, London. During this research fellowship, I have conducted clinical and metabolic studies on the consequences of conventionally-treated hypopituitarism in adults (body composition, bone mass and metabolism, quality of life and cardiovascular risk). I was also responsible on the planning and running of a trial of GH replacement therapy in hypopituitary adults to assess the effects on well-being, body composition, physical performance, bone mass and metabolism, lipid metabolism and carbohydrate tolerance. The work resulted in numerous presentations at national and international meetings and several publications in quality journals. In addition to the research work, I was doing regular endocrine, diabetes and lipid clinics at St. Mary's, St Charles’ and Northwick Park hospitals. Research fellows are also involved in the academic and clinical activities of the unit of metabolic medicine including teaching of medical students and supervision of the B.Sc. (Clinical Science) students during their research project module. During this period, I kept my skills in acute general medicine by covering absent colleagues at the registrar/SR level on regular basis. I have also done a full time locum senior registrar at Northwick Park Hospital, Harrow in acute general medicine and diabetes/endocrinology between 1.10.1992 and 31.12.1992. The acute on take rota was 1:5. (Consultant: Dr Charles. Edmonds). Consultant: Professor Desmond G. Johnston, PhD FRCPath FRCP 1.2.89-12.9.89 Medical Registrar General medicine, Bedford General Hospital, Bedford. I was working for two consultant physicians with interest in diabetes and gastroenterology. The on take rota was 1:3. The duties include one general medical and two diabetic clinics and one GI endoscopy session per week. In addition to the normal medical ward work, the registrar looks after patients in the coronary care and intensive care units. Consultants: Dr. A.A. Buchanan, BSc FRCP Dr. J.H.B. Saunders, MD FRCP

23.3.87 - 16.1.89 Medical Registrar: General medicine, Leicester General Hospital, Leicester. Working for a consultant physician with interest in diabetes and endocrinology (19 months). I used to assist and supervise the SHO’s and HO’s on the ward and on coronary care unit (when on call). Regular OPD work includes a general medical clinic, a diabetic clinic and a diabetic foot clinic per week. There are 3 other less frequent diabetic clinics conducted in the community around Leicester. The team takes part in care of diabetic patients during pregnancy both as in and out-patients. For the remaining 3 months of this post I worked for two consultant physicians with special interest in gastroenterology. Duties include 3 OPD clinics a week and one endoscopy session. The on call rota throughout the post was 1:4. Consultants: Dr. A. C.(Felix) Burden MD FRCP Dr. C.P.T. Alexander, FRCP Dr. A.C.B. Wicks, MD FRCP 1.12.86 - 20.3.87 Medical Registrar: General medicine, Hairmyres Hospital, East Kilbride, Scotland This was an acute medical post with on take rota of 1:6. In addition to ward work, I was doing 2-3 general medical OPD clinics weekly. Consultants: Dr D. Datta, FRCP Dr Chris J. Clark, MD FRCP 1.3.86 - 30.11.86 Senior House Officer: General medicine, Victoria Infirmary , Glasgow, Scotland. I was involved in the day-today care of acute patients with unselected medical problems and doing twice a week general medical, cardiology and diabetes OPD Clinics. Consultants: Prof. Norman. MacKay, FRCP, Dr David Ballantyne, MD FRCP Dr Duncan MacIntyre, MD FRCP, Dr Colin M. Kesson, MD FRCP 1.11.85 - 26.2.86 Clinical Attachment: General medicine, St Laurence's Hospital, Dublin, Ireland. During this period I was attending ward rounds, OPD clinics and the clinical meetings in the hospital. Consultant: Dr James Finuacane, BSc MD FRCPI 1.11.83 - 30.9.85 Medical S.H.O./Registrar:

In general medicine, Tripoli central hospital. During this post I have acquired more experience in acute medicine and endocrinology. I also had some experience in gastroenterology, including upper GI endoscopy and flexible sigmoidoscopy. I was doing general medical, endocrine and gastroenterology OPD clinics. I also had the opportunity of bedside teaching of medical students. Consultants: Prof. Ibrahim H. Sherif, FRCPEd Dr. Mohamed Abu Baker Ahmed, FRCPEd 1.5.83 - 31.10.83 Medical Senior House Officer: Intensive Care Unit, Tripoli Central Hospital. During this period I gained clinical experience in all aspects of intensive care medicine including resuscitation, cardiac pacing and care of patients on assisted ventilation. Consultant: Dr. Mohamed AbuBaker Ahmed, FRCPEd 1.3.82 - 30.4.83 Senior House Officer: In general medicine, Tripoli Central Hospital, Tripoli Libya. I have been involved in the day to day care of patients with acute medical problems, and in a unit with particular interest in general endocrinology. I had extensive practice in all bedside clinical procedures I was doing a general medical and an endocrine clinic weekly. Consultant: Prof. Ibrahim H. Sherif, FRCPEd. 1.3.81 - 28.2.82 Junior House Officer: Internship rotation in medicine and surgery, in the main teaching hospitals in Tripoli, Libya. Consultants: Prof. Ibrahim H. Sherif, FRCPEd. Prof. A. Atluri, FRCS

PUBLICATIONS: Full Paper: A. Original Publications: Sherif IH, Vanderley C, Beshyah S & Bosairi S. Sella size and contents in Sheehan's syndrome. Clinical Endocrinology 1989; 30: 613-618. Jones R, Beshyah SA, Curryer G & Burden AC. Modification to the "Leicester Scotchcast Boot". Practical Diabetes 1989; 6: 118 -119. Beshyah SA, Anyaoku V, Niththyananthan R, Sharp P & Johnston D G. The effect of subcutaneous injection site on absorption of human growth hormone: Abdomen versus thigh. Clinical Endocrinology 1991; 35: 409-412 Shahi M, Beshyah SA, Hackett D, Sharp P, Johnston DG & Foale R. Myocardial dysfunction in treated hypopituitary adults: a possible explanation for increased vascular mortality. British Heart Journal 1992: 67: 92-96 Beshyah SA, Jowett NI, Burden AC. Metabolic control during Ramadan fasting. Practical Diabetes 1992; 9: 54-55 Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN and Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188- 1192 Beshyah SA, Markussis V, Harbourne T, Nicolaides AN and Johnston DG. Normal haemostatic mechanisms despite increased vascular mortality in hypopituitary adults. Hormone and Metabolic Research 1993; 25: 449-450. Beshyah SA, Sharp P, Gelding SV, Halliday D & Johnston DG. Whole- body leucine turnover in adults on conventional treatment for hypopituitarism. Acta Endocrinologica 1993; 129: 158-164. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A & Johnston DG. Effect of growth hormone replacement therapy on calcium and bone metabolism in hypopituitary adults. Clinical Endocrinology 1994; 40: 383-392. Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R and Johnston DG. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. European Journal of Endocrinology 1994; 130: 451-458. Rutherford OM, Beshyah SA & Johnston DG. Quadriceps strength before and during growth hormone treatment in hypopituitary adults: relationship to changes in lean body mass and IGF-I. Endocrinology and Metabolism 1994; 1: 41-47. Lynch S, Merson S, Beshyah SA, Sharp P, Skinner E, Priest RG & Johnston DG. Psychiatric morbidity in adults with hypopituitarism. Journal of The Royal Society of

Medicine 1994; 87:445-447. Beshyah SA, Anyaoku V, Newton P and Johnston DG. Metabolic abnormalities in growth hormone deficient adults: I. Serum insulin like growth factor-I. Endocrinology and Metabolism 1994; 1: 167-172. Beshyah SA, Henderson A, Niththyananthan R, Sharp P, Richmond W and Johnston DG. Metabolic abnormalities in growth hormone deficient adults: II. Carbohydrate tolerance and lipid metabolism. Endocrinology and Metabolism 1994; 1: 173-180. Rutherford OM, Beshyah SA, Schott J, Watkins Y & Johnston DG. Contractile properties of the quadriceps muscle in growth hormone deficient hypopituitary adults. Clinical Science 1995; 88: 67-71. Beshyah SA, Freemantle C, Shahi, M, Anyaoku, V, Merson S, Lynch S, Skinner E, Sharp P, Foale R and Johnston DG. Replacement treatment with biosynthetic human growth hormone in growth hormone deficient hypopituitary adults. Clinical Endocrinology 1995; 42: 73-84. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. The effects of glucocorticoid replacement regimen on glucose tolerance and intermediary metabolism in hypopituitary adults. Clinical Endocrinology 1995; 42: 85-90. Beshyah SA, Shahi M, Foale R and Johnston D G. Cardiovascular effects of prolonged growth hormone replacement in adults. Journal of Internal Medicine 1995; :237:35-42. Beshyah SA, Freemantle C, Thomas E, Rutherford OM, Page B & Johnston DG. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clinical Endocrinology 1995; 42: 178-189. Beshyah SA, Henderson A, Niththyananthan R, Skinner, E., Anyaoku, V., Richmond, W, Sharp P and Johnston DG. The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. Journal of Clinical Endocrinology and Metabolism 1995; 80: 356-363. Beshyah SA, Kyd P, Thomas E, Fairney A and Johnston DG. The effect of long-term growth hormone replacement therapy on bone metabolism and bone mineral density in hypopituitary adults. Clinical Endocrinology 1995; 42: 249-254. Beshyah SA, Freemantle C, Thomas E, Page B, Murphy M & Johnston DG. Comparison of body composition measurements derived from total body potassium, bio-impedance analysis and dual energy X-ray absorptiometry in hypopituitary adults before and during growth hormone replacement. American Journal of Clinical Nutrition 1995; 61: 1186-1194. Beshyah SA, Rutherford OM, Thomas E, Murphy M & Johnston DG. Assessment of

regional body composition by dual energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment. Endocrinology and Metabolism 1995; 2: 147-155. Beshyah SA, Henderson A, Baynes C, Copping D, Richmond W and Johnston DG. Post-heparin plasma lipase activity in hypopituitary adults. Hormone Research 1995, 44:69-74. Beshyah SA, Gelding SV, Andres C, Johnston DG and Gray IP. Beta cell function in hypopituitary adults before and during growth hormone treatment. Clinical Science 1995; 89: 321-328. Al-Shoumer KAS, Page B, Thomas E, Beshyah SA & Johnston DG. Effects of four years’ treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults. European Journal of Endocrinology 1996; 135: 559-567 Markussis V, Beshyah SA, Fisher C, Parker K, Nicolaides AN & Johnston DG. Abnormal carotid wall arterial wall dynamics in symptom-free hypopituitary adults. European Journal of Endocrinology 1997; 136: 157-164. Al-Shoumer KAS, Gray R, Anyaoku V, Huges C, Beshyah S, Richmond W & Johnston DG. Effects of four years’ treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical Endocrinology 1998; 48: 795-802 Chrisoulidou A, Kousta E, Beshyah SA, Robinson S and DG Johnston. How much and by what mechanisms does growth hormone replacement improve the quality of life in GH-deficient adults ? In: S M Shalet (ed.): Growth hormone in Adults. Bailliere's Clinical Endocrinology and Metabolism 1998; 12 (2): 261-279. Chrisoulidou A, Beshyah SA, Rutherford R, Spinks TJ, Mayet J, Kyd, P, Anyaoku V, Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R & Johnston DG, Effects of seven years growth hormone (GH) replacement therapy in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 2000: 85: 3762 - 3769. Bosseri S & Beshyah SA. Characteristics of diabetic patients with end-stage renal failure on chronic haemodialysis in Tripoli, Libya. Diabetes International 2001; 11: 19-21. Beshyah SA. Tomaso Casoni (1880-1933): a forgotten pioneer remembered. Libyan Journal of Medicine. 2008;3(4):197-9 Beshyah S. Libyan journal of medicine: achievements and challenges. Libyan J Med. 2008 Dec 1;3(4):204-5 Beshyah SA. Goran Rothman: The Swedish physician, botanist, author and North

African explorer. Libyan Journal of Medicine. 2009 Mar 1;4(1):48-50

Beshyah SA, Benbarka MM, Khalil AB. The Practices and Outcomes of Diabetic Patients during Ramadan Fast: A Survey in a Specialist Clinic. Ibnosina Journal of Medicine and Biomedical Sciences. 2009; 1(1): 16-19

Beshyah SA. Diabetic patients and Ramadan fasting: What advice do they get and from whom?. Qatar Medical Journal 2009;18:77-8. Benbarka MM, Khalil AB, Beshyah SA, Marjei S, Awad SA. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report. Diabetes Technol Ther. 2010;12(4):287-90. Khalil AB, Beshyah SA, Benbarka MM, DaBell J, Bernsen R. The effect of sitagliptin therapy in suboptimally controlled metformin-treated type 2 diabetes patients: A Middle Eastern experience. International Journal of Diabetes and Metabolism 2010; 18:55-58 Bisheya AF, El-Mijbri SAB, Beshyah SA, Sherif IH. Community pharamacists’ knowledge, attitudes and practices in diabetes care in Tripoli, Libya. Ibnosina Journal of Medicine and Biomedical Sciences 2011;3: 89-95. Beshyah SA, Khalil AB, Benbarka MM and Mustafa HE. Hospitalization Patterns of Diabetic Patients to a Tertiary Hospital in AbuDhabi, United Arab Emirates. Ibnosina J Med BS 2011;3:113-23 Beshyah SA, Saadi HF, Sherif IH. Continuing medical education in the developing world: timely need for better structure and regulation as a quality issue. Ibnosina Journal of Medicine and Biomedical Sciences 2012; 4 (1):1-8 Beshyah SA, Khalil AB, Roberts Jr. DL, Noshi M. Subacute Thyroiditis Complicated by Extra-Thyroidal Abscess: A Very Rare Presentation of Tuberculous Thyroiditis. Ibnosina Journal of Medicine and Biomedical Science. 2012; 4(4):127-133. Zaidi, M. A., Griffiths, R., Beshyah, S. A. & Zaidi, M. A. Blood and body fluid exposure related knowledge, attitude ad practices of hospital based healthcare providers in UAE. Safety and Health at Work. 2012; Khalil AB, Beshyah SA, Awad SA. Benbarka MM, Haddad M, Al Hassan D, Kahwatih M, Nagelkerke N. Ramadan Fasting in Diabetes Patients on Insulin Pump Therapy Augmented by Continuous Glucose Monitoring: An Observational Real-Life Study Diabetes Technol Ther. 2012;14(9):(in press) Beshyah SA, Al Mehri W and Khalil AB. Osteoporosis and Its Management: An Exploratory Study of the Knowledge, Attitudes and Practices of Physicians Working in the United Arab Emirates. Submitted to: Archives of Osteoporsis

Mustafa HE, Bernsen RM, Beshyah SA. Glycaemic management of type 2 diabetic patients attending a tertiary care centre in United Arab Emirates. Submitted to: Journal of Diabetology. B. Review Articles Beshyah SA and Sherif IH. Ramadan fasting and diabetes mellitus. Practical Diabetes Digest 1989; 1: 31-32 Sharp P, Beshyah SA and Johnston DG. Growth hormone disorders and diabetes. In: Alberti KGGM & Johnston DG (eds.): Secondray Diabetes. Bailliere's Clinical Endocrinology and Metabolism 1992; 6: 819-828 Johnston DG, Beshyah SA, Markussis V, Shahi M, Sharp P, Foale R and Skinner E. Metabolic changes and vascular risk factors in hypopituitarism. Hormone Research 1992; 38(S1): 68-72. Al-Shoumer KAS, Beshyah SA and Johnston DG. Growth hormone and malignancy. Endocrine-Related Cancer 1994 1: 19-26. Beshyah S. Islamic views on medical ethics. [Translation to Arabic]. Bulletin of the Islamic Call Society (Tripoli, Libya). 1998; 15:827-832

الحق ترجمة .المؤلف ي (مقالة مترجمة من اإلنجلیزیة إلى العربیة)نظرة إسالمیة في مبادئ األخالق الطبیة

1998سنة 832-827ص 15مجلة كلیة الدعوة اإلسالمیة العدد .سالم العریفي بشیھ Beshyah SA and Johnston DG. Cardiovascular disease and risk factors in adults with hypopituitarism. Clinical Endocrinology. 1999; 50:1-15 Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S. and Robinson S. Long term effects of growth hormone therapy on intermediary metabolism and insulin sensitivity in Journal of Endocrine Investigations 1999; 22: 37 - 40. Beshyah SA, Benbarka MM and Sherif IH. Practical management of diabetes during Ramadan fast. Libyan Journal of Medicine. 2007; 2 Beshyah SA and Sherif IH. Care for People with Diabetes during the Moslem Pilgrimage (Haj): An Overview . Libyan Journal of Medicine. 2007; AOP: 071211 Zaidi MA, Beshyah SA and Griffith R. Needle Stick Injuries: An Overview of The Size of The Problem, Prevention And Management. Ibnosina Journal of Medicine and Biomedical Sciences 2010;2(2):53-61. Beshyah SA. Non-Communicable Diseases And Diabetes Care Guidelines: Epidemiology And Call For Collective Action. February, 6th 2010, Dat Elmad Conference Hall Complex, Tripoli, Libya Ibnosina Journal of Medicine and Biomedical Sciences. 2010;2: 142-148.

Beshyah SA. Fasting During The Month of Ramadan for People with Diabetes: Medicine and Fiqh United at Last Ibnosina Journal of Medicine and Biomedical Sciences. 2009; 1(2): 58-60 Beshyah SA, Fathalla W, Saleh A, Al-Kaddour A, Noshi M, Al Hatheethi H, Al-Saadawi N, Elsiesi H, Amir N, Almarzouqi M, Khalil A, Benbarka M, Ahmed U, Mustafa HE, Al-Mahmeed W. Ramadan Fasting and The Medical Patient: An Overview for Clinicians. Ibnosina Journal of Medicine and Biomedical Sciences 2010; 2(5): 240-257. Book Chapters: Beshyah SA, Shahi M, Mayet J, Foale R and Johnston DG. Growth hormone and the cardiovascular system. In: M. Ranke and J.S. Christiansen (eds). The Complexity of Endocrine Systems. J &J-Verlag , Mannaheim, 1996: pp 131-155. Johnston DG, Al-Soumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku. Interactions of cortisol and growth hormone replacement: Intermediary metabolism. In: SWJ Lamberts (Ed.) The Diagnosis and Treatment of Pituitary Insufficiency. BioScientifica Ltd. Bristol. 1997: pp 63-77. Sherif IH & Beshyah SA. Diabetes and Ramadan. In: G.V.Gill, J-C Mbanya & G. Alberti (Eds.) Diabetes in Africa. FSG Communications Ltd. Cambridge. 1997, pp 269-273. Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku. Growth hormone replacement in young adults: if and when to continue. In: R Stanhope (ed) Adolescent Endocrinology BioScientifica Ltd. Bristol. 1998; pp Beshyah SA. Is cardiovascular mortality increased in hypopituitary adults ?. In: J.P.Monson (ed) Challenges in Growth Hormone Therapy. Blackwell Science. pp 93-105; 1999 Beshyah SA, Lakhdar A and Gill GV. Acute diabetic emergencie in the Arab World. In: A A Lakhdar & GV Gill (editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005, pp: 199-210. Beshyah SA and Sherif I. Diabetes during Ramadan and Haj. In: A A Lakhdar & GV Gill (editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005, pp: 225-240. Beshyah SA and Blouza-Chabchoub S. Diabetes and Pregnancy. In: A A Lakhdar & GV Gill (editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005, pp 249-267. II. Other Contributions: Abstracts of Presentations:

Beshyah SA & Burden AC. Haemoglobin, haematocrit and foot ulceration. Diabetic Medicine 1988; 5 (Suppl): 30 Burden A C, Jones R, Beshyah S A & Curryer G. Modification of the "Scotchcast Boot". Diabetic Medicine 1988; 5 (suppl): 30 Beshyah S A, Jowett N I & Burden A C. Effects of Ramadan fasting on metabolic control in diabetes. Diabetic Medicine 1988; 5 (suppl.): 32-33. Jowett N I, Ray-Chaudri K, Beshyah S & Burden A C. Standard diabetic care and serum cholesterol. Diabetic Medicine 1989; 6 (suppl 2): 27A Lynch S, Beshyah SA, Merson S, Sharp P, Priest RG & Johnston DG. Psychological features of growth hormone deficiency in adults. Journal of Endocrinology 1990; 127 (Suppl): 60 Copping D, Beshyah SA, Baynes C, Henderson A, Richmond W, Sharp P & Johnston DG. Plasma lipids, body fat distribution and plasma lipase activity in growth hormone deficient adults. Journal of Endocrinology 1990; 127 (Suppl): 61 Beshyah SA, Sharp PS, Anyaoku V, Fishman D & Johnston DG. Absorption of subcutaneously injected human growth hormone. Journal of Endocrinology 1990; 127 (Suppl): 59 Beshyah SA, Freemantle C, Parnell J, Johnston DG & Sharp P. Body composition in hypopituitarism: bioelectrical impedance versus total body potassium. Journal of Endocrinology 1991; 129 (Suppl): 232 Shahi M, Beshyah S, Hackett D, Sharp P, Foale R & Johnston D G. The effect of growth hormone deficiency on cardiac structure and function in hypopituitarism. Journal of Endocrinology 1991; 129 (Suppl): 179 Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. Cardiac structure and function in growth hormone deficiency. British Heart Journal 1991; 66(1): 58 Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. The effects of growth hormone deficiency on cardiac structure and function. European Heart Journal 1991; 12 (8-Abstracts Supplement): P389 Beshyah SA, Thomas E, Sharp P and Johnston DG. Bone mineral status in hypopituitary adults. Journal of Endocrinology 1991; 131 (Suppl): 95 Markussis V, Beshyah S A, Fisher C, Renton S, Nicolaides AN and Johnston D G.Increased carotid intima-media thickness in hypopituitary adults. Journal of Endocrinology 1991; 131 (Suppl): 96 Newton PJ, Beshyah SA, Anyaoku V, Sharp P and Johnston DG. Time course of

metabolic response to subcutaneously injected human growth hormone. Journal of Endocrinology 1991; 131 (Suppl): 45 Beshyah SA, Anyaoku V, Skinner E, Niththyananthan R, Sharp P and Johnston DG. Increased diabetes and glucose intolerance in adults treated for hypopituitarism. Journal of Endocrinology 1992; 132 (Suppl): 240 Markussis V, Beshyah SA, Harbourne T, O'Brien D, Chrysanthou B, Nicolaides AN and Johnston DG. Increased vascular mortality in hypopituitary adults is not contributed to by abnormal clotting mechanisms. Journal of Endocrinology 1992; 132 (Suppl): 241 Beshyah SA, Kyd PA, Sharp P, Johnston DG & Fairney A. Biochemical markers of bone formation in hypopituitary adults. Bone and Mineral 1992; (Suppl 1) 222 Beshyah SA, Gelding SV, Robinson S, Murphy C, Sharp P, Halliday D & Johnston DG. Leucine turnover in hypopituitary adults. Clinical Science 1992; 83: 4P-5P. Shahi M, Beshyah S, Sharp P, Johnston D G & Foale R. Beneficial effects of growth hormone replacement therapy on myocardial function. British Heart Journal 1992; 68(1): 129 Beshyah S A, Markussis V, Fisher C, Nicolaides AN and Johnston D G. Vascular disease in hypopituitary adults . Cardiovascular Disease Prevention: UK 1992 held on 28-31 July 1992, London. Conference Programme and Abstracts Book (Poster number 23, page 45). Beshyah S A, Henderson A, Niththyanathan R, Skinner E, Baynes C, Richmond W and Johnston DG. The atherogenic risk factors in hypopituitary adults. Cardiovascular Disease Prevention: UK 1992 held on 28-31 July 1992, London . Conference Programme and Abstracts Book ( Poster 24, Page 45). Beshyah S A, Henderson A, Anyaoku V, Baynes C, Richmond W, Sharp P and Johnston DG. Metabolic risk factors for vascular disease adult hypopituitarism. Ninth International Congress of Endocrinology, 1992: Abstract P.11.03.053), Nice, France. Markussis V, Beshyah S A, Fisher C, Nicolaides AN and Johnston D G. Abnormal carotid compliance and distensibility in hypopituitarism. Ninth International Congress of Endocrinology, 1992: Abstract N= P.08.01.045), Nice, France. Beshyah SA, Sharp P, Anyaoku V, Henderson A, Niththyananthan R, Skinner E, Freemantle C, Parnell CJ, Richmond W & Johnston DG. Effects of growth hormone replacement on body composition, lipid metabolism and carbohydrate tolerance in 40 hypopituitary adults. Journal of Endocrinology 1992; 135 (Suppl): P114 Beshyah SA, Sharp P, Kyd P, Thomas E, Fairney A & Johnston DG. The effect of biosynthetic human growth hormone (replacement) therapy on calcium and bone

metabolism in hypopituitary adults. Journal of Endocrinology 1992; 135 (Suppl): P119 Beshyah SA, Sharp P, Halliday D & Johnston DG. The effects of growth hormone therapy on leucine metabolism in hypopituitary adults. Clinical Science 1993; 84: 43p Beshyah SA, Anyaoku V, Newton P, Sharp P & Johnston DG. Clinical and anthropometric correlations of serum insulin-like growth factor 1 in growth hormone deficient adults. Journal of Endocrinology 1993; 137 (Suppl): P138 Beshyah SA, Gray IP, Niththyananthan R, Andres C & Johnston DG. The effect of growth hormone therapy on fasting insulin and proinsulin levels in hypopituitary adults. Journal of Endocrinology 1993; 137 (Suppl): P139 Beshyah SA, Shahi M, Anyaoku V, Skinner E, Sharp P, Foale R & Johnston DG. Clinical and physiological effects of biosynthetic human growth hormone replacement therapy in hypopituitary adults. Clinical Science 1993; 85 (Suppl.29):1P. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. Glucocorticoid replacement regimen and glucose tolerance in hypopituitary adults. Journal of Endocrinology 1993; 139 (Suppl.): P126 Beshyah SA, Rutherford OM, Thomas E, Murphy M & Johnston D.G. Regional body fat distribution in hypopituitary adults before and after growth hormone treatment: A study by dual energy X-ray absorptiometry. Journal of Endocrinology 1993; 139(Suppl.): P127 Beshyah SA, Henderson A, Niththyananthan R, Anyaoku V & Johnston DG. Does glucocorticoid replacement therapy contribute to the increased vascular risk in growth hormone deficient hypopituitary adults? Journal of Endocrinology 1993; 139 (Suppl.):P128 Rutherford OM, Beshyah SA, Watkins Y, Schott J & Johnston DG. Contractile properties of the quadriceps muscle in growth hormone deficient hypopituitary adults. Journal of Endocrinology 1993; 139 (Suppl.):P129 Rutherford OM, Beshyah SA & Johnston DG. Quadriceps strength in adult growth hormone deficiency before and during growth hormone treatment. Journal of Physiology 1993:473: 213P. Beshyah SA, Freemantle C, Page B, Thomas E, Murphy M & Johnston DG. Changes in body composition during growth hormone therapy in adults: Comparison of total body potassium, bio-impedance and dual energy X-ray absorptiometry. Clinical Science 1994; 83 (suppl 30): P22 Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. Day to day variation in glucose tolerance and intermediary metabolites caused by glucocorticoid replacement therapy in hypopituitary adults. Clinical Science 1994; 83

(Suppl 30):P22 Beshyah SA, Freemantle C, Shahi M, Foale R and Johnston D.G. Effects of long term growth hormone replacement in hypopituitary adults on body composition, exercise tolerance and muscle strength. Journal of Endocrinology 1994; 140 (Suppl.) :P166. Beshyah SA, Henderson, A, Richmond, W and Johnston, D.G. The effect of long term growth hormone replacement in hypopituitary adults on plasma lipids, lipoproteins and apoproteins. Journal of Endocrinology 1994; 140 (Suppl.) :P165. Al-Shoumer KAS, Andres C, Beshyah SA, Gray, IP and Johnston DG. Day to day variation in pancreatic beta cell products caused by glucocorticoid replacement therapy in hypopituitary adults. Journal of Endocrinology 1994; 140 (Suppl.) :P164. Beshyah SA, Niththyananthan R, Skinner E, Sharp P and Johnston DG. The effect of long term growth hormone replacement on carbohydrate tolerance in hypopituitary adults. Endocrinology and Metabolism 1994;1 (Suppl. B): 32 Beshyah SA, Skinner E, Aghil FM and Johnston DG. Resting energy expenditure in growth hormone deficient adults. Journal of Endocrinology 1994; 143 (Suppl.): P75. Beshyah SA, Kyd P, Fairney A and Johnston DG. The effects of long term growth hormone replacement therapy on calcium and bone metabolism in hypopituitary adults. Bone 1994; 15: 729-730. Beshyah SA, Skinner E, Aghil FM and Johnston DG. The effect of growth hormone replacement on resting energy expenditure in growth hormone deficient adults. Journal of Endocrinology 1995;144: P293. Beshyah SA, Shahi M, Mayet J, Skinner E, Foale R and Johnston DG. Heart size and function in hypopituitary adults: Comparison with normal controls and clinical and metabolic correlations. Journal of Endocrinology 1995; 147: OC46. Al-Shoumer KAS, Hughes C, Richmond W, Beshyah SA and Johnston DG. Beneficial changes in plasma lipids, lipoproteins in hypopituitary adults after 4 years of growth hormone replacement therapy. Journal of Endocrinology 1995; 147: OC47. Chrisouidou A, Anyaoku V, Beshyah SA, Al-Shoumer KAS, Robinson S and Johnston DG. Effects of GH treatment for 7 years versus no treatment on anthropometry and vascular risk factors in adult hypopituitarism. Journal of Endocrinology 1998; 150(Suppl.): P151 Chrisoulidou A, Kyd P, Beshyah SA, Rutherford O, Fairney A and Johnston DG. Effects of 7 years of growth hormone (GH) treatment on bone metabolism in adult hypopituitarism. Endocrinology. Proceedings of the 81st Meeting of the Endocrine Society, San Diego, 12-15 June 1999. p394,

Chrisoulidou A, Ariff B, Mayet J, Beshyah SA, Shahi M, Foale R and Johnston DG. Effects of 7 years of growth hormone (GH) treatment on heart function and structure in adult hypopituitarism. Proceedings of the 81st Meeting of the Endocrine Society, San Diego, 12-15 June 1999: P2-528 pp 392.

Bosseri, S, Beshyah SA, Ismail MMA, Lazreg I, Shafeh T & Sherif IH. Clinical and biochemical characteristics of 270 Sheehan’s syndrome patients. Journal of Endocrinology. 2000; 164(Suppl):P202

Ismail MMA, Alaswad M, Ejamail A, Abdelaziz H, Shawesh K, Dorar N, Beshyah S & Sherif I. Metabolic control of type 2 diabetes using Repaglinide during the fasting month of Ramadan; IDF Programme Book; Abstract P332, November 2000. Khawaja T, Alaswad M, Kekkli M, Beshyah SA & Sherif IH. Reduced bone mass in Sheehan’s syndrome. Endocrine Abstracts 2001; 1: P11 Abouglila K, Magbari M, Sayer JW & Beshyah SA. Management of hyperglycaemia during acute myocardial infarction: an audit of DIGAMI-based practice Diabetic Medicine 2001; Beshyah SA, Bay NA and Sherif IH. Awareness of Libyan women of the menopause. Third Pan Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th 2001. Proceedings Book. Beshyah SA, Bisheya AF, El-Mijbri S. and Sherif IH. Role of community pharmacists in diabetes care.Third Pan Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th 2001.

Beshyah SA and Sherif IH. A “Short Diabetes Knowledge Test” in Arabic. Third Pan Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th 2001. Beshyah SA, Aylwin S, Abouglila K & Monson JP. 'Brittle Addison's disease' but not 'Brittle diabetes' in a young woman with Addison's disease and type 1 diabetes mellitus. I. Endocrine Abstracts 2002, 3: P19 Khoo B, Field B, Rosenfelder B, Lowe DG, Beshyah SA & Monson JP. Cushing's syndrome due to apparently autonomous adrenal hyperplasia in a patient with multiple endocrine neoplasia type I. Endocrine Abstracts 2002, 3: P122 Beshyah SA, Bay NA & Sherif IH. Awareness of Libyan women of the menopause and their attitudes to hormone replacement therapy. Endocrine Abstracts 2002, 3: P214 Ravikumar C, Mukhtar SF & Beshyah SA. Transient thyrotoxicosis following total laryngectomy. Endocrine Abstracts 2002; 4: P8 Mukhtar SF and Beshyah SA. Unusualy long 'honeymoon' in a 45 year old man with type 2 diabetes mellitus. Diabetic Medicine 2004; 21(suppl.):P214.

Beshyah SA, Al-Fallouji H & Neave F. Complete right vocal cord paralysis: a very rare complication of radioiodine therapy for hyperthyroidism. Endocrine Abstracts 2004, 7: P301 Beshyah SA. (invited speaker) Epidemiology, clinical management and outcome of diabetic pregnancies in the Arab world: An overview. Int J Diabetes & Metabolism (2005) 13: 30-59 Beshyah SA. (invited speaker) Evaluation and management of clinically-inapperent adrenal masses (incidentaloma) Programme Book. 6th Pan Arab Congress of Endocrinology and Diabetes. March 2-4, 2005 Alexandria, Egypt Beshyah SA. Optimal use of the old and newer oral antidiabetic drugs. Abstract Book of The Fourth Libyan Diabetes and Endocrinology Conference 2006:WS1.2 (invited) Koduah D, Stoner E, Phillips R and Beshyah SA. Lesson of the week: delayed diagnosis of secondary hypoadrenalism due to isolated ACTH deficiency in an adult because of lack of hyperpigmentation and electrolyte disturbances. Abstract Book of The Fourth Libyan Diabetes and Endocrinology Conference 2006:P04 Sagar AS, Sherif IH and Beshyah SA. The practical diabetes knowledge of the final year medical students in Tripoli, Libya. Abstract Book of The Fourth Libyan Diabetes and Endocrinology Conference 2006:P09 Beshyah SA and Sherif IH. Medical complications of obesity in adults. Libyan Journal of Medicine. 2007; 2 (supplement 2): S2.1 (invited) Beshyah SA and Benbarka MM. Hospitalization pattern of people with diabetes . Libyan Journal of Medicine. 2007; 2 (supplement 2): P8. Beshyah SA. Effective insulin therapy. Libyan Journal of Medicine. 2008; 3 (supplement 1): S1.4 (invited). Beshyah SA. Practices and outcomes of diabetic patients during Ramadan fast in Abu Dhabi, United Arab Emirates. Libyan Journal of Medicine. 2008; 3 (supplement 1): OC1 Beshyah SA Who advises diabetic patients during Ramadan ? Libyan Journal of Medicine. 2008; 3 (supplement 1): P14. Letters, Proceedings, Book reviews: Beshyah SA. Thyroid emergencies (letter). Hospital Update 1987;13: 585 Beshyah SA. Coding human insulin (letter). Practical Diabetes 1987; 4: 245.

Beshyah SA, Thomas E, Skinner E, Sharp P & Johnston DG. Total body and spine bone mineral density in women with hypopituitarism (Proceedings). In: Ring EFJ, ed. Current Research in Osteoporosis and Bone Mineral Measurement II:1992. London: The British Institute of Radiology,1992: pp 17-18 Beshyah SA, Thomas E, Freemantle C, Parnell CJ and Johnston DG. The place of dual energy X-ray absorptiometry in measurement of lean body mass and percent body fat in hypopituitary adults (Proceedings). In: Ring EFJ, (ed). Current Research in Osteoporosis and Bone Mineral Measurement II:1992. London: The British Institute of Radiology, 1992: pp 62-63 Sharp P, Beshyah SA and Johnston DG. Cardiovascular risk factors in growth hormone deficiency: effects of growth hormone replacement Endocrinology and Metabolism 1995; 2 (Suppl A): 13-14. Lynch S, Beshyah S & Merson S. Psychiatric aspects of hypopituitarism (letter). Journal of The Royal Society of Medicine 1995; 88:603-604 [PubMed Indexed] Beshyah SA, Schiff R & Al-Jehani FS. National crash call number is needed (letter). Br. Med. J. 1996; 313; 429. [PubMed Indexed]

Al-Shoumer KAS, Kousta E, Beshyah S and Johnston DG. GH deficiency - Does it cause atherosclerosis? The 3rd Internationational hGH symposium on GH deficiency in Adults. Vienna , 6 September 1996. Beshyah SA. Taking growth hormone away from paediatrics (Book review). Lancet, 1997; 349:366-367. Beshyah S (Editor) Supplement The Fifth Libyan Diabetes and Endocrinology Conference, 1-3 May 2007, Teachers’ Union Hall, Tripoli, Libya. Libyan Journal of Medicine. 2007, 2 Salhin AA, Hajjaji IM, Deeb AA and Beshyah SA. Meeting Report: The Fifth Libyan Diabetes and Endocrinology Conference, 1-3 May 2007, Teachers’ Union Hall, Tripoli, Libya. Libyan Journal of Medicine. 2007, 2 Al Hajjery, OM, Majdi G and Beshyah SA. Meeting Report: Sheikh Khalifa Medical City Medicine Update 2007, Hilton Hotel, Abu Dhabi, UAE. 24-26th April 2006. Libyan Journal of Medicine. 2007 (volume 2) Beshyah S and Salhin AA. (Guest Supplement Editors). Supplemnt The Sixth Libyan Diabetes and Endocrinology Conference, 28-38 April 2008, Skydome, Tripoli, Libya. Libyan Journal of Medicine. 2008 (volume 3) Beshyah SA. Libyan Journal of Medicine: Achievements and challenges. (Letter) Libyan Journal of Medicine. Libyan J Med. 2008 Dec 1;3(4):204-5.

Salhin A, Besheya TA, Beshyah SA. Conference Report: The Seventh Libyan Diabetes and Endocrinology Conference (LDEC2009), April 7-9, 2009 Tripoli, Libya. Ibnosina Journal of Medicine and Biomedical Sciences Vol 1, No 3 (2009) Elamami A, Gad S, Beshyah SA. The fourth annual conference of the Arab Association for the Study of Diabetes and Metabolism (AASD); 18–20 November, 2009, Cairo Sheraton Hotel, Cairo Egypt. Ibnosina Journal of Medicine and Biomedical Sciences Vol 2, No 2 (2010) Salhin A, Beshyah S. Abstracts of the 7th Libyan Diabetes and Endocrinology Conference. Ibnosina Journal of Medicine and Biomedical Sciences 2009; 1(1): 25-43 Salhin AA, Eltabal SA, Habeb AM, Beshyah SA. Abstracts of the Eighth Libyan Diabetes and Endocrinology Conference. Ibnosina Journal of Medicine and Biomedical Sciences. 2010; 2(5): 212-236 Beshyah SA, Deeb A. Excellence in Diabetes and Endocrinology 2010. Ibnosina Journal of Medicine and Biomedical Sciences 2010; 2(6): 294-306 Beshyah SA. Book Review: Textbook of Diabetes. Ibnosina Journal of Medcine and Biomedical Sciences 2011,3(4):133-134 Patients’ Educational Leaflets/Booklets: Beshyah SA. The Basic Information on Diabetes: A simplified guide for Arab diabetic patients in Britain (Patients Information Booklet; Arabic). Arab Health Care Foundation, London. 1996

المعلومات األساسیة عن السكري Issam M Hajjaji & Salem A Beshyah. Guide to Diabetes in Libya (in Arabic): 2002

في لیبیا دلیل مرض السكرMedia Interviews: Interview with National Libyan Radio: Health and safety during Ramadan fasting. 1985. Broadcast divided on several episodes during the month of Ramadan 1985.

برنامج البیت السعید Interview with Radio Spectrum International- Arabic Services 1996: On General Health Issues with live Q&A.

عیادة على الھواء برنامجInterview with MBC Satellite TV 1997: On General Health Issues with live Q&A.

صحتك بالدنیا برنامج

Interview on the Daily Paper Al-Sharq Al-Awsat (Arabic) on Ramadan Fasting and Diabetes 2002. Interview with Ghazala Magazine (Arabic): Diabetes in Libya. January 2005:

بیاحوار حول مرض السكري في لی Interview with OEA Daily Paper (Tripoli, Libya) on the Diabetes in Libya, The Sixth Libyan Diabetes and Endocrinology Conference. Oea 2008; Year 2, Number 219 Page 3. (date 5th May 2008). Interview with Al-Bayan News Paper (Abu habi, UAE) on 16 December 2007

حول سالمة الحجاج من مرضى السكري WORK IN PROGRESS:

1. Book: Basic Information on Thyroid Disease (Arabic); Stage 80% Complete 2. Book: Basic Information on Diabetes (Arabic) Stage 60% completion. 3. Paper: Central Hospital Abu Dhabi (1966-2008): Over 40 years of Services to

the Community. A short historical account of the journey of Central hospital. Stage: data collection and early drafting.

4. Type 2 Diabetes: a chapter in a multi-author book “Oea Medical Review” 5. Causes and management of Osteoporosis: a survey of the knowledge,

attitudes and practices of physicians in the United Arab Emirates - Survey completed; data analysed, first draft of manuscript produced.

6. Causes and management of obesity: a survey of the attitudes and practices of physicians in the United Arab Emirates – Survey completed; data being analysed.

IX. OTHER ACADEMIC ACTIVITIES: 1. Membership of learned societies: Member, British Diabetic Association, Member, British Society for Endocrinology Member, Growth Hormone Research Society Member, British Medical Association. Member, Arab Medical Association (UK & Ireland) Member, ABCD: Association of British Clinical Diabetologists. Fellow; Royal Colleges of Physicians of London Member, Libyan Doctors Society.

Founder Member, Pan Arab Congress of Endocrinology and Diabetes Founder Member, Libyan Association for Diabetes and Endocrinology

Full Member, Emirates Endocrine Club 2006-2008 2. I have acted as a referee for the following journals:

Endocrinology and Metabolism European Journal of Endocrinology. Clinical Endocrinology. Jamahyria Medical Journal (Member, International Advisory Board) Libyan Journal of Medicine Qatar Medical Journal Ibnosina Journal of Medicine and Biomedical Sciences.

Chair of the Programme Organizing Committee for The Fourth, Fifth, Sixth and Seventh Libyan Diabetes and Endocrinology Conferences.

Member, The UAE National Diabetes Committee’s Guidelines Advisory Group 2007-2008 and Reviession group 2011.

Founder Honorary Treasurer, The Libyan Association for Diabetes and Endocrinology, Tripoli, Libya 2008-todate (two terms).

Member, The National Libyan Diabetes Care Guidelines Task Force 2008-2010.

Web master of The Libyan Association for Diabetes and Endocrinology Official Web Site www.endodiablibya.org

Coordinator: LADE Summer School 2007-2010, a series or lectures and mini-symposia organized by the Libyan Association for Diabetes and Endocrinology in Tripoli. www.endodiablibya.org/news.html

Associate Editor, Ibnosina Journal of Medicine and Biomedical Sciences. 2010-to date. (one term is 2 years).

SUPPORTING DOCUMENTS:



1st Annual Meeting

October 12, 2012











Name: NABIL KAMAL ELNAGGAR

Address: HAI ALJAMEA HOSPITAL P.O BOX .10153

City: JEDDAH 21433

Country: KSA


Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the

purposes of Chapter business? ___ yes ___ no

Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

___ President

___ Vice President

___ Secretary

___ Treasurer



mailto:[email protected]?subject=Gulf%20Chapter%20AACE%20Nomination

CANDIDATE STATEMENT

I have the honor to apply for being one of the director group of the AACE chapter in the

GULF area since I’m a member of the international committee of the AACE, I’ve been

working in the field of diabetes exclusively for the last 30 years in the Kingdom of Saudi

Arabia, I’ve been involved in almost all the activities taking place in the middle east, I’ve

organized a lot of international conferences and symposia in the region, we carried on a

lot of professional education programs for both physicians and educators along with

training courses for diabetes nurses. I’ve instituted the oldest and most reputed society

for diabetologists (Jeddah Diabetes Club) and another one (Jeddah Hypertension &

Atherosclerosis Club) which are very active in promoting updates in diabetes fields.

I have the vision that I can serve and promote AACE Gulf chapter efficiently; supported

by my long experience, extensive relations, popularity and enthusiasm, besides being a

member of the international committee of the AACE.

I have also the goal of developing professional growth in this area through providing

AACE guidance and improving quality of services for both the health care providers and

the patients.

I aim also to initiate and enhance the collaboration of the working and active societies,

associations clubs and authorities in the Gulf to work hand in hand with the AACE

chapter for improving the care of diabetics.

Again, it will be my honor and privilege to share in the Gulf chapter as a member of the

directory board.

Dr. Nabil Elnaggar.

DR. NABIL EL NAGGAR DR. NABIL EL NAGGAR, MBBCh, MSc, FICA, FESC DDiiaabbeettoollooggiisstt && HHeeaadd ooff DDiiaabbeetteess CCeenntteerr,, HHaaii AAlljjaammeeaa HHoossppiittaall..

CChhaaiirrmmaann ooff JJeeddddaahh DDiiaabbeetteess CClluubb..

CChhaaiirrmmeenn ooff JJeeddddaahh HHyyppeerrtteennssiioonn aanndd AAtthheerroosscclleerroossiiss CClluubb..

HHeeaadd ooff CCMMEE CCoommmmiitttteeee ooff HHaaii AAllJJaammeeaa HHoossppiittaall,, JJeeddddaahh,, SSAA. EDUCATION & EXPERIENCE GGrraadduuaatteedd 11997777,, CCoolllleeggee ooff MMeeddiicciinnee,, AAlleexxaannddrriiaa UUnniivveerrssiittyy,, RRoottaattiinngg HHoouusseeooffffiicceerr iinn AAlleexxaannddrriiaa UUnniivveerrssiittyy

HHoossppiittaallss 11997788--11997799,, RReeggiissttrraarr ooff IInntteerrnnaall MMeeddiicciinnee,, DDeeppaarrttmmeenntt ooff DDiiaabbeetteess aanndd MMeettaabboolliissmm 11997799--11998822,, MMSScc

ddeeggrreeee iinn IInntteerrnnaall MMeeddiicciinnee 11998822,, FFeelllloowwsshhiipp ooff tthhee SScciieennttiiffiicc CCoouunncciill ooff tthhee IInntteerrnnaattiioonnaall CCoolllleeggee ooff

AAnnggiioollooggyy 11998855,, CCeerrttiiffiieedd PPrrooffeessssiioonnaall DDiiaabbeetteess IInnssttrruuccttoorr ((VViirrggiinniiaa UUnniivveerrssiittyy)),, TTrraaiinneedd iinn mmaannyy cceenntteerrss iinn

EEuurrooppee aanndd UUSSAA ((JJoosslllliinn)) iinn tthhee ffiieelldd ooff DDiiaabbeettoollooggyy iinncclluuddiinngg iinnssuulliinn ppuummpp tthheerraappyy,, ddiiaabbeettiicc ffoooott ccaarree,,

PPrrooffeessssiioonnaall PPhhyyssiicciiaann TTrraaiinniinngg aanndd PPaattiieenntt DDiiaabbeetteess EEdduuccaattoorr ttrraaiinniinngg,, AAddvvaanncceedd ttrraaiinniinngg oonn VVaassccuullaarr

MMeeddiicciinnee aanndd AAtthheerroosscclleerroossiiss.

MEMERSHIPS: FFeellllooww ooff tthhee AAmmeerriiccaann CCoolllleeggee ooff AAnnggiioollooggyy ((FFIICCAA))

MMeemmbbeerr ooff AAmmeerriiccaann DDiiaabbeetteess AAssssoocciiaatteedd ((AADDAA))

MMeemmbbeerr ooff ((AAAACCEE)) AAmmeerriiccaann AAssssoocciiaattiioonn ooff CClliinniiccaall EEnnddooccrriinnoollooggiissttss

LLiiffee MMeemmbbeerr ooff tthhee IInntteerrnnaattiioonnaall DDiiaabbeetteess FFeeddeerraattiioonn ((IIDDFF))

MMeemmbbeerr ooff tthhee EEuurrooppeeaann AAssssoocciiaatteedd ooff SSttuuddyy ooff DDiiaabbeetteess ((EEAASSDD))

FFeellllooww ooff tthhee EESSCC ((EEuurrooppeeaann SSoocciieettyy ooff CCaarrddiioollooggyy)),,MMeemmbbeerr ooff tthhee pprreevveennttiivvee aanndd rreehhaabbiilliittaattiioonn ccoommmmiitttteeee

MMeemmbbeerr ooff EESSHH ((EEuurrooppeeaann SSoocciieettyy ooff HHyyppeerrtteennssiioonn))

MMeemmbbeerr ooff EEggyyppttiiaann GGrroouupp ooff DDiiaabbeetteess ((EEGGSSDD))

MMeemmbbeerr ooff BBrriittiisshh DDiiaabbeetteess AAssssoocciiaattiioonn ((BBDDAA))

MMeemmbbeerr ooff AAmmeerriiccaann GGaassttrrooeenntteerroollooggyy AAssssoocciiaattiioonn ((AAGGAA))

QQuuaalliiffiieedd DDiiaabbeetteess PPrrooffeessssiioonnaall IInnssttrruuccttoorr ((VViirrggiinniiaa UUnniivveerrssiittyy))

MMeemmbbeerr ooff EEAAEEDDAA ((EEggyyppttiiaann AAssssoocciiaattiioonn ffoorr EEnnddooccrriinnoollooggyy ,, DDiiaabbeetteess aanndd AAtthheerroosscclleerroossiiss))..

TThhee EEggyyppttiiaann PPhhyyssiicciiaann SSyynnddrriiccaattee

SCIENTIFIC ACTIVITIES:

HHeeaadd ooff sscciieennttiiffiicc CClluubbss ((JJDDCC,, JJHHAACC)),, EEddiittoorr iinn cchhiieeff ooff ddiiffffeerreenntt llooccaall PPuubblliiccaattiioonnss && NNeewwsslleetttteerrss iissssuueedd mmoonntthhllyy,,

OOrrggaanniizzeerr ooff mmaannyy ttrraaiinniinngg ccoouurrsseess pprrooggrraammss aanndd CCMMEE pprrooggrraammss iinn tthhee ffiieelldd ooff ddiiaabbeetteess,, sshhaarriinngg iinn aawwaarreenneessss

PPrrooggrraammss tthhrroouugghh rraaddiioo bbrrooaaddccaassttss,, nneewwssppaappeerr aarrttiicclleess,, aanndd WWoorrlldd MMeeddiiccaall HHeeaalltthh DDaayyss CCeelleebbrraattiivvee aaccttiivviittiieess,,

OOrrggaanniizzeerr aanndd PPrreessiiddeenntt ooff mmaannyy IInntteerrnnaattiioonnaall CCoonnffeerreenncceess hheelldd iinn JJeeddddaahh ((JJDDCC IInntteerrnnaattiioonnaall DDiiaabbeetteess

SSyymmppoossiiuumm,, JJeeddddaahh IInntteerrnnaattiioonnaall DDiiaabbeetteess TTaasskkffoorrccee PPrrooggrraamm,, SSaauuddii--DDuuttcchh ssyymmppoossiiaa,, AAnnnnuuaall JJDDCC--SSGGHH

IInntteerrnnaattiioonnaall SSyymmppoossiiaa,, JJDDCC CCoollllaabboorraattiivvee DDiiaabbeetteess WWoorrkkggrroouupp……eettcc)).. IInntteerreesstteedd iinn DDiiaabbeetteess RReesseeaarrcchh,, ssttuuddyy ooff

aassppeeccttss rreellaatteedd ttoo tthhee MMeettaabboolliicc ssyynnddrroommee aanndd ddyysslliippiiddeemmiiaa,, oobbeessiittyy,, aanndd ccaarrddiioovvaassccuullaarr rriisskk ffaaccttoorrss..

FFrreeqquueenntt SSppeeaakkeerr iinn llooccaall ,, NNaattiioonnaall aanndd IInntteerrnnaattiioonnaall SSyymmppoossiiaa..

PUBLICATIONS:

EEDDIITTOORR OOFF JJDDCC nneewwsslleetttteerr ((mmoonntthhllyy))

EEDDIITTOORR OOFF JJHHAACC nneewwsslleetttteerr ((TThhee VVeesssseell)) ppuubblliisshheedd mmoonntthhllyy

EEDDIITTOORR OOFF ““MMeenn’’ss HHeeaalltthh”” nneewwsslleetttteerr ((BBiimmoonntthhllyy))

11.. SSaaiieedd KKhhaaddeerr ,, WWaalleeeedd AAbbddeellFFaattttaahh ,, AAbbdduullqqaawwii AAllmmaannssaarrii ,, NNaabbiill KK.. EEllnnaaggggaarr..SSaaffeettyy aanndd eeffffiiccaaccyy ooff

sswwiittcchhiinngg ttoo bbiipphhaassiicc iinnssuulliinn aassppaarrtt 3300//7700 ((BBIIAAsspp 3300)) uunnddeerr tthhee rroouuttiinnee ddiiaabbeettiicc ccaarree iinn ppaattiieennttss wwiitthh

ttyyppee 22 ddiiaabbeetteess:: TThhee IIMMPPRROOVVEE™™ oobbsseerrvvaattiioonnaall ssttuuddyy iinn tthhee GGuullff rreeggiioonn.. IInntteerrnnaattiioonnaall JJoouurrnnaall ooff DDiiaabbeetteess

MMeelllliittuuss 22 ((22001100)) 111100––111133..

22.. PPhhiilliipp HHoommee ,, NNaabbiill EEll NNaaggggaarr ,, MMoohhaammmmeedd KKhhaammsseehh ,, GGuuiilllleerrmmoo GGoonnzzaalleezz--GGaallvveezz,,

CChhuunndduuoo SShheenn ,, PPrraaffuull CChhaakkkkaarrwwaarr ,, WWeennyyiinngg YYaannggff.. AAnn oobbsseerrvvaattiioonnaall nnoonn--iinntteerrvveennttiioonnaall

ssttuuddyy ooff ppeeooppllee wwiitthh ddiiaabbeetteess bbeeggiinnnniinngg oorr cchhaannggeedd ttoo iinnssuulliinn aannaalloogguuee tthheerraappyy iinn nnoonn--WWeesstteerrnn

ccoouunnttrriieess:: TThhee AA11cchhiieevvee ssttuuddyy.. DDiiaabbeetteess RReesseeaarrcchh aanndd CClliinniiccaall PPrraaccttiiccee,,22001111,, 9944:: 335522--336633

33.. PPhhiilliipp HHoommee,, SSiiddddhhaarrtthh NN SShhaahh,, GGuuiilllleerrmmoo GGoonnzzaalliizz--GGaallvveess,, NNaabbiill KK EEllnnaaggggaarr,,

PPrraaffuull NN CChhaakkkkaarrwwaarr,, LLeeoonn EE LLiittwwaakk.. SSttaarrttiinngg IInnssuulliinn DDeetteemmiirr iinn OOllddeerr VVeerrssuuss YYoouunnggeerr

AAdduullttss wwiitthh TTyyppee 22 DDiiaabbeetteess MMeelllliittuuss:: RReessuullttss ffrroomm tthhee AA11cchhiieevvee SSttuuddyy..

PPrreesseenntteedd aatt tthhee AAmmeerriiccaann DDiiaabbeetteess AAssssoocciiaattiioonn,, 88––1122 JJuunnee 22001122,, PPhhiillaaddeellpphhiiaa,, PPAA,, UUSSAA..

44.. BBaassssaamm BBeenn AAbbbbaass,, MMDD,, WWaalleeeedd AAbbddeell FFaattttaahh,, MMDD,, NNaabbiill eell--NNaaggaarr,, MMDD,, MMaaggddyy AAbbddeell FFaattttaahh AAbbddoouuaanndd,, MMDD,,

AAbbdduullqqaawwii AAllmmaannssaarrii,, MMDD,, DDiiaaaa MMaannssoouurr EEwwaaiiss,, MMDD..IInnssuulliinn ddeetteemmiirr:: SSaaffeettyy aanndd eeffffiiccaaccyy ooff ttrreeaattmmeenntt wwiitthh iinnssuulliinn

ddeetteemmiirr iinn aa ppooppuullaattiioonn ooff ppeeooppllee wwiitthh ddiiaabbeetteess ((ttyyppee 11 oorr ttyyppee 22)) iinn SSaauuddii AArraabbiiaa aanndd tthhee GGuullff ccoouunnttrriieess:: AAnn ooppeenn

llaabbeell nnoonn--iinntteerrvveennttiioonnaall ssttuuddyy oonn ppeeooppllee iinn rroouuttiinnee cclliinniiccaall ddiiaabbeetteess ttrreeaattmmeenntt ((TThhee PPrreeddiiccttiivvee SSttuuddyy.. TThhee RReevviieeww

ooff DDiiaabbeettiicc SSttuuddiieess HHeerrmmaannsseenn,, LLuunndd,, CClleemmmmeennsseenn,, eett aall..VVooll.. 44 ⋅⋅ NNoo.. 22 ⋅⋅ 22000077

55.. NNaabbiill EEll NNaaggggaarr,, JJiihhaadd HHaaddddaadd,, RRaacchhiidd MMaalleekk,, ZZaannaarriiaahh HHuusssseeiinn,, JJiiaann––WWeenn CChheenn,, WWeennyyiinngg YYaannggIImmpprroovveedd

ggllyyccaaeemmiicc ccoonnttrrooll iinn ppeeooppllee wwiitthh TT22DD sswwiittcchheedd ffrroomm aa ggllaarrggiinnee--bbaasseedd pprraannddiiaall iinnssuulliinn rreeggiimmeenn ttoo aa bbaassaall--bboolluuss

rreeggiimmeenn wwiitthh iinnssuulliinn ddeetteemmiirr aanndd iinnssuulliinn aassppaarrtt:: AA11cchhiieevvee ddaattaa.. SSuubbmmiitttteedd TToo bbee pprreesseenntteedd iinn tthhee EEAASSDD aannnnuuaall

MMeeeettiinngg 22001122,, BBeerrlliinn,, GGeerrmmaannyy.. CCoonnttrrooll//TTrraacckkiinngg NNuummbbeerr:: AA--1122--554488--EEAASSDD..TTrraacckkiinngg NNuummbbeerr:: AA--1122--554488--EEAASSDD..

66.. EEll NNaaggggaarr NN,, SSooeewwoonnddoo PP,, KKhhaammsseehh MMEE,, CChheenn JJ,, HHaaddddaadd JJ.. EEffffiiccaaccyy aanndd ssaaffeettyy ooff bbiipphhaassiicc iinnssuulliinn aassppaarrtt 3300 iinn

ppaattiieennttss oonn pprriioorr bbiipphhaassiicc hhuummaann iinnssuulliinn:: DDaattaa ffrroomm AA11cchhiieevvee;; aa 2244--wweeeekk,, iinntteerrnnaattiioonnaall,, pprroossppeeccttiivvee,, mmuullttii--cceennttrree,,

ooppeenn--llaabbeelllleedd,, nnoonn--iinntteerrvveennttiioonnaall ssttuuddyy.. UUnnddeerr PPuubblliiccaattiioonn..

77.. NNaabbiill EEll NNaaggggaarr,, JJiihhaadd HHaaddddaadd,, RRaacchhiidd MMaalleekk,, ZZaannaarriiaahh HHuusssseeiinn,, JJiiaann––WWeenn CChheenn,, WWeennyyiinngg YYaanngg

IImmpprroovveedd ggllyyccaaeemmiicc ccoonnttrrooll iinn ppeeooppllee wwiitthh TT22DD sswwiittcchheedd ffrroomm aa ggllaarrggiinnee--bbaasseedd pprraannddiiaall iinnssuulliinn rreeggiimmeenn ttoo aa

bbaassaall--bboolluuss rreeggiimmeenn wwiitthh iinnssuulliinn ddeetteemmiirr aanndd iinnssuulliinn aassppaarrtt:: AA11cchhiieevvee ddaattaa.. UUnnddeerr PPuubblliiccaattiioonn..

88.. EEll--NNaaggggaarr NN,, KKhhuuddaaddaa KK,, MMaarriisswwaammyy NN,, EEll--SSaayyeedd HH,, AAbbddeell FFaattttaahh WW.. SSaaffeettyy ooff IInnssuulliinn AAnnaalloogguueess iinn PPeeooppllee wwiitthh

TTyyppee 22 DDiiaabbeetteess iinn tthhee GGuullff rreeggiioonn:: aa SSuubbggrroouupp AAnnaallyyssiiss ffrroomm tthhee AA11cchhiieevvee SSttuuddyy.. PPrreesseenntteedd iinn tthhee 33rrdd WWoorrlldd

CCoonnffeerreennccee ooff tthhee DDiiaabbeetteess AAssiiaa SSttuuddyy GGrroouupp ((DDAASSGG)) 22001122..

CURRICULUM VITAE

PERSONAL DETAILS: Name: Dr. Imad El-Din Ginawi El-Sadig Sex: Male Date of Birth: 19-January-1955 Place of Birth: Khartoum, Sudan Nationality: Sudanese Marital Status: Married Three children (15, 13 & 11) Address: Uptodate Medicare Centre, Al Dhiyafah Street, Dubai Islamic Bank

Building, Flat 116, Satwa P.O. Box 117476

Dubai U.A.E. Contact Information: Home: 009714-2236272 Mobile: 0097150-6258252 Business: 009714-3986608 0097150-7700402 Fax: 009714-3984417 E-mail: [email protected] EDUCATION: Congress High Secondary School, Omdurman, Sudan 1969-73 Faculty of Medicine, University of Khartoum, Sudan 1973-79 QUALIFICATIONS: MB, BSc April 1979 MRCP-UK March 1996 MEMBERSHIP OF LEARNED SOCIETIES:

Collegiate Member of the Royal College of Physicians of Edinburgh Collegiate Member of the Royal College of Physicians of London Member of the British Endocrine Societies. Member of The American Association Of Clinical Endocrinologists Member of The American Diabetes Association

CLINICAL INTEREST: General Medicine,

Diabetes & Endocrinology REGISTRATION: Full Registration GMC-UK DOH License, Dubai as: Medical Specialist& Endocrinologist PRESENT APPOINTMENT: Medical Specialist & Endocrinologist, 19/01/2005 Till present UpToDate Medicare Centre, Dubai Medical Specialist & Endocrinologist 01.12.1999 till 30/12/2004 Ultra Care Medical Group, Dubai PREVIOUS APPOINTMENTS: Staff Grade Physician 05.08.1999-31.10.1999 Diabetes & Endocrinology Sunderland Royal Hospital-UK Specialist Registrar (LAS) 01.07.1999-31.07.1999 Diabetes & General Medicine Llandough Hospital,University Hospital of Wales,Cardiff Medical Registrar 06.08.1997-30.06.1999 General Medicine & Endocrinology University Department of Medicine, Glasgow Royal Infirmary Senior House Officer 05.02.1997-05.08.1997 Geriatric & General Medicine Roodlands and Eastern General Hospital East-Lothian NHS Trust, Edinburgh Medical Resident (Senior House Physician) 17.09.1995-30.12.1996 General Medicine Zayed Military Hospital, Abu Dhabi, United Arab Emirates General Practitioner (Medical Officer) 24.04.1986-16.09.1995 General Medicine Al-Falah Military Hospital, Sharjah, U.A.E.

Medical Officer 07.08.1985-24.11.1985 General Medicine Soba University Hospital, Khartoum, Sudan General Practitioner 19.02.1982-18.12.1984 Accident & Emergency Medicine Al-Salam Hospital, Sadah, North, Yemen Medical Officer (Senior House Officer) 01.07.1980-18.12.1981 General Medicine Omdurman University Hospital, Khartoum, Sudan Rotating Internship (Junior House Officer) 01.07.1979-30.06.1980 Omdurman University Hospital, Omdurman, Sudan Short Term Locum Posts: Locum Specialist Registrar in Diabetes and Endocrinology 03.07.2001-27.07.2001 Oldham Hospital, Manchester, UK Locum Medical Registrar, Cardiology & General Medicine 23.05.1999-28.05.1999 Greenish District General Hospital, London Locum Medical Registrar, Respiratory & General Medicine 29.07.1998-03.08.1998 Greenish District General Hospital, London POST-GRADUATE TRAININGS: January 1985 Attended the five-month Course in Internal Medicine at the

Edinburgh Postgraduate Board, Pfizer Foundation. October 1990 One month Clinical Attachment with Dr. M.P. Skander,

Consultant Geriatrician, Good Hope Hospital, Sutton, Coldfield, Birmingham, in Geriatric and General Medicine.

August 1990 One month Clinical Attachment with Dr. S.D. Gupta,

Consultant Geriatrician, Sunderland District General Hospital, in Geriatric & General Medicine.

October 1994 One month Clinical Attachment with Professor L.K.

Borysiewicz, University Hospital of Wales, in Infectious Diseases & General Medicine.

CONFERENCES & COURSES: IDF Dec 2011 2Ist World Diabetes Congress EASD Sept 2011 Lisboa Purtugal ADA July 2011 Sandeigo USA Endo July 2011 Boston –US 10-13 March 2011 CV RISK Management Asia Pacific regional meeting, Istanbul,Turkey 20-24 September 2010 46th Annual Meeting of EASD Stockholm, Sweden 23-26 April, 2010 Exploring gold standards for lipid management in CHD, diabetes & stroke of the vascular biology group,Hangzhou, China. 27-28 February ,2010 GOLD(Global Outreach for learning in Diabetes) The middle East and Asia Pacific Meeting Maximizing the benefits of individualized treatment in type 2 Diabetes. Dubai ,UAE IDF 2009 20th World Diabetes Congress 18-22 October ,2009 Montreal ,Canada 30-31 October 2008 First Middle East Stand Alone Limassol, Cyprus 25-28 September 2008 A new Dawn in Cardio & Vascular Protection Barcelona, Spain 7-11 September 2008 44th Annual Meeting of the European Association for

the Study of Diabetes Rome, Italy 29 August-03 September 2008 European Society of Cardiology Congress Munich, Germany 22-25 May 2008 The Thyroid & Reproductive Symposium Riga 2008 Merck Serono Diabetes Symposium Grand Hyatt, Dubai 25-28 November 2007 10th Congress of the European Society for Sexual

Medicine Lisbon, Portugal

19-20 October 2007 Optimizing Diabetes Care Symposium Limassol, Cyprus 26-27 October 2007 3rd International Summit on Cardio Metabolic Risk

Associated with Intra-abdominal Adiposity Prague, Czech Republic 17-21 September 2007 43rd Annual meeting of The European Association for

the Study of Diabetes Amsterdam, The Netherlands 04-08 March 2007 Meeting of the British Endocrine Society Birmingham, UK 03-04 February 2007 The Journey of Risk Progression & Reduction Istanbul, Turkey 08 September 2006 First Annual Update on Diabetes and Endocrinology Ras-Alkhaima, U.A.E. 16-18 June 2006 Roses Assembly Meeting Cairo, Egypt 07-10 June 2006 The 6th PAN-ARAB Congress of Gastroenterology Beirut, Lebanon 05-07 April 2006 “Present Trial” Summit Meeting Bangkok, Thailand 28-31 March 2006 The 10th Pan Arab Conference on Diabetes Cairo, Egypt 19-20 January 2006 Setting a New Standard in Cholesterol Management Dubai, U.A.E. 03-07 September 2005 European Congress of Endocrinology Goteborg, Sweden 19-20 June 2005 First Advisory Board Meeting (Crestor) Dubai, U.A.E. 24-26 March 2005 Cairo, Egypt (MSD meeting) 14-17 December 2004 Impart Summit Meeting: Novomix R 30 & Beyond Lisbon, Portugal

03-04 December 2004 Reducing the Burden of Cardiovascular and Metabolic Diseases: From Bench to Bedside Dubai, U.A.E.

25-26 November 2004 New Clinical Insights in Cardiovascular Protection Muscat, Oman 28 August- 01 September 2004 European Congress of Cardiology Munich, Germany 24-26 March 2004 “Arcoxia” Regional Opinion Leaders Meeting Beirut, Lebanon 22-24 March 2004 The British Endocrine Societies Meeting Briston, UK 13-20 February 2004 Optimizing Lipid Management: Reducing Cardiovascular

Risk, Beirut, Lebanon 13-14 January 2004 Advancing Nutrition in Diabetes Speakers Summit Bangkok, Thailand 03-13 October 2003 The Cardiovascular Continuum: “The Promise of

Protection” Marrakech, Morocco 16-17 September 2003 The Oxford Advanced Endocrinology Seminar,

St. Anne’s College, Oxford, UK 24-26 July 2003 Obesity Clinical Practice Update, presented and

Moderated by Prof Philip James (UK), and Prof Nick Finer (UK), Cairo, Egypt

06-09 June 2003 The Pfizer Cardiovascular Workshop Mont Carlo, France 26-29 January 2003 Arab Health Congress Dubai, U.A.E. 12-16 March 2000 The 19th joint Meeting of the British Endocrine Societies

in Birmingham, UK. August 1997-June 1999 Specialist Registrar Training Programme in Diabetes &

Endocrinology organized by west of Scotland Board for Specialist Registrars postgraduate training, as a day release teaching on monthly basis.

12-15 April 1999 The 18th joint meeting of the British Endocrine

Societies, at Bournemouth. 09-11 April 1999 Advanced University Programme on Osteoporosis at

Robinson College, Cambridge. 19 May 1998 CME medical education project in Diabetes and

Endocrinology by Scotland & North East England Section.

Nine wells Hospital, Dundee. September 1997 Osteoporosis Symposium, one day workshop organized

by the Royal College of Physicians of Glasgow 05-06 December 1997 The Caledonian Society for Endocrinology winter

meeting, Edinburgh. UK EXPERIENCE: My post in Sunderland Royal University Hospital, as Staff Grade Physician with Professor R.L. Kennedy (Professor of Diabetes & Endocrinology) and Dr. A.J. Chapman (Consultant Endocrinologist) in a busy Diabetes Centre and Endocrinology practice gave me good insight in the management and care of diabetic patients. I am involved twice weekly in Diabetes New Patient Clinic and once weekly in Diabetes Review Clinic, Diabetes Foot Clinic, Antenatal Diabetes Clinic (joint clinic with obstetrician), Thyroid Clinic and Endocrinology Clinic. I do Diabetics In-Patients ward round once weekly. My post as a Medical Registrar at the University Department of Medicine, Glasgow Royal Infirmary-General Medicine and Endocrinology, gave me good chance to practice medicine in a very busy 920-beds teaching hospital, where I have worked with Professor J.H. Mckillop (Professor of Medicine), Dr. J.A. Thomson (Reader in Medicine and Consultant Endocrinologist), Dr. H.W. Gray (Consultant Physician with interest in Nuclear Medicine) Professor G.D.O.Lowe (Professor of Vascular Medicine, Professor M. Lean (Professor of Human Nutrition) and Dr. F. Drybrugh (Consultant Biochemist). As the specialty interests of the Department included General Medicine, Endocrinology, Mineral Metabolism, Nuclear Medicine, Stroke Unit, and Thrombosis/Hemophilia, I have gained tremendous experience in these disciplines excluding nuclear medicine. My responsibility included in-patients Care as far as their investigations, management and day to day follow up are concerned. I also had full commitment in the Out-Patients Clinics, including General Medicine Clinic, Thyroid Clinic, General Endocrine Clinic and Mineral Metabolism Clinic. The Acute Medical Receiving Rota was 1 in 4, in which I was first on-call covered by SPR and Consultant from home, responsibility here was reviewing all patients with acute medical emergencies following referral from the community, A & E Department and the rest of the hospital Non-Medical Departments, arranging their appropriate investigations, performing emergency procedures and putting into action a clear management plan. I shared

Acute Receiving Duties in the CCU, once or twice every month. I did regular Independent Ward Rounds at least twice weekly. I used to cover the wards over the week-ends once or twice per month from home (on call). Excellent Experience gained in dealing with all medical and cardiac emergencies, stroke management and in general medicine. Good experience gained in management and investigations of Thyroid Disease, Adrenal Disorders, Gonadal Dysfunction, Parathyroid Disease, and Metabolic Bone Disease. During my post at Roodlands and Eastern General Hospital in Edinburgh, I spent six weeks each in Medical Unit, Geriatric Assessment and Rehabilitation Wards, Acute Admission wards at Eastern General Hospital and the long term Residential Wards, Acute Admission wards at Eastern General Hospital and the long term Residential Wards plus Day Hospital at Edenhall and Eastfortune Hospitals. In the medical unit, I worked with Dr. R. J. Kellt (Consultant Physician). I was in charge of a General Medical Ward with direct admission of medical emergencies from the community for management and further investigations. I worked with Dr. G.B. Rhind (Consultant Physician) looking after in-patients in the Acute Assessment and Rehabilitation wards, long term residential wards and day hospitals. During this post, I enjoyed working as part of a multi disciplinary team including physiotherapists, OT & social workers. Excellent Experience gained in Geriatric Medicine. PREVIOUS WORK EXPERIENCE: In my internship year, in one of the three large teaching hospitals in Khartoum, I spent three months each in Obstetrics and Gynecology, General Surgery, General Medicine, and Pediatric Medicine. The following year, I worked wholly in the Department of Medicine at the same hospital, in a very busy general medical unit, where I learned to perform all basic procedures under supervision, and also started learning fibreotic upper gastrointestinal endoscopy. My post in north Yemen was spent largely in the Accident and Emergency Department, but also helped in primary care clinics. I have enjoyed working in Al-Salam Hospital with American and British Consultants, and junior staff of different nationalities. On my return to Sudan, I joined the Department of Internal Medicine at a second large teaching hospital in Khartoum, consolidating my basic training in general medicine. Because further postgraduate studies require more resources than I could afford in Sudan, I decided that I should take advantage of an offer of a better paid post with the UAE Armed Forces, starting in Sharjah. There, initially I had to work in all departments, but after two years I managed to get myself attached full-time to the medical department, where I worked with Dr. M.A. El-Bur, whose particular interest was Cardiology in addition to General Medicine, and Dr. M. Abdullkarim, who was a chest physician, with both of whom, I covered all aspects of Acute Medical Care. In particular, I was looking after patients in ICU, and I learned to perform some specialized Non-Invasive Cardiac investigations, such as Exercise Tolerance test and Echocardiography. I passed the MRCP Part 1 in February 1993. In 1995, I had the opportunity to follow Dr. El-Bur to the main Military Hospital in Abu Dhabi, in UAE, where there were a full range of consultants in Department of Medicine, better

Laboratory and X-Ray facilities and Cardiac Catheterization Laboratory. In addition to General Medicine with Professor N McD Davidson, I rotated every four months through Cardiology, Gastroenterology, Diabetes & Endocrinology, Respiratory Medicine, and Infectious Diseases. There were no house physicians here, so I was first on-call (rota varied between 1:4 and 1:7), with Specialist or Consultant second on-call from home. Duties involved the management of all medical emergencies with ICU cover (which also receives acute cardiac emergencies), in-patient care and various specialties out-patients clinics. I passed the MRCP Part 11 in March 1996. In 1997, my ambition forced me to come to UK to have some experience in western medicine and to raise my knowledge in general medicine to the highest level. CLINICAL SKILLS: I am competent in routine procedures, including central venous cannulation, Pleural aspiration and drainage (fluid/air), acetic fluid drainage and lumbar puncture. I am familiar with Treadmill Exercise Testing, Echocardiography, and Cardiopulmonary Resuscitation. I have recently updated my ALS PROVIDER Certificate which will expire on 14/09/2000. I can perform endotracheal intubation, and have limited experience in controlling ventilators. I am familiar with the various Endocrinological & Mineral metabolism investigations, patient’s management and long term follow up. CME is an ongoing personal goal. I have never had any difficulty learning new techniques, and I am keen to learn all other tasks that develop in the future, which I should think present no problems. TEACHING EXPERIENCE: Based in a teaching hospital (Glasgow University Medical Dept.), I gained an extensive teaching experience. I was involved in teaching of both undergraduate and postgraduate MRCP candidates clinical teaching sessions. Once weekly, I used to teach the final medical students bedside clinical methods, and another one hour session on practical procedures. I also taught the Dental medical students bedside medical history taking. Teaching also occurred in the out-patients clinics. I took an active part in the very successful teaching programme in GRI for candidates sitting part 11 of MRCP, involving preparation for the long and short cases and viva. Since passing the MRCP, I have been given increasing responsibilities in teaching others and arranging teaching programmes. I have enjoyed teaching juniors, particularly after passing the MRCP, and I am keen to continue to do so. Once weekly, a unit clinical meeting was held for either Case presentation, unit Research results, Audit or X-ray meeting. I had regular presentation in these meetings. AUDIT EXPERIENCE: I am involved in our once weekly mineral metabolism audit in which we discuss selected patients who imposed either diagnostic or management dilemma.

An audit for endocrinology cases is held every two months, which I also attend. RESEARCH EXPERIENCE:

Ongoing research:Vrtue study: Combaring Vildagliptin and Metformin with Sulphonyl ureas and Metformin during Ramadan

Edge study International study comparing the the efficacy and tolerability of Vildagliptine and other oral hypoglycaemic tablets in combination therapy Study will close 31/03/2011

I have been involved in Impart research study I have been involved in Prove it research study I have been involved in Achieve 1 & Achieve 2 research study as well

I have been involved in research at Glasgow Royal Infirmary about:

Unnecessary parathyroidectomy in Familial Hypocalciuric Hypocalcaemia at the west of Scotland.

How useful is nuclear medicine scanning in the investigation of primary hyperparathyroidism.

I have great desire to do more research in future. PUBLICATIONS:

An abstract: Cushing’s syndrome caused by CRH secretion from a carcinoid tumour? Has been accepted for a poster presentation & published in Proceedings of the ACB (Association of Clinical Biochemists) National Meeting, Focus 99, Manchester UK, 17-21 May 1999. An abstract: Unnecesarry parathyroidectomy in Familial Hypocalciuric Hypercalcaemia. A poster and publication of this research study has been presented at the Scottish Society for Experimental Medicine meeting in Aberdeen on the 7th of May 1999. An abstract: How useful is nuclear medicine scanning in primary hyperparathyroidism. Accepted for poster presentation & publication at the Scottish Society for Experimental Medicine on 7th of May 1999. Management of thyrotoxicosis in pregnancy: Electronic response to an Editorial in BMJ

02-Jan-1999: Vol. 318 5-6, issue 7175 (www.bmj.com)

CAREER INTENTIONS: My first aim must be to convey my experience in General medicine, Diabetes and Clinical Endocrinology gained in UK best Hospitals in this part of the world, as I have already upgraded my level to match that of my peers working in Western Health Care and western teaching hospitals. I intend to join a teaching hospital if possible to provide the expertise I gained in UK in teaching Internal Medicine to the medical undergraduate & postgraduate students. Research in Diabetes and Endocrinology is also on of my goals under the right setting. Working both in my chosen Subspecialty, General Medicine & having the joy of Teaching and Research will only be the driving force for my future career intentions. MEMBERSHIP OF LEARNED SOCIETIES:

Collegiate Member of the Royal College of Physicians of Edinburgh Collegiate Member of the Royal College of Physicians of London Member of the British Endocrine Societies. Member of the American Association of Clinical Endocrinologists Member of the American Diabetes Association

RECREATIONAL ACTIVITIES:

Computers Reading Exercise: Walking, jogging

REFEREE: Provided on demand:

Provisional Old: -United Arab Emirates

-North Yemen -Sudan

Recent: -UK



1st Annual Meeting

October 12, 2012 Attn: Gulf AACE Chapter Members, In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model, the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This meeting is open to all Gulf-AACE members and their invited guests.

If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173. 1 Name: Dr. Amin Jayyousi Address P.O BOX 39098 City: Doha Country: Qatar Email: [email protected] , [email protected] 2 Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the purposes of Chapter business? __√_ yes ___ no 3 Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

___ President ___ Vice President ___ Secretary ___ Treasurer _√__ Board of Director Member

1

WEILL CORNELL MEDICAL COLLEGE, CORNELL UNIVERSITY CURRICULUM VITAE

Date of preparation: 12th. MARCH 2012

A. GENERAL INFORMATION

Required Information:

Name: AMIN A.JAYYUOSI Office address: QATAR- DOHA – P.O. BOX 3050 Office telephone: +974-4439-2308 Office fax: +974-4439-2745 Home address: QATAR-DOHA – P.O. BOX 39098 Home telephone: +974-4411-3678 Cell phone: +974-5553-0236 Beeper: 211-0284 Email: [email protected] Citizenship: QATARI If not a U.S. Citizen, do you have, for the U.S.A., an Immigrant visa or Non-immigrant Visa

Yes, I have

Optional Information:

Birth date: March 13th, 1953 Birth place: JORDAN Marital status: SINGLE Spouse’s name: -------------- Children’s name and ages: --------------- Race/Ethnicity: ARAB

B. EDUCATIONAL BACKGROUND

Degree Institution Name and Location

Dates attended

Year Awarded

M.B.B.S JORDAN UNIVERSITY - JORDAN

1971-1978 1978

MASTER PROGRAM OF INTERNAL MEDICNE

JORDAN UNIVERSITY - JORDAN

1979-1982 1982

C. PROFESSIONAL POSITIONS AND EMPLOYMENT

1. Post-doctoral training (include residency/fellowships)

Title Institution name and location Dates held ROTATING INTERN JORDAN UNIVERSITY 1978-1979

2

HOSPITAL RESIDENT 1 IN INTERNAL MEDICINE

JORDAN UNIVERSITY HOSPITAL

1979-1980

RESIDENT 2 IN INTERNAL MEDICINE


1980-1981

CHIEF RESIDENT IN INTERNAL MEDICINE


1981-1982

2. Academic positions (teaching and research)

Title Institution name and location Dates held

3. Hospital positions (e.g., attending physician)

Title Institution name and location Dates held SPECIALIST INTERNAL MEDICINE

HAMAD HOSPITAL/DOHA-QATAR

1982-1984

SPECIALIST ENDOCRINE & DIABETES

HAMAD HOSPITAL/DOHA-QATAR

1984-1992

CONSUALTANT C HAMAD HOSPITAL/DOHA-QATAR

1992-1996

CONSUALTANT B HAMAD HOSPITAL/DOHA-QATAR

1996-2000

CONSUALTANT A HAMAD HOSPITAL/DOHA-QATAR

2000-PRESENT

4. Other Employment

Title Institution name and location Dates held

D. LICENSURE, BOARD CERTIFICATION, MALPRACTICE

1. Licensure

a. State Number Date of issue Date of last registration

JORDAN MEDICAL LICENSE

1978 TILL NOW

QATAR MEDICAL LICENSE

1982 TILL NOW

3

b. If no license: 1. Do you have a temporary certificate?

2. Have you passed the examination for foreign medical school graduates?

c. DEA number (Optional):

2. Board Certification

Full Name of Board Board Certificate Date of Certification

JORDAN BOARD OF INTERNAL MEDICINE

1982 1982

3. Malpractice insurance

Do you have Malpractice Insurance? NO, I DON’T Name of Provider:

Premiums paid by:

E. PROFESSIONAL MEMBERSHIPS (medical and scientific societies)

Member/officer Name of Organization Dates held JORDANIAN MEDICAL SYNDICATE 1978- PRESENT JORDANIAN MEDICAL SOCIETY OF INTERNAL MEDICEN

1984- PRESENT

GULF LIPID CLUB BOARD MEMBER 1989 GGSD (GULF GROUP FOR STUDY OF DIABETES ) BOARD MEMBER

2010

QATAR DIABETES ASSOCIATION FOUNDING MEMEBR

1996

AACE (AMERICAN ASSOCIATION OF CLINCAL ENDOCRINOLOGY)

2000

QATAR MEDICAL SOCIETY 2007 Active Member American Endocrine Society 2012

F. HONORS AND AWARDS

Name of award Date awarded KING HUSSEIN OF JORDAN Award 1982 Qatar Diabetes Association Award 2007 HMC Award for 25 years service 2008 KING ABDALLAH BIN ABD ALAZIZ Award 2010 STARS OF EXCELLENCE HAMAD HOSPITAL 2011

4

Award DALM ΧVII Diabetes, Obesity the Metabolic syndrome Doha-Qatar , March 14th -16th ,2011

2011

Diabetes Awareness Campaign Award 2012

G. INSTITUTIONAL/HOSPITAL AFFILIATION

1. Primary Hospital Affiliation: HAMAD MEDICAL COORPORATION HOSPITALS

2. Other Hospital Affiliations:

3. Other Institutional Affiliations:

H. EMPLOYMENT STATUS

Name of Current Employer(s): HAMAD MEDICAL COORPORATION Employment Status: SENIOR CONSULTANT

ENDOCRINOLOGY & DIABETES

I. CURRENT AND PAST INSTITUTIONAL RESPONSIBILITIES AND PERCENT EFFORT

1. Teaching (e.g., specific teaching functions, courses taught, dates)

Course, role, institution, etc. Dates Lecturer, Qatar University students “Medical laboratory course” 1988-1992

Lecturer, Qatar Nurses High school 1989-1994

Preceptor, “Medicine Patient and Society I”. Weill Cornell Medical College in Qatar

2004-present

SPEAKER IN DIABETES LECTURES FOR PRIMARY HEALTH CARE PHYSICIANS AND PHYSICIANS IN PRIVATE SECTOR.

SINCE 1982

GIVING LECTURES IN DIABETES/ ENDOCRINE WEEKLY ACTIVITY

SINCE 1982

DEPARTMENT OF MEDICINE GRAND ROUND LECTURES AND CASE PRESENTATION

YEARLY

LECTURING RESIDENT MEDICINE AND PRIMARY HEALTH CARE PHYSICIAN ROTATING IN DIABETES/ ENDOCRINE DIVISION

SINCE 1982

TEACHING RESIDENT DURING WARD ROUND SINCE 1982

TEACHING RESIDENT IN OUTPATIENT CLINIC SINCE 1982

2. Clinical care (duties, dates)

Duties Date

Consultant , Running seven Clinics per week, Endocrine & Diabetes

1984-present

5

• Four morning clinics (7:00 AM – 11:00 AM)

• Three evening clinics ( 5:30 PM- 9:00 PM)

Consultant, Ward Rounds for Medical Students, Residence and fellows ; Inpatient surgical & medical, Women Hospital, Cancer Centre, Geriatric Hospital, Psychiatry Hospital, Cardiac Centre.

1984-present

Consultant , On Call Duty, covering consultations at night for Hamad Medical Corporation Hospitals ( A&E and Inpatients)

1984-present

3. Administrative duties, including committees, dates

Duties Dates Advisor, His Excellency SH.Hamad Bin Suhaim Althani X-Minister of public health In Qatar

1990-1992

Committee Member for selection Endocrine & Diabetes fellows.

2010-present

Committee Member for gestational diabetes guidelines 2011

Committee Member of women hospital out patient department

2011

Acting Head Endocrine & Diabetes section 2000-present

Committee Member Diabetes unit project 2011-Present

Advisory Board Member for Eli-Lilly company 2011

Advisory Board Member for Bristol Mayer Squib Company

2011

4. Research

Description Dates (if

Applicable)

My main interest is multi-disciplinary focusing on diabetes prevention in Qatar as well as diabetes problem from aetiology, Presentation , Complications and Management in Qatar

Research with Weill Cornell Medical college Qatar:

• High prevalence of the APOE Arg 145 cys Dyslipidemia At-risk polymorphism in African Derived populations

• Identification of Novel risk locus for type 2 diabetes in Qataris linked to selected skin pigmentation genes

• Exome Sequencing of only seven Qataris identifies deleterious alleles relevant to Qatar’s national health profile

Principal Investigator(PI): “Efficacy & Durability of GLP-1 / Thiazolidinedione versus Basal-Bolus insulin therapy in poorly controlled type 2 DM patients” NPRP No. : 5-273-3-079

Co-Investigator : “Qatar Diabetes Prevention Study” submitted for funding QNRF

6

Co-Investigator: The impact of structured medication therapy management on the clinical & Humanistic outcomes of diabetes: A randomized controlled trial in Qatar. NPRP No. : 5- 206- 3- 060

Co-Investigator : “CORRELEATE STUDY” With Cedars-Sinai Hospital & Cardiac Centre in Qatar

Supervisor : Comparison between different types of statins used to treat dyslipidemia in diabetic patients in Qatar with focus on efficacy and safety profile on hepatic and renal functions, Funding : HGH Medical research centre approved 27500 QR

Current Percent Effort (%) Does the activity involve WCMC students/researchers? (Yes/No)

Teaching 35% Yes Clinical Care 35% Yes Administration 10% NO Research 20% Yes

TOTAL: 100%

J. RESEARCH SUPPORT

Current Research Support:

1. Source Amount Duration of support (dates)

HGH Medical research centre 27500QR 1 year

Name of Principal Investigator: Lulwa Barakat

Individual's role in project, including percent (%) effort:

40%

Title or Subject (Optional): Comparison between different types of statins used to treat dyslipedmia in diabetic patients in Qatar with focus on efficacy and safety profile on hepatic and renal functions.

K. EXTRAMURAL PROFESSIONAL RESPONSIBILITIES

Responsibility Dates

Speaker: GGSD “ Gulf Group for Study of Diabetes, Doha- Qatar

December 26th 2009

Organizer & Moderator: First International Diabetes October 19th -20

7

course with Harvard Medical School , MODULES I & II 2009

Organizer & Moderator: First International Diabetes course with Harvard Medical School , MODULES III & IV

January 16th 2010

Speaker: 3rd International Gulf Group for the study of diabetes, Jeddah- Saudi Arabia

February 9th -11th 2010

Organizer & Moderator: First International Diabetes course with Harvard Medical School , MODULE V

March 6th 2010

Speaker: WORLD DIABETES DAY, Prediction & prevention of diabetes type 2.

November 2011

Speaker: DIABETES AND PREGNANCY IN QATAR January 2011 Speaker & Moderator: XVII International DALM symposium on diabetes, obesity and the metabolic syndrome

March 14th -16th 2011

Speaker & Moderator & Member of Organizing Committee: First International AACE Gulf Conference on diabetes obesity and other endocrine diseases

January 14th – 16th 2011

Moderator: Diabetes educator symposium November 17th 2011

IDF “World diabetes congress Dubai” December 4th – 8th 2011

The 3rd Congress of the Jordanian society of endocrinology, diabetes and metabolism “JSED”

May 3rd -7th 2010

1st Qatar National chronic disease surveillance strategy workshop

November 16th – 17th 2009

Qatar Health conference, Primary health track December 15th 2010

Lilly Diabetes forum, Beirut – Lebanon May 28th -29th 2010

45thAnnual meeting of EASD “ European Association for the Study of Diabetes” Vienna- Austria

September 30th- 2nd October 2009

46thAnnual meeting of EASD “ European Association for the Study of Diabetes” Stockholm-Sweden

September 20th -24th 2010

2nd DASG International conference “ Secondary prevention of Diabetes” Doha-Qatar

March 26th -27th 2010

Therapeutic choices in patients with diabetes: Implications for glycemic control, treatment adherence and quality of life Eli Lilly Company, Barcelona- Spain

September 29th 2009

Workshop on insulin pump therapy and REAL TIME CGM, Doha- Qatar

January 20th 2007

Diabetic foot symposium, Doha-Qatar November 19th 2005

Board Member : 1st Gulf Lipid Club conference, Muscat- Oman

1989

International conference “Childhood diabetes & obesity, Doha- Qatar

October 10th -12th 2008

2nd World Congress CODHY “ Controversy to Consensus in Diabetes, Obesity and Hypertension” Barcelona- Spain

October 30th –November 2nd 2008

17th Annual meeting and Clinical Congress AACE, Orlando- Florida

May 14th 2008

8

“Changing the course to glucose control” Dubai-UAE November 9th &10th 2007

The Second Congress of JSED- AACE, Amman –Jordan May 16th-19th 2007

AlAmal Hospital First Cancer Conference, Doha-Qatar February 5th -7th 2009

47thAnnual meeting of EASD “ European Association for the Study of Diabetes”, Lisbon- Portugal

September 2011

Diabetes Expert forum Eli Lilly Company, ” Barcelona- Spain

May 20th-21st 2011

Fasting and Diabetes symposium by NovoNordisk, Doha- Qatar

Jun 11th 2011

ACGME competencies, assessment Tools, Supervision and feedback technique workshops, Doha – Qatar

October 6th 2011

Moderator: The First Qatar Thalasemia Forum on Growth and Endocrine Complications of Thalasemia and the first meeting of the international Group for studying Endocrine complications of Thalasemia, Doha – Qatar

October 2nd -3rd 2011

Medical Education Conference HMC & Weill Cornell Medical College, Qatar

January 20th -22nd 2012

Workshop Gestational Diabetes HMC & Brighman women hospital

January 29th 2012

Bydureon Advisory Board Meeting, Dubai- UAE February 25th, 2011

Advance in diabetes Master Class Meeting, Dubai- UAE April 30th 2011 Moderator: Open Medical Institute Satellite Symposium” Diabetes Management”-Doha/Qatar

May 5-6, 2012

Expert Meeting: “ORIGIN Study” Focused meeting- Abou Dhabi/UAE

May 10th, 2012

Awarded: The fourth Annual Forum: Qatar National Research Fund Doha/Qatar

May 15, 2012

21st American Association of Clinical Endocrinologists Philadelphia/USA

May 23-27, 2012

L. BIBLIOGRAPHY

1. Articles in professional peer-reviewed journals

1. Jayyousi A, Wisam Ghadban, Mahmoud Zirie, Daoud Al-Khateeb, Hassan Mobayedh, Ahmed El-Aloosy. Radioiodine treatment of hyperthyroidism, success rate & influence of thyrostatic medication. Saudi Medical Journal. 2003; April : 24(4) :347-51.

2. Jayyousi A, M.Zirie, Ibrahim Mohd .Denovo mutation in multiple Endocrine Neoplasia – 2B: Family study & Review of Literature. The Endocrinologist. 2001; 11: 237-243

3. Jayyousi A. Antithyroid drugs: a review, HAMAD Pharmacy Bulletin & drug information. 1985; Vol. 2, No. 6, 1-3.

9

4. Jayyousi A. NABIL ISSEH. Dyslipidemia in Qatari patients with non-insulin dependent diabetes, international diabetes digest. 1996. Vol.7, No. 1.

5. Jayyousi A., A.Toukan etal Trithiozine in treatment of duodenal ulcer.Jordan Medical Journal 1984; Vol.18, No.1.

2. Presentations (Optional. Other than invited lectures. List 10-20 best or most recent only)

Lectures delivered on the following subjects “ Didactic/ CME”

1. CONN’s disease. 2. Insulinoma. 3. Graves’ disease. 4. DKA. 5. Polycystic ovary disease. 6. Hypoglycemia. 7. Does intensive glucose control reduce CV disease risk 8. Thyroid disease and pregnancy. 9. Gestational of diabetes 10. Thyroiditis. 11. Addison’s disease. 12. Pheochromocytoma. 13. Prevention of diabetes. 14. Prolactinomas. 15. Thyroid Nodules. 16. Diabetes therapy update for pharmacists in private sector. 17. Diabetes overview for primary health care physicians. 18. Diabetes awareness campaign for Indian community. 19. Patient education about diabetes awareness & endocrine disease through

media ( Radio station, Aljazeera Satellite and News papers both Arabic and English).

20. Booklets for patients education about diabetes and exercise, Fasting Ramadan, Hajj, Sick days.

Date: 07/06/2012 Signature: Amin A. Jayyuosi



1st Annual Meeting

October 12, 2012











1 Name: DR SATENDRA KUMAR MULTANI

Address: AL ZAHRAWI HOSPITAL,OMAN STREET,AL NAKHEEL

City: RAS AL KHAIMAH, PO BOX 5442

Country: UNITED ARAB EMIRATES



purposes of Chapter business? _YES__ yes ___ no


___ President

___ Vice President

___ Secretary

___ Treasurer



1

CURRICULUM VITAE

CARRIER OBJECTIVES: To obtain a respectable position in the field of Endocrinology through optimal delivery of updated and evidence based knowledge to the suffering human beings & by getting involved in clinical research with special reference to diabetes, thyroid disorders & metabolic bone disorders.

PERSONAL STRENGTH AND SKILLS:

I am a highly motivated, Innovative, Proactive, Ambitious, Committed, Goal oriented, & Balanced person with strong work ethics. I am endowed with excellent communication, leadership, organizational and interpersonal skills.

EDUCATIONAL QUALIFICATION

QUALIFICATION PERIOD FROM� TO �.

ACADEMIC INSTITUTE

COUNTRY YEAR

AWARDED

M.B.B.S. (INTERNSHIP)

September 1992 to

March 1998.

SSMC, APSU, Rewa, Madhya Pradesh

India April, 1998

MD (General/Internal Medicine)

May 1998 to April 2001

GMC, BU, Bhopal, Madhya Pradesh

India June, 2001

Dr Satendra Kumar Multani MBBS, MD (Med), DNB (Med), MNAMS, DM (Endocrinology),FACE, MRCP-SCE(Endocrinology)

Endocrinologist / Diabetologist Al Zahrawi Hospital ,PO Box- 5442, Al Nakheel Ras Al Khaimah, UAE. Adjunct Faculty, Internal Medicine, RAK MHSU, Ras Al Khaimah, UAE. Contact No: - + 971 50 3732514 Off. - + 971 7 2288544 Fax No.: +971 7 2288588 DOB- 26th April 1975 Email- [email protected] [email protected]

2

DNB (General/Internal Medicine)

May 1998 to April 2001

National Board of Examinations, New Delhi

India September, 2003.

DM(Endo-crinology)

August 2001 to July 2004

Seth GSMC, KEMH, Mumbai

India August, 2004

ADDITIONAL QUALIFICATION / TRAINING DETAILS:

• MRCP(UK)-SCE(Endocrinology) – Specialty Certificate Examination In Endocrinology conducted by Royal College of Physicians UK- June 2012.

• Fellow of American College of Endocrinology (FACE) - Awarded by American College of Endocrinology at Boston, April 2010.

• Visiting Fellow in Endocrinology, Diabetes & Metabolic Bone Clinic at University of Basel, Switzerland, August 2009.

• Visiting Fellow in Endocrinology and Diabetes at Diabetes –Endocrinology Centre of Western New York, July /August 2008.

• First international Diabetes Course in the UAE (5 Modules- 2009-2011) organized by AACE- Came first in UAE in course evaluation.

• IOF Osteoporosis Diagnosis Course with Densitometry Certification (Passed the exam with highest marks), Dubai, UAE, in March 2008.

• 17th IOF Advanced Training Course on Osteoporosis at Lyon, France, January 2008.

• Research in Diabetology (Research in Diabetes Epidemiology and Biostatistcs) Course held by Steno Diabetes center, Denmark at Aurangabad , India in Feb 2005.

• Advance training in Hormone assays (RIA /IRMA) at Bhabha Atomic Research Centre (BARC), Mumbai, India in October 2004.

• IELTS - Band score - 7.5, Speaking-8, Writing- 7, Listening -7, Reading-8.

• MNAMS - Member of National Academy of Medical Science, New Delhi.

CURRENT POSITION

Specialist A – Endocrinologist & Diabetologist Al Zahrawi Hospital, Ras Al Khaimah, UAE. Period – From June 2005 to till date (7 years). Currently I am working as an Endocrinologist & Diabetologist in this private hospital at Ras Al Khaimah, UAE. I am independently responsible for managing most of the problems related to diabetes, thyroid, hypertension, lipid disorders and adult endocrinology. I have started the Endocrine & Diabetes department in this hospital and it is supported by state of art laboratory.

My achievements during this tenure are as follows:

3

A. I have been actively involved in Diabetes education for diabetic patients and I have conducted various diabetes education programmes at hospital and community level.

B. I have been regularly organizing educational programmes on “Obesity Prevention and Management” for general public including my patients.

C. To update the physicians of this Emirate on Diabetes and other Endocrine related disorders, I started the CME programmes in collaboration with AKMG, Ministry of Health and Medical Universities. We had organized the “First Annual Update on Endocrinology and Diabetes in September 2006” in RAK. The last meeting organized by me was on 5th March 2010 – 3rd Endocrine & Diabetes Update.

D. Guest speaker & chairman for various diabetes & Endocrine related CME activities at Ras Al Khaimah, Dubai, Ajman, and Fujairah.

E. Besides these, I am constantly updating my knowledge & expertise by attending national/ international CME programmes and conferences.

Adjunct Faculty in Internal Medicine, RAK MHSU, Ras Al Khaimah, UAE. Since last 4 years, I am attached to one and only medical university in Ras Al Khaimah emirate of (RAKMHSU) as an Adjunct faculty in department of Internal medicine. I am actively involved in teaching related to diabetes & endocrinology, conducting research with faculty from different departments and organizing CME activities for students, faculty as well as for clinicians in this region.

Visiting Fellow in Endocrinology , Diabetes & metabolic bone clinic at University of Basel , Switzerland , August 2009. I went as a visiting fellow to this centre and worked with Dr. Marius Kraenzlin and his team . Dr. Kraenzlin is a consultant of Calcium- and Bone Metabolism in the Division of Endocrinology, Diabetology and Clinical Nutrition at the University Hospital Basel and he is the professor of endocrinology and the faculty of medicine at the University of Basel. He is a committee member of various scientific societies and past president and actual secretary of the Swiss Society for Osteoporosis and secretary of the Swiss Society of Endocrinology and in Diabetology. He is involved in clinical research studies of metabolic bone disease with a particular interest in biochemical markers. M. Kraenzlin is author of more than 150 scientific articles. He is the IOF representative for Clinical Densitometry Course conducted all over the world time to time. He is also a regular reviewer for several scientific journals. His centre is one of the largest centres in Switzerland dealing with metabolic bone disorders. I felt fortunate to be there and my learning about metabolic disorders was tremendous. I came across the commonest to rare metabolic disorders. The most important aspect of my learning was rational use of various bone markers & newer molecules in management of osteoporosis. Overall it was great experience which has added a lot to my learning curve in endocrinology.

Visiting Fellow- Endocrinology And Diabetes At Diabetes Endocrinology Centre Of Western New York, Buffalo (USA). Period - July /August 2008.

4

I went to this centre to work with Dr. Paresh Dandona who is the founder and director of the department. This centre is part of a comprehensive clinical care and education programme sponsored by Kaleida Health , the region’s largest health care system and State University of New York at Buffalo School of Medicine and Biomedical Sciences . This centre is the regional leader in the advancement of research and treatment for diabetes and its complication. The centre is renowned for its work on role of oxidative stress in diabetes and effect of various antidiabetic therapies on it. The researchers for the centre have demonstrated the unique properties of Insulin in terms of anti-inflammatory, anti atherogenic, antifibrinoloytic actions. They have also demonstrated the prevalence of hypogonadism in type 2 diabetes patients and its clinical importance. It was great opportunity for me to work at this centre and the experience that I gained as a visiting fellow was unforgettable and outstanding in terms of learning the American standards of care for diabetes patients, the importance of aggressive management of diabetes and its related complications, understanding & implementing the rigorous research protocols etc.

PREVIOUS POSITIONS HELD

A. Lecturer (Consultant) in Endocrinology and Diabetes. Seth G. S. Medical College, KEM Hospital, Mumbai, INDIA 400012. Period- 16th November 2004 to 24th May 2005. I have worked as a lecturer in Endocrinology and Diabetes in this Municipal Corporation Hospital. This was a consultant post and I was a part of team of consultants in decision and policy making of department besides handling the patients independently. During this period, I received the A R SETH best paper award for my research during superspecialty training.

B. Senior Specialist Registrar (Endocrinology And Diabetes) Seth GS Medical College, KEM Hospital, Mumbai, INDIA 400012.

Period- 2nd August 2004 to 15th November 2004 I have worked as a post DM senior registrar in Endocrinology and Diabetes in this largest Municipal Corporation Hospital in Mumbai. This was equivalent to consultant post and I

was a part of team of consultants in decision and policy making of department. During this period I have undergone advanced laboratory training (RIA/IRMA COURSE) at BARC, Mumbai.

Details Of Specialist Registrar (Fellow-Ship) Training (Dm) In Endocrinology And Diabetes Duration – Three years (From 1st August 2001 to 31st July 2004) Supervised by - Professor and Head Dr. Nalini S. Shah Professor and Former Head Dr. Padma S. Menon King Edward Memorial Hospital is a largest teaching and tertiary care hospital of approximately 1800 beds established in 1926 and located in Mumbai, India. The Endocrinology department is nationally renowned, particularly for clinical and research activities relating to diabetes mellitus and other endocrine disorders. This department

5

handles the adult as well as Pediatric endocrine cases as one of the professors is trained in pediatric endocrinology at UK. Both the endocrinology consultants supervised me throughout my training at KEM Hospital. This was evidence-based comprehensive training and it covered all the aspects of adult and pediatric endocrinology. During this period, I gained adequate expertise in diagnosis and management of diabetes mellitus, thyroid disorders, neuro-endocrinology, growth and puberty disorders, intersex disorders, adrenal disorders, metabolic bone diseases etc. During this period, I was actively involved in research, teaching & other academic activities. I had regularly presented interesting cases, seminars & journals in interdepartmental, intradepartmental & intercollegiate meetings. It was a comprehensive 3 years training covering all the aspects of adult and pediatric endocrinology.

CONFERENCES/ COURSES/ WORKSHOPS:

• 2011 � IDF,Dubai,4th – 8th Dec 2011. � IOF Regionals, Dubai.1st Middle East & Africa Osteoporosis Meeting,19th-

22nd October 2011,Dubai,UAE. � 2nd International Diabetic Foot Conference,24th-25th Sept 2011, Dubai, UAE. � 13th European Congress of Endocrinology, 30th April- 4th May 2011,

Rotterdam, Netherland. � 20th Annual Congress of American College of Clinical Endocrinologists

(AACE), April 2011, San Diego, USA. � Update on Medical & Surgical Practice- Participated as Speaker &

Delivered a talk on Osteoporosis, Jan 2011, RAK. � Cardiology Update, Feb 2011, RAK.

• 2010 � Emirates Endocrine Congress, December 2010,Dubai. � The International Diabetes Summit, October 2010, Dubai. � 70TH Scientific Sessions ADA – 25th –29th June 2010, Orlando, Florida USA. � IOF World Congress on Osteoporosis & 10TH European Congress on

Clinical & Economical Aspects of Osteoporosis & Osteoarthritis, May

2010, Florence, Italy. � 19th Annual Congress of American College of Clinical Endocrinologists

(AACE), April 2010, Boston, USA. � Gulf 6th Growth Update Meeting, April 2010, Dubai, UAE. � GOLD (Global Outreach for Learning in Diabetes) meeting, Feb 2010

Dubai, UAE.

• 2009 � AFES ASEAN Federation of Endocrine Societies, Nov 2009, Bangkok,

Thailand. � Emirates Diabetes Congress 2009, November 2009, Dubai, UAE. � Introductory Hands On Thyroid Ultrasound Workshop at Endo Society

meeting 8th June 2009, Washington DC. � 91ST ENDO Society Meeting 9 – 13th June 2009 – Washington DC. � 69TH Scientific Sessions ADA – 5th – 9th June 2009, New Orleans, USA. � 7th Gulf Heart Association Conference, 9-11th April, Dubai, UAE. � GOLD (Global Outreach for Learning in Diabetes) meeting, 21-22nd March

2009, Istanbul, Turkey. � Mayo Clinic Endocrine update 2009 (in Collaboration with Al Noor

Hospital) 18-20th March, Abu Dhabi, UAE.

6

TEACHING EXPERIENCE

I have been actively involved in teaching throughout my post graduation, specialist registrar training and after that till date. Currently I am holding the teaching post at RAK Medical & Sciences University since last 3 yrs. My total teaching experience after post graduation is around 8 years.

RESEARCH EXPERIENCE

I have been actively involved in research activity after registration for post graduation to till date. It was a part of my training during MD and DM and I have done following prospective studies during my training : A. During post graduation- “Vitamin C (Ascorbic acid) estimation in serum and

gastric juice in patients infected with Helicobacter pylori.”

B. During Endocrinology Fellowship Training - “Study of Bone Mineral Density and effect of Various Environmental factors on it, in resident doctors working at Teaching Hospital.”

C. During Current Employment: Currently I am involved in research activities in collaboration with RAK Medical & Health Sciences University and have presented papers in various International Conferences.

PAPERS AND PUBLICATIONS

• SK Multani, M Jain, FK Hassan. Poster presentations on “Pre-Diabetes & Cardiovascular Risk Factors in Multiethnic Hypertensive Population of United Arab Emirates (UAE)” at 20th Annual Congress of American College of Clinical Endocrinologist, April 2011, San Diego,USA.

• SK Multani, M Jain. Poster Presentation on “Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Multiethnic Diabetic population of UAE & It’s Correlation with Cardiovascular Risk Factors” at 20th Annual Congress of American College of Clinical Endocrinologits , April 2011,San Diego,USA.

• Multani SK et al. Survey and evaluation of various epidemiological factors in a multiethnic Diabetic Population in Ras Al-Khaimah, UAE. Indian Journal of Pharmacy Practice Volume 4 Issue 1 Jan-Mar, 2011,18-25.

• Multani SK, Sarathi V, Shivane V, Bandgar TR, Menon PS, Shah NS. Study of bone mineral density and effect of various environmental factors on it, in resident doctors working at a teaching hospital. J Postgrad Med Jan2010 Vol 56 Issue 1.

• SK Multani, M Jain (Abstract Published) .Prevalence of Obesity & Central obesity in multiethnic Type 2 Diabetic population of UAE & their association with other co morbidities. 70TH Scientific Sessions ADA – 25th –29th June 2010. Orlando, Florida USA.

• SK Multani, M Jain, FK Hassan. Poster presentations on “Hypovitaminosis D in Multiethnic Population of United Arab Emirates (UAE)” at World Congress on Osteoporosis, May 2010, Florence, Italy.

• SK Multani, M Jain. Poster Presentation on “Clinico-epidemiological Characteristics & Glycemic Control in Arab /Nonarab Diabetic Population

7

in UAE” at 19th Annual Congress of American College of Clinical Endocrinologits , April 2010,Boston,USA.

• SK Multani, NS Shah, PS Menon, M Jain. Poster Presentation- Vitamin D Status in Resident Doctors Working at a Tertiary Hospital in Mumbai, India. ENDO Society Annual Meeting 2009, Washington DC,USA.

• SK Multani, Meenakshi Jain. (Published)- Clinico –Biochemical Profile of Type 2 Diabetes Patients among the Multiethnic Population in United Arab Emirates (Abstract). 69TH Scientific Sessions ADA 2009,New Orleans ,USA.,

• Jain RK, Asthana BS, Multani SK, Rajdev S. Prospective Study of Pre & Post Treatment Levels Of Vitamin –C In Serum And Gastric Juice In Dyspeptic Patients Infected With Helicobacter Pylori (Abstract). Jr. of Gastroenterology and Hepatology 2001; 16(suppl).

• Kalgikar A M, Khandelwal AG, Chandratreya S, Multani SK, Shah NS, Menon PS. Metformin In Polycystic Ovary Syndrome (Abstract). ESICON (Endocrine Society of India Annual Conference) 2002, Kolkata (India).

• John M, Bandgar T, Multani SK, Mappa P, Shah NS, Menon PS. Does Postoperative Cortisol Levels Predict Long Term Cure In Cushing’s Disease (Abstract). ESICON 2003, Bangalore (India).

• Mappa P, Bandgar T, John M, Multani SK, Shah NS, Menon PS. Respose To Radioactive Iodine In Patients With Graves’ disease (Abstract). ESICON 2004, Guwahati (India).

• Multani SK. Study Of Bone Mineral Density And Effect Of Various Environmental Factors On It, In Resident Doctors Working At Teaching Hospital (Abstract). ESICON 2004, Guwahati (India). I have got the A R Seth award of year 2004 for this paper presentation.

• Bandgar T, Mappa P, John M, Multani SK, Shah NS, Menon PS. ComparisonvOf Block Replacement Therapy And Carbimazole Treatment In The Management Of Graves’ Toxicosis (Abstract). ESICON 2004, Guwahati (India).

• Multani SK , Shah N. S. Diagnosis and management of Precocious Puberty. Impressions- Quarterly Journal of MBIAP (Mumbai branch of Indian Academy of Pediatrics) Sept 2004; 4(3): 6-9.

PROFESSIONAL ORGANIZATIONS : I am the member of following Professional organizations:

• Life member of International Diabetes Federation (IDF)

• American Diabetes Association (ADA).

• European Association for the Study of Diabetes (EASD).

• American Association of Clinical Endocrinologists (AACE).

• Emirates Osteoporosis Society (EOS).

• Life member of Endocrine Society of India (ESI).

• Life member of Association of physicians of India (API).

• Life member of RSSDI, India.

• Life member of Indian Thyroid Society (ITS).

• Life member of Indian Society of Bone Mineral and Research (ISBMR) and IOF.

• Pediatric Endocrine Society, India.

LICENSURES

• MOH, UAE (Specialist A License – Endocrinology)

• DOH- Evaluation- Specialist A – Endocrinology, License not issued but evaluation is valid till June 2012.

8

• MMC (Maharashtra Medical Council),India.

• MCI (Medical Council of India)

• MP Medical Council

AWARDS AND HONOURS:

• Honored by MOH for contribution in Private sector in Treatment of Diabetes.

• Honors in Anatomy, Pharmacology and Pathology during MBBS.

• Distinction in Internal Medicine during MBBS.

• A R Seth award for Year 2004 for best paper presentation at annual Conference of Endocrine Society of India.

• Nominated for A.V. Gandhi Award For Excellence In Endocrinology in India, 2004.

CLINICAL INTERESTS: Besides diabetes following are my areas of special interest:

• Metabolic bone disorders - Vitamin D deficiency and osteoporosis.

• Pubertal disorders in Children.

• Pregnancy and Diabetes.

• Metabolic syndrome and prediabetes.

• Thyroid disorders in Pregnancy.

• Growth hormone deficiency – childhood and adult.

REFERENCES

1. Dr. Paresh Dandona, MD,Dphil,FRCP,FACP.FACE,FACC Founder & Director Diabetes- Endocrinology Centre of Western New York Kaleida Health 3 Gates Circle, Buffalo, NY (USA) 14209

Off- 1716 8874069 Fax- 1716 887 4773 Email- [email protected]

2. Dr. Marius Kraenzlin , MD. Professor, Department of Endocrinology & Diabetes. Missionsstrasse 24 CH-4055 Basel Tel. +41 61 264 97 97 Fax +41 61 264 97 96 Email: [email protected]

3. Dr. Ajay Chaudhuri MD, MRCP(UK) Assistant Director Diabetes- Endocrinology Centre of Western New York Kaleida Health 3 Gates Circle, Buffalo, NY (USA) 14209

Off- 1716 8874069 Fax- 1716 887 4773

4 . Dr. Nalini Shah, MD,DM (Endocrinology) Prof and Head, Department of Endocrinology OPD No. 103, Old building, First floor Seth G S Medical College and K E M Hospital, Parel, Mumbai, 400012, INDIA. Telephone no: Mobile - (0) 9820223288, Office - +91 22 24168714



1st Annual Meeting

October 12, 2012











1 Name: Huda Ezzeddin Mustafa

Address: P.O. Box 45620

City: Abu Dhabi

Country: United Arab Emirates



purposes of Chapter business? __√_ yes ___ no


___ President

___ Vice President

___ Secretary

___ Treasurer

__√__ Board of Director Member

_√___ CV or bio-sketch included √____ Candidate statement included

Candidate Statement

27th. Aug. 2012

Dear Sir/Madam,

I would like to congratulate all Endocrinologists in the Gulf region for this

great opportunity to have a Chapter Board of Directors in this part of the

world.

By nominating myself to be a member of this prestigious scientific Board, it

gives me a chance to help other colleagues in the field of Diabetes &

Endocrinology to get linked to latest scientific developments, national and

International meetings, research opportunities, and further career

development.

This goes in line with the country’s general mission in encouraging

scientific advances, and to have representatives from the local medical

circle in international scientific bodies like the American Association of

Clinical Endocrinologists, particularly women physicians from the Gulf

region who proved their success in leadership positions.

I believe with my modest expertise, good communication skills, and my

devotion and dedication, I would serve positively on the Gulf Chapter Board

of Directors.

Kind regards,

Huda Ezzeddin Mustafa MSc, MRCP, ECNU

ACEE membership: 10619

CURRICULUM VITAE

Dr. Huda Ezzeddin Ibrahim Mustafa MSc. MRCP (Endocrine & Diabetes), ECNU

Personal Details

Date Of Birth 31 May, 1970

Address P.O.Box: 45620 Abu-Dhabi, U.A.E.

Nationality United Arab Emirates E-mail [email protected] [email protected]

Marrital status Married

Telephone (Work) (mobile)

++ 9712 8191307 ++ 97150 6156923

Qualifications Postgraduate:

Endocrine Certification in Neck Ultrasound. 2011 American College of Clinical Endocrinology

Royal College of Physicians Certification in Endocrinology & Diabetes 2010 United Kingdom

MSc Health Sciences (Diabetes), 2009. Warwick Medical School. The University of Warwick. Coventry. UK.

Membership of the Royal College of Physicians of London. MRCP (UK), 2001.

Diploma In Clinical Endocrinology (1996) Hammersmith hospital, Imperial College, formerly Royal Postgraduate Medical School. London, UK.

Diploma in Health Emergencies In Large Populations (1994) University of Geneva, faculty of Medicine. In collaborationwith the International Committee of the Red Cross (ICRC), and

World Health Organization (WHO).

Undergraduate:

Primary University Degree: MBBS 1992. College of Medicine and Medical Sciences. King Faisal University, Saudi Arabia.

Internship: July 92 – July 93. King Fahad University Hospital. Al-Khobar, SA.

Posts & Clinical Experience September, 2010 – Date Consultant in Endocrinology and Diabetes. Centre for Diabetes & Endocrinology. Sheikh Khalifa Medical City in partnership with Cleveland Clinic. Abu Dhabi, United Arab Emirates.

September, 2007 – August, 2010 Specialist in Endocrinology & Diabetes. Centre for Diabetes & Endocrinology. Sheikh Khalifa Medical City in partnership with Cleveland Clinic. Abu Dhabi, United Arab Emirates.

mailto:[email protected]

April, 2003 – August, 2007 Specialist Physician and Endocrinologist in the Department of Internal Medicine. Mafraq Hospital. Abu-Dhabi, United Arab Emirates.

October, 2004 – Date (Honorary Post) Lecturer post in Gulf Medical College of Ajman/ Mafraq Hospital

January, 2003 – August, 2007 (Honorary Post) Chief Coordinator of Internship Program in Mafraq Hospital, Abu Dhabi.

August, 2002 – August, 2007 (Honorary Post) Quality Improvement representative for the department of Internal Medicine & Cardiology in Mafraq Hospital in accreditation for the Joint Commission Standards of Health Care.

September, 1995 – September, 1996 Honorary Clinical Assistant in the Department of Endocrinology and Metabolism. Hammersmith Hospital. London, UK. ( GMC No. 96/0182 ).

October, 1996 – April, 2003 (Senior Resident Physician) October, 1993 – August, 1995 (Junior Resident Physician) Resident Physician in the department of Internal Medicine of Mafraq Hospital, Abu-Dhabi.

July, 1992 – July, 1993 Internship Training programme. King Faisal University teaching Hospitals. Eastern province. Al Khobar. Saudi Arabia

Specialised skills

3-5 January, 2012 Good Clinical Practice in Medical researchMinistry of Health. Dubai. UAE

20th. August, 2011

Endocrine Certification in Neck Ultrasound (ECNU) American College of Endocrinology, US

27th. June, 2008

Good Clinic Practice training. NovoNordisk.

30th. April, 2008

Certified Pump Trainer. Medtronic Minimed Paradigm Real Time System.

21-24 January, 2008 Insulin Pump Therapy, theory and practice MSc Diabetes module. Warwick Medical School. Coventry. UK

19 – 23 March, 2007 Understanding Research and Critical Appraisal in Health Care Warwick Medical School. Coventry. UK

Memberships

Member of the Royal College of Physicians of London. UK.

Member of the Society for Endocrinology, UK.

Member of the American Diabetic Association, USA.

Member of the American Association of Clinical Endocrinologists, USA.

Member of the Diabetes Education Study Group (DESG), Europe.

Member of the Diabetes Education Study Group of Abu-Dhabi

Papers and Presentations

H.M.Attia, H. Ezzeddin, T. Khader. A Localized Morphoea/Idiopathic polymyositis overlap. Clinical Rheumatology 1999;15 No 3: 307-309.

H. Mustafa, A.P. Goldstone, S. Bloom. Long Term Follow-up of pancreatic Vipomas. The 16th.

Joint Meeting of British Endocrine Societies. April, 1997. Harrogate, UK (Poster).

H. Ezzeddin, M Sharaan, T Hashem. The Outcome of Implimenting the diabetes therapeutic patient education programme in primary health care setup in Abu-Dhabi. International Journal of Diabetes and Metabolism 2006;14(S1):39.

H. Mustafa, R. Amin, R. Ahmad, K. Al Jaberi. The effect of Diabetes Education on glycaemic

control during the month of Ramadan in a tertiary hospital. The 12th Annual International

Diabetes Complications Workshop in Al Ain. Faculty of Medicine & Medical Sciences. UAE University. Al-Ain, Abu Dhabi, UAE. ( March, 2007)

H. Mustafa. Coffee Consumption & Diabetes. The 13

th. Annual International Diabetes

Complications Workshop in Al Ain. Faculty of Medicine & Medical Sciences. UAE University. Al-Ain, Abu Dhabi, UAE. (March, 2008)

H. Mustafa. International Diabetes Management Practices Study (IDMPS. Wave 3). A

worldwide disease registry. American Diabetes Association meeting. Paris, France (April, 2008)

H. Mustafa, S. Llahana, R. Bernsen. Glycaemic control in people with DM2 in A tertiary Centre

of the UAE: an audit of A1c in relation to different anti-diabetes management strategies. The 14

th. Annual International Diabetes Complications Workshop in Al Ain. Faculty of Medicine &

Medical Sciences. UAE University. Al-Ain, Abu Dhabi, UAE. (April, 2009)

H. Mustafa, S. Beshyah. Lesson of the week: Not just another “Hairy Woman”. The seventh Libyan Diabetes & Endocrinology Conference (CDEC 2009), 7

th – 9

th April 2009. Tripoli, Libya

(Poster 11).

H. Mustafa. “Polycystic Ovarian Syndrome: an overview”. EXCELLENCE in Diabetes and Endocrinology International Conference. Abu Dhabi, UAE (October 2010)

H. Mustafa. “Polycystic Ovarian Syndrome in Adolescence”. International Conference of Pubertal Disorders. Kuwait (March 2011)

Beshyah SA, Khalil AB, Benbarka MM and Mustafa HE. Hospitalization Patterns of Diabetic Patients to a Tertiary Hospital in AbuDhabi, United Arab Emirates. Ibnosina J Med BS 2011,3(4):113-123

H. Mustafa “Hirsutism in the Arab World”. Pan Arab Congress of Endocrinology & Diabetes. Beirut, Lebanon (October 2011)

Clinical Audits

Insulin PumpTherapy Audit in a Tertiary Diabetes Center SKMC. Abu Dhabi, UAE (2011-2012)

Glycaemic control in people with diabetes in SKMC-Diabetes centre in relation to anti-diabetic management strategies. Abu Dhabi, UAE. (2008)

Diabetes control in type 2 DM in Primary Health Care of Abu Dhabi (UAE). (2004)

Patient satisfaction following cardiac catheterisation procedures. (2004)

Bed occupancy rate before and after the introduction of outpatient cardiac catheterisation service. Mafraq Hospital, Abu Dhabi. UAE (2001-2003)

Staff compliance with registration of pre and post cardiac catheterisation checklists. Mafraq Hospital, Abu Dhabi, UAE (2003)




Attn: Gulf AACE Chapter Members, In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model, the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This meeting is open to all Gulf-AACE members and their invited guests. If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173. Name: Mahmoud ALI Zirie Address: Hamad Medical Corporation,P O BOX 3050 City: Doha Country: Qatar Email: [email protected] Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the purposes of Chapter business? ___ yes ___ no Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

___ President ___ Vice President ___ Secretary ___ Treasurer ___ Board of Director Member ___ CV or bio-sketch included ___ Candidate statement included

1

CURRICULUM VITAE

Name: Mahmoud A. Zirie, MD Date of preparation: July15th, 2012

A. GENERAL INFORMATION

Office Address:

Hamad Medical Corporation Department of Medicine P.O.Box: 3050

Office Telephone:

(974)44392488, 44392434

Office Fax:

(974) 44392745

Home Address:

P.O.Box: 39370, Doha- Qatar

Home Telephone:

(974) 44868436

Cell Phone:

(974) 55564898

Beeper:

2231198

Email:

[email protected] [email protected]

Citizenship:

Jordan

2

B. DEGREES :- Degree Institution name, city and state Dates attended Year Awarded

MBBS School Of medicine,

Jordan university – Amman- Jordan

1973-1980 1980

CERTIFICATION

Name of specialty Board Certificate #

Date of Certification

American Board of Endocrinology, Diabetes and Metabolism Nov. 1997 American Board – Internal Medicine Aug. 1994 Arab Board - Internal Medicine Mar. 1988 MRCP – Part I Oct. 1987 Jordan Board - Internal Medicine May 1986 Flex June 1993 TOEFL Nov. 1990

ECFMG July 1990

3

C. BIBLIOGRAPHY

Peer Reviewed Articles 1. "Plantar Temperature Response toWalking in Diabetes with and without Acute

Charcot: The Charcot ActivityResponse Test (CART)," by Bijan Najafi, James Wrobel, Gurtej Grewal, Robert Menzies, Talal Talal, Mahmoud Zirie and David G. Armstrong . Accepted for publication in Journal of Aging Research.

2. High Prevalence of the ApoE Arg145Cys Dyslipidemia At-risk Polymorphism in

African- derived Population (submitted for publication) Maen D. Abou Ziki*1,2, Yael Strulovici-Barel*1, Neil R. Hackett1, Juan L. Rodriguez-lores1, Jason G. Mezey1,3, Jacqueline Salit1, Sharon Radisch1, Charleen Hollmann1, Lotfi houchane2, Joel Malek2, Mahmoud A. Zirie4, Amin Jayyuosi4, Antonio M. Gotto, Jr5, and Ronald Crystal1,5 (1Department of Genetic Medicine ,Weill Cornell Medical College ,New York, New York,2Department of Genetic Medicine,Weill Cornell Medical College – Qatar 3Department of Biological Statistics and Computational Biology ,Cornell University , Hamad Medical Corporation ,5Department of Medicine ,Weill Cornell Medical College New York, NY )

3. Quantitative Proteomic And Metabolomic Profiling By UPLC-MS/MS Confirms

Altered Pathways In Diabetes", in the HUPO2010 Sydney, AU. Authors: *Prabhjit Kaur and *Nasser Rizk (*Equal Contri-bution), Sereen Ibrahim, Prabhdeep Cheema, Kathryn Sheikh, Mahmood Zirie, Amrita KCheema

4. The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication

Nadir Kheir1, William Greer2, Adil Yousif3, Hajer Al-Geed1, Randa Al Okkah1, Mahmoud Zirie4, Amy Sandridge5, Manal Zaidan6 1College of Pharmacy, 2Sidra Medical and Research Centre, 3Department of Statistics, College of Arts and Sciences, Qatar University, 4Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar; 5Private Research Consultant, 6Al Amal Cancer Centre, Hamad Medical Corporation, Doha, Qatar, Dove press Journal : Patient Preference and Adherence July 2010, Volume 2010:4 Pages 247 - 254

5. Inflammatory Markers and intimal Media Thickness in Diabetics with Negative

Myocardial Perfucion Scan.Douraid K.Shaker,Ibrahim Mohammed, Mahmoud A. Zirie,Dawod Al Khateeb,Abdul Salim Kiliyanni,Jasim Al Suwaidi. J Clin Med Res Publish a head of print doi:10.4021/jocmr2009.05.1239

4

6. Success Rate of Radioiodine treatment of Hyperthyroidiism in Qatari Patients.

Sara M Darwish, Wisam K Gadban, Mahmoud A. Zirie, Daoud A. Al Khateeb (Accepted for Publication in Qatar Medical Journal)

7. Is male fertility associated with type 2 diabetes mellitus? Bener A, Al-Ansari AA,

Zirie M, Al-Hamaq AO. Int Urol Nephrol. 2009 Apr 21. PMID: 19381857 8. Prevalence of Metabolic Syndrome According to Adult Treatment Panel III and

International Diabetes Federation Criteria: A Population-Based Study. Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Metab Syndr Relat Disord. 2009 Mar 25. [Epub ahead of print] 9. Prevalence of diagnosed and undiagnosed Diabetes Mellitus and its risk factors in

a Population –bases study of Qatar; Abdulbari Bener, Mahmoud Zirie, Ibrahim M. Janahi, Abdulla O.A.A. Al Hamaq, Manal Musallam, nick J. Wareham; Diabetes Research Clinical Practice ;2009-4450 (8 pages)

10. The Prevalence of Erectile Dysfunction in Type 2 Diabetic and Non-Diabetic Men: A Comparative study; Abdulbari Bener, Abdullah Al ansari, Mahmoud Zirie, Abdulla O.A.A. Al Hamaq, Ibrahim M. Janahi, Hashim S. Mohammed. Curr Urol 2007;1:89-94

11. Lack of association between the Pro12Ala polymorphism of the PPAR-gamma 2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Badii R,Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hamaq AO, Ghoussaini M, Froguel P, Wareham NJ. Acta Diabetol. 2008 Mar; 45(1):15-21.

12. Hypoadiponectinemia in obese and diabetic subjects in state of Qatar. Nasser Rizk, Reham Awni, Mohamed Osman and Mahmoud Zirei, Int J Diabetes & Metabolism (2008) 16:123-129]

13. Intelligent Diabetes Assistant: Using Machine Learning to Help Manage Diabetes Duke D.L., Thorpe C., Mahmoud M, Zirie M. Camegie Mellon Univ. – Qatar Campus, Doha. Computer System and Applications, 2008 AICCSA 2008 IEEE/ACS International Conference. April 2008(913-914).

14. Metabolic Syndrome and its components among Qatari population. Musallam M ,

Bener A, Zirie Mal-Gaud Y, Al-Hamaq A, Othman M, Tewfiq I. Int. J. Food Safety, Nutrition and Public Health, Vol. 1, No.1,2008 (88-102).

5

15. Lipids, Lipoprotein (a) profile and HbA1c among Arabian Type 2 diabetic patients. Abdulbari Bener, Mahmoud Zirie , Mohammed H. Daghasg, Abdulla O.A.A Al Hamaq, Ghazi Daradkeh, Ammar Rikabi. Biomedical Research 2007; 18 (2): 97-102.

16. Prevalence and predictors of osteoporosis and the impact of life style factors on

bone mineral density; Abdulbari Bener, Mohammed Hammoudeh and Mahmoud Zirie; APLAR J. of Rheeumatology 2007; 10: 227-233

17. Lipoprotein profile in Arabian type 2 diabetic patients. Relationship to coronary

artery diseases. Daghash MH,Bener A,Zirie M,Dabdoob W,Al-Hamaq AO,Al-Arabi ZA. Int. J Cardiology. 2007 Sep 14; 121(1):91-2...

18. Erectile dysfuncion in men with and without type 2 diabetes mellitus. Bener A,Al-

ansari A,Zirie M,Al-HamaqAO,Janahi I,Mohammed H S.Current Urology 2006 19. Which Comes First- Renal dysfunction or High Blood Pressure?: Elevated Blood

Pressure and Risk of End- Stage Renal Disease in subjects without Baseline Kidney Disease.(Hsu CY, McCulloch CE,…, Zirie M,…. Van der Woude FJ) J Am Soc Nephrol 16:2817-2820,2005

20. Carnosine as a protective factor in diabetic nephropathy: Association with a

leucine repeat of the carnosinase gene CNDP1. Bart Janssen ….Mahmoud Zirie…Fokko J.van der Woude. Diabetes 2005, 54:2320-2327.

21. Bone density measured by dual energy x-ray absorptiometry in Qatari women, (Mohammed Hammoudeh, Mohammed Al-Khayarin,Mahmoud Zirie, Abdulbari Bener), [maturitas.2005 Nov-Dec; 52(3-4)319-27.Epub 2005 Jul 1].

22. Is obesity a protective factor for osteporosis. ( Abdulbari BENER, Mohammed

HAMMOUDEH, Mahmoud ZIRIE, Richard HELLER). Aplar Journal of Rheumatology 2005; 8: 32-38).

23. Genetics, Obesity and Environmental risk factors associated with type 2 diabetes.

(Abdulbari Bener, Mohamoud Zirie, Ammar Al-Rikabi.), [Croat Med J. 2005 Apr; 46(2):302-7 ].

24. Zinc states in type 2 DM. and it’s relation to glucose and lipids profile. ( Gazi

Daradkeh, Mahmoud Zirie, Amine Jayyousi, I. Mohammad, B. Al-Owainati, M. Daghash , M. Othman), [ completed, to be submitted for publications].

25. First documented case of conn’s syndrome in Hamad Medical Corporation. ( Dr.

Sara Darwish, Mahmoud Zirie, Issam A. Al- Bozom ).Qatar medical journal

6

26. Complications of Diabetes Mellitus among Patients attending outpatient clinics in Qatar. [Zirie M.A., Yousef M.F. Al Mashaly A] Qatar Medical Journal, Vol. 12. No. 2, Dec. 2003

27. Radioiodine treatment of hyperthyroidism. Success rate and influence of

thyrostatic medication. Wisam K. Ghadban, MD, MRCP(UK), Mahmoud A. Zirie, MD, FACE, Daoud A. Al-Khateeb, MD, Amin A. Jayyousi, MD, Hassan M. Mobayedh, MD, Ahmed A. El-Aloosy, PhD. Saudi (Med J 2003; Vol. 24 (4): 347-351

28. De Novo Mutation in Multiple Endocrine Neoplasia – 2B Family Study and

Review of Literature Mahmoud Zirie, MD, FACE, Ibrahim Mohammed, MD, FACE, Amin Jayyousi, MD, Mohammed Al Harami, MD, FRCS. . The Endocrinologist; Vol. 11 No. 3, 237 – 243, 2001.

29. Multiple Endocrine Neoplasia – 2A: Report of a family with a study of three

generations in Qatar; Mahmoud Zirie, MD, FACE, Ibrahim Mohammed, MD, FACE, Mohammed El-Emadi, MD, FRCS, Abdurazzak Haider, MD, FASCP. Endocrine Practice; Vol. 7, No. 1, 19-27; 2001

30. Diabetes Retinopathy; Zirie M A: Diabetes Insight, Vol 1, No. 4,; 19-20, June

1998. 31. New Classification and Diagnostic Criteria for Diabetes, Optimal BP control in

diabetic; Zirie M A: Diabetes Insight, Vol. 1, No. 4; 21-22, June 1998. 32. Intensive Insulin Therapy; Zirie, M A.: Diabetes Insight; Vol. 1, No. 3, 11 – 16,

December 1997. 33. Carbamazepine (e BZ) Interfering with 24-hour urine-free cortisol; Zirie, M A.

Griffing G. The Endocrinologist; 7:116-118, 1997. 34. Diabetes Centers; Zirie, M A.. Diabetes Insight; Vol. 1, No. (1): 16-18, Nov. 1996. 35. Peripheral Vascular Disease and Diabetic Foot; Zirie, M A: - Nov. 1996. Special

symposium published by Qatar Diabetes Association. Books, Book Chapters and Reviews (

Mahmoud Zirie, MD, Ibrahim Janahi, MD. Your Guide to Diabetes, an educational book directed to Diabetic patients. Published by Hamad Medical Corporation, Doha-Qatar, Feb. 2004.

Mahmoud Zirie,MD. Ibrahim Janahi,MD .Sara Darwish,MD.

.photographed book for Diabetes, an educational book directed to Diabetic patients. Published by Hamad Medical Corporation, Doha-Qatar, April 2008

7

D. PROFESSIONAL POSITIONS AND EMPLOYMENT

Post-doctoral training including residency/fellowship

Title Institution name, city and state

Dates

1. In USA FELLOWSHIP: Second Year Post-Doctoral Fellow, Endocrinology, Diabetes and Metabolism University of Missouri Columbia, MO 65212 July 1995 – June 1996

First Year Post-Doctoral Fellow, Endocrinology, Diabetes and Metabolism University of Missouri Columbia, MO 65212 July 1994 – June 1995

RESIDENCY: PGY – III Resident* Internal Medicine Michigan State University Hurley Medical Center Flint, MI 48503 July 1993 – June 1994 PGY – I Resident Internal Medicine Michigan State University Hurley Medical Center Flint, MI 48503 July 1992 – June 1993

One year credit for previous experience.

8

2. Outside USA Rotating Internship Jordan University Hospital Amman – Jordan July 1980 – June 1981 Resident

Internal Medicine Jordan University Hospital

Amman – Jordan July 1981 – June 1982 Resident Internal Medicine

Hamad General Hospital Doha – Qatar July 1982 – Dec. 1982 Arab Board for Internal Medicine Residency Program Hamad General Hospital Doha – Qatar Jan. 1983 – Dec. 1985

Senior Resident- Medicine Jan. 1986 – June 1986 Hamad Medical Corporation Doha – Qatar

9

Hospital positions (attending physician, if applicable)

Title Institution name, city and state

Dates

Consultant, Head\Endo.Diab .and metabolism

Hamad Medical Corporation (HMC) Doha – Qatar

April 97- to date

Consultant, Endocrinology, Diabetes and Metabolism

HMC Doha – Qatar

July 96-April 97

Senior Specialist Endocrinology, Diabetes and Metabolism

HMC Doha – Qatar

March 90 – June 92

Specialist Endocrinology, Diabetes and Metabolism

Hamad Medical Corporation Doha – Qatar

July 88 – Feb.90

Specialist Internal Medicine

Hamad Medical Corporation Doha – Qatar

July 86 – June 88

Academic Position

Assistant Professor of Medicine -Weill Cornell Medical College in Qatar

10

E. Licensure

State Number Date of Issue Date of last registration

Missouri - USA 106733 Aug.03.94 Valid through Jan.31.2013

DEA BZ 4223830 Qatar 4597 10/11/2009 present

F. Professional Membership (medical and scientific societies)

Member/officer Name of Organization

Dates held

Fellow, American Association of Clinical Endocrinologists May 2000 – present

Fellow, American College of Physician Jan. 2000 – present

Member, American Association of Clinical Endocrinologists April 1998-May 2000

Member, American college of physicians April 1995-Jan.2000

Associate, American college of physicians July 1992-April 1995

Member of Jordan Medical Association July 1980 - present

Registered Internist in Jordan May 1986 - present

Member, Qatar Diabetes Association Aug.1996-present

G. Honors and Awards

Name of award

Date awarded 1. Hamd Medical Corporation Spirit of Service Award Glowing

Star 2010 May 23rd ,2010

2. Stars of Excellence (Employee awards and Recognition Program) From Hamd Medical Corporation

May 23rd ,2010

3. Diabetes Asia study Group (DASG) March , 2010 4. Supreme Council of Health – Public Health Department -

Qatar March , 2010

5. Hamd Medical Corporation (Participation in Qatar Health 2009)

Dec, 2009

6. the Gulf Group for the Study of Diabetes Dec, 2009 7. Qatar Diabetes Association (Participation in International

Conference – Childhood Diabetes & Obesity) Oct, 2008

8. Hamd Medical Corporation (Participation in1st Qatari ophthalmology subspecialty symposium

May, 2008

11

9. Qatar Diabetes Association (Participation in Diabetes Integrated Care symposium

April 2007

10. Hamad Medical Corporation (Participation in3rd Qatar International Medical Congress

Nov. 2005

11. Hamad Medical Corporation – Maternal and Child health section

Feb., 2002

12. Computer literacy training, HMC April 06 - 10 ,2002

13. WHO work shop on training the trainers, HMC, Doha- Qatar

Dec. 22 - 26, 2000

14. First Qatar International Oncology Conference “Management of Breast, Colon, Thyroid and Lymphoma in the New Millennium”, Doha – Qatar.

Nov. 18 – 20, 1999

15. Qatar Diabetes Association. Participation in the leadership Assessment Workshop on childhood and Adolescent Diabetes.

Dec. 12. 1999

16. Qatar Diabetes Association. Participation in the activities during “Diabetes Week”.

Nov. 13 - 18, 1999

17. The Environment Friend Center, Doha – Qatar March 22 -26, 1998

18. Arab Board of Internal Medicine, Doha – Qatar Sep. 1998 19. Qatar Diabetes Association. Diabetes and Human Rights,

Doha – Qatar. Nov. 14- 16, 1998

20. Qatar Diabetes Association – Volunteers day, Doha – Qatar. Dec. 05, 1998 21. Youth and Sports Association. Umsalal Youth Center, Doha -

Qatar. Nov. 18, 1998

22. Hamad Medical Corporation – Public Relations; Diabetes – TV Program. Doha – Qatar.

Jan. 01, 1997

H. Institutional/Hospital Affiliation

Primary Hospital Affiliation: Cornell Medical College – Qatar Campus Other Hospital Affiliations: Other Institutional Affiliations:

12

I. Current and Past Institutional Responsibilities and Recent Effort Teaching (list courses and your role)

Residents from different training programs (as listed below), rotate in Endo/Daib. Division. We teach them theoretical and practical aspects of Endo, Diab. And metabolism, this includes: - Attend DM/Endo clinics to see how we manage patients, asking them to do

history and physical examinations then to discuss the case with the attending physician.

Attend inpatients rounds, with bed side teaching. Attend Endo/Diab. Educational Activities (Lectures, case presentations,

journal club). We ask them to participate actively by preparing and delivering topics under supervision of the staff . Arab Board for Internal Medicine Physicians to run diabetes clinics in Primary Health centres Residents from expatriate training program (ETP) Residents from Family Medicine program. Teaching for medical students during summer vacation.

Educational Activities:-

In the capacity of head of Endo/Diab. Division., I Prepare the schedule and participate in the following activities:

1. Weekly Activity, Tuesday 7-8 am. Covered by endocrine staff. 2. Endocrine Surgical Conference, once /month. 3. State of the art lecture, once / year, to medicine department. 4. Endocrine case presentation, Monday, house staff conference, 2

times/ year.

Clinical Care:- I am participating in clinical patient care since my graduation 1980. I do 3 half day clinics per week, 3 mornings (7-11) am., each clinic serves 18-25 patients

- Sunday7-11 am. : General Endocrine clinic. - Tuesday 8-11 am. : Thyroid clinic - Thursday 7-11 am.: Diabetic clinic

The rest of the time is divided between inpatients rounds, consultations, research, and administrative issues.

Administrative duties (including committees):-

13

Title Date Head of Endocrinology, Diabetes and Metabolism

Division Hamad Medical Corporation Doha – Qatar

April 1997- present

Chief of Dietetic & Nutrition Section

June 1997– Dec. 2000

Committees:

1. Hamad Medical Corporation-Doha – Qatar

Promotion Committee- Medicine Dept. Academic Health System- Community

engagement Hyperbaric Medicine Service – Clinical

Committee Pharmacy Transformation Program Clinical

Practice Workgroup Action on Diabetes -Steering Committee Research Advisory Committee

2. Primary health care Health Promotion committee 3. Qatar Diabetes association

Head of scientific committee

4. International Committees AACE-Gulf Chapter

Efforts

Current percent effort %

Teaching 20% Clinical Care 50% Administration 10% Research 20% Total 100%

J. Research Effort (present)

14

1. Body Worn Sensor Technology for improving diabetic care during activity of

Daily living. [Proposal No. : NPRP 08 -499-3-109 Funded by QNRF second cycle]. Dr. Mahmoud A. Zirie, consultant –Endocrinology\Diabetes ,Hamad Medical Corporation Prof. David Armstrong ,University of Arizona-USA Dr. Bijan Najafi, Rosalind Franklin University ,North Chicago-USA

2. System approach towards diabetes research using molecular profiling tools.

[Proposal No. : NPRP 08-740-3-148 Funded by QNRF second cycle]. Dr.Mahmoud A.Zirie,consultant –Endocrinology\Diabetes ,Hamad Medical Corporation Dr.Nasser Rizk Md, PhD who is a Professor of physiology and endocrinology at the Qatar University Dr. Amrita K. Cheema in the department of Oncology in Georgetown University, Washington D.C. USA.

3. Collection of Blood for Gene Expression/Genomic Studies in Individuals

with Diabetes (Qatar) Ronald G. Crystal, MD Genetic Medicine (WCMC – NY and Qatar) and Medicine (WCMC – NY Lotfi Chouchane, PhD Genetic Medicine (WCMC – Qatar) Mahmoud Zirie, MD Head of Endocrinology, HMC Amin Jayyousi, MD Consultant Endocrinology, HMC Ibrahim Mohammed, MD Consultant Endocrinology, HMC

4. Characterization of Metabolic Defects in Arab and Mexican American

Subjects at Increased Risk of Type 2 Diabetes Dr. Mahmoud Zirie-HMC Dr. Muhammed Abdulghani-Texas University USA (NPRP 4-247-3-076 Funded by QNRF)

5. Metabolic Syndrome in patients receiving antipsychotics in the Qatari and

Kuwaiti population Dr. Mahmoud Zirie, Dr. Hassan Al Amin WCMC-Qatar (NPRP 4-267-3-085 Funded by QNRF)

6. Efficacy and Durability of GLP-1/Thiazolidinedione versus Basal-Bolus Insulin Therapy in Poorly Controlled T2DM Patients (NPRP 5 - 273 - 3 - 079 funded by QNRF) Prof. Muhammad Abdul-Ghani(UTHSCSA), Prof. Ralph DeFronzo( UTHSCSA), Dr. Mahmoud Zirie (Hamad Medical Corporation), Dr. Amin Jayyousi(Hamad Medical Corporation) 7. Creation of a Metabolic Core Facility for Obesity, Diabetes and Cardiovascular Research in HMC( NPRP 5 - 467 - 3 - 124 funded by QNRF), Dr. Mahmoud Zirie (Hamad Medical Corporation),Prof. Muhammad Abdul-Ghani( UTHSCSA) Prof. Ralph DeFronzo (UTHSCSA)

8. The Qatar Diabetes Prevention Study (QDPS): Effect of Metformin/ Pioglitazone/Exenatide on the Incidence of T2DM and Microvascular

15

Events In Qatari IGT individuals. NPRP X-029-3-011,(submitted to the Exceptional program - QNRF), 5-years projects.

Lead PI- Mahmoud Zirie, MD, Hamad Medical Corporation, Doha, Qatar Co-PI Abdul-Bari Bener- PhD, Hamad Medical Corporation, Doha Qatar. Co-PI Amin Jayyousi, MD, Hamad Medical Corporation, Doha, Qatar. Co-PI Abdallah Al-Hammaq, PhD, Qatar Diabetes Association. Co-PI Khaled Al Bader, MD, Primary Health Care Corporation, Doha, Qatar. Co-PI- Muhammad Abdul-Ghani, MD, PhD, Diabetes Division, UTHSCSA, San Antonio, TX. Co-PI Ralph DeFronzo, MD, Diabetes Division, UTHSCSA, San Antonio, TX.

K. Abstract: Zirie, M, Mohammed, I, El-Emadi M, Haider, A. Multiple Endocrine Neoplasia Type 2A: The role of genetic study. 24 – 28 Oct. 2000. Amman – Jordan. Zirie, M, Griffing G, University of Missouri-Columbia. Ret-Proto-Oncogen in hereditary Medullary Thyroid Carcinoma. Hamad Medical Corporation, Doha – Qatar, April 6-8, 1996. Zirie M, Griffing G, University of Missouri-Columbia. Carbamazepine interfering with 24-hour urine free cortisol. American College of Physicians, Missouri Regional Meeting, September 29 - October 1, 1995, Lake Ozark, Missouri.

Thanigari S, Zirie M, Horowitz S, Carmigniani S, Griffing G, University of Missouri-Columbia. Thyrotoxic periodic paralysis with painless thyroiditis. American College of Physicians, Missouri Regional Meeting, September 29 – October 1, 1995, Lake Ozark, MO. Zirie M, Setter M. Michigan State University, Hurley Medical Center, Flint. Theophylline toxicity and the use of hemodialysis. American College of Physicians, 40th annual Michigan Scientific Meeting, September 22 – 25, 1994, Grand Traverse Village, Michigan. Zirie M, Setter M, Michigan State University Center, Flint. Theophylline toxicity and the use of hemodialysis. American College of Physicians, 16th Annual Associates Meeting, May 6, 1994. Flint, Michigan.

L. Training Courses-Hamad Medical Corporation

16

Essential Disaster Administration & managements Support (EDAMS) Course Immediate life Support (ILS) on 15th October , Hazardous Materials & waste Management Infection Control Fire Safety Immediate life Support (ILS) Hamad Medical Corporation - General Orientation Program 13th July ,2005

M. Conferences:

1. AACE 21st Annual Scientific & Clinical Congress, May 23-27,2012.Philadelphia,PA-USA

2. 47th Annual Meeting of the. European Association for the Study of Diabetes(EASD) 12 - 16 September 2011 · Lisbon · Portugal.

3. XVII International DALM symposium on Diabetes, Obesity, and the Metabolic Syndrome, March 14-16,2011 Doha-Qatar

4. First International AACE Conference on Diabetes, Obesity and Other Endocrine Diseases The American Association of Clinical Endocrinologists (AACE), in collaboration with Hamad Medical, Inc, in Qatar, the Qatar Diabetes Association and the Qatar Foundation, is organizing the First International AACE Conference on Diabetes, Obesity and Other Endocrine Diseases to be held at the Sheraton Convention Center in Doha, Qatar from January 14-16, 2011. (Dr. Mahmoud Zirie, speaker & Chairman of organizing committee)

5. The 3rd Congress of the Jordanian Society of Endocrinology, Diabetes & Metabolism (JSED) , The 2nd Joint JSED-AACE Congress & The 9th Congress of the Pan Arab Society of Endocrinology & Diabetes (PASED). On May 3-7 2010 Amman Jordan.

6. Secondary Prevention in Diabetes, 2nd Diabetes Asia study Group (DASG) International Conference, on March 26-27, 2010. [Speaker]

7. The 3rd international Gulf Group for the Study of Diabetes Conference Feb. 9-11, 2010 , kingdom of Saudi Arabia Jeddah

8. American Association of Clinical Endocrinologists 1st International Diabetes course in Qatar Module V- March 6th , 2010 [Speaker]

17

9. American Association of Clinical Endocrinologists 1st International Diabetes course in Qatar Modules III & IV - Jan 16th , 2010

10. Diabetes & Cardiovascular Risk organized by The Gulf Group for the Study of Diabetes – 26 December 2009, Doha- Qatar [Speaker]

11. Qatar Health 2009 – 13th -14th December 2009, Doha- Qatar [Speaker]

12. 11th European Congress of Endocrinology. Istanbul, Turkey, 25-29 April 2009.

13. Childhood Diabetes and Obesity, Doha-Qatar October 10-12,2008 [Speaker]

14. AACE 17th Annual Meeting & Clinical Congress The Art & Science of Endocrinology: Focusing on Best Patient Outcomes May 14-18, 2008 Walt Disney World Dolphin Resort Orlando, FL

15. 1st Qatari Ophthalmology Subspecialty Symposium Doha-Qatar 9th -10th May,2008.

16. Diabetes, Genetics, Enviromental Factors. Qatar University-Doha-Qatar.Dec.13th 2007

17. Fighting Osteoporosis on two fronts; Dubai. UAE, December 16,2005.

18. Diabetic Foot Symposium (put feet first …. Prevent amputation) Doha, Qatar, November 19,2005. (Organizer).

19. Diabetes Update 2005; Manama, Bahrain, September 29 – 30, 2005.

20. 6.European Society of Hypertension (15th European Meeting on Hypertension).Milan – Italy, June 17-21, 2005.

21. Reducing Cardiovascular risk pathways to prevention. Sharm El-Sheikh- Egypt, 14 – 17 April, 2005.

22. International Symposium on Male infertility. Doha – Qatar, March 26, 2005 (Speaker).

23. The first international -Gulf Group for Study of Diabetes- Conference. Dubai – UEA, 13 -15 Feb. 2005.

24. The 3rd International scientific symposium – Diabetes and Obesity. Doha- Qatar, Feb. 5, 2005. (Organizer & Speaker).

18

25. Intensive Adult Workshop on Insulin Pump therapy and CGMS “Medtronic”, April 15 – 16, 2004, Dubai, UAE.

26. Diabetes Foot Multi-disciplinary Team Symposium. Doha-Qatar, March 6, 2004.

27. Diabetes and the Kidney disease, an International Conference arranged by Qatar Diabetes Association and Hamad medical Corporation, Doha – Qatar, 20 – 21 Feb. 2004 (Speaker)

28. Osteoporosis Awareness Symposium, Doha – Qatar, Oct. 23, 2003. [ speaker ].

29. 11th European Congress on Obesity, 30th May – 3rd June, 2001, Vienna, Austria.

30. 5th Joint Symposium between Department of Medicine (HMC) and Primary Health Care. Diabetes Mellitus. March 22, 2001, Doha – Qatar (Speaker).

31. The Gulf Group for the study of Diabetes. February 14 – 15, 2001, Doha-Qatar (Speaker).

32. 2nd Pan-Arab Endocrinology Conference. 24 – 28 Oct., 2000, Amman – Jordan (Speaker).

33. 2nd Joint Symposium between Medical Department (HMC) and Primary Health Care. “Osteoporosis”, June 1, 2000. Doha – Qatar.

34. American Association of Clinical Endocrinologists. Ninth Annual Meeting and Clinical Congress, May 3-7, 2000. Atlanta-GA-USA.

35. The Third Conference of the Pan-Arab Hypertension Society. February 5-9, 2000, Abu Dhabi, UAE.

36. First International Conference on Erectile dysfunction and Infertility in Qatar. February 26-28, 2000. Doha-Qatar, “Member of organizing committee”.

37. 6th Doha Medical Symposium “What is New?” May 17, 2000.

38. Hypertension Management in the New Millennium. March 30, 2000, Doha-Qatar “Speaker”.

39. Osteoporosis. June 1, 2000, Doha – Qatar, “Speaker”.

19

40. First Qatar International Oncology Conference “Management of Breast, Colon, Thyroid and Lymphomas in the New Millennium”. Nov. 18th – 20th, 1999; Doha – Qatar.

41. 35th Annual Meeting of the European Association for the study of Diabetes. September 28 - October 2, 1999; Brussels – Belgium.

42. Are all Glitazones the same? Addressing Insulin resistance as a fundamental issue. A satellite symposium held on Tuesday 28th September 1999, Brussels – Belgium.

43. Repaglinide a prandial glucose regulator. Implication of UKPDS, Insulin in Type 2 Diabetes. April 22, 1999; Hurgadah – Egypt.

44. 4th Doha Medical symposium on Interesting cases in Hamad General Hospital. April 15, 1999; Doha – Qatar.

45. Individualization of the Antihypertensive therapy for the complicated patient. Middle-East University program, March 18 – 19, 1999. Dubai – UAE.

46. 2nd Hamad Medical Corporation – Nephrology symposium. March 13-14, 1999. Doha-Qatar.

47. 3rd Doha Medical Symposium on Diabetes Mellitus: Clinical Manifestation and Recent Development. Hamad Medical Corporation, Doha-Qatar, December 1st, 1998 “organizing committee”.

48. Clinical Endocrinology Update “98”. Boston, Massachusetts, USA, Nov. 1 – 4, 1998.

49. 2nd Doha Medical Symposium: Gross and Microscopic diagnosis. Hamad Medical Corporation, Doha – Qatar June 25th, 1998 “Speaker”.

50. Gastro/Diabetes forum: diabetes in the Gulf. Clinical evaluation of type 2 diabetes mellitus, Insulin treatment for type 2 DM, and Humulog “Lispro Insulin”. May 4 – 8, 1998, Istanbul – Turkey.

51. Valsartan, A new class for Hypertension Management, Manama Bahrain. March 21, 1998.

52. Neurological Sciences Course. Hamad Medical Corporation, Doha – Qatar. March 1 – 3, 1998 (Speaker).

20

53. First Qatar International Pediatric Conference. Hamad Medical Corporation, Doha – Qatar. December 15 – 17, 1997.

54. Diabetes Education For A Better Life. Hamad Medical Corporation, Doha – Qatar. December 13, 1997 (Speaker).

55. Endocrinology, Diagnosis and Treatment. National Institute of Health, October 15 – 19, 1997, Bethesda MD, USA.

56. Hypertension Risk And Therapy: Strategies For Prevention of Target Organ Damage. Middle East – Africa University Program. May 8 – 9, 1997, Dubai, UAE.

57. Recent Advances in Laboratory Medicine and Pathology. Hamad Medical Corporation, Doha – Qatar. April 5 – 7, 1997.

58. International Symposium on Emergency Trauma Care. Hamad Medical Corporation. February 18 – 20, 1997, Doha – Qatar.

59. Peripheral Vascular Disease and Diabetic Foot. Hamad Medical Corporation. November 14, 1996, Doha – Qatar (Speaker).

60. Minimized Insulin Pump therapy Symposium, St. Louis, Missouri, April 20, 1996.

61. Current Concepts in Thyroid Disease. Hamad Medical Corporation, April 6 – 8, 1996. Doha – Qatar (Speaker).

62. Diabetes Update 1995. Diabetes Research and Training Center, Indiana University School of Medicine and The Regenstrief Institute. November 6 – 8, 1995. Marshal, Indiana.

63. Clinical Endocrinology Update 1995 “Syllabus”. The Endocrine Society, October 22 – 25, 1995, San Diego, California.

64. American College of Physicians, Missouri Affiliate Regional Meeting. September 29 – 30, 1995, Lake Ozark, MO.

65. Diabetes and Endocrinology In The New Medical Environment. Fifth Annual Endocrine Fellows Foundation Scientific Forum. June 8 – 9, 1995, Atlanta Georgia.

66. American College of Physicians, Missouri Regional Meeting. October 14, 1994, Lake Ozark, Missouri.

21

67. New Concepts and Directions in Thyroidology. September 27, 1994, Chicago, Illinois (University of Colorado, School of Medicine).

68. American College of Physicians, 40th annual Michigan Scientific Meeting. Septembre 22 – 25, 1994, Grand Traverse Village, Michigan.

69. American College of Physicians 16th Annual Associates Meeting. May 6, 1994, Flint, Michigan.

70. Advance in Internal Medicine. April 25 – 29, 1994, University of Michigan, Ann Arbor, Michigan.

71. Clinical Endocrinology. April 11 – 15, 1994, Harvard Medical School, Boston, Massachusetts.

72. The First Gulf Conference on Intensive Care Medicine. November 26 – 28, 1991, Hamad Medical Corporation, Doha – Qatar.

73. Hypertension Associated with Diabetes Mellitus. November 21 –23, 1991, Harvard Medical School, Boston, Massachusetts.

74. Diabetes Mellitus. February 16 – 18, 1990, Hamad Medical Corporation, Doha – Qatar (Speaker).

75. First Arab Symposium on Hyperlipidemia and Atherosclerosis.

76. May 10, 1989, Kuwait City, Kuwait.

Secretary / Treasurer

Candidates

1. Wiam Ibrahim Hussein, MD FACE FACP; Bahrain

2. Khalid Faiq Mohammed Salih, MD FACE; UAE



1st Annual Meeting

October 12, 2012











1 Name: Wiam Ibrahim Hussein

Address: Gulf Diabetes and Endocrinology Center

City: Manama

Country: Bahrain

Email:[email protected]


purposes of Chapter business? __X_ yes ___ no


___ President

___ Vice President

_X__ Secretary

__X_ Treasurer


_X__ CV or bio-sketch included ___ Candidate statement included

1

CURRICULUM VITAE

NAME: Wiam Ibrahim Hussein, MBBS, FACP, FACE ADDRESS: P.O.Box 16165

Adliya, Manama

Kingdom of Bahrain

CONTACT NUMBERS: Telephone: (00973) 39726000 (Mobile)

Fax: (00973) 17239200

E-mail: [email protected]

PRESENT POSITION

10/2007-present Consultant Endocrinologist & Medical Director, (Joslin Diabetes

Center up to 2008) at Gulf Diabetes Specialist Center, Bahrain.

August 1998 – 8/2007: Consultant & Section Head, Endocrinology, Diabetes &

Metabolism (Medical Director of Outpatient Clinic) Saad Specialist Hospital, Al Khobar, Kingdom of Saudi Arabia

EDUCATION AND TRAINING

July 1997 – June 1998 Advanced Endocrinology and Clinical Research Fellowship. The Cleveland Clinic Foundation, Ohio, USA

July 1995 – June 1997 Endocrinology, Diabetes and Metabolism Fellowship The Cleveland Clinic Foundation, Ohio, USA

I am the Chair, Steering members of the AACE Gulf Chapter and had worked for the last year with

USA- AACE to get their approval for this Gulf Chapter hoping to continue as Secretary/Treasurer

in the Gulf Chapter.



1st Annual Meeting

October 12, 2012











1 Name: KHALID FAEQ MOHAMMED SALIH KASHEF AL-GHETAA

Address:NATIONAL HOSPITAL/PO BOX 30666

City:ABU DHABI

Country:UAE



purposes of Chapter business? _yes__ yes ___ no


___ President

___ Vice President

___ Secretary

yes___ Treasurer



Curriculum Vitae

Name:Khalid Faiq Mohammad Salih.

Family name: KASHIF AL-GITTAA

Date of Birth: July, 29/1963.

Nationality: Iraqi

Passport No:G1510929

Postal address: United Arab Emirates.Abu

Dhabi,P.OBox:30666

E-Mail Address: [email protected]

Telephone : mobile

:00971555504255,ground:0097126396002,

Fax: 0097126720900

Qualifications

1.HIGH DIPLOMA IN LAPAROSCOPY/STRASBOURGE

UNIVERSTY /FRANCE MARCH 2012

2. Fellow of American College of Surgeons (USA) F.A.C.S

, 2011

3. Fellow of American College of Endocrinology/USA

(F.A.C.E) 2011.

4. Fellow of Iraqi commission for medical specializations

(Iraqi Board) /Baghdad/Iraq/ November 1994(1990—1994)

FICMS.

5. Higher Diploma degree in General Surgery / Baghdad

college of Medicine /University of Baghdad/ September 1994

6. PrimaryMedical Degree: M.B.Ch.B /Kufa college of

Medicine / Kufa University, Iraq/1987

7. Specialist surgeon A/United Arab Emirates/Ministry of

Health/in2.10.2005

8. Abu Dhabi Health Authority council License, number:

5799(GAHS), since 2006 and till now.

9. Oncoplastic Breast and Aesthetic Surgery, San Diego

/USA, 2009, one day full workshop.

10. IEO,European Institute of Oncology,Milano/italy

Breast Cancer: Oncologic and Reconstructive Surgery.

Interactive course with Live surgery,15—17 June 2009

11. World Health Leader in Medicine and Surgery, 2012,

CAMBRIDGE/GREAT BRITAIN

WORK EXPERIENCE: /NMC, 22.7.2006 till present 1. National Hospital

Member of NMC hospital in Abu Dhabi on 22.7.2006,as a

consultant general surgeon dealing with all emergency and

elective surgical procedures, Thyroid surgeon, Breast cosmetic

surgery and continued with his work since that time.

1999 to 25.6.2006 2. Dijla Private hospital,

20 beds private, Breast and thyroid center / experienced

thyroid And Breast surgeon/Baghdad/Iraq/ consultant thyroid

and neck surgery referral.

3. AL-YARMOOK TEACHING HOSPITAL FULL SPECIALIST

GENERAL SURGEON FROM SEP/2005 TILL JAN 2006

Nov 1998 to Sept 2004 Karama teaching hospital-4. Al

fully dependant consultant in general surgery in 400 beds

teaching hospital /Baghdad/Iraq/ , dealing with all emergency

and elective surgical problems, namely Trauma cases and neck

and thyroid and Breast diseases. One Year vacation ends on

27.9.2005, returned back to Al Yarmook hospital.

Oct.1997 to Nov.1998 yarmook teaching hospital,-5. Al

600 beds. As a full responsible specialist in General

Surgery, Dealing with all elective and trauma surgical cases.

Jan. 1995 to Oct.1997, Najaf Teaching-6. Al

Hospital with 600 beds main hospital in Najaf, full

responsibility specialist in general surgery , dealing with all

elective and trauma cases in addition to Forensic medicine.

7.Enrolled in a four years training program at the Medical

city teaching hospital /Baghdad/ working as a registrar , full

time resident, to get the fellowship of Iraqi commission for

medical specializations./from Oct.1990 to Nov.1994.

8. Full time resident in Al-Najaf teaching Hospital from

March 1990 to Oct 1990/department of surgery.

9. General practioner in a primary health center in Al-

Hira&Souk Shaalan destricts in Najaf from Feb.1989 to

March.1990.

10.Rotational training in the Medical City Teaching

hospital /Baghdad/Iraq/From Aug.1987 to Dec.1988 as full

time S.H.O, in Obestetrics&Gynecology(2months),CCU (1

month),Internal medicine(3 months),Cardiovascular surgery

unit(3 months),General Surgery (3 months), Pediatric Unit (3

months).

11.October 1997: Join the teaching staff of Department of

Surgery ,as Lecturer in General Surgery, college of Medicine ,

Al-Mustansirya University, Baghdad , and still at present(

Vacation from the college for one year) , Candidate for

Assistant prof. applied 4 papers for this purpose.

12. December 1994: Lecturer in General Surgery, Join

the teaching staff of the Department of surgery, college of

Medicine, Kufa university.

13. About to Award assistant professor from Al-

mustansirya university in 2006.

14. Award membership of American Associations for

Endocrinologist in 2007.(AAC).

15. Award membership of BAETS (British Association Of

Endocrine and Thyroid Surgeons), 2008.

16. Participating in BAETS annual meeting 9-10 October in Marseille France were two papers presented and accepted as poster

presentation

17. Accepted and presenting Oral paper 3th International Congress of

Endocrinology - ICE 2008 (November 8-12, 2008 - Rio de Janeiro, Brazil).

18. Newly published Recurrent Laryngeal nerve is no more injury…..

in MEDIMOND srl 2008

19.Oncoplastic Breast surgery Workshop, USA San Diego, April 23

2009.

20.Attend and participating in Milano Workshop for Breast

reconstructive surgery 15—17 june 2009

21. Passed the BLS course on July 2009

WORK SCOPE: 1. I have worked with all types of surgical cases including

Trauma cases sharing in two programs during Iraqi/Iranian

War in Al-Imara Hospital in 1998 as a resident with a team

taken from Medical city Teaching hospital for 3 weeks and

during first gulf war in Al-Imara also for 3 weeks also, dealing

with all kinds of trauma cases.

2. Dealing with all elective surgical cases during 11years

post graduate experiences, notably Gastric surgery especially

Highly selective Vagotomy and I have 4 years Experiences in

Biliary surgery dealing with wipples procedures and

sophisticated biliary procedures like segment 3 biliary

explorations and others.

3. more than 100 cases experiences in large multiple

recurrent incisional Abdominal hernias using the way of

Darning , success in about 100%.

4. Neck Surgery, referral Consultant Surgeon from all

over Iraq, Dealing with Neck tumor Surgery and Block

Dissection of Neck including central compartment and lateral

compartment dissections.

5.Thyroid Surgeon referral , More than 3000

thyroidectomy in the last 10 years , all well documented and

pictured most of it,for different thyroid diseases, more than

300 thyroid tumors, about 800 toxic thyroids more than 1000

nontoxic, etc.Head of Department of thyroid and Neck surgery

in Dijla private hospital.

6. Doing all kinds of Breast surgical diseases including

Mastectomies, lumpectomies, Quadrentectomies etc more than

500 cases over past 15 years.

6. Performed more than 40 thyroidectomies in Abu Dhabi,

National hospital, in the last 12 months.

:RESEARCH PROJECTS IN IRAQ. PRIMARY SUBSTERNAL ABERRANT THYROIDS 1.

2006 Recurrent Laryngeal Nerve Injury is no more a Major 2...

complication in thyroid surgery by using Intracapsular and

Infracapsular resections.2003..

3. The effect of Response of cAMP to TSH stimulation in

Benign and Malignant thyroid gland tumors the activity of

Adenylate cyclase in these tumors. 2001. Published recently.

4.Unusual presentations of Hashimotos thyroiditis in Iraq

.1999.published

5. Stab wounds accidents in Al-Najaf, Morbidity and

Mortality. 1996. published.

6.Lower Urinary tract injury associated with Pelvic

fractures , a prospective study.1997.published.

LOCAL COURSES AND MEETINGS: 1`.Participate in the second national meeting of

Surgery in Iraq from 11-12/12/2002

2. Participate in first national meeting of Surgery from 14-

16/9/2000.

3. Participate in fourteenth meeting of Cancer in Iraq

from 7-9/3/2000

4. Participate in first meeting of Iraqi society of Surgeon

from 13-14/10/1999.

5. Passes successfully the program of the ways of

teaching in Al-mustansirya university from 1.8.1998 to

26.8.1998.

Laparoscopic Surgery course in Medical City Teaching

Hospital, for 2 weeks, 2000.

6. Upper and Lower GIT endoscopy , 4 years training

, more than 2000 endoscopies, from 1990 to 1994.

7. Conduct CME meeting on 24.12.2006, in NMC hospital

in Abu Dhabi, presenting; Primary substernal thyroids in Iraq,

and Recurrent laryngeal nerve injury is no more complication

in thyroid surgery.

8 attending most of meetings and CME held here in Abu

Dhabi in the last 6 months.

INTERNATIONAL COURSES:

1. Participate in the 29th annual meeting of the Egyptian

Society of Surgeons from 13-15/2/2002, presenting two

papers.

2. Participate in 4th meeting of Jordan association of

Urological Surgeons from 3-5/12/2003.

3. Awarded training certificate for Laparoscopic Surgery

from Al-Mansura GIT center in Egypt .2001, 3 weeks course.

4.Oncoplastic Breast and Aesthetic Surgery, San Diego

/USA,2009 ,one day full workshop

5.IEO,European Institute of Oncology,Milano/italy Breast

Cancer: Oncologic and Reconstructive Surgery. Interactive

course with Live surgery,15—17 June 2009

TEACHING EXPERIENCES: 1.Lecturer in General Surgery in Al-Mustansirya college of

Medicine/Baghdad/Iraq. From Oct.1997 till now teaching from

third year up to sixth year medical students, in clinical bases

and in theory, in addition in putting questions and in

examinations, candidate to assistant prof. in the department of

Surgery.

2. Lecturer in General; Surgery in Kufa college of

Medicine, in Najaf, from Dec.1994 to Oct.1997.

I am a member of Latin American Thyroid Society in

2005. I am a member Of Iraqi Association since 1987

3.Member of AACE since 2007 4.member of BAETS SINCE 2007

:REFEREES

1. Dr.Raysan Al-Fayad . FRCS, prof. in General Surgery,

Al-Musansirya, college of Medicine. Tel. 00964790189190

2. Dr.Najeeb Slaiwa, FRCS, Director of Department of

Surgery in Al-mustansirya college of

Medicine.Baghdad.Tel.009647901617548

3 Dr.Shawqi y Fawzi , Consultant Surgeon, Al-Qasimya

hospital, Al-SHRJA/UAE, Tel. mobile: 0508974581.

4. Proff.Abdul Baqi Al-Khatib, plastic consultant surgeon,

chief of plastic department, Zayed Military hospital,MCA.

Vice President

Candidates

1. Ali Saeed Alzahrani, MD FACE; KSA

2. Ali Barnard Khalil MD, FACE; UAE



1st Annual Meeting

October 12, 2012











1 Name: Ali S. Alzahrani

Address: MBC-46, P.O. Box 3354

City: Riyadh, 11211

Country: Saudi Arabia

Email: [email protected] [email protected]


purposes of Chapter business? _X yes ___ no


___ President

__X_ Vice President

___ Secretary

___ Treasurer


__X_ CV or bio-sketch included _X__ Candidate statement included

Nomination Statement- Ali Alzahrani, MD

1

I have been a member of the AACE since 1995 and I believe I understand its Nobel

mission. I have also served as a member of the International Committee of AACE

and that gave me a chance to appreciate the important role AACE is playing in

spreading knowledge, establishing networking and fostering the field of

Endocrinology and Metabolism within USA and around the globe. I have been an

active clinician and a researcher and I understand the difficulties and opportunities

that similar colleagues face in our region. Recently, I spent a year and half at the

Johns Hopkins University School of Medicine and that gave me a chance to also

witness and understand similar issues that face clinicians/researchers in the USA. I

am a member of a number of local societies including the Saudi Hypertension

Management Group and the Saudi Society of Endocrinology and Metabolism and I

have been actively involved in developing programs, organizing courses and

working with colleagues to improve the health care in our region. With these

experiences, I would like to nominate myself for the position of the vice president of

the Gulf Chapter. My objectives are to work with my colleagues, the Board Members

to:

1. Carry out the principle mission/values of AACE in our region

2. To enhance education for physicians by organizing workshops, local

endocrine clubs and major regional conferences.

3. I strongly believe that one major objective for us in the Gulf Chapter is to

initiate and enhance research in our region. We lack some of the most

important data on major endocrine diseases, such as diabetes and metabolic

disorders, thyroid diseases and metabolic bone diseases. Through the Gulf

Nomination Statement- Ali Alzahrani, MD

2

Chapter, I am hoping that we can start some research projects on these

subjects and others. Our role also is to help and collaborate with other

colleagues pursuing research pertinent to the health issues in our region

4. As a scientific body, the Gulf Chapter of AACE can communicate, network and

involve other scientific forums/groups in the region to influence decisions by

the health authorities in the Gulf regions for the sake of better health car. We

hope that the Gulf Chapter will be an important voice to be listened to and

sought out for opinion on important issues pertaining to Endocrinology and

Metabolism

5. Lastly, for any organization to be strong and thriving, financial strength is

very important. I hope that we will be able to generate funds that will

support our activities. This will come through fees for the educational

activities, support from industry and donations. I hope also that we can also

help AACE increases their membership. Our activities and visibility will

surely increase the number of people joining our Gulf Chapter and the

mother organization, AACE.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 1 of 25

Curriculum Vitae

ALI SAEED ALZAHRANI, MD, FACE

Updated: 01 August 2012

I. Current Position and Address

Consultant Endocrinologist,

Department of Medicine

Associate Professor,

Alfaisal University

Scientist and Head,

Molecular Endocrine Unit/Department of Molecular Oncology

King Faisal Specialist Hospital and Research Centre

P.O. Box 3345, Riyadh 11211

Kingdom of Saudi Arabia

Tel No. 4472490

E-mail: [email protected] or [email protected]

Recent appointment (March 2010-September 2011):

Visiting Scientist

Division of Endocrinology and Metabolism

Johns Hopkins School of Medicine

Baltimore, MD

USA

II. Personal Information

Nationality : Saudi

Marital Status : Married with four children

III. Graduate and Postgraduate Education Degrees

1989 MBBS, College of Medicine, King Saud University, Riyadh, KSA

Grade: Very Good, GPA 4.24/5.00

Postgraduate Training

1989 – 1990 Rotating Intern in Pediatrics, Ob/Gyn, Surgery, and Internal Medicine (three

months each), King Khalid University Hospital, Riyadh, KSA

Grade: Excellent

Jan – Dec 1993 Chief Resident, Department of Medicine, King Faisal Specialist Hospital &

Research Centre, Riyadh, KSA

1990 – 1995 Resident, Department of Medicine, King Faisal Specialist Hospital & Research

Centre, Riyadh, KSA

April 1995 - June 1997 Clinical and Research Fellow in Endocrinology & Metabolism,

The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

mailto:[email protected]

Ali Saeed Alzahrani

CV, 01 August 2012

Page 2 of 25

IV. CERTIFICATIONS

March 1994 MRCP UK, Royal College of Physicians of the United Kingdom

April 1994 ABIM (Arab Board of Internal Medicine)

1996 United States Medical Licensing Exam (USMLE)

June 1997 Fellowship in Endocrinology and Metabolism, The Johns Hopkins University

School of Medicine, Baltimore, Maryland, USA

V. Professional Experience

1998-2000 Associate Consultant Endocrinologist



Riyadh, KSA

2000-Present Consultant Endocrinologist



Riyadh, KSA

2001-2002 Acting Chairman

Department of Medicine,

King Faisal Specialist Hospital &Research Centre

Jeddah, KSA

2003-2006 Deputy Chairmen



Riyadh, KSA

2007 – Jan 2010 Section Head, Endocrinology



Riyadh, KSA

VI. Memberships and Fellowships

2003 Fellow, Royal Colleges of the United Kingdom (London) – FRCP

1995-1997 Former member of The Medical and Surgical Association of the Johns Hopkins

University

1996-present Member, the Endocrine Society of North America (USA)

Ali Saeed Alzahrani

CV, 01 August 2012

Page 3 of 25

2000-present Member, The American Association of Clinical Endocrinologists (USA)

2000 Fellow, The American College of Physicians- FACP

2000 Fellow, The American College of Endocrinology -FACE

2003 Fellow, Royal Colleges of the United Kingdom (Edinburgh) – FRCP (Edin)

VII. Awards and Honors

May 2002 First Research Distinction Award, Department of Medicine, KFSH&RC,

Riyadh

May 2003 First & Second, Research Distinction Award, Department of Medicine,

KFSH&RC

May 2004 Second, Research Distinction Award, Department of Medicine, KFSH&RC

May 2006 Second & Fourth, Research Distinction Award, Department of Medicine,

KFSH&RC

VIII. Committees and Administration

1999-2001 Deputy Director, Internal Medicine Residency Training Program, Department

of Medicine, KFSH&RC, Riyadh, KSA

1999- 2001 Coordinator, Medical Grand Rounds, Department of Medicine, KFSH&RC,

Riyadh, KSA

2000-Present Member, Radiation Safety Committee, KFSH&RC, Riyadh, KSA

1998-2001 Member, Resident Education Committee, KFSH&RC, Riyadh, KSA

2001-2002 Member, Clinical Pathways Committee, KFSH&RC, Jeddah, KSA

2001-2002 Chairman, Business Working Group Committee, KFSH&RC, Jeddah, KSA

2001-2002 Co-Chairman, Business Council Committee, KFSH&RC, Jeddah, KSA

2001-2002 Member, Regional Council Committee, KFSH&RC, Jeddah, KSA

2001-2002 Member, Executive Advisory Group, KFSH&RC, Jeddah, KSA

Ali Saeed Alzahrani

CV, 01 August 2012

Page 4 of 25

2001-2002 Member, Charity Council Committee, KFSH&RC, Jeddah, KSA

2001-2002 Member, Evidence-Based Medicine, KFSH&RC, Jeddah, KSA

2001-2002 Member, Makkah Region Health Council, KFSH&RC, Jeddah, KSA

2001-2002 Member, Strategic e-Health Committee, KFSH&RC, Jeddah, KSA

2001-2002 Associate Executive Director, Health Outreach & Business Affairs,

KFSH&RC, KSA

2001- 2005 Adjunct Scientist, Research Center, KFSH & RC, KSA

2002-15 Feb 2010 Director, Endocrine Fellowship Training Program, Department of Medicine,

KFSH&RC, Riyadh, KSA

2002- Present Member, Fellowship Committee, Department of Medicine

2000-Present Member, Saudi Arabian Hypertension Management Group, Riyadh, KSA

2002-2004 Coordinator, Case presentation weekly meeting, KFSH&RC, KSA

2002-Present Member, Radiation Safety Committee, KFSH&RC, KSA

2002-2004 Member, Credential Committee, KFSH& RC, KSA

2002-Present Member, Research Promotion Group, Department of Medicine, KFSH&RC,

Riyadh KSA

2002-Present Member, Evidence-Based Medicine working Group, Department of Medicine,

KFSH&RC, KSA

2003-2005 Member, Editorial Board, Annals of Saudi Medicine, KFSH&RC, Riyadh,

KSA

2004-Present Member, Ambulatory Care Committee, King Faisal Specialist Hospital &

Research Centre, Riyadh, KSA

2004-Present Patient Eligibility Review Committee, King Faisal Specialist Hospital &

Research Centre, Riyadh

2002-2004 Coordinator, Morbidity & Mortality Committee, KFSH&RC, KSA

2004-Present Ambulatory Care Task Force

March 2006-present Ambulatory Care Committee

- Present Chairman, Clinical Utilization Management Committee, CFO#723 (Rev.2)

- Present Chairman, Hospital Internet Website Content Review Committee, CFO#870

Ali Saeed Alzahrani

CV, 01 August 2012

Page 5 of 25

Feb 2007-2007 Co-Editor-in-Chief, Annals of Saudi Medicine

Oct 2007 - Present Member, Research Unit, Department of Medicine

01 Dec 07-10 Jan 2010 Editor-in-chief, Annals of Saudi Medicine

01 Jan 08-10 Jan 2010 Associate Executive Director, Health Sciences Library

08 July 2009 - Member, KFSH&RC Diabetes Research Program, (CED 1369-30 dated 08 July

30 March 2010 2009)

03 April - present International Committee, American Association of Clinical Endocrinologists

(AACE)

Courses and Meetings

June 1990 Advanced Cardiac Life Support (ACLS), King Faisal Specialist Hospital & Research

Centre (KFSH&RC), Riyadh, KSA

November 1990 Workshop on Chemical Warfare Decontamination & Detoxification of Casualties,

KFSH&RC, Riyadh, KSA

May 1991 Design & Analysis in Clinical Research Course, KFSH&RC, Riyadh, KSA

December 1992 International Symposium on Acute Ischemic Syndromes, KFSH&RC, Riyadh, KSA

December 1993 International Symposium on Rheumatic Valvular Heart Diseases, KFSH&RC, Riyadh,

KSA

November 1994 The 2nd

International Conference on AIDS, KFSH&RC, Riyadh, KSA

June 1995 The Endocrine Society Meeting, Washington, DC, USA

September 1995 International Thyroid Congress, Toronto, Ontario Canada

June 1995 The International Congress of Endocrinology, San Francisco, California, USA

November 1996 The Endocrine Fellows’ Meeting, San Diego, California, USA

November 1996 American Thyroid Association Annual Meeting, San Diego, California, USA

April 1997 The Annual Meeting of the American Association of Clinical Endocrinologists,

Philadelphia, Pennsylvania, USA

June 1997 The Endocrine Society Meeting, Minneapolis, Minnesota, USA

June 1998 The Endocrine Society Meeting, New Orleans, Louisiana, USA

Ali Saeed Alzahrani

CV, 01 August 2012

Page 6 of 25

April 1999 The Annual Meeting of the American Association of Clinical Endocrinologists, San

Diego, California, USA

October 1999 New Horizons in the Management of Diabetes Mellitus Symposium, King Fahad

Military Medical Complex, Dhahran, KSA

November 1999 the First National Thyroid Cancer Program Symposium, KFSH&RC, Riyadh, KSA

February 2000 Intensive Review Clinical Course in Medicine, Buraidah, Al-Qassim, KSA

May 2000 The Annual Meeting of the American Association of Clinical Endocrinologists

June 2000 The Endocrine Society’s 82nd

Annual Meeting, Toronto, Ontario, Canada

October 2001 Saudi Preparatory Course Part II for Internal Medicine, King Fahad National Guard

Hospital, Riyadh, KSA

January 2002 Principals of Medical Management, online Course as part of ongoing accreditation for

The American College of Physician Executives.

February 2002 Implementing Information Systems Interact Session, online course as part of ongoing

accreditation for The American College of Physician Executives.

March 2002 Organizational Politics for PE, online course, as part of ongoing accreditation for The

American College of Physician Executives.

April, 2002 Clinical Endocrinology 2002, Harvard Medical School, Boston, MA, USA

April 2002 Physician in Management seminar, San Diego, CA, USA as part of ongoing

accreditation for The American College of Physician Executives.

May 2002 Introduction to Informatics Interact Session, online course, as part of ongoing

accreditation for The American College of Physician Executive.

July 2002 Oxford Teaching Evidence Based Medicine Course 2002, Oxford, United Kingdom

March 2004 Fifth Pan Arab Congress on Endocrinology and Diabetes, Riyadh, Saudi Arabia.

June 2004 American Diabetes Association, Orlando, FA, USA

June 2004 Endocrine Society Meeting, New Orleans, USA

June 2004 AACE Thyroid Ultrasound & FNA Biopsy Accreditation Course, Atlanta, GA

Feb 2005 Symposium on Cardiovascular Risk Factors, Royal College of Physicians (London)

March 2005 Endocrine Panarab Conference, Alexandria

April 2005 Frontiers in Thyroid Cancer, American Thyroid Association, Baltimore, MD, USA

June 2005 The Endocrine Society’s 87th Annual Meeting, San Diego

Ali Saeed Alzahrani

CV, 01 August 2012

Page 7 of 25

Oct 2005 Annual Congress of the European Association of Nuclear Medicine, Istanbul, Turkey

June 2006 Endocrine Society’s 88th Annual Meeting, Boston, USA

Sept 2007 32nd Annual Meeting of the European Thyroid Association, Leipzig

June 2008 Endocrine Society’s 90th Annual Meeting. San Francisco, USA

March 2009 The 6th Annual ENETS (European Neuroendocrine Tumor Society) Conference,

Granada, Spain

June 2009 The Endocrine Society’s 91st Annual Meeting, Washington, DC, USA

Reviewer of major projects/journals:

KACST SMJ JCEM

KWAIT RAC

International Journal of Cancer: Reviewed manuscript #IJC-08-1766 entitled ―Genetic and plasma

variation of insulin-like growth factor binding proteins in relation to

prostate cancer incidence and survival‖

Editorial Board Membership

Annals and British Journal of Diabetes & Vascular Disease

1. Bibliography

1.1 Invited Lectures

1.1.1 Ali S. Alzahrani. Medullary Thyroid Cancer; Screening, Diagnosis, and Follow Up. The First

National Thyroid Cancer Program Symposium, 21-23 November 1999, King Faisal Specialist

Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.

1.1.2 Ali S. Alzahrani. Tutor, Intensive Review Course in Internal Medicine, King Fahad Specialist

Hospital, 03 February 2000, Buraidah, Qassim.

1.1.3 Ali S. Alzahrani. Management of Hyperthyroidism. Medical Outreach Program, King Fahad

Hospital, 27 May 2000, Jeddah, Saudi Arabia.

1.1.4 Ali S. Alzahrani. Tutor; Intensive Course in Internal Medicine, King Fahad National Guard

Hospital, 23 August 2000, Riyadh, Saudi Arabia.

1.1.5 Ali S. Alzahrani. Thyroid Cancer. Medical Grand Rounds, King Faisal Specialist Hospital,

Jeddah, 6 September 2000, Jeddah, Saudi Arabia.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 8 of 25

1.1.6 Ali S. Alzahrani. Management of Thyroid Cancer and Thyroid Nodules, Thyroid Disorders

(symposium) Bisha, September 28th, 2000.

1.1.7 Ali S. Alzahrani. Hypertension: Difficult Cases. DM, Dyslipidemia, HTN (symposium). October

2000, Dubai, UAE.

1.1.8 Ali S. Alzahrani. Endocrine Hypertension. DM, Dyslipidemia, HTN (symposium). October 2000,

Dubai, UAE.

1.1.9 Ali S. Alzahrani. Management of Thyroid Cancer. 2nd

National Thyroid Cancer Program

Symposium, Ajiad General Hospital, 5-6 November 2000, Makkah.

1.1.10 Ali S. Alzahrani. Management of Thyroid Nodules. 2nd

National Thyroid Cancer Program

Symposium, Ajiad General Hospital, 5-6 November 2000, Makkah.

1.1.11 Ali S. Alzahrani. Tutor, Intensive Review Course in Internal Medicine, King Fahad Specialist

Hospital, 3 February 2001, Buraidah, Qassim.

1.1.12 Ali S. Alzahrani. Advances in Thyroid Cancer (state of the art lecture). Third Pan Arab

Conference, 25-28 October 2001, Damascus, Syria.

1.1.13 Ali S. Alzahrani. How to Approach a Patient with Goiter. Thyroid Diseases Workshop for

General Surgery Residents. King Faisal Specialist Hospital & Research Centre, Jeddah, 10 January

2002.

1.1.14 Speaker- Osteoporosis Workshop, King Fahad National Guard Hospital, Jeddah, 10 Oct 2003

1.1.15 Residents Lecture: ―Thyroid, Men & Adrenal, King Faisal Specialist Hospital & Research Centre.

17 October 2002.

1.1.16 Examiner, Intensive Internal Medicine Review Course, King Khalid National Guard Hospital

(KKNGH), Jeddah, 12-26 Oct 2002.

1.1.17 Speaker, Non-Communicable Diseases Symposium, ―Management of HTN in Diabetes & Medical

Management of Obesity‖, Makkah, 21 Oct 2002.

1.1.18 Speaker, 1st Osteoporosis Scientific Day, National Guard Health Affairs, Riyadh, 24 Oct 2002.

1.1.19 A Speaker & Chairman, One day symposium on Diseases of World Economy, Diabetes, Obesity,

And Hypertension, Arab Health Conference, Dubai, January 2003.

1.1.20 Invited speaker, Management of Hypertension in Diabetes Mellitus, King Abdulaziz University

Hospital, 06 Jan 2003.

1.1.21 Examiner, Intensive Review Course in Internal Medicine, King Fahad Specialist Hospital,

Buraidah, Al Gassim, KSA, 15 Jan 2003.

1.1.22 Speaker, Medical Grand Rounds, Department of Medicine, ―Stem Cell and Therapeutic Cloning.

The Future of Medicine, 17 Feb 2003.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 9 of 25

1.1.23 Speaker, Meet the Expert: Diabetic Nephropathy, 1st Saudi Diabetes Congress ―SDC‖, King

Abdulaziz University Hospital, 09 April 2003.

1.1.24 Speaker, 6th Gulf Group for the Study of Diabetes ―GSSD‖, Jeddah Kingdom of Saudi Arabia, 21-

22 May 2003.

1.1.25 Examiner, Clinical and oral exam for Fellowship Program, King Khaled University Hospital,

Riyadh, 04 June 2003.

1.1.26 Speaker, Evaluation and Management of Infertile Male, The Endocrinologist approach, Urology

Department, KFSH&RC, Riyadh, 25 June 2003.

1.1.27 Presenter, ―Simply unexpected‖, Medicine Case Presentation, KFSH&RC, 24 Sept 2003.

1.1.28 Presenter, ―Following a Standard approach: it pays off‖, Medicine Case Presentation, Department

of Medicine, KFSH&RC, 24 Sept 2003.

1.1.29 Lecturer, 10-Day Subspecialty Review Course, Department of Medicine, KFSH&RC, 10-19 Sept

2003

1.1.30 Examiner, Intensive Internal Medicine Review Course, King Abdulaziz Medical City, Jeddah, 04

October 2003.

1.1.31 Speaker, Combined Adult/Peds Endocrine Rounds, Department of Medicine, KFSH&RC,

Wednesday, 08 October 2004

1.1.32 Examiner, Saudi Board Clinical Course in Internal Medicine, Riyadh Armed Forces Hospital, 15

Dec 2003.

1.1.33 Lecturer, ―9th Review Course in Internal Medicine, 17 December 2003, Buraidah, Qassim.

1.1.34 Examiner, Final Saudi Board Clinical Examination, December 2003, Riyadh.

1.1.35 Speaker and Temporary adviser- the Regional Consultation on Hypertension Prevention and

control, World Health Organization, Abu-Dhabi, UAE, 20-22 December 2003

1.1.36 Speaker, ―Management of Hypertension in DM‖, World Health Organization, Abu Dhabi, UAE,

February 2004.

1.1.37 Speaker, ―Issues in the follow-up to Thyroid Cancer‖, Fifth Pan Arab Congress on Endocrinology

and Diabetes, Riyadh, Saudi Arabia, 28 February – 2 March 2004.

1.1.38 Speaker, ―Hypertension in Diabetes‖, Fifth Pan Arab Congress on Endocrinology and Diabetes,

Riyadh, Saudi Arabia, 28 February 2004.

1.1.39 Speaker, ―Primary Hypeparathyroidism‖: Medical VS Surgical Management‖, The International

Conference on Advances in Internal Medicine, King Abdulaziz National Guard Medical City,

Jeddah, 16-17 March 2004.

1.1.40 Speaker, ―Management of Osteoporosis‖, The International Conference on Advances in Internal

Medicine, King Abdulaziz National Guard Medical City, Jeddah, 16-17 March 2004.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 10 of 25

1.1.41 Speaker, ―Islet Cell Transplantation & Stem Cell Research in Diabetes‖, Recent Advances in

Diabetes Symposium, Jeddah, 22 March 2004.

1.1.42 Speaker and temporary adviser, ―Management of Male Osteoporosis‖: Practical considerations‖,

World Health Organization, Beirut, Lebanon, 06-08 May 2004.

1.1.43 Presenter, ―F-18 Fluorodeoxyglucose Positron Emission Tomography (PET) in the Follow-up of

Differentiated Thyroid Cancer (DTC), 6th RPG Day, 24 May 2004, KFSH&RC

1.1.44 Speaker, A Lecturer, 6-Day Subspecialty Review Course, Department of Medicine, King Faisal

Specialist Hospital & Research Centre. 14 September 2004.

1.1.45 Lecturer, ―Review of Endocrinology‖, Intensive Internal Medicine Review Course, King Khaled

National Guard Hospital, Jeddah, 15 September 2004.

1.1.46 Speaker, ―How to manage the bad couples diabetes and obesity‖, 9th World Diabetes Day-

Professional Program, Four Seasons Hotel by King Abdulaziz University Hospital, Riyadh, 25

November 2004.

1.1.47 Speaker, ―Long-Term Follow-up of Thyroid Ca‖, Thyroid Seminar, King Abdulaziz University

Hospital, Riyadh, 04 January 2005.

1.1.48 Speaker, Medical Grand Rounds: ―Thyroid Cancer: A Local and International Perspective‖,

Department of Medicine, KFSH&RC, 21 February 2005.

1.1.49 Speaker, ―Saudi Guidelines for Management of Hypertension‖, 2nd

London Symposium on

Vascular Biology of Atherosclerosis and its Impact in Clinical Practice. London, United Kingdom,

27 February 2005

1.1.50 Speaker, ―Update on Thyroid Cancer‖, Department of Medicine, Riyadh Military Hospital, 30

March 2005.

1.1.51 Grand Round, ―Thyroid Cancer: A Perspective from another continent‖ John Hopkins Hospital,

Baltimore, Maryland, 13 April 2005.

1.1.52 Speaker, ―Thyroid Cancer in Saudi Arabia‖, King Fahad National Guard Hospital, Riyadh, 21 April

2005.

1.1.53 Speaker, Department of Medicine Case Presentation: ―Common and Rare‖, King Faisal Specialist

Hospital & Research Centre, 15 June 2005.

1.1.54 Invited Speaker, ―Designing the Research, Summarization of Data and the Testing Differences

Between Two Groups‖, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia,

14-15 September 2005.

1.1.55 Invited Speaker, 8th Saudi/Arab Board Preparatory Course for Internal Medicine Part II, King

Abdulaziz Medical City, Postgraduate Training Centre, Riyadh, Saudi Arabia, 17-21 Sept 2005.

1.1.56 Invited Speaker, ―Insulin Therapy in Type 2 Diabetes‖, International Diabetes Day‖, King

Abdulaziz Medical City, Riyadh, 23-24 November 2005.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 11 of 25

1.1.57 Invited Speaker, ―Risk Factors for Cardiovascular Disease in Saudi Arabia‖, 2nd

Partners’

International Symposium on Cardiovascular Disease, Dubai, 7-8 December 2005.

1.1.58 Invited Speaker, ―An update in the management of Thyroid Cancer‖, 3rd

Diabetes Educator

Course, King Faisal Specialist Hospital & Research Centre, Jeddah, 18 April 2006.

1.1.59 Case Presentation, “the Mid-Liner‖ and ―Revisiting a given Diagnosis: A Rewarding Outcome‖,

Department of Medicine, King Faisal Specialist Hospital & Research Centre, 26 April 2006.

1.1.60 Invited Speaker, “Management of Hypertension in Diabetes Mellitus. The National Hypertension

Symposium, Jubail, Saudi Arabia. 30 May 2006.

1.1.61 Invited Speaker, ―Hypertension Co-morbidities‖, The National Hypertension Symposium, Jubail,

Saudi Arabia. 31 May 2006.

1.1.62 Invited Speaker, Management of Hyperthyroidism‖. Health Outreach Locum Program, King Fahad

Hospital, Al Baha. 08-28 July 2006.

1.1.63 Invited Speaker, ―Endocrine Case‖, Health Outreach Locum Program, King Fahad Hospital, Al

Baha. 08-28 July 2006

1.1.64 Invited Speaker, ―Management of hypertension in diabetes‖. Health Outreach Locum Program,

King Fahad Hospital, Al Baha. 08-28 July 2006

1.1.65 Speaker, “General Endocrinology MCQs‖, 6-Day Subspecialty Review Course, Department of

Medicine, King Faisal Specialist Hospital & Research Centre.

1.1.66 Invited Speaker, ―Endocrinology Review‖, 9th Saudi/Arab Board Preparatory Course for Internal

Medicine Part II. National Guard Health Affairs, King Abdulaziz Medical City. 19 September

2006.

1.1.67 Invited speaker, ―Insulin Therapy in Type 2 DM‖, Intensive Diabetes Course for Physicians.

National Guard Health Affairs, King Abdulaziz Medical City. 24 January 2007.

1.1.68 Speaker, ―Pheochromocytoma: Local experience‖ & ―A Man with abdominal and brain Tumors‖.

Medical & Surgical Aspects of Neuroendocrine Disorders Symposium. King Faisal Specialist

Hospital & Research Centre, Riyadh, Saudi Arabia, 03-04 April 2007.

1.1.69 Invited speaker, ―Differentiated thyroid cancer; a Middle East perspective‖. First Joint JSED-

AACE Congress Amman, Jordan. 17 May 2007.

1.1.70 Invited speaker, ―Co-morbidities: DM and Dyslipidemia‖, The First training course on the

implementation of the Saudi Hypertension Management Guidelines, Mecca Almudarama, Mecca,

30 May 2007.

1.1.71 Invited speaker, ―Diagnosis beyond doubt in endocrinology: role of molecular biology‖. 8th Pan

Arab congress on Endocrinology and Diabetes (PACED 8), Kuwait, 07-12 Nov 2007.

1.1.72 Invited Speaker, “Management of Hypercalcemia”, 8th Acute Medicine Symposium, Riyadh

Military Hospital, Riyadh, Saudi Arabia. 27 November 2007.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 12 of 25

1.1.73 Invited speaker, ―Epidemiology of Diabetes in Saudi Arabia‖, 7th IEA-EMPO Scientific Meeting "

Epidemiology": Translating Research to Health Care", Epidemiology Workshop, Research Centre,

King Faisal Specialist Hospital & Research Centre, Riyadh. 27 Nov 2007.

1.1.74 Invited speaker, ―Management Approach (How to switch from oral hypogyny to insulin therapy,

Part I). 1st course of prevention & management of heart disease and its risk factor in Family

Medicine setting. King Abdulaziz Medical City, Riyadh, Saudi Arabia, 28 November 2007.

1.1.75 Invited speaker, ―Management Approach (How to switch from oral hypogyny to insulin therapy,

Part II). 1st course of prevention & management of heart disease and its risk factor in Family

Medicine setting. King Abdulaziz Medical City, Riyadh, Saudi Arabia, 29 November 2007.

1.1.76 Invited speaker, “Endocrinopathies associated with HIV/AIDS‖, Fourth Annual HIV/AIDS

Workshop. Department of Medicine, King Faisal Specialist Hospital & Research Centre. 01

December 2007.

1.1.77 Lecturer: ―A Glance at the Nucleus‖, Wednesday Case Presentation: Department of Medicine,

KFSH&RC. 09 January 2008.

1.1.78 Invited speaker: ―Disorders of Vit D Deficiency-beyond the bone‖ Second Annual Endocrine

disorders Conference, King Fahad Medical City. 27 Feb 2008.

1.1.79 Invited speaker: ―Thyroid Cancer‖, Internal medicine Update 2008. King Saud University,

Riyadh, Saudi Arabia. 05 March 2008.

1.1.80 Invited speaker: ―Management of thyroid nodules‖, Update in Diabetes & Endocrinology

Symposium, Madinah, KSA. 22-23 March 2008.

1.1.81 Invited speaker: ―Update in Thyroid Cancer Management‖, Update in Diabetes & Endocrinology

Symposium Medina, KSA.22-23 March 2008.

1.1.82 Invited speaker: ―Non-Surgical Treatment for Obesity‖, Update in Diabetes & Endocrinology

Symposium, Medina, KSA.22-23 March 2008.

1.1.83 Invited speaker: ―Insulin therapy in Type 2 DM‖, 5th Diabetes Educators Course‖, Postgraduate

Training Center, National Guard Hospital. 05 April 2008.

1.1.84 Invited speaker: 2nd

Diabetes & Endocrinology Symposium. King Abdulaziz hospital & Oncology

Center, Jeddah, KSA, 26-27 August 2008.

1.1.85 Speaker: ―Pheochromocytoma: An Ever Fascinating Tumor‖, Medical Grand Rounds, Department

of Medicine, KFSH&RC, 20 Oct 2008.

1.1.86 Invited speaker: ―Pheochomocytoma‖, Family Medicine Educational Meeting, KFSH&RC,

Riyadh, 11 November 2008.

1.1.87 Speaker “Endocrine Case Discussion‖, Dammam Central Hospital, Health Outreach Services, 13

May 2009.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 13 of 25

1.1.88 Speaker ―Mathematics in Medicine: X + Y = X + X, Case Presentation, Department of Medicine,

KFSH&RC, 27 May 2009.

1.1.89 Speaker, “Insulin therapy in Type II Diabetes‖, 13th Medicine Update Symposium, Al Madinah,

Saudi Arabia, 19-20 May 2009.

1.1.90 Speaker, ―Recent Update in the Management of Thyroid Cancer‖, 9th Update in Internal Medicine

on endocrinology & Metabolic Disorders. King Faisal University College of Medicine, Riyadh,

Saudi Arabia. 09-10 December 2010.

1.1.91 Speaker, ―Initiation and adjustment of Insulin Therapy in Type 2 DM: Case-Based Approach‖, 3rd

International Gulf Group for the Study of Diabetes (GGSD) Conference, Jeddah Saudi Arabia. 09-

11 February 2010.

1.2 Meeting Abstracts

1.2.1 Muhammad M. Hammami, Ali S. Alzahrani, Abdul I. Butt, M. Phil, Leticia J. Vencer, Syed S.

Hussain. Primary Hyperparathyroidism and Polyostotic Fibrous Dysplasia: A mild Variant of the

McCune Albright Syndrome (poster). The Endocrine Society Meeting, Washington, DC, 1995.

1.2.2 Zainab Muttair, Ali S. Alzahrani. Thyroid Lymphoma: Clinical, Pathological and Therapeutic

Data of a Large Series (poster). The annual meeting of the American Association of Clinical

Endocrinologists, San Diego, California, USA, 1999.

1.2.3 Majid Al Mandil, Ali S. Alzahrani, Mohammed Ahmed. The frequency and predictive factors of

malignancy in the residual thyroid tissue after partial thyroid surgery in patients with differentiated

thyroid cancer (poster). The Endocrine Society Meeting, Toronto, Ontario, Canada.

1.2.4 Ali S. Alzahrani, Majid Al Mandil, Seima Bakheet, Abdalraof Almahfouz. A High Concordance

Between Pretreatment Diagnostic Whole Body Scan (DXWBS) Using Iodine 123

Isotope and Post

Therapy Iodine 131 Whole Body Scan (TXWBS) in Differentiated Thyroid Cancer (poster). The

Endocrine Society Meeting, Toronto, Ontario, Canada.

1.2.5 Alya Al-Hajjaj, Mohammed Ahmed, Ali S. Alzahrani, The Molecular Genetics, Clinical &

Histopathological Findings in Medullary Thyroid Cancer Patients: King Faisal Specialist Hospital

& Research Centre Experience (poster). The Endocrine Society Meeting, Toronto, Ontario, Canada,

2000.

1.2.6 Ali S. Alzahrani, Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig Ingemansson, Mohammed Ahmed,

Abdulraof Almahfouz. Impact of Second Surgery on the Serum Thyroglobulin (TG) and the Course

of the Disease in Patients (pts) with Papillary Thyroid Cancer (PTC) Who Have Elevated TG

Levels, Negative Diagnostic Radioactive Iodine Whole Body Scan (DXWBS) and

Recurrent/Persistent Disease Limited to the Neck (oral presentation). The Endocrine Society

Meeting, Toronto, Ontario, Canada, June 2000.

1.2.7 Ali S. Alzahrani, A case of Hashitoxicosis developing severe hyperthyroidism after radioactive

Iodine therapy and Hepatotoxicity secondary to Methimazole Treatment (poster). The Endocrine

Society Meeting, Toronto, Ontario, Canada, June 2000.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 14 of 25

1.2.8 Ali S. Alzahrani, Alya al-Hajjaj. Severe Hypertension Secondary to Renal Artery Stenosis and

Cushing’s Syndrome in a Single Patient (poster). The Endocrine Society Meeting, Toronto,

Ontario, Canada, June 2000.

1.2.9 Ali S. Alzahrani, Siema Bakheet, Majid Al Mandil, Alya Al-Hajjaj, Abdulraof AlMahfouz,

Abdallah al Haj. 123

I Isotope as a diagnostic agent in the follow up of patients with differentiated

thyroid cancer: Comparison with post therapy 131

I Whole Body Scanning (speaker).

Medical/Surgical Treatment of Thyroid Disorders in the Kingdom of Saudi Arabia (symposium),

King Faisal Specialist Hospital & Research Centre, 12-14 February 2001.

1.2.10 S. Bakheet (speaker), Ali S. Alzahrani. Role of FDG-PET scanning in the Management of Thyroid

Cancer: KFSH&RC Experience. Medical/Surgical Treatment of Thyroid Disorders in the Kingdom

of Saudi Arabia, King Faisal Specialist Hospital & Research Centre (symposium), 12-14 February

2001.

1.2.11 Ali S. Alzahrani, Majid Al Mandil, Mohammed Ahmed, Gamal Eldin H. Mohammed. The

Frequency and Predictive Factors of Malignancy in Residual Thyroid Tissue After Partial Thyroid

Surgery in Patients with Differentiated Thyroid Cancer (speaker). Medical/Surgical Treatment of

Thyroid Disorders in the Kingdom of Saudi Arabia, King Faisal Specialist Hospital & Research

Centre, 12-14 February 2001.

1.2.12 Ali S. Alzahrani. Medullary Thyroid Carcinoma (speaker). Medical/Surgical Treatment of

Thyroid Disorders in the Kingdom of Saudi Arabia, King Faisal Specialist Hospital & Research

Centre, 12-14 February 2001.

1.2.13 Ali S. Alzahrani, Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig Ingemansson, Mohammed Ahmed,

Abdulraof Almahfouz. Impact of second surgery on the serum thyroglobulin (TG) and the course of

the disease in patients with papillary thyroid cancer (PTC) who have elevated TG level, negative

diagnostic radioactive iodine whole body scan (DXWBS) and recurrent/persistent disease limited to

the neck (speaker). Medical/Surgical Treatment of Thyroid Disorders in the Kingdom of Saudi

Arabia, King Faisal Specialist Hospital & Research Centre, 12-14 February 2001.

1.2.14 M. Ahmed, Al. Alarifi, A. Almahfouz, Ali S. Alzahrani, A. Al Sugair, and S. Al Sobhi. PET

Scanning in adrenal cortical carcinoma (ACC). Presented at the Endocrine Society 83rd

Annual

Meeting, Denver, Colorado, 20-23 June 2001.

1.2.15 M. Ahmed, A. Alarifi, A. Al Hajjaj, A. Almahfouz, and Ali S. Alzahrani. Hemosiderin

endocrinopathies (HE) in patients with β-Thalassemia major (βTM). Submitted to the Endocrine

Society 83rd

Annual Meeting to be held in Denver, Colorado, USA 20-23 June 2001.

1.2.16 Ali S. Alzahrani. Stem Cells Technology (speaker). Stem Cell Symposium. King Faisal Specialist

Hospital & Research Centre, Jeddah, Kingdom of Saudi Arabia, 6 August 2001.

1.2.17 Ali S. Alzahrani. Frequency of Malignancy in the Contralateral Lobe After Partial Thyroidectomy

(poster). Third Pan Arab Conference, Damascus, Syria, 25-28 October 2001.

1.2.18 Ali S. Alzahrani, Saif Al Sobhi, Hamad Al Suhaibani. Preoperative Ultrasound-Guided Surgical

Approach for Residual/Recurrent Differentiated Thyroid Cancer. Annual Endocrine Society

Meeting, San Francisco, USA June 2002.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 15 of 25

1.2.19 Ali S. Alzahrani, Afaf Al Shammary, Bakir Bin Saddiq. Predictive Factors of Elevated

Thyroglobulin (Tg) and Negative Diagnostic Radioiodine Whole Body Scan in Differentiated

Thyroid Cancer (DTC). Annual Endocrine Society Meeting, San Francisco, USA June 2002.

1.2.20 Ali S. Alzahrani, Hassan Al Eid, Hussain Raef, Fouad Al Dayel. Pheochromocytoma: Twenty-

Year Experience. Annual Endocrine Society Meeting, San Francisco, USA June 2002.

1.2.21 Ali S. Alzahrani, Salwa B Alaidarous. Operating on Empty Sella for Cushing’s Disease: The

Value of Inferior Petrosal Sinus Sampling. Annual Endocrine Society Meeting, San Francisco,

USA June 2002.

1.2.22 Ali S. Alzahrani. Kallmann’s Syndrome Presenting with Ambigious Genitalia. Annual Endocrine

Society Meeting, San Francisco, USA June 2002.

1.2.23 Ali S Alzahrani. Serum thyroglobulin at the first follow-up visit after radioactive iodine ablation

predicts the long-term course of differentiated thyroid cancer: Do we need repeated scanning? , 5th

Annual Research Promotion Day, Department of Medicine, KFSH&RC, Riyadh 27 May 2003.

1.2.24 Ali S Alzahrani. Pre-operative Neck Ultrasound Mapping for persistent/recurrent papillary thyroid

cancer. 5th Annual Research Promotion Day, Department of Medicine, KFSH&RC, Riyadh 27 May

2003.

1.2.25 Ali S Alzahrani. Sensitive assay for the determination of fluvastatin in Plasma utilizing high-

performance liquid chromatography with fluorescence detection. 5th Annual Research Promotion

Day, Department of Medicine, KFSH&RC, Riyadh 27 May 2003.

1.2.26 Ali S Alzahrani. The value of high resolution ultrasonography in diagnosing recurrent persistent

differentiated thyroid carcinoma. 5th Annual Research Promotion Day, Department of Medicine,

KFSH&RC, Riyadh 27 May 2003.

1.2.27 Ali S Alzahrani. Generating an answerable questions. Evidence-Based Medicine Workshop. 28-

29 May 2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.

1.2.28 Ali S Alzahrani. Evidence-Based Medicine; Diagnosis. Evidence-Based Medicine Workshop. 28-

29 May 2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.

1.2.29 Ali S Alzahrani. How to search for Evidence. Evidence-Based Medicine Workshop. 28-29 May

2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.

1.2.30 Yufei Shi, Ali Alzahrani, Ranjit S Parhar, Minjing Zou. Gene Therapy for Anaplastic Thyroid

Carcinoma with a single Chain Interleukin 12 Fusion Protein. Presented at the 6th Annual Research

Celebration Day, 24 May 2004. King Faisal Specialist Hospital & Research Centre. Winner-

Second Best score.

1.2.31 A Almahfouz, E Alfadhli, M Ahmed, H Raef, and A Alzahrani. Factors Predictive of Clinical

Responses to Pioglitazone in Uncontrolled Diabetic Patients. Presented at the 6th Annual Research

Celebration Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.

1.2.32 H Raef, H Al Suhaibani, A Alzahrani and M Ahmed. The Value of Ethanol Injeciton of local

Metastasis in the Treatment of Differentiated Thyroid carcinoma. Presented at the 6th Annual

Research Celebration Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 16 of 25

1.2.33 M Mehthel, M Ahmed, A Alzahrani, A Almahfouz, A Alarifi, and H Raef. Metabolic Bone

Disease as a Clue to the Dx of Celiac Disease. Presented at the 6th Annual Research Celebration

Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.

1.2.34 Yufei Shi, Ranjit S Parhar, Minjing Zou, Essa Baitei, Ali Alzahrani, Futwan Al Mohana, Nadir R

Farid. Gene Therapy of Anaplastic Thyroid Carcinoma with a Single Chain Interleukin-12 Fusion

Protein. Presented at the Endocrine Society 85th Annual Meeting of the Endocrine Society, held in

Philadelphia, June 2003.

1.2.35 A Alzahrani, E Ba Essa, and N Al Juhani. Comparison of Familial and Sporadic Types of

Papillary Thyroid Cancer. Presented at The Endocrine Society’s 86th Annual Meeting, New Orleans,

Louisiana, USA, 16-19 June 2004.

1.2.36 S Abdel Salam, M Mehthel, and A Alzahrani. Persistent Hypertension Following Complete

Resection of Extra Adrenal Pheochromocytoma (Paraganglioma). Presented at The Endocrine

Society’s 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.

1.2.37 A Alzahrani, S Abdel Salam, S Bakheet, G Mohammed, B Al Matouq and H Raef. Comparison F-

18-Fluorodeoxyglucose Positron Emission Tomography with Post I131 Therapy whole Body Scan

in Thyroglobulin-Positive, Scan-Negative Differentiated Thyroid Cancer. Presented at The

Endocrine Society’s 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.

1.2.38 A Alzahrani, M Al Mehthel, S Abdel Salam, A Almahfouz, and H Raef. A rare cause of

undetectable serum thyroglobulin in scan-positive widespread metastatic follicular thyroid cancer.

Presented at The Endocrine Society’s 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19

June 2004.

1.2.39 M Al Mehthel, S Abdel Salam, and A Alzahrani. Four months of inhospital management of severe

refractory hypocalcemia following parathyroidectomy of a single parathyroid adenoma. Presented

at The Endocrine Society’s 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.

1.2.40 A Alzahrani, G Mohamed, S Abdel Salam, S Bakheet, H Raef, and S Al Sobhi. F-1-

Fluorodeoxyglucose positron Emission Tomography (PET) in the follow-up of differentiated

thyroid cancer (DTC). Presented at The Endocrine Society’s 86th Annual Meeting, New Orleans,

Louisiana, USA, 16-19 June 2004.

1.2.41 A Alzahrani, H Al Suhaibani, S Al Sobhi, S Al Sifri, G Mohamed, and M Akhtar. Accuracy of

Neck Ultrasonography in Predicting the presence of persisten/recurrent (P/R) differentiated thyroid

cancer. Presented at The Endocrine Society’s 86th Annual Meeting, New Orleans, Louisiana, USA,

16-19 June 2004.

1.2.42 H Bin Yousef, A Alzahrani, S Al-Sobhi, H Al suhaibani, M Chaudhari and H Raef. Pre-operative

Neck Ultrasound Mapping for Persistent/Recurrent Papillary Thyroid Cancer. Presented at the

Annual Meeting of Endocrine surgeons Uppsala, Sweden, June 2004

1.2.43 Alzahrani A, Abdel Salam S, Mohammed G, Bakheet S and Raef H. The role of 18F-

Flourodeoxyglucose Positron Emission Tomography (PET) in the Initial Evaluation of

Differentiated Thyroid Cancer. International Congress of Endocrinology, Lisbon, Portugal, 31 Aug

– 04 Sept 2004.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 17 of 25

1.2.44 Ali Alzahrani, Suzan Abdel Salam, Gamal Mohammed, Ayman Rifai, Othman Solaiman and

Abdulaziz Al Sugair. F-18-Fluorodeoxyglucose Positron Emission Tomography (PET) in the initial

evaluation of Differentiated thyroid Cancer (DTC): Comparison with Diagnostic Radioiodine

Whole Body Scan (DxWBS). Submitted to The Endocrine Society’s 87th Annual Meeting, San

Diego, 04-07 June 2005.

1.2.45 Ali Alzahrani, Othman Solaiman, Suzan Abdel Salam, and Gamal Mohammed. Serum

Thyroglobulin at the First Follow-Up Visit after Radioiodine (RAI) Remnant Ablation Predicts the

long-term Course of Differentiated Thyroid Cancer (DTC). Presented at the Endocrine Society’s

87th Annual Meeting, San Diego, 04-07 June 2005.

1.2.46 Ali Alzahtrani, Abdulrahman Kabbani, Suzan Abdel Salam and Ayman Rifai. Recombinant TSH-

stimulated I131 Therapy of Highly Functioning Skeletal Metastases of Follicular Thyroid Cancer:

Acute Thyroid Hormone Changes and Risk of Hyperthyroidism. Presented at the Endocrine

Society’s 87th Annual Meeting, San Diego, 04-07 June 2005.

1.2.47 Othman Solaiman, Ali Alzahrani, Ayman Rifai and Suzan Abdel Salam. F-18-Flourodeoxyglucose

Positron Emission Tomography (PET) is more sensitive than post I131 therapy whole body scan in

Tg-positive, Scan –negative Papillary Thyroid Cancer (PTC). Presented at the Endocrine Society’s

87th Annual Meeting, San Diego, 04-07 June 2005.

1.2.48 Ali Alzahrani, Suzan Salam, Gamal Mohammed, Ayman Rifai, Othman Solaiman, Maha Al

Fehaily, And Saif Al Sobhi. F-18 Flourodeoxyglucose Positron Emission tomography (PET) in the

initial Evaluation of differentiated Thyroid Ca (DTC): Comparison with Histopathological

Examination of Subsequent Surgery. Presented at the Endocrine Society’s 87th Annual Meeting,

San Diego, 04-07 June 2005.

1.2.49 Almahfouz A, Alfadhli E, Ahmed M, Alzahrani A, and Raef H. Factors Predictive of Clinical

Responses to Pioglitazone in Uncontrolled Diabetic Patients. Presented at the Endocrine Society’s 87th

Annual Meeting, 4-7 June 2005.

1.2.50 O Demirkaya, A Rifai, and A Alzahrani. Quantification of Tumor Lesions in Whole Body Positron

Emission Tomography Images. Presented as Oral Presentation- Annual Congress of the European

Association of Nuclear Medicine, Istanbul, Turkey. 18 October 2005.

1.2.51 Ali S Alzahrani, Essa Biatie, Yufei Shi and Minging Zou. Thiamine Transporter Gene Mutations:

an example of Monogenic Diabetes Mellitus. Presented to Endocrine Society’s 88th Annual

Meeting, Boston, USA, 24-27 June 2006.

1.2.52 Ali S. Alzahrani, Hamad Al-Suhaibani, Gamal Mohammed, Saif Al Sobhi and Suzan Abdel Salam.

How Accurate is the radiologist’s impression of the nature of ultrasonographic findings detected during

the follow-up of differentiated thyroid cancer. Presented to Endocrine Society’s 88th Annual Meeting,

Boston, USA, 24-27 June 2006.

1.2.53 Ali Alzahrani, Khalid Abu-Amero, Minjing Zou and Yufei Shi. Germline Mitochondrial DNA

Mutations in Multiple Endocrine Neoplasia Type 2a. Presented to Endocrine Society’s 88th Annual

Meeting, Boston, USA, 24-27 June 2006.

1.2.54 Mohammed Sheef and Ali Alzahrani. Severe Primary Hyperparathyroidism masked by

Asymptomatic Celiac Disease. Presented to Endocrine Society’s 88th Annual Meeting, Boston,

USA, 24-27 June 2006.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 18 of 25

1.2.55 Summaya Eskandarani, Abdulraof AlMahfouz, Ali Alzahrani. An Unusual Cause of Ectopic

Adrenocorticotrophic Hormone (ACTH) Secretion: Cushing’s Syndrome Secondary to Prostate

Cancer. Presented at the 9th Annual Research Celebration Day, Department of Medicine, King

Faisal Specialist Hospital & Research Centre. 29 May 2007.

1.2.56 Nojoud Al Khaldi, Saleh Al-Ahmad, Ali Alzahrani. Diagnosis by Serendipity: Cushing's syndrome

Secondary to Cortisol-producing Adrenal Adenoma as the Presenting Feature of Multiple Endocrine

Neoplasia Type 1 (MEN 1). Presented at the 9th Annual Research Celebration Day, Department of

Medicine, King Faisal Specialist Hospital & Research Centre. 29 May 2007.

1.2.57 Ali Alzahrani1, Minjing Zou

2, Essa Baitei

2, Brian Meyer

2, and Yufei Shi

2. Frequent BRAF

V600E

Mutation and its Association with Aggressive Behavior of Papillary Thyroid Carcinoma. Presented at

the 9th Annual Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital

& Research Centre. 29 May 2007.

1.2.58 Omalkhair AlShaikh, MD, Ali Alzahrani. Multiple Paraganglioma Syndrome: a Skull Base

Paraganglioma Masquerading as Nasopharyngeal Cancer. Presented at the 9th Annual Research

Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 29

May 2007.

1.2.59 Ali S. Alzahrani, Mohei-eldin M. Abouzeid, Suzan Abdel Salam, Gamal Mohamed, Ayman Rifai,

Abdulaziz Al Sugair, MD, Tarik Amin. The Role of F-18-Fluorodeoxyglucose Positron Emission

Tomography in the Initial Evaluation of Differentiated Thyroid Cancer. Presented at the 9th Annual

Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research

Centre. 29 May 2007.

1.2.60 Mohamed Al Harthi, Saud Al Harthi, Ali Alzahrani. Pheochromocytoma/Paragangliomas: A Study

of Cases Seen At KFSHRC over the Last Decade. Presented at the 9th Annual Research Celebration

Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 29 May 2007.

1.2.61 Omar Al-Nozha, MD, Talal Dahan, MD, Ahmed Nazmi, MD, Ali Alzahrani. The Clinical,

Pathological and Outcome Profile of Thyroid Cancer in Saudi Arabia. Presented at the 9th Annual



1.2.62 Ali S. Alzahrani and Mohei-eldin M. Abouzeid. The Potential Role of F-18-Flourodeoxyglucose

Positron Emission Tomography in the Work up of Adrenal Nodules. Presented at the 9th Annual



1.2.63 Ali S Alzahrani. The Potential Diagnostic and Prognostic Role of F-18-Fluorodeoxyglucose

Positron Emission Tomography in the Initial Evaluation of Differentiated Thyroid Cancer. 32nd

Annual Meeting of the European Thyroid Association. Leipzig. 01-05 Sept 2007.

1.2.64 Ali Alzahrani, Muhammad Faiyaz-Ul Haque, Mohammed Tulaimat and Fouad Al Dayel. Multiple

paraganglioma Syndrome secondary to mutation in succinate dehydrogenase Type D. Presented at

the 10th Annual Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital

& Research Centre. 06 May 2008. (Podium presentation)

1.2.65 Ibrahim Madhkali, Rafif Farhat, Jalaluddin Bhuiyan, Kim Nicholson, Shaikhah Al-Moussa and Ali

Alzahrani. A new approach to the diagnosis of thyrotoxicosis facticia: Measurement of stool

Ali Saeed Alzahrani

CV, 01 August 2012

Page 19 of 25

thyroxine level. Presented at the 10th Annual Research Celebration Day, Department of Medicine,

King Faisal Specialist Hospital & Research Centre. 06 May 2008.

1.2.66 Ali Alzahrani, Mohei-eldin Abouzeid, Suzan Salam, Gamal Mohammed, Ayman Rifai, Abdulaziz

Al sugair and Tarek Amin. Accuracy of F-18-Fluorodeoxyglucose Positron Emission Tomography

in Predicting Residual Cancer after Incomplete Thyroidectomy for Differentiated Thyroid Cancer.

Presented at the 10th Annual Research Celebration Day, Department of Medicine, King Faisal

Specialist Hospital & Research Centre. 06 May 2008.

1.2.67 Mashaal Al Mowanya, and Ali Alzahrani. An Unusual multiplicity and aggressiveness of tumors

in mulitple endocrine neoplasia type 1. Presented at the 10th Annual Research Celebration Day,

Department of Medicine, King Faisal Specialist Hospital & Research Centre. 06 May 2008.

1.2.68 Rafif Farhat, Fatma Al Zidjali and Ali Alzahrani. Outcome of treatment of male infertility due to

hypogonadotrophic hypogonadism with gonadotrophins. Presented at the 10th Annual Research

Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 06

May 2008.

1.2.69 Ali Alzahrani, Mohei-eldin Abouzeid, Suzan Salam, Gamal Mohammed, AymanRifai, Abdulaziz

Al-Sugair and Tarek Amin. Accuracy of F-18-Fluorodeoxyglucose Positron Emission tomography

in predicting residual cancer after incomplete thyroidectomy for differentiated thyroid cancer:

radiopathological correlation study. Accepted for presentation at the Endocrine Society’s 90th

Annual Meeting. San Francisco, USA, 15-18 June 2008.

1.2.70 Mohammed Al-Harthy, Saud Al Harthy and Ali Alzahrani. Comparison of head and neck

paragangliomas with below neck paraganglioma/pheochromocytomas. Accepted for presentation at

the Endocrine Society’s 90th Annual Meeting. San Francisco, USA, 15-18 June 2008.

1.2.71 Rafif Farhat, Fatma Al Zidjali and Ali Alzahrani. Outcome of treatment of male infertility due to

hypogonadotrophic hypogonadism with gonadotrophins. Accepted for presentation at the

Endocrine Society’s 90th Annual Meeting. San Francisco, USA, 15-18 June 2008.

1.2.72 Ali Alzahrani, Hindi Al-Hindi, Mohammed Amed, Hussein Raef, Tarek Amin, Nora Alkahtani,

Mohammed Tuli and Abdulraof Almahfouz. Response of liver metastases from duodenal

neuroendocrine tumor to indium-111 octreotide therapy and chemoembolization. The 6th Annual

ENETS (European Neuroendocrine Tumor Society) Conference, Granada, Spain, 5-7 March 2009.

1.2.73 Ali Alzahrani, Omalkhaire Al Shaikh, Summaya Eskandrani, Abdulraof Almahfouz and Hindi Al-

Hindi. An unusual site and manifestation of a neuroendocrine tumor: Cushing’s syndrome

secondary to malignant neuroendocrine tumor of the prostate‖. The 6th Annual ENETS (European

Neuroendocrine Tumor Society) Conference, Granada, Spain, 5-7 March 2009.

1.2.74 Ali Alzahrani, Roua A Al Rijjal, Minjing Zou, Essa Baitei and Yufei Shi. A Novel Gene Mutation

of CYP27B1 in a large family with Pseudovitamin D Deficiency Rickets. 11th Annual Research

Celebration Day, Department of Medicine, 12 May 2009. (Oral presentation)

1.2.75 Ali Alzahrani, Rafif Farhat, Saud Al Harthi, Mohammed Al Harthi, Talal Dahhan, Omar Al Nozha

and Ahmed Nazmi. Impact of Therapeutic Interventions on the long-Term Outcome of Persistent

Differentiated Thyroid Cancer. The Endocrine Society’s 91st Annual Meeting, Washington, DC,

USA, 10-13 June 2009.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 20 of 25

1.2.76 Rafif Farhat, Abdullah Alarifi, Nora Al Kahtani, Imaddudin Kanaan, Mohei-eldin abouzeid and Ali

Alzahrani. The diagnostic Vaue of Fused Postiron Emission Tomography/computed Tomography

in the localization of Adrenocorticotropin-Secreting Pituitary Adenoma in cushing’s Disease. The

Endocrine Society’s 91st Annual Meeting, Washington, DC, USA, 10-13 June 2009.

1.2.77 Omalkhaire Al Shaikh, Hala Aba Alkhail, Muhammad Faiyaz Ul-Hague, Mohammed Ahmed,

Mohammed Tualimat, Fouad Al Dayel, and Ali Alzahrani. RET Oncogene Mutation Screening

and Genotype Phenotype Correlation in Familial Medullary Thyroid Cancer and MEN 2 Syndrome:

Data from the Middle East. The Endocrine Society’s 91st Annual Meeting, Washington, DC, USA,

10-13 June 2009.

1.2.78 Ali S Alzahrani, Reem Alamawi, Rafif Farhat, and Mohammed Tuli. Iodine-123 Isotope for

Recombinant Human Thyrotropin-Stimulated Diagnostic Whole Body Scanning in the follow-up of

Differentiated thyroid cancer. The Endocrine Society’s 91st Annual Meeting, Washington, DC,

USA, 10-13 June 2009.

1.2.79 Ali S Alzahrani, Roua A Al Rijjal, Minjing Zou, Essa Baitei and Yufei Shi. A Novel Gene

Mutation of CYP27B1 in a large family with Pseudovitamin D Deficiency Rickets. The Endocrine

Society’s 91st Annual Meeting, Washington, DC, USA, 10-13 June 2009.

1.2.80 Ali S. Alzahrani, Rafif Farhat, Omalkhaire Al-Shaikh, Sameerah Al-Shehri, Mohammed Al-

Harthy, Saud Al-Harthy, Ahmed Nazmi, Omar Al-Nozha, MD, and Talal Dahhan. Long-term

Outcome of Patients with Persistent Differentiated Thyroid Cancer Following the Initial

Management. The Endocrine Society’s 92nd

Annual Meeting, San Diego, California, USA. 19-22

June 2010.

1.2.81 Ali S. Alzahrani, Minjing Zou, Nora Al-Kahtani, John KAmartey, Essa Y Baitei, Hussein Raef,

Roua Al-Rijjal, Abdulraof Almahfouz, Ranjit S Parhar, Futwan A Al-Mohanna, Brian Meyer, and

Yufei Shi, MD. A Novel Biallelic Mutation in the Insulin Binding Domain of the Insulin Receptor

Causing Severe Insulin Resistance Syndrome in Five Unrelated Saudi Families; A Possible Founder

Mutation. The Endocrine Society’s 92nd

Annual Meeting, San Diego, California, USA. 19-22 June

2010.

1.2.82 Ali S. Alzahrani, MD, Omalkhaire Alshaikh, MD, Sameerah Al-Shehri, and Rafif Farhat.

Radioactive Iodine (I-131) Therapy for Thyroglobulin Positive, Scan Negative Differentiated

Thyroid Cancer. The Endocrine Society’s 92nd

Annual Meeting, San Diego, California, USA. 19-22

June 2010.

1.2.83 Ali S. Alzahrani, Minjing Zou, Essa Baitei, Roua Al-Rijjal, MD, Omalkhaire Al-Shaikh, and Yufei

Shi. A Novel Biallelic R94G Mutation of the Steroid 5-Reductase-2 (SRD5A2) Gene in Two

Unrelated Cases of 46XY Male Pseudohermaphordite. The Endocrine Society’s 92nd

Annual

Meeting, San Diego, California, USA. 19-22 June 2010.

1.3 Peer-Reviewed Publication

1.3.1 Ali S. Alzahrani and Saeed Bohlega. Chorea and high antiphospholipid antibodies: probable

primary antiphospholipid syndrome. Eru J Neurol 1995; 2:363-367.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 21 of 25

1.3.2 Ali S. Alzahrani, Michael A. Levine. Primary Hyperparathyroidism (review). The Lancet 1997;

340:1233-1238.

1.3.3 Ali S. Alzahrani, Michael Levine, William Schwindinger. Parathyroid Hormone Resistance

Syndromes. Chapter in a book (Hormone Resistance), Larry Jameson (Ed), 1999.

1.3.4 Muhammad M. Hammami, Ali S. Alzahrani, Abdul I. Butt, M. Phil, Leticia J. Vencer, Syed S.

Hussain. Primary Hyperparathyroidism-Associated Polyostotic Fibrous Dysplasia: Absence of

McCune Albright Syndrome Mutations. J. Endocrinol Invest 1997; 20:552-558.

1.3.5 Jehad Al-Watban, Ali S. Alzahrani, Zoltan Patay, and Maher Hassounah. Pits, Patches, and

Protuberances. Int J. Neurorad 1999; 5:133-135.

1.3.6 Ali S. Alzahrani. Insulin Resistance, Metabolic Diseases and Diabetic Complications (book

review), Gaetano Crepaldi, Antonio Tiengo, and Stefano Del Prato (editors) 1999. Annals of Saudi

Medicine, 2000.

1.3.7 Ali S. Alzahrani (Corresponding Author), Siema Bakheet, Majid Al Mandil, Alya Al-Hajjaj,

Abdulraouf Almahfouz, and Abdallah Al Haj. I Isotope as a Diagnostic Agent in the Follow Up of

Patients with Differentiated Thyroid Cancer: Comparison with Post 131

I Therapy Whole Body

Scanning. J Clin Endocrinol Metab, Nov 2001.

1.3.8 Ali S. Alzahrani (Corresponding Author), Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig

Ingemansson, Mohammed Ahmed, Abdulraof Almahfouz. Impact of Second Surgery on the Serum

Thyroglobulin (TG) and the Course of the Disease in Patients with Papillary Thyroid Cancer who

have Elevated TG Level, Negative Diagnostic Radioactive Iodine Whole Body Scan (DXWBS) and

Recurrent/Persistent Disease Limited to the Neck. J. Endocrinol Invest, May 2002.

1.3.9 Ali S. Alzahrani (Corresponding Author), Majid Al Mandil, Mohammed Ahmed, and Gamal

Eldin Mohammed. Frequency and Predictive Factors of Malignancy in Residual thyroid tissue and

cervical lymph nodes after Partial Thyroidectomy for Differentiated Thyroid Cancer. Surgery,

April 2002.

1.3.10 Al-Rawithi S, Hussein RF, Alzahrani A. Sensitive Assay for the Determination of Fluvastatin in

Plasma Utilizing High-Performance Liquid Chromatography With Fluorescence Detection. .Ther

Drug Monit. 2003 Feb;25(1):88-92.

1.3.11 Hussam Bin Yousef, Ali S Alzahrani, Mohammed Ahmed, Abdullah Alarifi, Abdulraof

Almahfouz, Hussein Raef and Saif Al Sobhi. Laparoscopic VS Open Adrenalectomy: Experience

at King Faisal Specialist Hospital & Research Centre, Riyadh. Annals of Saudi Medicine, Vol 23,

Nov 1-2, 2003

1.3.12 Ali S. Alzahrani (Corresponding Author), Management of Hypertension in Diabetic Patients

(Chapter for the Saudi Hypertension Management Group)

1.3.13 Yufei Shi, Ranjit S Parhar, Minjing Zou, Essa Baitei, George Kessie, Nadir R Farid, Ali Alzahrani

and Futwan Al-Mohanna. Gene Therapy of Anaplastic Thyroid Carcinoma with a Single Chain

Interleukin-12 Fusion Protein. Human Gene Therapy. 2003 Dec 10;14 (18) 1741-51.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 22 of 25

1.3.14 Hussam Bin Yousef, Ali Alzahrani (Corresponding Author), Saif Al Sobhi, Hamad Al Suhaibani,

Mohammed Chaudhari, and Hussein Raef. Preoperative Neck Ultrasonographic Mapping for

Persistent/Recurrent Papillary Thyroid Cancer. World J Surg 2004 Nov;28(11):1110-4.

1.3.15 Saleh Aldasouqi and Ali S Alzahrani (corresponding author), Terminology in Diabetes Mellitus, an

example of resistance to change. Saudi Medical Journal 2004; Vol 25(9): 1289-1291.

1.3.16 Saleh Al Dasouqi, David Nkansa-Dwamena, Samia Bokhari, Ali Alzahrani, Muthaza Khan, Amal

Reffi, and Amal Merdad. Is Subclinical Hypothyroidism Associated with Hyperhomocysteinemia.

Endocrine Practice Vol 10, No.5, September/October 2004, 399-403.

1.3.17 Abu-Amero KK, Alzahrani AS, Zou M and Shi Y. High frequency of somatic mitochondrial DNA

mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.

Oncogene, 2005 Feb 17; 24 (8) 1455-1460.

1.3.18 Ali Alzahrani (Corresponding Author), Alya Al –Hajjaj, Jehad Al Watban and Imaddudin

Kanaan. Severe Hypertension Secondary to renal artery stenosis and Cushing’s syndrome. Saudi

Med J 2005 Apr; 26 (4).668-73.

1.3.19 Ali S Alzahrani (Corresponding Author), Hamad Al Suhaibani, Suzan Abdel Salam, Saud Al

Sifri, Gamal Mohammed, Saif Al Sobhi, Othman Al Solaiman, and Mohammed Akhtar. Diagnostic

Accuracy of High Resolution Neck Ultrasonography in the follow-up of differentiated Thyroid

Cancer: A Prospective study. Endocr Pract. 2005 May-June; 11 (3): 165-71.

1.3.20 Alzahrani AS (Corresponding Author), Al Dasouqi S, Salam SA, Sultan A. Autoimmune

Thyroid Disease with Fluctuating Thyroid Function. Public Library of Science, Medicine (PLOS

Med) 2005 May;2 (5);e89.

1.3.21 Ali Alzahrani (Corresponding Author), Mohammed G, Al Shammary A, AlDasouqi S,

AbdelSalam S, Shoukri. Long Term Course and Predictive Factors of Elevated Serum

Thyroglobulin and Negative Diagnostic Radioiodine whole Body scan in differentiated thyroid

cancer. J Endocrinol Invest. 2005 Jun; 28 (6) 540-546.

1.3.22 Alarifi A, Alzahrani A (Corresponding Author), Salam SA, Ahmed M. Repeated Remissions of

Cushing’s Disease Due to Recurrent Infarctions of an ACTH-Producing Pituitary Macroadenoma.

Pituitary. 2005;8(2):81-7.

1.3.23 Alzahrani, AS (Corresponding Author). Resistin: Can we resist its role in insulin resistance?

Ann Saudi Med. 2005 Jul-Aug;25(4):281-2

1.3.24 Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Association of mitochondrial DNA transversion

mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.

Oncogene.2006 Feb 2;25 (5):677-84.

1.3.25 Ali S. Alzahrani (Corresponding Author), Gamal E. Mohamed, Ayman Rifai, Abdalaziz S. Al-

Sugair, Suzan A. Abdel Salam, Othman M. Sulaiman, , and Omer Demirkaya. The Role of F-18-

Fluorodeoxyglucose Positron Emission Tomography in the Follow-up of Differentiated Thyroid

Cancer. Endocrine Practice, 2006 Mar-Apr;12 (2):152-8.

Ali Saeed Alzahrani

CV, 01 August 2012

Page 23 of 25

1.3.26 Ali Alzahrani, Essa Y Baitei, Minjing Zou, and Yufei Shi. Clinical Case Seminar: Metastatic

Thyroid Follicular Carcinoma arising from congenital goiter due to a novel splice donor site

mutation in the thyroglobulin Gene. J Clin Endocrin Metab 2006 Mar;91 (3):740-6.

1.3.27 Mohammed Ahmed, Haroon Faraz, Abdulraof Almahfouz, Abdullah Alarifi, Hussein Raef, Fouad

Al Dayel, Abdulaziz Al Sugair and Ali Alzahrani. A case of vitamin D deficiency masquerading

as occult malignancy. Ann Saudi Med 2006;26 (3): 231-236.

1.3.28 Alzahrani AS, Baitei E, Zou M, Shi Y. Thiamine Transporter Mutations: an example of

Monogenic Diabetes Mellitus. Eur J Endocrinol. 2006 Dec;155(6):787-92.

1.3.29 Ali S Alzahrani (Corresponding Author). (Invited Review Article) Management of hypertension

in diabetes mellitus. Experts Rev. Endocrinol. Metab 2 (3), 2007.

1.3.30 Bouchama A, Kwaasi A, Dehbi M. Al Mohanna F, Eldali A, El-Sayed R, Tbakhi A, Alzahrani AS,

Roberts AG. Glucocorticoids do not protect against the lethal effects of experimental heatstroke in

baboons. Shock. 2007 May;27(5):578-83.

1.3.31 Elhadd TA, Al-Amoudi AA, Alzahrani AS. Epidemiology, clinical and complications profile of

diabetes in Saudi Arabia: a review. Ann Saudi Med, 2007 Jul-Aug;27 (4):241-50.

1.3.32 Siraj A, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed

M, Al-Sanea-O, Uddin S, Al-Kuraya K. Genome-wide expression analysis of Middle Eastern

papillary thyroid cancer reveals-Met as a novel target for cancer therapy. J Pathol.2007.

Oct;213(2):190-9.

1.3.33 Ahmed M, H Bin Yousef, W. Creer, HA Faraz, S. Al Sobhi, A Alzahrani, H Raef, A Al Ghamdi,

Y. Al Kadhi and F Al Dayel. Hurthle Cell Neoplasm of Thyroid Gland: Australia New Zealand

Journal of Surgery. 2008:78;139-143.

1.3.34 Alzahrani AS (Corresponding Author). Predictors of obstructive sleep apnea in snorers:

statistical errors—Comment from the Annals. Ann Saudi Med. 2008 Jan-Feb;28(1):60-1.

1.3.35 Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z, Al-Mohanna FA.

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment

of anaplastic thyroid carcinoma. Cancer Gene Ther. 2008 Feb;15 (2):101-7.

1.3.36 Ali Alzahrani (Corresponding Author) and Mohammed Al Sheef. Severe Primary

Hyperparathyroidism Masked by Asymptomatic Celiac Disease. Endocr Pract. 2008

Apr;14(3):347-50.

1.3.37 Alzahrani A (Corresponding Author), Abouzeid M, Abdel-Salam S, Gamal M, Rifai A, Al-

Sugair A, Amin T. The role of F-18 Fluorodeoxyglucose Positron Emission Tomography

in the Postoperative evaluation of differentiated thyroid cancer. Eur. J. Endocrinol., May

2008;158:683-689.

1.3.38 Alzahrani AS (Corresponding Author), Goiter (Invited chapter). In: Ebell MH, ed.

Evidence at Hand. 1st ed. Hoboken, NJ: John Wiley and Sons.

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Shi%20Y%22%5BAuthor%5D&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVAbstractPlusDrugs1

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Zou%20M%22%5BAuthor%5D&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVAbstractPlusDrugs1

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Baitei%20EY%22%5BAuthor%5D&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVAbstractPlusDrugs1

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Alzahrani%20AS%22%5BAuthor%5D&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVAbstractPlusDrugs1

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Parhar%20RS%22%5BAuthor%5D&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVAbstractPlusDrugs1

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Al-Makhalafi%20Z%22%5BAuthor%5D&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVAbstractPlusDrugs1

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Al-Mohanna%20FA%22%5BAuthor%5D&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVAbstractPlusDrugs1

Ali Saeed Alzahrani

CV, 01 August 2012

Page 24 of 25

1.3.39 Alzahrani AS (Corresponding Author), Multiple Endocrine Neoplasia type 1 (Invited

chapter). In: Ebell MH, ed. Evidence at Hand. 1st ed. Hoboken, NJ: John Wiley and Sons.

1.3.40 Alzahrani AS (Corresponding Author), Al-Harthy S. Multiple Endocrine Neoplasia type 2

(Invited Chapter) In: Ebell MH, ed. Evidence at Hand. 1st ed. Hoboken, NJ: John Wiley

and Sons.

1.3.41 Ali Alzahrani (Corresponding Author), Nojoud Al Khaldi, Yufei Shi, Roua Al AlRijjal,

Minjing Zou, Essa Y Baitei and Tarek Amin. Diagnosis by Serendipity: Cushing’s

syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of

multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 Mutation. Endocr

Pract. 2008 Jul-Aug:14 (5):595-602.

1.3.42 Zou M, Baitei EY, Alzahrani AS, Al-Mohanna F, Farid NR, Meyer B, Shi Y. Oncogenic

activation of MAP kinase by BRAF pseudogene in thyroid tumors. Neoplasia. 2009 Jan;

11(1):57-65.

1.3.43 Baitei EY, Zou M, Al-Mohanna F, Collison K, Alzahrani AS, Farid NR, Meyer B, Shi Y.

Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in

thyroid carcinoma. J pathol. 2009 Apr; 217: 707-715.

1.3.44 Alzahrani AS (Corresponding Author), Farhat R, Alarifi A, AlKahtani N, Kanaan I,

Abouzeid M. The diagnostic value of fused positron Emission tomography/computed

tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in

cushing’s disease. Pituitary. 2009: 12 (4) 309-14.

1.3.45 Al-Harthy M, Al-Harthy S, Al-Otieschan A, Velagapudi S, Alzahrani AS (corresponding

author). Comparison of pheochromocytomas and abdominal and pelvic paragangliomas

with head and neck paragangliomas. Endocr Pract. 2009 May-June: 15 (3):194-202.

1.3.46 Farhat R, Zidjali F, Alzahrani AS (Corresponding Author). Outcome of gonadotropin

therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary. 2010 Jun:

13(2):105-10.

1.3.47 Alshaikh O, Al-Mahfouz A, Al-Hindi H, Mahfouz AB, Alzahrani AS (Corresponding

Author). An unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing's

syndrome attributable to small cell prostate cancer. Endocr Pract. 2010 Mar-Apr;16(2):249-

54.

1.3.48 Alzahrani AS (Corresponding Author), Alshaikh O, Faiyaz-Ul-Haque M, Abalkhail H, Al-

Dayel F, Al Hindi HA. Multiple Paraganglioma Syndrome type 4 due to Succinate

Dehydrogenase B Mutation: Diagnostic and Therapeutic Challenges of a Skull Base

Paraganglioma Masquerading as Nasopharyngeal Cancer. Endocr Pract. 2010 May-

Jun:16(3):452-8.

1.3.49 Uddin S, Bavi P, Siraj AK, Ahmed M, Al-Rasheed M, Hussain AR, Ahmed M, Amin T,

Alzahrani A, Al-Dayel F, Abubaker J, Bu R, Al-Kuraya KS. Leptin-R and its association

http://www.ncbi.nlm.nih.gov/pubmed/19838805








Ali Saeed Alzahrani

CV, 01 August 2012

Page 25 of 25

with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer.

2010 Feb 18;17 (1):191-202. Print 2010 Mar.

1.3.50 Alzahrani AS, Zou M, Baitei EY, Alshaikh OM, Al-Rijjal RA, Meyer BF, Shi Y. A novel

G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1. J

Clin Endocrinol Metab. 2010 Sep;95(9):4176-83.

1.3.51 Alshaikh OM, Almanea H, Alzahrani AS (Corresponding Author). Paget disease of the

bone: Does it exist in Saudi Arabia? Ann Saudi Med. 2011 May-June: 31(3):305-10.

1.3.52 Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Mohanna FA, Meyer BF, Shi Y. Mutation

prediction by PolyPhen of functional assay, a detailed comparison of CYP27B1 missense

mutations. Endocrine. 2011 August: 40(1).

1.3.53 Alzahrani AS, Zou M, Baitei EY, Parhar RS, Al-Kahtani N, Raef H, Almahrouz A,

Amartey JK, Al-Rijjal R, Hammami R, Meyer BF, Al-Mohanna FA, Shi Y. Molecular

Characterization of a Novel p.R118C Mutation in the Insulin Receptor Gene from Patients

with Severe Insulin Resistance. Clin Endocrinol (Oxf). 2012 Apr;76(4):540-7

1.3.54 Ali Alzahrani, Graziano Ceresini, Saleh Al Aldasouqi, Ultrasound in Thyrotoxicosis: A

non-invasive, cost-3ffective, and widely available but under-utilized diagnostic tool.

Endocr Pract. 2012 Feb 20:1-35

1.3.55 Alzahrani Ali (Corresponding Author) Al Qarawi Abdullah, Al Suhaibani Fahad, Al Mana

Hadeel, Abalkhail Halah. Pancreatic metastasis arising from BRAF-positive papillary

thyroid cancer: the role of endoscopic ultrasound - guided biopsy and response to sorafenib

therapy. Thyroid. 2012 Mar 21. [Epub ahead of print]

1.3.56 Ali Alzahrani (Corresponding Author), Omalkhaire Al Shaikh, Mahmoud Tuli, Abdulaziz

Al Sugair, Reem Alamawi, Maha Al Rasheed. Diagnostis value of recombinant human

thyrotropin stimulated iodine 123 whole body scintigraphy in the follow up of patients with

differentiated thyroid cancer. Clin Nucl Med. 2012 Mar;37(3):229-34.


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Alzahrani%20AS%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Zou%20M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Baitei%20EY%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Alshaikh%20OM%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Al-Rijjal%20RA%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Meyer%20BF%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Shi%20Y%22%5BAuthor%5D







In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model, the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This meeting is open to all Gulf-AACE members and their invited guests.

If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173.

Name: Aly Bernard Khalil

Address: Sheikh Khalifa medical city

City: Abu Dhabi

Country: UAE


Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the purposes of Chapter business? __X_ yes ___ no

Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

___ President

_X__ Vice President

___ Secretary

___ Treasurer


_X__ CV or bio-sketch included _X__ Candidate statement included

Dear Colleagues,

I would like you to join me in suppor ng the ins tu on of the first chapter of the American Associa on of Clinical Endocrinologists in the Gulf area as well my candidacy for the posi on of Vice -President for the Gulf chapter Board of directors.

As stated in my brief bibliography, I have been one of the founders and ac ve par cipants of the United Arab Emirates endocrine Club. My mission was and s ll is to contribute to the enhancement of the level of the knowledge needed for the prac ce of clinical endocrinology.

With your support, I would like to be given the chance to serve officially as one of your representa ve in the first AACE chapter in the Gulf area.

Ali Khalil

Dr. Ali B KHALIL, MD, FRCPC, FAACE Consultant Endocrinologist, Department of Medicine, Sheikh Khalifa Medical City (SKMC), Abu Dhabi UAE Consultant at SKMC, Abu Dhabi, since 2003 Certified by the American board of Internal medicine since 1988 and the American board of Endocrinology and Metabolism since 1995 (recertified 2005). Ex- fellow of the American Endocrine Society Fellow of the American Association Clinical Endocrinologists FACE since 2005 Founding member of the endocrine group for the United Arab Emirates During my professional career, I have assumed different clinical and administrative positions the most relevant are highlighted below:

1- Head of the division of Endocrinology at the Queensway Hospital /Trillium Health Center between 1989-1998

2- President of the medical staff and member of the board of Governors at Queensway Hospital /Trillium Health Center between 1989-1998

3- Chairman of the medical surgical Intensive care Queensway Hospital /Trillium Health Center between 1998- 2000

4- President of the Ontario Diabetes Association Canada 1999-2000 5- Vice President of the Committee for Pensions and Civil Retirement for the government of

Abu Dhabi from 2006 to present 6- Deputy Chair of the Intensive care at Sheikh Khalifa medical city /Abu Dhabi 2000-2002 7- Chairperson of the Institutional review board for Research at SKMC: 2007-2011 8- Program Manager of the multidisciplinary Thyroid cancer program 2008 to -present

.

President Candidates

1. Fatma AlMarashi, MD FACE; UAE

2. Kamal A S Al-Shoumer, BSC, MB, DIC, PhD,

FRCP, FACE; Kuwait

3. Mahmoud Mohamed A Fikri, MBBCh, PhD;

UAE

4. Ahmed A K Hassoun, MD FACE; UAE



1st Annual Meeting

October 12, 2012











1 Name: FATMA H. ALMARASHI

Address: P. O. BOX 7013

City: DUBAI

Country: U.A.E.



purposes of Chapter business? __X_ yes ___ no


__X_ President

___ Vice President

___ Secretary

___ Treasurer



Dr. Fatma AlMarashi

Dr. Al Marashi recently served as the Medical Director at University Hospital, part of the Mohammed Bin

Rashid Academic Medical Center in Affiliation with Harvard Medical school Dubai Center in Dubai

Healthcare City, where she developed strategy for the Medical and Physicians Affairs Department. She has

been featured in many national TV programs for Diabetes and other Endocrinological Problems. She was a

contributing writer for the Healthcare Middle-East Journal providing physician and patient education material

on the topic of Endocrinology and Diabetes. She has organized many community activities in her field for

education of the community at large besides the courses for Education of the physicians to improve the

standards of care for patients with Endocrinological problems.

Dr. Fatma AlMarashi is the first UAE physician to earn American double board certification. She is the only

UAE physician with double American Board Degrees in Endocrinology, Diabetes and Metabolism. She is

American Board certified in Endocrinology and Internal Medicine. Dr. Al Marashi earned her medical degree

from Shiraz Medical School. She focused on Internal Medicine as her first specialty as a resident at St.

Vincent Hospital, a University of Massachusetts affiliate, in Worcester, MA,U.S.A. She furthered her

specialization by completing a fellowship in Endocrinology, Diabetes and Metabolism, at the University of

Texas Medical School in Houston, TX, U.S.A.She received her training from MD- Anderson and Herman

Hospital, Houston, USA. Dr AlMarashi has active Medical licenses in USA Massachusetts, Texas and

California, besides having a CPQ license and DOHMS License, UAE.

After coming back to UAE in 1998, she was constantly trying to get the Health care Standards improved in

UAE; she founded the Department of Endocrinology, Diabetes and Metabolism at Al Baraha Hospital

/MOH , and served as the Chair for five years. In her dedicated efforts to improve the healthcare status in

the U.A.E., Dr. Al Marashi was appointed as a U.A.E. representative in the Gulf Cooperation Council for the

Diabetes Control Committee in striving to control the rising number of diabetes cases in the area. In 1999,

she founded and served as Chairperson of the U.A.E. National Diabetes Control committee ( UAE- NDCC),

in the Ministry of Health and also founded and designed the first and only stand alone Diabetes and

Endocrine Center called Alsalam Diabetes and Endocrine center. She trained the staff for the center and

headed the project She also voluntarily helped and to develop Diabetes Center in Ajman Medical district. As a

Chair of UAE- NDCC. She developed Diabetes registry plat form for MOH and Developed Diabetes

standard of care for primary care for UAE.

She has participated in several courses, lectures and symposium to Educate Physicians as well as the

community, and the policy makers.

As a member of the Drug Formulary Committee in Ministry of Health from 2001-2003 she tried to put the

policies and procedures to develop and improve the drug approval processes. Afterwards she moved on to fill

the position as Chief of the Division of Endocrinology, Diabetes and Metabolism at Welcare Hospital before

joining Dubai Healthcare City. Dr. Al Marashi has consulted at multiple healthcare facilities in the U.A.E.

including Welcare, Al Baraha, Al Kuwaiti, Neurospinal and American Hospitals

Dr AlMarashi is a member of several International and National Scientific Associations. She is member of

International committee for American Association of Clinical Endocrinologist (AACE), and recently

appointed as a member of Primary Care Physician Education Initiative Committee of AACE USA.

She was a board member of Emirates Medical Association (EMA) and chair person of EMA Scientific

committee.

1

Gulf Chapter, AACE Priorities & experience President candidate: Dr. Kamal Al-Shoumer MD, DIC, PhD, FRCP, FACE

DR. AL-SHOUMER IS AN ASSOCIATE PROFESSOR OF MEDICINE AND CLINICAL ENDOCRINOLOGY AT THE DEPARTMENT OF MEDICINE, FACULTY OF MEDICINE, AT KUWAIT UNIVERSITY. HE IS SENIOR CONSULTANT & HEAD OF THE DIVISION OF ENDOCRINOLOGY & METABOLIC MEDICINE AT MUBARAK AL-KABEER TEACHING HOSPITAL IN KUWAIT. HE WAS THE VICE-DEAN OF THE FACULTY OF MEDICINE AT KUWAIT UNIVERSITY (APRIL 12TH 2004 - APRIL 11TH 2008). DR. AL-SHOUMER HAD HIS POST-GRADUATE EXPERIENCE IN THE UK AT ST MARY'S HOSPITAL IN LONDON WHERE HE RECEIVED HIS MRCP/FRCP. HIS FELLOWSHIP RESULTED IN A PHD IN ENDOCRINOLOGY & METABOLIC MEDICINE FROM UNIVERSITY OF LONDON, IMPERIAL COLLEGE, WHEN HE PERFORMED RESEARCH ON ADULT HYPOPITUITARISM AND ADULT GROWTH HORMONE THERAPY. HE HAS OVER 100 PUBLICATIONS INCLUDING PEER REVIEWED ARTICLES IN INTERNATIONAL JOURNALS, HE WROTE SEVERAL CHAPTERS IN TEXTBOOKS, PRESENTED SEVERAL RESEARCH PAPERS AND TOPICS AS INVITED SPEAKER IN LOCAL AND INTERNATIONAL MEETINGS, AND HE IS AN EDITORIAL BOARD MEMBER OF SEVERAL JOURNALS. HE IS AN EXTERNAL EXAMINER CERTIFIED BY THE ROYAL COLLEGE OF PHYSICIANS OF LONDON FOR THE MRCP-PACES . DURING HIS TERM OF ALL OFFICES, SEVERAL ADMINISTRATIVE, CLINICAL, AND ACADEMIC ACHEIVEMENTS WERE OBTAINED THAT RESULTED IN ACREDITATION/INCREASED RECOGNITION OF THE INSTITUTES HE WORKED AT. Mission: - To establish an administrative Gulf body that works to enhance the development of activities of all AACE Chapters - To assist endocrinologists to provide the highest quality of patient care -To work as an advocate for patient care issues in endocrinology, diabetes, metabolism and nutrition Channels: - To coordinate the work of Gulf body as the official representative of AACE in the Gulf:

a. In consistence with the views, policy and guidelines established by AACE, to serve as a communication link between members at Gulf region level.

b. To facilitate AACE policies and programs at the Gulf region. - To develop committees where appropriate to carry out the work of chapter. Preliminary committees include: Scientific & program committee, Membership committee, Nomination committee, and External relations committee. - To coordinate and help all committees in the plan and assist them in implementation of their functions. Basics needed to fulfil function: - To prepare the infrastructure needed (office, technical needs, IT matters) for the Chapter - To plan to assure adequate Gulf Chapter financial resources (along with the chapter’s treasurer) - To ensure committee will tackle the related necessary roles in:

a. Recruitment of new members as qualified by AACE. b. Establish necessary link among members (Website, email, periodic newsletter) c. Disseminate AACE clinical practice guidelines and endocrine educational tools that will enhance the delivery of

health care in the Gulf chapter. d. Foster mutually supportive professional relationships between AACE and endocrine organizations in the Gulf region.

Endocrinologists continued education To increase creativity and new skills developments for endocrinologists in Gulf Chapter by their involvement in workshops, symposia, or events organized by Gulf Chapter, or linked to or co-organized with other AACE chapters in a CME accredited manner by AACE Personal administrative experience of Dr. Kamal Al-Shoumer: A. At the student level: 1.President, Kuwait Medical Students Association at Faculty of Medicine, Kuwait University and President of Standing Committee for International Federation of Medical Students Associations (Oct.1984- Oct.1985) B. At the Post-Graduate level: 1.President, National Union of Kuwaiti students – UK and Ireland branch, the official association representing scholar Kuwaiti under- and post-graduate students in the UK and Ireland. (Sept. 1993-Sept.1994) C. At the department of Medicine level, Faculty of Medicine level: 1.Head of Division of Endocrinology & Metabolic Medicine (1997-to date). 2.Team Leader and Chief Coordinator of Endocrine system block at the new curriculum of Phase II program (Nov. 2005 to date) D. At the Faculty of Medicine and University of Kuwait levels: 1. President of Conference, Ninth Annual Health Sciences Poster Conference, Faculty of Medicine, HSC (2004). 2. Vice-Dean (Administration & Finance), Faculty of Medicine (April 2004 to April 2008) E. At the Regional Arab level: 1. President, Pan-Arab Society of Endocrinology and Diabetes (Nov. 2007-to May 2010)

1

CURRICULUM VITAE

KAMAL A. S. AL-SHOUMER B.Sc., M.B.B.Ch., D.I.C.(UK), Ph.D.(UK),

M.R.C.P.(UK), F.R.C.P. (UK), F.A.C.E.(USA)

ASSOCIATE PROFESSOR OF CLINICAL

ENDOCRINOLOGY AND MEDICINE

DEPARTMENT OF MEDICINE

FACULTY OF MEDICINE/KUWAIT UNIVERSITY

HEAD, DIVISION OF ENDOCRINOLOGY &

METABOLIC MEDICINE / FACULTY OF MEDICINE

& MUBARAK AL-KABEER UNIVERSITY

TEACHING HOSPITAL

EX-(PAST) VICE-DEAN, FACULTY OF MEDICINE,

KUWAIT UNIVERSITY

PRESIDENT OF PAN-ARAB SOCIETY OF

ENDOCRINOLOGY AND DIABETES

(NOV.2007 TO MAY 2010)

2

PERSONAL DETAILS Name : Kamal Abdul Aziz Sulaiman Al-Shoumer

Date of birth : 3rd Oct. 1961

Place of birth : Kuwait

Nationality : Kuwaiti

Address: P.O.Box 1086 Surra

45711 Kuwait

Fax: +965 25340549

Mobile: +965 99707539

E-mail [email protected] or [email protected]

QUALIFICATIONS B.Sc. 1983, Faculty of Medicine, Kuwait University (Kuwait).

M.B.B.Ch 1986, Faculty of Medicine, Kuwait University (Kuwait).

M.R.C.P. (Medicine) 1993, Membership, Royal College of Physicians (UK).

Ph. D. (Clinical Endocrinology) 1996, University of London (UK).

D.I.C. (Clinical Endocrinology) 1997, Imperial College of Science, Technology and

Medicine, London (UK).

F.R.C.P (UK) 2002, Fellowship, Royal College of Physicians (UK)

F.A.C.E (USA) 2003, Fellowship, American College of Endocrinology

SUMMARY OF POSTS Trainee July 1986 - July 1987

Assistant Registrar - General Medicine Aug. 1987 - April 1990

Registrar - General Medicine May 1990 - Feb. 1992

Honorary Registrar - Endocrinology March 1992 - March 1993

Clinical Research Fellow - Endocrinology

& Senior Registrar (Kuwait) April 1993- Dec 1996

Consultant & Head of Division of Endocrinology

& Metabolic Medicine - Dept. of Medicine - March 1997 to date

Assistant Professor of Medicine - Faculty of (I.D 9703152) Sept 1997 to 20th June 2001

Medicine

Associate Professor of Medicine - Faculty of 20th June 2001 to date

Medicine

Vice-Dean, Faculty of Medicine 12 April 2004 to 11April 2008

Current Post: Consultant/Head of division Since March 1997 to date

Of Endocrinology & Metabolic Medicine at

Faculty of Medicine & Mubarak Al-Kabeer

Teaching hospital

3

PROFESSIONAL HISTORY: Transitional Internship: This included rotations in the 4 major branches of medicine

1. General Surgery July 1986 - End Oct. 1986

Farwaniya Hospital - Kuwait

Consultant: Dr. Parkash FRCS

2. Obstetrics & Gynaecology Nov.1986 - End Dec. 1986

Al-Adan Hospital - Kuwait

Consultant: Dr. S. Kamil MRCOG

3. General Medicine Jan.1987 - End April 1987


Consultant: Dr. J. Cherian FRCP

4. Paediatrics May 1987 - End June 1987


Consultant: Dr. Sharda MRCPaed.

Postgraduate Training Programme (PGTP) in Medicine in Kuwait:

This included rotations in all subspecialities of Medicine including general medical rotations:

As Assistant Registrar

1. General Medicine July 1987 - End June 1988

Amiri Hospital- Kuwait

Consultants: Dr. H.K.Walia FRCP & Dr. Menon FRCP

2. General Medicine July 1988 - End Dec. 1988

Mubarak Hospital - Kuwait

Consultants: Prof.A.Razzaq FRCP & Prof.M.Barakat MD

3. Endocrinology subspeciality 1st-End Jan 1989


Consultant: Dr. Berg MD

4. Rheumatology rotation 1st-End Feb. 1989


Consultant: Dr.M.Sattar FRCP

5. Hematology rotation 1st-End March 1989

Amiri Hospital - Kuwait

Consultant: Dr. H.Habboush MRCP MRCPath

6. Coronary Care Unit 1st- End April 1989


Consultant: Dr. M.Khafaji MRCP

7. Intensive Care Unit 1st-End May 1989


Consultant: Dr.Farouq

8. Oncology rotation 1st - End June 1989

Kuwait Cancer Centre

Consultant: Dr.S.Mutawe FRCS

9. Cardiology rotation 1st July - End Sep. 89

Chest Disease Hospital - Kuwait

4

Consultants: Prof. G.Cherian MD, Dr. Nazir

10. Dermatology rotation 1st Oct.- 15 Nov. 1989

Shuwaikh Skin Centre- Kuwait

Consultant: Prof. M Al-Din MD

11. Psychiatry rotation 16 Nov.- End Dec. 1989

Psychiatric Diseases Hospital-Kuwait

Consultant: Prof.M.F.Islam MRCPsy

12. Neurology rotation 1st Jan-End March 1990

Ibn Sina Hospital-Kuwait

Consultant: Dr.R.Shakir MRCP

13. Respiratory diseases rotation 1st-End April 1990

Mubarak Hospital Respiratory Unit-Kuwait

Consultant: Dr. Karnick MD

As Registrar

14.Radiology rotation 1st-End May 1990

Amiri Hosp. Radiology Dep.-Kuwait

Consultant: Dr. Mohy MD

15.Emergency medicine 1st-End June 1990

A.&E. Amiri Hospital - Kuwait

Consultant: Prof. B. Al-Naqib FACP FRCP

16.General Medicine 1st June-End Feb. 1992

Amiri Hospital -Kuwait

Consultant: Dr. H.K.Walia FRCP

As Honorary Registrar (In UK)

In the Unit of Metabolic Medicine 2nd March 1992- March 1993

& Clinical Endocrinology at

St. Mary’s Hospital-London W2

Consultant: Professor D.G.Johnston PhD FRCP

Dr.R. S. Elkeles MD FRCP

As Clinical Research Fellow (Senior Registrar)

In the Unit of Metabolic Medicine April 1993 - Dec. 1996

St. Mary’s Hospital-London W2

Consultant: Professor D.G.Johnston PhD FRCP

Dr.R. S. Elkeles MD FRCP

During this period, I was involved in the academic activities of the Unit of Metabolic Medicine.

This included teaching at the Imperial College School of Medicine at St. Mary’s for medical

students in the course of Endocrinology. In addition to this, regular weekly clinics on general

endocrinology, diabetes and lipids at St Mary’s and St Charles’s Hospitals were part of my

clinical activities.

After 1996 to date:

1. Consultant & Head of Division of Endocrinology & Metabolic Medicine (1997-to date)

5

This post includes a full responsibility of patients as a head of division of Endocrinology &

Metabolic Medicine in the Medical Department at Mubarak Al-Kabeer Hospital. It covers

services in the subspeciality of Endocrinology and Metabolism. It includes inpatient care,

outpatient care, duties, arrangement of bone densitometry and metabolic day assessments. In

addition to regular in bedside teaching for medical students and postgraduates.

2. Assistant Professor of Medicine- Department of Medicine (1997-19th June 2001)

This includes full engagement in teaching activities in the Faculty of Medicine for undergraduates

and postgraduates. Organization of the 5th year Endocrine & Diabetes system course,

presentation of lectures to postgraduate candidates in the MRCP part I and II course, presentation

of lectures to students, and supervising the activities in the departmental endocrine laboratory

(with a backdated appointment since Sept. 1993).

3. Associate Professor, Department of Medicine, Faculty of Medicine (20th June 2001-to

date)

This post was achieved based on the distinguished research, community services and clinical

teaching for students and post-graduates in the Faculty of Medicine at Kuwait University and at

the Faculty of Internal Medicine at the Post-graduate Training Program.

4. Vice-Dean (Administration & Finance), Faculty of Medicine (12 April 2004 to 11 April

2008)

ADMINISTRATIVE EXPERIENCE: A. At the student level:

1. Director of student affairs committee, Kuwait Medical Student Association (KuMSA), the

official association representing medical students at Faculty of medicine, Kuwait

University (Oct.1981-Oct.1982)

2. Vice-President of KuMSA and Director of students affairs committee in KuMSA

(Oct.1982- Oct.1983)

3. Director of the Standing Committee of Refugees (SCOR) at the International Federation

of Medical Students Association (IFMSA) (1983-1985)

4. Vice-president of the General Assembly of the IFMSA 1984 meeting held at Solbaka,

Sweden

5. President, KuMSA at Faculty of Medicine, Kuwait University and President of Standing

Committee for IFMSA (Oct.1984- Oct.1985)

B. At the Post-Graduate level:

1. President, National Union of Kuwaiti students – UK and Ireland branch, the official

association representing scholar Kuwaiti under- and post-graduate students at UK and

Ireland. (Sept. 1993-Sept.1994)

C. At the Faculty of Medicine level: Department of Medicine:

1. Head of Division of Endocrinology & Metabolic Medicine (1997-to date).

2. Member, of the departmental Research Committee (1997-1999). 3. Chief Coordinator, of departmental Research Committee (1999-2002)

6

4. Member, of departmental Postgraduate Committee (1999 to date).

5. Chief Coordinator, department Examination Committee (2002-2004)

Under and Post-graduate teaching levels and program:

1. Coordinator at Kuwait Institute for Medical Specialization (KIMS), Postgraduate training

program in Medicine - Mubarak Al-Kabeer Hospital (2000-2004) 2. Chief Coordinator of the Endocrinology system course to the 5th year students in the

Faculty of Medicine (1998 to date) 3. Team Leader and Chief Coordinator of Endocrine system block at the new curriculum of

Phase II program (Nov. 2005 to date) 4. Chief Coordinator of Updates on Endocrinology & Metabolism (UEM) (1999-2006) 5. Co-ordinator, Joint Mayo clinic and Kuwait National program to fight hypertension, Fight

hypertension congress 15-17th

Jan. 2007

Faculty of Medicine level

1. Executive Member, the organizing committee for the annual poster day at

Faculty of Medicine, Health Sciences Center (1997 to 2004).

2. Member, the executive board of Medical Research Council (MRC) of the

Faculty (1998-2001).

3. Member of the Faculty of Medicine Scientific Affairs Advisory Committee (1999)

4. Chairman, Faculty Committee for staff salary cadre recommendations (2005-6)

5. Chairman, Faculty Committee for space allocation in faculty of medicine (2005-6)

6. Chairman, Faculty Recruitment Committee for support academic staff at Faculty of

Medicine (2006-)

7. Chairman of Committee, Ninth Annual Health Sciences Poster Conference

2004.

8. Director, Faculty of Medicine Consultation Office (2006 to date)

9. Member, Interview Committee of new applicants to Faculty of Medicine (2005-

7)

D. At Deanship level of Faculty of Medicine: 1. Vice-Dean (Administration & Finance), Faculty of Medicine (12 April 2004 to April

2008)

2. Acting Dean, Faculty of Medicine at the following periods;

- 17 July 2004 to 1st August 2004

- 25 Sept. 2004 to 29 Sept. 2004

- 16th

November 2004

- 27 Nov. 2004 to 29 Nov. 2004

- 25 Dec. 2004 to 28 Dec. 2004

- 8th

Jan 2005 to 10th

Jan 2005

- 2nd

July 2005 to 29th

July 2005

- 8th

Oct. 2005 to 12th

Oct. 2005

- 18th

Feb. 2006 to 20th

Feb. 2006

- 15th

July 2006 to 2nd

August 2006

- 10th

Sept. 2006 to 14th

Sept. 2006

- 24th

March 2007 to 29th

March 2007

7

3. Dean Representative of Faculty of Medicine of Kuwait on the third Conference

of Arab Society of Medical Faculties, held on 12-13 April 2006, Irbid, Jordan

E. At the University level: 1. Council member, University Recruitment committee for support academic staff (2004-

2005-2006-2007)

2. Member, University Committee for the study of merging colleges (2004-5)

3. Member, University Committee to study the cadre for support academic staff, teaching

assistants and English language tutors (Jan-May 2006)

4. Member, University Committee for the evaluation of certificates for academic staff

(2007- )

F. At the regional Arab level:

1. President, Pan Arab Society for Endocrinology and Diabetes (Nov. 2007- May 2010)

ACADEMIC ACTIVITIES : PublishedResearch papers in refereed cited journals:

1. Al-Shoumer KAS, Beshyah SA & Johnston DG. (1994) Growth hormone and malignancy.

Endocrine-Related Cancer; 1 : 19-26

2. Al-Shoumer KAS, Beshyah SA, Niththyanathan R & Johnston DG. (1995) Effect of

glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in

hypopituitary adults. Clinical Endocrinology; 42: 85-90

3. Al-Shoumer KAS, Ali K, Anyaoku V, Niththyananthan R & Johnston DG. (1996) Overnight

metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical

Endocrinology; 45, 171-178.

4. Al-Shoumer KAS, Page B, Thomas E, Murphy M, Beshyah SA & Johnston DG. (1996)

Effects of four years’ treatment with biosynthetic human growth hormone (GH) on body

composition in GH-deficient hypopituitary adults. European Journal of Endocrinology ; 135:

559-567.

5. Al-Shoumer KAS, Cox K, Hughes C, Richmond W & Johnston DG. (1997) Fasting and post-

prandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.

Journal of Clinical Endocrinology and Metabolism ; 82: 2653-2659.

6. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. (1997) Metabolic effects of short-term

reproduction of the normal diurnal cortisol rhythm in hypopituitary adults. Endocrinology &

Metabolism ; 4: 207-214.

7. Al-Shoumer KAS, Anyaoku V, Richmond W & Johnston DG.(1997) Elevated leptin

concentrations in growth hormone-deficient hypopituitary adults. Clinical Endocrinology; 47:

153-159.

8. Al-Shoumer KAS, Gray R, Anyaoku V, Hughes C, Beshyah SA, Richmond W & Johnston

DG. (1998) Effects of four years’ treatment with biosynthetic human growth hormone (GH) on

glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical

Endocrinology, 48, 795-802.

9. Kousta E, Chrisoulidou A, Lawrence N J, Al-Shoumer KAS, Parker KH, McCarthy MI &

Johnston DG. (1998) The circadian rhythm of leptin is preserved in growth hormone deficient

hypopituitary adults.Clinical Endocrinology; 48, 685-690.

8

10. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S and Robinson S.

(1999). Long-term effects of GH therapy on intermediary metabolism and insulin sensitivity in

hypopituitary adults. Journal of Endocrinological Investigation , 22, 37-40.

11. Kousta E, Chrisoulidou A, Lowrence NJ, Anyaoku V, Al-Shoumer KAS & Johnston DG.

(2000) The effects of growth hormone replacement therapy on overnight metabolic fuels in

hypopituitary patients.Clinical Endocrinology 52, 17-24

12. Al-Shoumer KAS, Vasanthy BK, Makhlouf HA & Al-Zaid MM. (2000) Leptin levels in

Arabs with primary hyperthyroidism. Annals of Saudi Medicine, 20, 113-118.

13. Doi SAR, Loutfi I & Al-Shoumer KAS. (2001) A mathematical model of optimized

radioiodine-131 treatment of Graves’ hyperthyroidism. BMC Nuclear Medicine 1:1

14. Parappil A, Doi SAR & Al-Shoumer KAS. (2002) Diagnostic criteria for diabetes revisited:

making use of combined criteria. BMC Endocrine Disorders 2:1

15. Al-Gharabally A, Doi SAR, Al-Shoumer KAS (2002) Spironolactone for the treatment of

hypercalcuric hypocalcemia. Journal of Bone and Mineral Metabloism 20, 243-247

16. Abalkhail S, Doi SAR, Al-Shoumer KAS. (2003) The use of corticosteroids versus other

treatments for Graves’ ophthalmopathy: a quantitative evaluation. Medical Sciences Monitor

9(11), CR477-483.

17. Mehraj S, Doi SAR, Al-Shoumer KAS.(2004) Technical observations on the assessment of

thyroid volume by palpation and ultrasonography. Journal of Ultrasound in Medicine 23(2), 261-

266.

18. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Irregular cycles and steroid

hormones in polycystic ovary syndrome. Hum Reprod. 2005 Sep;20(9):2402-8.

19. Lasheen I, Doi SA, Al-Shoumer KAS. Glucocorticoid replacement in panhypopituitarism

complicated by myelinolysis. Med Princ Pract. 2005 Mar-Apr;14(2):115-7.

20. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Ovarian steroids modulate

neuroendocrine dysfunction in polycystic ovary syndrome. J Endocrinol Invest. 2005 Nov

28(10):882-92.

21. Al-Shoumer KAS, Vasanthy BA, Al-Zaid MM. Effects of treatment of hyperthyroidism on

glucose homeostasis, insulin secretion and markers of bone turnover. Endocrine Practice 2006,

12 (2): 121-130.

22. Doi SA, Lasheen I, Al-Humood K, Al-Shoumer KAS. Relationship between cortisol

increment and basal cortisol: implications for the low dose short adrenocorticotrophic hormone

stimulation test. Clin Chem. 2006 Apr; 52(4):746-9.

23. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Steroidogenic alterations and

adrenal androgen excess in PCOS. Steroids. 2006, 71: 751-759.

24. S. A.R. Doi, D. Issac, S. Abalkhail, M. M. Al-Qudhaiby, M. F. Hafez, and KAS Al-Shoumer.

TRH Stimulation When Basal TSH is Within the Normal Range: Is There "Sub-Biochemical"

Hypothyroidism? Clin. Med. Res., October 1, 2007; 5(3): 145 - 148.

25. Sheikh, M; Abalkhail, S; Doi, SAR; Al-Shoumer, KAS. Normal measurement of orbital

structures: Implications for the assessment of Graves' ophthalmopathy. Australasian Radiology.

51(3):253-256, June 2007.

26. Kamal Al-Shoumer, Hafez Mohamad, Suhail Doi. A case of hypocortisolemic clinical

Cushing’s syndrome. Annals of Saudi Medicine (2008): 28(2):124-127.

9

27. Kamal Al-Shoumer, Adnan Al-Asoosi, Suhail Doi, Bagavathy Vasanthy. Serum leptin and

metabolic variables in Arabs with type 2 diabetes. Annals of Saudi Medicine (2008): 28(5): 267-

370.

28. Kamal Al-Shoumer & Bagavathy Vasanthy. Serum chromogranin A concentration in

hyperthyroidism before and After medical treatment. Journal of Clinical Endocrinology &

Metabolism (2009): 94: 2321–2324. Published online on April 14, 2009 as doi:10.1210/jc.2008-

2231

29. Moussa Alkhalaf and Kamal Al-Shoumer. Cytogenetic abnormalities and azoospermia

factor (AZF) microdeletions in infertile men from Kuwait. J Mol Genet Med (2010), 4(1), 232-

234

30. Kamal Al-Shoumer & Vasanthy Nair. Prevalence of low bone mass in post-menopausal

Kuwaiti women resident in the largest province at Kuwait. Archives of osteoporosis (2012 In

press)

Published Reviews, Book Chapters:

31. Al-Shoumer KAS, Kousta E, Beshyah S & Johnston DG. Growth hormone (GH) deficiency -

Does it cause atherosclerosis ? In Proceedings of 3rd International hGH Symposium on GHD in

adults (1996) (ed. JS Christiansen, JOL Jørgensen, AVZ Mühlen & W Waldhäusl), pp. 20-25,

Medical Forum International, The Netherlands.

32. Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku V.

Interactions of cortisol and growth hormone replacement: intermediary metabolism. In The

diagnosis and treatment of pituitary insufficiency (1997) (ed.SWJ Lamberts), pp. 63-77.

BioScientifica Ltd, Bristol.


Growth hormone replacement in young adults: if and when to continue?. In Adolescent

Endocrinology (1998) (ed.R Stanhope), pp. 17-23. BioScientifica Ltd, Bristol.

34. Doi SA, Towers PA, Scott CJ, Al-Shoumer KAS. PCOS: an ovarian disorder that leads to

dysregulation in the hypothalamic-pituitary-adrenal axis? Eur J Obstet Gynecol Reprod Biol.

2005 Jan 10;118(1):4-16

35. Perros P & Al-Shoumer KAS. Endocrinology alarm bells. Textbook: Alarm Bells in

Medicine 2005, BMJ Books, Blackwell Publ, 25-29.

36. Doi SA, Abalkhail S, Al-Qudhaiby MM, Al-Humood K, Hafez MF, Al-Shoumer KAS.

Optimal use and interpretation of the aldosterone rennin ratio to detect aldosterone excess in

hypertension. J Human Hypertens. 2006 Jul 20 (7):482-9.

37. Al-Shoumer KAS. Vitamin D: A Methodological Update. United Updates 2011, Jan. Issue 4:

12-17.

38. Al-Shoumer KAS & Gharib Hossein. Hyperthyroidism: Toxic Nodular Goiter and Graves

Disease. Surgery of the Thyroid and Parathyroid Gland, Second Edition. Edited by Gregory W.

Randolph, M.D., F.A.C.S (in press 2012)

Editor of a book:

39. Al-Shoumer KAS. Reflections of Health Sciences Center Poster Days 1996-2001, April

2001, Kuwait.

10

40. Diabetes: The hidden pandemic and its impact on the middle east and northern Africa.

Published and distributed on MENA Diabetes Leadership forum 2010 Dubai, 1-38. (12-13 Dec.

2010)

Published abstracts in refereed journals & presented (Posters) in meetings

41. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. (1993) Glucocorticoid

replacement regimen and glucose tolerance in hypopituitary adults. Journal of Endocrinology;

139 (Suppl.): P126.

42. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. (1994) Day to day

variation in glucose tolerance and intermediary metabolites caused by glucocorticoid replacement

therapy in hypopituitary adults. Clinical Science; 86 (Suppl.30): 22P.

43. Al-Shoumer KAS, Andres C, Beshyah SA, Gray IP & Johnston DG. (1994) Day to day

variation in pancreatic beta cell products caused by glucocorticoid replacement therapy in

hypopituitary adults. Journal of Endocrinology; 140 (Suppl.): P164.

44. Al-Shoumer KAS, Ali K, Niththyanathan R & Johnston DG. (1994) 24 Hour glucose and

insulin profiles in hypopituitary adults on conventional replacement therapy.Diabetic Medicine;

11(Suppl.2): P54.

45. Al-Shoumer KAS, Anyaoku V & Johnston DG. (1995) Total plasma cortisol profiles in

hypopituitary adults with growth hormone deficiency on conventional replacement therapy.

Endocrinology and Metabolism ; 2 (Suppl.B): page 143.

46. Al-Shoumer KAS, Hughes C, Ali K, Richmond W & Johnston DG. (1995) Abnormalities of

lipid metabolism in ACTH-deficient hypopituitary adults on conventional replacement therapy.

Journal of Endocrinology; 144 (Suppl.): P107.

47. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. Plasma free cortisol profiles in

conventionally treated hypopituitary adults. 77th Annual Meeting of the American Endocrine

Society: Washington DC, held on 14-17 June (1995). Conference Programme and Abstract Book

(Poster P3-75, page 487).

48. Al-Shoumer KAS, Gedroyc W, Beshyah SA, Anyaoku V & Johnston DG. Does growth

hormone (GH) treatment cause reactivation or recurrence of pituitary tumours in hypopituitary

patients (HP). Fifth International Congress on Hormones and Cancer: Quebec City, held on 16-20

September (1995). Conference Programme and abstract Book (Poster 94, page 118).

49. Al-Shoumer KAS, Cox K, Richmond W & Johnston DG. (1995) Plasma lipid profiles over

24 hours in hypopituitary adults (HPA) on conventional replacement therapy.Journal of

Endocrinology; 147 (Suppl.): P67.

50. Al-Shoumer KAS, Anyaoku V, Niththyanathan R & Johnston DG. (1996) Abnormalities of

intermediary metabolites in hypopituitary adults with growth hormone (GH) deficiency on

conventional replacement. Endocrinology and Metabolism ; 3 (Suppl A), 122.

51. Al-Shoumer KAS, Anyaoku V, Gray R & Johnston DG. (1996) Effects on glucose and

insulin of short- term reproduction of the normal diurnal cortisol rhythm in ACTH-deficient

hypopituitary adults.Journal of Endocrinology ; 148 (Suppl.): P141.

52. Al-Shoumer KAS, Page B, Anyaoku V, Beshyah S & Johnston DG. (1996) Body

composition in hypopituitary adults (HPA): results after four years of growth hormone (GH)

replacement therapy. Journal of Endocrinology ; 148 (Suppl.): P142.

11

53. Al-Shoumer KAS, Gray R, Barr J, Anyaoku V, Ali K & Johnston DG. (1996) Plasma

glucose and insulin in hypopituitary adults: results after 4 years of growth hormone (GH)

replacement. Diabetic Medicine ; 13 (Suppl.3): P50: S27-28.

54. Al-Shoumer KAS, Gray R, Barr J, Anyaoku V, Hughes C, Richmond W & Johnston DG.

Carbohydrate tolerance and lipid metabolism in hypopituitary adults after long-term growth

hormone (GH) replacement. 10th International Congress of Endocrinology: San Francisco, held

on 12-15 June (1996). Conference Programme and Abstract Book (Poster P2-464, page 520).

55. Al-Shoumer KAS, Kyd P, Murphy M, Thomas E & Johnston DG. (1996) Preserved increase

in bone turnover and maintained level of bone mass in growth hormone (GH) deficient

hypopituitary adults treated with human biosynthetic GH for four years.Journal of

Endocrinology;151(Suppl.): P66.

56. Al-Shoumer KAS, Anyaoku V, Gray R, Hughes C, Richmond W & Johnston DG.(1997)

Anthropometric and metabolic effects of four years treatment with biosynthetic human growth

hormone (GH) in hypopituitary adults (HPA). Endocrinology and Metabolism ; 4 (Suppl. A),

P047, page 53.

57. Al-Shoumer KAS, Kousta E, Richmond W & Johnston DG. (1997) Increased prevalence of

abnormal fasting lipids and lipoproteins in growth hormone (GH) deficient hypopituitary adults.

Endocrinology and Metabolism ; 4 (Suppl. B), Poster A3, page 157.

58. Kousta E, Chrisoulidou A, Lawrence N, Al-Shoumer KAS, Markou A & Johnston DG. The

circadian rhythm of leptin is preserved in hypopituitary patients. 24th International Symposium

on Growth Hormone and Growth factors in Endocrinology and Metabolism, Antwerp, held on 3-

4 October (1997). Conference Programme and abstract Book (Poster A7, page 54).

59. Al-Shoumer KAS, Ali K, Anyaoku V & Johnston DG. (1997) Intravenous versus oral

hydrocortisone replacement therapy in ACTH-deficient hypopituitary adults: effects on metabolic

fuels. Journal of Endocrinology; 155 (Suppl. 2): P47.

60. Chrisoulidou A, Anyaoku V, Beshyah SA, Al-Shoumer KAS, Robinson S & Johnston DG.

(1998) Effects of GH treatment for 7 years versus no treatment on anthropometry and vascular

risk factors in adult hypopituitarism. Journal of Endocrinology , 156 (Supp.), P151.

61. Al-Shoumer KAS, Makhlouf HA, Al-Zaid MM, Qurtum M & Hussein AAA. Effects of

treatment of thyrotoxicosis on carbohydrate metabolism in hyperthyroid adults. Third Health

Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait, April 20, 1998,

Conference Programme and abstract Book (page 40).

62. Al-Shoumer KAS, Vasanthy BK, Makhlouf HA & Al-Zaid MM. Increased bone turnover in

untreated thyrotoxicosis. Third Health Sciences Poster day, Faculty of Medicine, Kuwait

University, Kuwait, April 20, 1998, Conference Programme and abstract Book (page 41).

63. Al-Shoumer KAS, Kyd P, Murphy M, Thomas E, Beshyah SA & Johnston DG. Effects of

longterm growth hormone (GH) therapy on bone metabolism in GH-deficient adults. 80th Annual

Meeting of the American Endocrine Society: New Orleans, Louisiana, held on 24-27 June 1998.

Conference Programme and Abstract Book (P1-213, page 165).

64. Al-Shoumer KAS, Vasanthy BK & Makhlouf HA. (1998) Leptin concentration in thyrotoxic

patients. Journal of Endocrinology ; 159 (Supp): P87.

65. Al-Shoumer KAS, Vasanthy BK & Makhlouf HA. Effects of treatment of hyperthyroidism

on leptin concentrations. 2nd Meeting of the British Thyroid Association. St. Thomas’ Hospital,

London, held on 25 November 1998. Programme and Abstract Book ( P11, page 17).

12


The effects of GH therapy on overnight metabolic fuels in hypopituitary patients. 26th

International Symposium on GH and Growth Factors in Endocrinology and Metabolism. Palma

de Mallorca, held on 23-24 October, 1998. Programme and Abstract Book (B3, page 68).

67. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK. Leptin concentration in women with

hirsutism. Forth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,

April 25, 1999, Conference Programme and abstract Book (page 56).

68. Al-Shoumer KAS, AlBony A, El-Gazzar A & Vasanthy BK. Outcome of radionuclide

technetium thyroid scan (TC-99M pertechnetate) over twelve months in Mubarak Al-Kabeer

Hospital. Fourth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,


69. Al-Juwaiser A, Abdulla MA & Al-Shoumer KAS. Fine needle aspiration biopsy of the

thyroid gland in Mubarak Al-Kabeer Hospital. Fourth Health Sciences Poster day, Faculty of

Medicine, Kuwait University, Kuwait, April 25, 1999, Conference Programme and abstract Book

(page 135).

70. Al-Shoumer KAS & Vasanthy BK. Reduced leptin concentration in women with hirsutism.

81st Annual Meeting of the American Endocrine Society: San Diego, California, held on 12-15

June 1999. Conference Programme and Abstract Book (P1-449, page 230).

71. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK.(1999) Leptin levels in Arab women with

hirsutism and its metabolic correlations. Journal of Endocrinology ; 163 (Suppl): P67.

72. Al-Shoumer KAS, Vasanthy BK & Al-Zaid MM. Effects of antithyroid therapy on

biochemical markers of bone turnover in primary hyperthyroidism. Fifth Health Sciences Poster

day, Faculty of Medicine, Kuwait University, Kuwait, April 24, 2000, Conference Programme

and abstract Book (page 63).

73. Al-Shoumer KAS, Vasanthy BK, Shalabi FM, Makhlouf HA & Al-Zaid MM.

Hyperproinsulin-aemia and insulin resistance in primary hyperthyroidism. Fifth Health Sciences

Poster day, Faculty of Medicine, Kuwait University, Kuwait, April 24, 2000, Conference

Programme and abstract Book (page 64).

74. Al-Shoumer KAS, Al-Assoussi A & Doi S. (2000) Variations in leptin concentrations in type

2 diabetes in Arabs. Diabetes, 49 (Suppl 1): 1424-PO, page A340.

75. Al-Shoumer KAS , Vasanthy BK & Al-Zaid MM. Effects of hyperthyroidism on glucose

homeostasis, insulin secretion and markers of bone turnover. 82nd Annual Meeting of the

American Endocrine Society: Toronto, Canada, held on 21-24 June 2000. Conference Programme

and Abstract Book (2429, page 587-8).

76. Al-Shoumer KAS, Vasanthy BK, Al-Assoussi A & Doi A (2000) Leptin level in Arabs with

type 2 diabetes (Second Pan-Arab Congress of Diabetes and Endocrinology and The 10th

International Clinical Genetics Seminar, October 20-24, 2000, OP-61, page 87).

77. Al-Shoumer KAS , Vasanthy BK & Al-Zaid MM. Glucose homeostasis and bone

metabolism in hyperthyroidism: Follow up after therapy. 11th International Congress of

Endocrinology. Australia, Sydney, held on 29 October-2 November 2000. Conference

Programme and Abstract Book (Abstract P764, page 285). 78. Al-Shoumer KAS, Doi SAR, Vasanthy BK & Al-Asoussi A. Bone metabolism in type 2

diabetes. Sixth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,


13

79. Al-Shoumer KAS, Vasanthy BA & Akanji A. Lipoprotein (a) in hyperthyroidism: effects of

medical therapy. Sixth Health Sciences Poster day, Faculty of Medicine, Kuwait University,

Kuwait, April 23, 2001, Conference Programme and abstract Book (page 71).

80. Ghanem H, El-Meliegy A, Mansi M, Younis N, Al-Shoumer K, Al-Rubaei S & Merhej S.

(2001) Hormone replacement therapy for PADAM: Outcome and safety (Middle East Multicenter

Trial), The Journal of Andrology, May/June Sup, P5/6-073, page 172. 81. Al-Shoumer KAS , Doi SA & Vasanthy BK. (2001) Markers of bone turnover and

longstanding type 2 diabetes in Kuwait. 83rd Annual Meeting of the American Endocrine

Society: Denver, USA, held on 20-23 June 2001. Conference Programme and Abstract Book (P3-

76, page 465).

82. Al-Shoumer KAS, Vasanthy BK, Shalabi FM & Al-Zaid MM. Bone metabolism in hirsute

women. Seventh Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,


83. Al-Shoumer KAS, Vasanthy BK & Al-Zaid MM. Sreum interleukin-6 (IL-6) and soluble

interleukin-6 Receptor (sIL-6) in hyperthyroidism due to Graves’ disease: effects of medical

therapy. Seventh Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,


84. Al-Shoumer KAS, Vasanthy BK, Shalabi FM & Al-Zaid MM. (2002) Markers of bone

metabolism in hirsute women. 84th Annual Meeting of the American Endocrine Society: San

Francisco, USA, held on 19-22 June 2002. Conference Programme and Abstract Book (P2-630,

page 467-8).

85. Al-Shoumer KAS, Vasanthy BK, Al-Zaid MM. Human Chromogranin A (CgA) in patients

with hyperthyroidism, Eighth Annual Health Sciences Poster Day 2003, P. 71

86. Al-Shoumer KAS, Vasanthy BK. Leptin and metabolic variables in Arab patients with type 2

diabetes in a University teaching hospital in Kuwait. 2003 Syllabus AACE 14-18th

May, San

Diego, Abs # 77, P. 318-319.

87. Johnston, DG, Kearney T, Robinson S, Venkatesan S, Chrisoulidou A, Bannister P,

Anayaoku V, Parker K, Beshyah S, Al-Shoumer KAS (2003) Hypopituitarism and

atherosclerosis. 85th Annual Meeting of the American Endocrine Society: Philadelphia, USA,

held on 19-22 June 2003. Conference Programme and Abstract Book (S29-1).

88. AL-Qudaiby MM, Doi SAR, Al-Shoumer KAS. Reversible renal dys function in immune

thrombocytopenic diabetic patient induced by Intravenous Immunoglobulin (IVIG). Ninth

Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait,

April 19-21, 2004, Conference Programme and abstract Book (page 75).

89. Naddaf S , Anim H, Farghaly M, Behbehani AM, Al-Shoumer KAS, Collier D, Elgazzar A

.

Ultrastructure Of Hyperfunctioning Parathyroid Glands: Does It Explain Various Patterns Of

Sestamibi Uptake? Ninth Annual Health Sciences Poster Conference, Faculty of Medicine,

Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract Book (page

61).

90. Girgis M.,Chadha G., Doi SAR, Al Shoumer KAS, Al Shammari S. Kearns Sayre Syndrome

in a young Kuwaiti male-A case report. Ninth Annual Health Sciences Poster Conference, Faculty

of Medicine, Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract

Book (page 82).

91. Doi SAR, Parappil A, Sheikha A, Al-Shoumer KAS. Redefining Optimal Glucose Cutoff’s

In The Diagnosis Of Diabetes. Ninth Annual Health Sciences Poster Conference, Faculty of

14

Medicine, Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract

Book (page 79).

92. Lasheen I, Doi SAR, Al-Shoumer KAS, Al-Aqeel AAA. Glucocorticoid replacement in

panhypopituitarism complicated by myelinolysis: A Case Report. Ninth Annual Health Sciences

Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 19-21, 2004,


93. Al-Shoumer K.A.S., Doi S.A.R., Abalkhail S, Nair V.S.Is osteoporosis common in Arab

women in Kuwait? Ninth Annual Health Sciences Poster Conference, Faculty of Medicine,

Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract Book (page

77).

94. Al-Shoumer KAS , Doi SAR & Vasanthy BK. (2004) Prevalence of low bone mass in Arab

women in the largest district area in Kuwait. 86th Annual Meeting of the American Endocrine

Society: New Orleans, USA, held on 16-19 June 2004. Conference Programme and Abstract

Book (P2-527).

95. Al-Shoumer K.A.S., Vasanthy BA, Al-Zaid M. New markers for disease activity in

hyperthyroidism. Tenth Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait

University, Kuwait, April 25-27, 2005, Conference Programme and abstract Book (page 95).

96. Doi SA, Al-Zaid M, Tower PA, Scott CJ, Al-Shoumer K.A.S. Pathophysiology of

neuroendocrine dysfunction in polycystic ovary syndrome. Tenth Annual Health Sciences Poster

Conference, Faculty of Medicine, Kuwait University, Kuwait, April 25-27, 2005, Conference


97. Al-Shoumer KAS , Vasanthy BA, Al-Zaid MM. (2005) New marker of disease activity in

hyperthyroidism: human chromogranin A (CgA). 87th Annual Meeting of the American

Endocrine Society: San Diego, USA, held on 4-7 June 2005. Conference Programme and

Abstract Book (P1-579).

98. Al-Shoumer K.A.S., Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM. Risk factors and

predictors of increased risk for type 2 diabetes in Arabs resident in Kuwait. Eleventh Annual

Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 24-

26, 2006, Conference Programme and abstract Book (page 93).

99. Al-Shoumer K.A.S., Vasanthy BA, Doi SA. The relation between intact proinsulin and

adiponectin with insulin resistance. Eleventh Annual Health Sciences Poster Conference, Faculty

of Medicine, Kuwait University, Kuwait, April 24-26, 2006, Conference Programme and abstract

Book (page 96).

100. Al-Shoumer KAS , Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM (2006)

Cytokines and obesity-related hormones in Arabs with type 2 diabetes resident in Kuwait. 88th

Annual Meeting of the American Endocrine Society: Boston, USA, held on 24-27 June 2006.

Conference Programme and Abstract Book (P2-594).

101. Al-Shoumer K.A.S., Vasanthy BA, Doi SA. Abnormal cardiovascular risk profel in Arab

patients with polycystic ovary syndrome Twelvth Annual Health Sciences Poster Conference,

Faculty of Medicine, Kuwait University, Kuwait, April 24-26, 2007, Conference Programme and

abstract Book (page 96).

102. Al-Shoumer KAS , Vasanthy BA, Abalkhail S, Doi SA, Al-Gudhaiby MM (2007) Intact

proinsulin to adiponectin ratio is a strong predictor of insulin resistance in type 2 diabetes. 89th

Annual Meeting of the American Endocrine Society: Torronto, Canada, held on 24-27 June 2007.


15

103. Al-Shoumer K.A.S., Vasanthy BA, Doi SA, Abalkhail S, Hafez MF. Spectrum of bone

mineral density in Arab women resident in Kuwait. Thirteenth Annual Health Sciences Poster

Conference, Faculty of Medicine, Kuwait University, Kuwait, April 24-26, 2008, Conference


104. Al-Shoumer KAS , Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM, Hafez MF

(2008) Arab women with polycystic ovary syndrome: cardiovascular risk profile. 90th Annual

Meeting of the American Endocrine Society: San Francisco, USA, held on 15-18 June 2008.


105. Abalkhail S., Hilali N., Al-Kandari N., Doi SA, Al-Duaij S, Hafez MF, Nair VS, Ali AH,

Al-Shoumer K.A.S. Oscillations on osteocalcin levels in uremic patients Maintained on regular

hemodialysis. 14Th Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait

University, Kuwait, April 21-23, 2009, Conference Programme and abstract Book (page 72).

106. Al-Otaibi FK, Al-Bader MD, Al-Shoumer K.A.S, Al-Yatama FI. The effect of clothing and

cultural practice on bone mineral density (BMD) in Kuwaiti pre-menopausal women. 14Th

Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait,

April 21-23, 2009, Conference Programme and abstract Book (page 183).

107. Al-Shoumer KAS & Vasanthy BA. (2009) Low bone mass is prevalent in young Arab

women resident at Kuwait. 91ST

Annual Meeting of the American Endocrine Society:

Washington DC, USA, held on 10-13 June 2009. Conference Programme and Abstract Book (P2-

237).

108. Al-Shoumer K.A.S., Nair VS, Ali AH, Haider MZ. Genotyping of non-classical congenital

adrenal hyperplasia (NCCAH) in a subgroup of Kuwaiti females. 15th Annual Health Sciences

Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 20-22, 2010,


109. Al-Shoumer K.A.S., Nair VS, Ali AH. Genetic Assessment of a Subgroup of Kuwaiti

Females with Non-Classical Congenital Adrenal Hyperplasia (NCCAH). Endocrine

Reviews, Supplement 1, June 2010, 31[3]: S733.

110. Al-Shoumer K.A.S., Nair VS, Ali AH. Vitamin D levels in Kuwaiti subjects with type 2

diabetes. 16th Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait

University, Kuwait, May 3-5, 2011, Conference Programme and abstract Book (page 68).

111. Al-Shoumer K.A.S., Nair VS, Abalkhail S. Changes in acid-labile subunit and insulin-

like growth factor 1 in hyperthyroidism after medical treatment. 93rd

Annual Meeting of the

American Endocrine Society: Boston, USA, held on 4-7 June 2011. Conference Programme and

Abstract Book (P3-593, P. 197)

112. Ali A.H., Nair V.S. and Al-Shoumer K.A.S. Effects of lifestyle and environmental factors

on bone mineral density in healthy Kuwaiti females. 17th Annual Health Sciences Poster

Conference, Faculty of Medicine, Kuwait University, Kuwait, May 8-10, 2012, Conference


113. Al-Shoumer K.A.S., Nair VS, Ali A.H. Does Insulin Resistant Type 2 Diabetes Alter

Vitamin D Status. 94th

Annual Meeting of the American Endocrine Society: Houston, USA, held

on 23-26 June 2012. Conference Programme and Abstract Book (Mon-369. P. 166))

ORAL PRESENTATIONS:

I. INTERNATIONAL CONFERENCE & INVITED SPEAKER (Presented & published)

16

114. Al-Shoumer KAS, Niththyanathan R & Johnston DG. (1994) Profiles of intermediary

metabolites in hypopituitary adults on conventional replacement therapy. Journal of

Endocrinology; 143 (Suppl.): O31 (London, 23-25 November, 185th Meeting of the Society for

Endocrinology).

115. Al-Shoumer KAS, Hughes C, Richmond W, Beshyah S & Johnston DG. (1995) Beneficial

changes in plasma lipids, lipoproteins and apolipoproteins in hypopituitary adults (HPA) after 4

years of growth hormone (GH) replacement therapy. Journal of Endocrinology ; 147 (Suppl.):

O47 (London, 22-23 November, 186th Meeting of the Society for Endocrinology).

116. Al-Shoumer KAS, Anyaoku V & Johnston DG. (1996) Serum leptin and its anthropometric,

gender and metabolic relations in hypopituitary adults with growth hormone (GH) deficiency.

Journal of Endocrinology; 151 (Suppl.): O11 (London, 26-28 November, 187th Meeting of the

Society for Endocrinology).

117. Al-Shoumer KAS, Kousta E, Richmond W & Johnston DG. (1997) Increased prevalence of

abnormal fasting lipids and lipoproteins in growth hormone (GH) deficient hypopituitary adults.

Endocrinology and Metabolism ; 4 (Suppl. B), P. A3, page 157 (Berlin, Germany).

118. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK. (1999) Changes in leptin values in Arabs

with hirsutism: Mubarak Al-Kabeer University teaching hospital experience in Kuwait.(First Pan-

Arab Congress of Endocrinology and Metabolic Diseases, October 20-23, 1999, OPS 10).

119. Al-Shoumer KAS, Vasanthy BK, Al-Assoussi A & Doi A (2000) Leptin level in Arabs

with type 2 diabetes (Second Pan-Arab Congress of Diabetes and Endocrinology and The 10th

International Clinical Genetics Seminar, October 20-24, 2000, Amman, Jordan, OP-61, page 87).

120. Al-Shoumer KAS, Doi SAR & Al-Assousi A (2001). Markers of bone turnover and

metabolic abnormalities in type 2 diabetes in Kuwait. Conference of Diabetes in The Arab World,

24-26th March 2001, Bahrain, Oral presentation, Abstract book page 55.

121. Al-Shoumer KAS , Doi SA & Vasanthy BK. (2001) Bone metabolism in Arab with type 2

diabetes mellitus. Third Pan Arab Congress on Edocrinology and Diabetes 25-28 October 2001,

Damascus. OP. 83 page 103

II. AS AN INTERNATIONAL INVITED SPEAKER

122. Al-Shoumer KAS. (2001) Syndrome X : the clinical presentation of insulin resistance. 5Th

Pan Arab Conference On Diabetes, 27-30 March 2001, Cairo, Egypt, OPII 005.

123. Al-Shoumer KAS (2001) Dysleptinemia in endocrinology and Metabolism. Third Pan Arab

Congress on Edocrinology and Diabetes 25-28 October 2001, Damascus. Plennary talk, page 6

124. Al-Shoumer KAS (2002) The role of endocrine and metabolic disorders in the outcome of

pregnancy and fertility. International Symposium: Recent advances in the management of

infertility. March 9-11 2002, Kuwait Absract book page 34-35.

125. Al-Shoumer KAS (2002) Is diabetes mellitus associated with osteoporosis. 6Th Pan Arab

Conference on Diabetes. March 26-29, 2002, Cairo, Egypt.

126. Al-Shoumer KAS (2002) Subclinical thyroid diseases. Fourth Pan Arab Congress on

Endocrinology and Diabetes 23-26 October 2002, Tunisia. Plennary talk, Symposium on thyroid.

127. Al-Shoumer KAS (2004) Chronic complications of Diabetes mellitus (cardiovascular

disease). Fifth Pan Arab Congress on Endocrinology and Diabetes 28 Feb. to 2nd

March 2004,

Riyadh. Main session talk.

17

128. Al-Shoumer KAS (2005) Adult hypopituitarism and growth hormone deficiency. The 1st

Jordanian Congress of Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P.

21

129. Al-Shoumer KAS (2005) Leptinology and endocrinology. The 1st Jordanian Congress of

Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P. 32.

130. Al-Shoumer KAS (2005) Overview of osteoporosis. The 1st Jordanian Congress of

Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P. 26

131. Al-Shoumer KAS (2005) The Syndrome of adult GH deficiency: Clinical implications. The

2nd

International conference of Endocrinology & Diabetes , Jeddah 11-12 April, P. 21

132. Al-Shoumer KAS (2005) Obesity and diabetes mellitus. The 14nd

Annual scientific Meeting

of the Syrian Diabetes Association, Lattakia- Syria 10-12 November

133. Al-Shoumer KAS (2006) Adrenal incidentaloma. Seventh Pan Arab Congress on

Endocrinology and Diabetes 4-7 May 2006, Rabat- Morocco. Main session talk.

134. Al-Shoumer KAS (2008) Obesity, DM & ED. Second AACE/ESEO meeting in Alexandria,

23rd to 25th of April, 2008.

135. Al-Shoumer KAS (2009) Epidemiology of thyroid diseases. Merck Serono 's 1st

International Forum on Thyroid disorders in the Middle East. - Dubai, U.A.E. - 19-20 February

2009

136. Al-Shoumer KAS (2010) Initiation and adjustments of lanreotide autogel therapy in

acromegaly: case-based examples from Kuwait. In Symposium: Novel treatment in the

management of acromegaly. Ritz carlton, Istanbul-Turkey, March 18th

2010.

137. Al-Shoumer KAS (2011) Challenges in the management of acromegaly. In Symposium:

Therapeutic strategies in growth hormone secreting adenoma”. Dubai– UAE, 16-18th March

2011

II. LOCAL CONFERENCE LECTURES PRESENTATIONS (invited speaker):

1. “Growth hormone in IDDM adolescents” in Update in Diabetes, 17-19 November 1997,

Faculty of Medicine - KIMS.

2. “Thyroid diseases in adult clinical practice” in Workshop on Thyroid Diseases, 13-16 June

1998, Faculty of Laboratory Medicine - KIMS.

3. “Secondary dyslipidaemia-Thyroid disease” in Workshop on Disorders of Lipid Metabolism,

3-5 May 1999, Faculty of Laboratory Medicine - KIMS.

4. “Leptin and endocrine disorders” in Update in Endocrinology and Metabolism (UEM), 1-4

November 1999, Faculty of Medicine, Kuwait.

5. “ Fitness to work for Diabetes mellitus” in Symposium of fitness to work in Kuwait, 22-26

April, 2000, Kuwait Medical Association, Kuwait.

6. “Evaluation of a patient with a thyroid nodule” in Update in Endocrinology and Metabolism, 7-

8th April 2001, CME activity, Faculty of Medicine, Kuwait.

7. “Primary amenorrhea” in Training progromme For Obst & Gynecology, 7-11th April 2001,

Kuwait Medical Association, Kuwait.

8. Association between diabetes mellitus and osteoporosis” Update in Endocrinology and

Metabolism, 1-2 April 2002, Faculty of Medicine, Kuwait

9. Subclinical thyroid disease. Update in Endocrinology and metabolism, 26-27th

April 2003.

Faculty of Medicine, Kuwait

18

10. Controversial aspects of GH therapy in adults. Update on Growth Hormone therapy. 14-15

Feb. 2004, Kuwait Medical Association.

11. “Solitary thyroid nodule: clinical approach” in Workshop on Thyroid Diseases, 9th

Feb 2005,

Faculty of Laboratory Medicine - KIMS.

12. “DM, obesity and erectile dysfunction” in 2nd

Diabetic workshop of Sheikh Nasser Alsabah

Medicak health Center. 2-3rd

April 2005.

13. “Definition and diagnosis of osteoporosis”. Update in Endocrinology and metabolism:

workshop on osteoporosis, 4th April 2005. Faculty of Medicine, Kuwait

14. “New modalities of treatment for osteoporosis”. Update in Endocrinology and metabolism:

workshop on osteoporosis, 5th April 2005. Faculty of Medicine, Kuwait

15. Andropause. The first Amiri Endocrinology Conference “Obesity-Endocrine problems after

5th

decade” 18-19 April 2005

16. Osteoporosis. Workshop on women health, Ministry of Health, 2-4th

May 2005, Kuwait.

17. Evaluation and preoperative assessment of adrenal masses. 1st Update in Urologic

laparoscopy. 14th

–15th

May 2005

18. Definition of insulin resistance”. Update in Endocrinology and metabolism: Insulin resistance

syndrome: the endocrine perspective”, 17th April 2006. Faculty of Medicine, Kuwait

19. Leo Pharma meeting. “Falls and Fractures in Osteoporosis”: Osteoporosis overview, Radisson

SAS Hotel, Kuwait 7 June 2006. Speaker and chairman of session.

20. Chairman of symposium “Testosterone administration: new androgel preparations”. Dec.

2008, Crown Plaza Hotel, Kuwait.

21. Chairman of workshop: “Plain Vitamin D or its active analogue in osteoporosis”, 12 Jan.

2009, Radissons SAS Kuwait.

22. Update on metabolic syndrome. Lecture: Adipocytokines. 29-30 April 2009, Faculty of

Medicine, Kuwait.

23. Update in Men’s Health. Lecture: Male Menopause. 23-24 April 2011, Movenpick Hotel %

Resort Al-Bidaá, Kuwait

III. EDUCATIONAL LECTURES TO MEDICAL SUBSPECIALITIES:

1. “Endocrine emergencies” in the programmed schedule to emergency medicine in Mubarak Al-

Kabeer Hospital, 26th April 1997, Mubarak Al-Kabeer Hospital, Kuwait.

2. “Management of diabetic Ketoacidosis and hyperosmolar coma” in the programmed schedule

to emergency medicine in Mubarak Al-Kabeer Hospital, 15th Dec. 1997, Mubarak Al-Kabeer

Hospital, Kuwait.

3. “Hirsutism and polycystic ovary syndrome” in Programmed polyclinic activities, 26th May

1999, Salmiyah specialized centre, Hawalli area, Kuwait.

4. Presentation of monthly endocrine talks in department of medicine at Mubarak Al-Kabeer

Hospital to other subspecialities

5. “Polycystic ovary syndrome” in training programme for Salmiya speciality center, 27th May

2001, Kuwait.

6. Osteoporosis Symposium for Primary care physicians, Overview on osteoporosis and the

relations with diabetes. 12th

April 2004. Kuwait Medical Association.

7. “Diabetes mellitus, obesity and erectile dysfunction” in 2nd

Diabetic Workshop: diabetes and

ED, 2-3 April 2005, KMA

19

8. “Update on the current Treatment of Vitamin D deficiency: Tuesday 16th

March 2010, Hisham

Al-Obaidan meeting room, Mubarak Al-Kabeer Hospital, Kuwait

9. Update on osteoporosis to orthopaedic surgeons. Al-Razi Orthopedic Hospital, 27 Jan 2011,

Kuwait.

RESEARCH 1.Cardiovascular risk factors in hypopituitarism (1992-1995) at St. Mary’s Hospital, London

2. Research grant (MM041, Kuwait University 1999) “Metabolic abnormalities in patients with

primary hyperthyroidisim” Completed Sept. 2000, Kuwait

3. Hirsutism in Arab populations : intermediary metabolites and obesity related-factors

(completed 2002), Kuwait.

4. Pattern of behaviour of type 2 Diabetes Mellitus in Kuwait in relation to pathogenesis

(completed 2004), Kuwait.

5. Correlation between histopathological and clinical diagnosis in hyperparathyroidism (Kuwait

University granted, MN01/01)

6. Prevalence of low bone mass in Kuwait (ongoing)

7. Bone mineral density in patients with rheumatoid arthritis at various disease activity

8. Bone metabolism in patients with Multiple sclerosis

ATTENDED POSTGRADUATE COURSES & SYMPOSIA-CONFERENCES 1. Section of Measurements in Medicine “ Arterial wall changes using high resolution ultrasound

: A risk factor or screening test”. The Royal Society of Medicine, London. 11 Oct. 1993.

2. Postgraduate Education Course in Endocrinology and Diabetes, St. Mary’s Hospital, London.

24 Feb. 1994.

3. Postgraduate training course in Endocrinology. Society for Endocrinology/ Royal Society of

Medicine Endocrine Section/ British Diabetic Association. St. Mary’s Hospital Medical School,

London W2 6th-7th July 1994.

4. Cardiovascular Disease Prevention II. Kensington Town Hall, London 19th - 22nd July 1994.

5. Forum on lipids in Clinical Medicine :“ Diabetes lipids and atherosclerosis ”. Royal society of

Medicine; London 27 Oct. 1994.

6. International Symposium : A new look at insulin resistance in type 1 diabetes. St.

Bartholomew’s Hospital Medical College, London 14th July 1995.

7. Update in Diabetes. Faculty of Medicine - Kuwait University. Kuwait, 17-19 November 1997.

8. Polycystic Ovary Syndrome: Metabolic challenges and New Treatment Options”. New

Orleans, Louisiana, June 23rd, 1998.

9. Growth hormone deficiency across the lifespan. New Orleans, Louisiana, June 24rd, 1998.

10. Osteoporosis: A call for action. Jumeira Beach Hotel, Dubai; 26-27 February 1998.

11. 189Th Meeting of the British Society for Endocrinology, London 23-24 November 1998.

12. 2ND Meeting of the British Thyroid Association, St. Thomas’ Hospital, London 25

November 1998.

13. The first Gulf Osteoporosis Conference. Al-Bustan Palace Hotel, Muscat, Sultanate of Oman,

20-23 March 1999.

14. The first GCC Conference of Faculties of Medicine: “Medical Education in GCC Countries”.

Faculty of Medicine, Health Science Centre-Kuwait University, Kuwait, 26-28 April 1999.

20

15. Evista Global Medical conference & 21st Annual Meeting of the American Society for Bone

and Mineral Research. Indianapolis/St. Louis, Sept. 27 - October 4, 1999.

16. 81ST Annual Meeting of the American Endocrine Society, San Diego, California 12-15 June

1999.

17. The 2nd World Congress on The Aging Male, Geneva, Switzerland, February 9-13, 2000.

18. 82nd Annual Meeting of the American Endocrine Society, Toronto, Canada 21-24 June 2000

19. 11th International Congress of Endocrinology, Sydney, Australia 29th Oct -2nd Nov. 2000.

20. VIIth International Congress of Andrology, Montreal, Canada, 15-19th June 2001.

21. 83rd Annual Meeting of the American Endocrine Society, Denver, USA 20-23 June 2001

22. Symposium of Treating to target in type 2 diabetes mellitus, Prague, Czech Republic May 5-

58th, 2002.

23. 84th Annual Meeting of the American Endocrine Society, San francisco, USA 19-22 June

2002

24. Thyroid Ultrasound Accreditation Course, Washington DC, USA 24-25 August 2002

25. Obesity Workshop: “Reductil Medical Education Programme” 23 July 2003, Cairo, Egypt

26. 18th

International Diabetes Federation Congress, August 24-29, 2003, Paris, France.

27. Diabetes Regional Experts Avandia Meeting (DREAM). Athenes, September 20-21. 2003

28. Bone mineral density certification course. Amman Dec 18th

2003.

29. Osteoporosis and needs for action. Rome 15th

march 2004.

30. Therapeutic Innovation in the osteoporosis field. El Gouna, Red Sea, Egypt, April 23-24,

2004.

31. 86th Annual Meeting of the American Endocrine Society, New Orleans, USA 16-19 June

2004.

32. 40Th

Annual Meeting of the European Association for the Study of Diabetes, 5-9 September

2004, Munich, Germany

33. Intensive Pediatric Workshop on Insulin Pump Therapy & CGMS. Kuwait SAS, 24

September 2004.

34. The first International GGSD Conference. Dubai 13-15th

Feb. 2005

35. Six Pan Arab Congress of Endocrinology & Diabetes, Alexandria 2-4 th March 2005

36. Advancing to new levels in osteoporosis management, Rome March 13th

2005

37. 87th Annual Meeting of the American Endocrine Society, San diego, USA 4-7 June 2005.

38. The 14th

Annual scientific Meeting of the Syrian Diabetes Association, Lattakia- Syria 10-12

November 2005.

39. Conference:”New approach for the treatment of postmenopausal osteoporosis, Cairo-Egypt 8-

9 Dec. 2005

40. Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and

Osteoarthritis. Vienna, Austria 15-18th

March 2006.

41. Seventh Pan Arab Congress of Endocrinology & Diabetes, Rabat- Morroco 4-7th May 2006.

42. Leo Pharma meeting. Falls and Fractures in Osteoporosis, Radisson SAS Hotel, Kuwait 7

June 2006

43. 88th Annual Meeting of the American Endocrine Society, Boston, USA 24-27 June 2006.

44. 89th Annual Meeting of the American Endocrine Society, Toronto, Canada 24-27 June 2007.

45. 90th Annual Meeting of the American Endocrine Society, San Francisco USA 15-18th

June

2008.

21

46. 91st Annual Meeting of the American Endocrine Society, Washington DC, USA 10-13

th June

2009.

47. The 3rd

International Conference of Gulf Group for the Study of Diabetes (GGSD), 9-11 Feb.

2010, Jeddah, KSA, Invited as Chairperson, session II first day.

48. 92nd

Annual Meeting of the American Endocrine Society, San Diego, USA 19-22 June 2010.

49. 93rd Annual Meeting of the American Endocrine Society, Boston, USA 4-7 June 2011.

50. ASBMR 2011 Annual Meeting of the Society for Bone and Mineral Research. San Diego

USA, September 16 - 20, 2011

51. 93rd Annual Meeting of the American Endocrine Society, Houston, USA 23-26 June 2012.

52. 2012 Pituitary Masterclass meeting. Massachusetts General Hospital at Boston, USA. 28th

June to 1st July 2012.

SOME OF THE CITATIONS: 1. Al-Shoumer KAS, Ali K, Anyaoku V, Niththyananthan R & Johnston DG. (1996) Overnight

metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical

Endocrinology; 45, 171-178.

2. Al-Shoumer KAS, Page B, Thomas E, Murphy M, Beshyah SA & Johnston DG. (1996) Effects

of four years’ treatment with biosynthetic human growth hormone (GH) on body composition in

GH-deficient hypopituitary adults. European Journal of Endocrinology ; 135: 559-567.

3. Al-Shoumer KAS, Kousta E, Beshyah S & Johnston DG. Growth hormone (GH) deficiency -

Does it cause atherosclerosis ? In Proceedings of 3rd International hGH Symposium on GHD in

adults (1996) (ed. JS Christiansen, JOL Jørgensen, AVZ Mühlen & W Waldhäusl), pp. 20-25,

Medical Forum International, The Netherlands.

4. Peacey SR, Guo C-Y, Robinson AM, Price A, Giles MA, Eastell R & Weetman (1997)

Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical

Endocrinology 46, 255-261.

5. Monson JP (1997) The assessment of glucocorticoid replacement therapy. Clinical

Endocrinolgy 46, 269-270.

6. Al-Shoumer KAS, Cox K, Hughes C, Richmond W & Johnston DG. (1997) Fasting and post-

prandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.

Journal of Clinical Endocrinology and Metabolism ; 82: 2653-2659.

7. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. (1997) Metabolic effects of short-term

reproduction of the normal diurnal cortisol rhythm in hypopituitary adults. Endocrinology &

Metabolism ; 4: 207-214.

8. Al-Shoumer KAS, Anyaoku V, Richmond W & Johnston DG.(1997) Elevated leptin

concentrations in growth hormone-deficient hypopituitary adults. Clinical Endocrinology; 47:

153-159.


Interactions of cortisol and growth hormone replacement: intermediary metabolism. In The

diagnosis and treatment of pituitary insufficiency (1997) (ed.SWJ Lamberts), pp. 63-77.

BioScientifica Ltd, Bristol.

10. Kousta E, Chrisoulidou A, Lawrence N J, Al-Shoumer KAS, Parker KH, McCarthy MI &

Johnston DG. (1998) The circadian rhythm of leptin is preserved in growth hormone deficient

hypopituitary adults.Clinical Endocrinology; 48, 685-690.

22


Growth hormone replacement in young adults: if and when to continue?. In Adolescent

Endocrinology (1998) (ed.R Stanhope), pp. 17-23. BioScientifica Ltd, Bristol.

12. Pancreatic & Salivary secretion in Current Awareness in Biomedicine (1998) Vol 20 (15), 1-

8.

13. Evans LM, Davies JS, Goodfellow J, Rees JAE & Scanlon. (1999) Endocthelial dysfunction

in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology 50, 457-464.

14. Al-Shoumer KAS, Gray R, Anyaoku V, Hughes C, Beshyah SA, Richmond W & Johnston

DG. (1998) Effects of four years’ treatment with biosynthetic human growth hormone (GH) on

glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical

Endocrinology, 48, 795-802.

15. Gill MS, Toogood AA, Jones J, Clayton PE & Shalet SM. (1999) Serum leptin response to

acute and chronic administration of growth hoemone (GH) to elderly subjects with GH

deficiency. Journal of Clinical Endocrinology and Metabolism 84, 1288-1295.

16. Rodriguez-Arnao J, Jabbar A, Fulchert K, Besser GM & Ross RJM. (1999) Effects of growth

hormone replacement on physical performance and body composition in GH deficient adults.

Clinical Endocrinology 51, 53-60.

17. Leonssson M, Oscarsson J, Bosaeus I, Lundgren BK, Johannsson G, Wiklund O & Bentgsson

B-A. (1999) Growth hormone (GH) therapy in GH-deficient adults influences the response to

dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low

density lipoprotein cholesterol levels. Journal of Clinical Endocrinology and Metabolism 84,

1296-1303.

18. Peacey SR, Guo CY, Eastell R & Weetman AP. (1999) Optimization of glucocorticoid

replacement therapy: the long-term effect on bone mineral density. Clinical Endocrinology 50,

815-819.

19. Abs R, Bentgtsson B-A, Hernberg-Stahl E et al (1999) GH replacement in 1034 growth

hormone deficient hypopituitwry adults: demographic and clinical characteristics, dosing and

safety. Clinical Endocrinology 50, 703-713.

20. Barretto ES, Gill MS, de Freitas MES et al (1999) Serum leptin and body composition in

children with familial GH deficiency (GHD) due to a mutation in the growth-hormone-releasing

hormone (GHRH) receptor. Clinical Endocrinology 51, 559-564.

21. Brennan BMD, Rahim A, Blum WF, Adams JA, Eden OB & Shalet SM (1999)

Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone

deficiency or leptin insensitivity. Clinical Endocrinology 50, 163-169.

22. Beshyah SA & Desmond Johnston (1999) Cardiovascular disease and risk factors in adults

with hypopituitarism. Clinical Endocrinology 50, 1-15.

23. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S and Robinson S.

(1999). Long-term effects of GH therapy on intermediary metabolism and insulin sensitivity in

hypopituitary adults. Journal of Endocrinological Investigation , 22, 37-40.

24. O’Neal DN, Hew FL, Best JD & Alford F. (1999) The effect of 24 months recombinant

human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in

hypopituitary adults previously treated with conventional replacement therapy. Growth Hormone

& IGF Research 9, 165-173.

23


(2000) The effects of growth hormone replacement therapy on overnight metabolic fuels in

hypopituitary patients.Clinical Endocrinology 52, 17-24

26. Damjanovic SS, Petakov MS, Raicevic S, Micic D, Marinkovic J, Diegues C, Casanueva FF

& Popovic V (2000) Serum leptin in patients with acromegaly before and after correction of

hypersomatotropism by transsphenidal surgery. Journal of Clinical Endocrinology and

Metabolism 85, 147-154.

27. Abdu TAM, Neary R, Elhadd TA, Akbaer M & Clayton RN (2001) Coronory risk in growth

hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile

abnormalities. Clinical Endocrinology 55, 209-216.

28. French human growth hormone recepients. (1999) American J Epidemiology 147, 597-604

29. Hawkins EP (1999) Nutrients in the news - human growth hormone. Natural Pharmacy

30. Kuhnel W (1997) Leptin - Neue Mglichkeiten in Diagnostik und Therapie. Med Research

Review 17 (3), 225-234.

31. Braught L. Liquid mineral fortified HGH: A tremendous advancement in anti-aging.

Published by Reality Health Research.

32. Jeffcoate W (1999) Assessment of corticosteroid replacement therapy in adults with adrenal

insufficiency. Ann Clin Biochem 36, 151-157.

33. Vance M L, Mauras N (1999) Growth hormone therapy in adults and children. The New

England Journal of Medicine 341 916), 1206-1216.

34. Pfeifer M (2001) Syndrome of growth hormone deficiency in adults: effects of growth

hormone replacement therapy. Zdrav Vestn 70, 296-299.

35. Sulaiman AM, Freaney R, Smith TP, McBrinn Y, Murray B, Mckenna TJ (2003) The impact

of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in

patients with adrenal insufficisncy. Clinical Endocrinology 59, 380-387.

TEACHING ACTIVITIES: 1. Undergraduate teaching:

A. Faculty of Medicine:

1. Full teaching load consisting of Formal lectures, seminars, case discussions, tutorials and

bedside teaching. This comes to approximately over 120 hours per year as follows:

- Participation in lecturing for the Endocrinology system course teaching for BSc

students at St. Mary’s Hospital (1994-1996, didactic 3 hours per course, # of

students=70 per yr)

- Teaching in the theory Endocrinology system course for the fifth year students

(1997-) (12 hrs didactic per course of 36 hours over 4 weeks every year, # of

students=72-94 per yr)

- Bedside clinical teaching for fifth year clinical students in Mubarak Hospital (1997-)

(2 hours per week over 36 weeks every year, # of students=72-93 per yr divided

into groups, each of 6 students)

- Bedside clinical teaching for seventh year clinical students in Mubarak Hospital (1997-)

(2 hours alternating with 3 hours per week over 36 weeks every year, # of

students=48 per yr, divided into groups, each of 4 students)

- Preparation and execution of examination for undergraduates (1997-)

B. Faculty of Pharmacy:

24

- Teaching the third year students in the Pathophysiology course No. 332 (1999-)

(2 hours per course every year, # of students=40 per yr)

C. Ministry of Health : To paramedics:

- Teaching of basic handling, investigation and treatment of endocrine disorders

- Legislation and formation of standard protocols for dynamic tests in endocrinology

2. Postgraduate Teaching:

- Member, Faculty of Medicine, Kuwait Institute for Medical Specializations (KIMS)

- KIMS, Postgraduate training program in Medicine - program (PGTP) coordinator for

Mubarak Al-Kabeer Hospital (2000-2004)

- Teaching of candidates to MRCP part I (November 1997)

- Clinical session teaching for PGTP and MRCPII candidates in Mubarak Al-

Kabeer Hospital

- Journal Club Teaching to PGTP candidates in Mubarak Al-Kabeer Hospital (1997-)

- Teaching in the program for postgraduates in Immunology in Faculty of

Medicine (1998-9)

- Teaching Residants in the board program for postgraduates in Nuclear Medicine

in Faculty of Medicine (2000-)

- Arrangement of educational sessions to members of endocrinology division

every fortnight

- Attendance, participation and presentations at intra and interdepartmental medical

clinical meetings and grand rounds accounting for approximately 120 hours per year

COMMUNIY& UNIVERSITY SERVICES: A. University:

1. Member of Faculty of Medicine Research Committee (1998-2001).

2. Interview Committee of new applicants to Faculty of Medicine.

3. Health Sciences Poster Day Committee (1997 to 2003).

4. Establishment of endocrine laboratory in Faculty of Medicine.


6. Council member, University Recruitment committee for support academic staff (2004-

2005-2006)

7- Member, University Committee for the study of merging colleges (2004-5)

B. Ministry of Health:

1. Major contribution in:

a. Establishment of endocrine division in Mubarak Al-Kabeer Hospital

b. Foundation of Dynamic testing service to endocrine patients in

Mubarak Al-Kabeer Hospital

c. Establishment of a regular service of Bone Mineral Density

assessment using Dual Energy x-ray absorptiometry (DEXA) in

Mubarak Al-Kabeer Hospital (1997-2002)

2. Supervision of training in endocrinology for postgraduates (residents and fellows) in

Ministry of Health.

3. Member, Interview committee for endocrinology applicants in the Ministry

25

4. Member, Diabetes Team: Committee for prevention and control of Diabetes mellitus

(1998-2003)

C. Societies:

International:

1. Collegiate member, Royal College of Physicians of London.

2. Member, Medical & Scientific section, British Diabetic Association (BDA).

3. Member, British Society for Endocrinology (BES).

4. Member, Growth Hormone Research Society (GRS).

5. Member, British Medical Association (BMA).

6. Member, American Endocrine Society.

7. Member, American Diabetes Association (ADA).

8. Member, New York Academy for Science.

9. Member, American Association of Clinical Endocrinologists (AACE).

10. Member, International Diabetes Federation (IDF).

11. President, Pan-Arab Society of Endocrinology and Diabetes (2007-to 2010)

Faculty of Medicine committees:

Faculty:

1. Member, of the organizing committee for the annual poster day in the Health

Sciences Center (1997 to 2004).

2. Member, the executive board of Medical Research Council (MRC) of the

Faculty (1998-2001).


4. Chairman, Committee for staff salary cadre recommendations (2005-6)

5. Chairman, Committee for space allocation in faculty of medicine (2005-6)

6. Chairman, Recruitment Committee for support academic staff at Faculty of Medicine

(2006 -2008)

Department of Medicine:

1. Member, of the departmental Research Committee (1997-1999).

2. Chief Coordinator, of departmental Research Committee (1999-2002)

3. Member, of departmental Postgraduate Committee (1999 to date).

4. Chief Coordinator, department Examination Committee (2002-2004)

D. Journals:

1. Referee of papers submitted to Kuwait Medical Association Journal (1997-todate)

2. Referee papers submitted to Annals of Saudi Medicine Journal (2001 to date)

3. Referee of papers submitted to MPP , Faculty of Medicine Journal (2000 to date)

4. Referee to Journal of Woman Health (2008-)

5. Referee to JCEM (2010 to date)

5. Co-editor of the 4th Health Science Center Poster day “programme & abstract book”.

6. Local Editorial Board (member), Kuwait Medical Journal (2000- to date)

7. Advisory Board member, Diabetes Care, Mediteranian issues

E. Other Community services:

1. Provision of health services to patients with endocrinological disorders

2. Educational television and radio programmes (more than 30 appearances) and

newspaper articles (more than 30 short and long topics).

26

3. Head of University Faculty Association mission to Saudi Arabia for Mekka (23-

25th

Feb 2000)

F. Other Professional Achievements:

1. Evaluator of grants for projects to the Faculty of Medicine.

2. Referee to grants submitted to the Kuwait Foundation for the Advancement of

Sciences.

3. Coordinator & founding member of the thyroid disease study group - established in July

1997.

4. Coordinator of the Endocrinology system course to the 5th year students in the

Faculty of Medicine (1998 to 2011).

5. Member of the organizing committee for the Diabetes Update 17-19th November 1997.

6. Holder of an active licence for use of radioactive materials (1997 to date).

7. Holder of Full registration in the General Medical Council in London (1993 to date).

8. Holder of a certificate from the American College of Endocrinology on thyroid

Ulrasound Accreditated course

9. Chief Coordinator of Update on Endocrinology & Metabolism (UEM) in 1-4

November 1999.

10. Chief Coordinator of Update in Endocrinology and Metabolism CME in 7-8th

April 2001.

11. Member of Expert Panell of Middle East on Hormone Replacement Therapy

12. Listed in Who’sWho in the World, 19th Edition 2002

13. Listed in Who’sWho in Medicine and Healthcare 2002-2003

14. Invited as Conference Chairman, “New approach for the treatment of postmenopausal

osteoporosis” Cairo-Egypt 8-9th

Dec. 2005.

15. Coordinator and team leader on the endocrine block for the curriculum reforms phase

II in the faculty of Medicine (2005 to date)

16. Invited as Chairperson, session II first day of the 3rd

International Conference of Gulf

Group for the Study of Diabetes (GGSD), 9-11 Feb. 2010, Jeddah, KSA

G. Honors:

Winner of best clinical abstract in the 8th

Health Sciences Annual Poster Day (2003),

Faculty of Medicine. Abstract : Al-Shoumer KAS, Vasanthy BK, Al-Zaid MM. Human

Chromogranin A (CgA) in patients with hyperthyroidism, Annual Health Sciences Poster

Day 2003, P. 71

Listed in Who’sWho in the World, 19th Edition 2002

Listed in Who’sWho in Medicine and Healthcare 2002-2003

President, Ninth Annual Health Sciences Poster Conference 2004.

Chief Representative of Faculty of Medicine, Kuwait on the third Conference

of Arab Society of Medical faculties, held on 12-13 April 2006, Irbid, Jordan

H. Examiner ;

· Faculty of Medicine, Undergraduate students (2001- to date)

· MRCP (PACES) Postgraduate UK examination (October 2003-Oman Center, October

2004-Oman Center, 26-28th

March 2006-Oman center, October 2006-Oman Center,

October 2007 Kuwait, 26th

March 2009, Kuwait; 24TH

March 2010, Kuwait,

November 2010, Kuwait; 24 March 2011, Kuwait, March 2012)

27

· Saudi Medical Board post-graduate program, KSA, examiner 9-13 December 2006

· Saudi Commission for Health specialities- Sub-speciality examination, Saudi Board of

Endocrinology and Metabolism in adults, 23 Jan. 2010.

· Oman Medical College, Sohar Medical campus. Examiner on 2011.

· Master thesis examiner:

· 1. Diabetic hand syndromes among with Type 2 Diabetes Mellitus: it’s related factors,

and it’s associations with microvascular complications (May 2008, in NCDEG,

Jordon).

· 2. Factors associated with poor glycemic control among patients with type 2 diabetes

attending NCDEG (May 2008, in NCDEG, Jordon).

· 3. The Effect of Clothing on Vitamin D Status, Bone Turnover Markers and Bone

Mineral Density in Young Unmarried Kuwaiti Females (Kuwait University, Faculty of

Medicine, Physiology Department, June 2010).

I. Certifications in techniques and investigations:

· Thyroid Ultrasound by AACE (24-25th

August 2002 post-course attendance and

passing the certification exam)

· Bone Densitometry by IOF/ISCD (18-19th

Dec. 2003 post-course attendance and

passing the certification exam)



1st Annual Meeting

October 12, 2012 Attn: Gulf AACE Chapter Members, In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model, the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This meeting is open to all Gulf-AACE members and their invited guests.

If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173. 1 Name: Dr. Mahmoud Fikri Address: Ministry of Health, Muhaisnah 2 , Near Etisalat Academy P.O.Box 1853 City: Dubai Country: United Arab Emirates Email: [email protected] 2 Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the purposes of Chapter business? √ yes ___ no 3 Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

_√__ President ___ Vice President ___ Secretary ___ Treasurer ___ Board of Director Member ___ CV or bio-sketch included ___ Candidate statement included

Statement of why I would like to serve for the AACE Gulf Chapter Board of

members

From my current positions and status that I have in this country and in the Gulf

region, as I represent the Assistant undersecretary for Health policies and as I am

the Chairman of the National Committee for control of Diabetes and as a member

of the Gulf NCDs, I see working as a president for AACE Gulf chapter will represent

an opportunity to influence policies and decision making processes for Diabetes

control and for Capacity Building of manpower for Diabetes and strengthening

the alliances and cooperation with international, regional and local public or

private sectors and institutions working in the field of Diabetes and

endocrinology.

This is in addition to my long association with AACE and their activities in this

country. I have the honor of facilitating and strengthening the ties of AACE with

UAE MOH since 2009 when we have started our collaboration in training the

Medical doctors in Diabetes by conducting the First international AACE Diabetes

training in the country, later on in 2010 – 2011 we have managed to bring on

board participants of this course from the other Gulf Countries. In addition to our

participation in the first AACE Diabetes Conference held in Doha/Qatar.

For all of this reasons, I am definitely capable of performing the duties of the

president of the AACE Gulf Chapter.

Dr. Mahmoud Fikri

Assistant Undersecretary Health policies

Chairman National Committee for Control of Diabetes

CURRICULUM VITAE

A. PERSONAL INFORMATION:

Name : MAHMOUD MOHAMED A. FIKREE

Date and Place of Birth : October 1st 1953, Kalba-Sharjah

Sex : Male

Marital Status : Married

Nationality : United Arab Emirates (UAE)

Designation : Assistant Undersecretary for Preventive Medicine

Address : Resi: Sharjah, P O Box 32222, Tel: 971-65487333

Fax: 971-6-5487773

Off: Ministry of Health, Abu Dhabi, P O Box 848

UAE. Tel: 971-2-6323480, Fax: 971-2-632691

E-mail: [email protected]

Honorary positions:

a) Member of International Advisory Committee of World Congress on Vaccines

/ Infections Control World Organization.

b) Nominated for appointment as Assistance to the Director General of World

Health Organization, (Geneva, 2005)

c) Member of the Advisory Council of the Emirates of Sharjah and Chairman of

the Health Committee of the Council 2000

d) Member of the Board Directors for the WHO Center for Health Development

and Research in Japan (KOBE)

e) Member of the Board of Directors of the World Surveys Council-WHO

(COHERD)

f) Vice Chairman of the World Health Assembly-Geneva 2005

g) Member of Advisory Board of UK COCHRANE Center- Bahrain Branch

h) Member of Advisory Board of GCC Health Counsel (1996-2005)

B. EDUCATION

Qualification School / University Year

MFPHM

Membership

Royal College of Physicians of the United

Kingdom, UK (faculty of Public Health)

2000

FACP American College of Physicians, USA 1999

Ph. D. in

Dermatology

University of Medicine and Pharmacy, Carol

Devila, Romania

1999

Membership of

ACP

American College of Physicians, USA 1997

C. CURRENT PROFESSIONAL LICENSE

Consultant public health medicine - MOH, UAE

D. CURRENT PROFESSIONAL POSITIONS AND APPOINTMENTS

International Level

1996-2001 Member of the Executive Board, World Health Organization,

Geneva

1995 to 2006 Member of Gulf Cooperative Council Executive Board Health

Council – GCC Health Minister Council

1995 Chairman of World Bank –Health Sector Study , UAE team

1995-1996 Chairman(Director) of UAE Family Health Study, part of the

GCC countries –Family Health Study

Country Level

Period Place of Employment and Designation

1980-1984 Director of Kalba Hospital - 90 bedded hospital in Sharjah,

Ministry of Health, UAE

1984-1986 Director of Sharjah Regional Hospitals 300-bedded hospitals in

Sharjah East Coast, Ministry of Health UAE

1986-1988 Deputy Director of Sharjah Medical District, Ministry of Health,

UAE

1988-1997 Director of Curative Medicine Department, Ministry of Health,

UAE

1990-May 1996 Director of Ras Al Khaimah Medical District administering the

health facilities of the district which included 3 General Hospitals,

18 Primary Health Centres and a staff of 1800 persons.

May 1996-1997 Director General of Hospital Administration, as part of the

Curative Medicine Department

Mar 1998 – 2006 Assistant Undersecretary for Preventive Medicine, directing the

Member of AACE Americal Association of Clinical Endocrinologist 2011

Fellowship of

Community

Medicine

College of Physicians and Surgeons, Pakistan 1996

M Sc.

Dermatology and

Venereology

Faculty of Medicine, Cairo University, Egypt 1989

DTM and Hygiene Liverpool School of Tropical Medicine and

Hygiene, UK

1984

Internship Ain Shams University, Cairo, Egypt 1980

MBBCh. Ain Shams University, Cairo, Egypt(with Honors) 1979

High School Ministry of Education School, UAE 1973

Mother and Child health, School Health, Occupational Health,

Disease Prevention and Control and Health Education

departments and International Health Regulations as National

Focal Points.

April 2006-2009 CEO for Health Policies Affairs – In charge of departments of:

Primary Health Care, Special Health care, Health Insurance,

Health Promotional Education, Health Legislation, Preventive

Medicine and Disease Control Department.

Other posts

2010 Chairman of the National Cancer Control Board

2009 to Date Assistant Undersecretary for Health Policies Affairs -In charge of

departments of: Primary Health Care, Special Health care, Health

Insurance, Health Promotional Education, Health Legislation,

Preventive Medicine, Disease Control Department and 6 National

Programs..

2009 to Date Chairman of the Higher National Scientific Board for H1N1

Control and Prevention.

2009 to Date Reporter (Member) of the Supreme National Board for H1N1

Control and Prevention

(Strategic level).

2009 to Date Chairman of the Higher National Board for the Control and

Prevention of Diabetes Mellitus.

2006 to Date Chairman of National AIDS Prevention and Control Committee.

2002 to Date Chairman of the National Scientific Board for Vaccination.

1991 to Date Manager of National Cancer Control Program.

Other special duties:

2007 to Date Chairman and Director for Polio Eradication Program.

2000 to Date Iodine Deficiency Elimination Program.

1996 to Date Chairman of National Malaria Control Program.

1996 to Date Chairman of National Board for Premarital Testing Program.

E. NATIONAL AND REGIONAL ACHIEVEMENTS

- Responsible for Polio Eradication Program - achieved by 2002.

- Responsible for Malaria-Free Certification - achieved by Oct. 2007.

- Responsible for Iodine deficiency Disease Elimination - achieved by Oct. 2010.

- Responsible for Measles Elimination - Under Process.

1986 to 2006 Manager of National AIDS Prevention Program, UAE

1996-2002 Chairman of National Drug Formulary Committee

1992-2000 Manager of National Committee for Organ Transplantation, UAE

1996 Vice Chairman of National Drug Registration Committee

F. Summary of leadership and managerial experience:

In the last 26years of my work in the Ministry of Health in 1980, I have contributed in

different capacities to create effective and efficient health management systems.

During the initial years of my work, I participated in the development and

management of secondary and tertiary care hospitals in the various districts of UAE.

These include the Kalba General Hospital, Khorfakkan General Hospital, old Al

Qassimi Hospital-Sharjah and the extension of the Saqr Hospital in Ras Al Khaimah.

As Assistant Undersecretary for Curative Medicine, I was instrumental in developing

the National Strategy, Federal Laws and byelaws for Organ transplantation within the

country. In addition I also played a key role in the development of Radiation

Protection and Control Laws and hospital units in the Ministry of Health. Another of

my proud achievements in the Ministry has been the development of a National

Cancer Registry to help assess the burden of cancers in the UAE. Within the Ministry,

I have utilized my heath management skills to contribute to the restructuring of the

Ministry of Health and development of short and long-term strategies for the Ministry

of Health in 1985. On numerous occasions such as the Liberation of Kuwait (1991),

Haj Pilgrimage (1989) and Earthquake in Yemen (1984), I have had the honor of

leading country level medical relief teams to provide medical aid.

While leading the Preventive Medicine department, I was responsible for upgrading

and adapting the National Immunization Program of UAE in line with the EPI

program of World Health Organization. Older vaccines such as Measles vaccine

(monovalent) have been replaced with combined Measles Mumps and Rubella (MMR)

vaccine.and newer vaccines such as Hepatitis B, HiB(against H.Influenzae B) have

been introduced into the program. As Undersecretary of the Preventive Medicine, I

have played a pivotal role in directing efforts towards eradication/elimination of

infectious diseases by setting up the requirement for WHO accredited laboratories and

an efficient surveillance system particularly in the field of Poliomyelitis, Malaria and

Measles. Due to these efforts, the United Arab Emirates has achieved Polio and

Malaria-free status. Within the Ministry, I have been actively involved in undertaking

capacity development to face new threats from emerging and remerging diseases such

as SARS and Avian Flu and prevent their importation through collaboration with

global partners –WHO as well as local and regional organizations. Under my

leadership the school health department strengthened its school health services and

provided free vaccination to not only government but also private schools. I was

instrumental in accepting the Abu Dhabi declaration of the International School

Health Conference to adopt the concept of Health Promoting Schools in UAE. I have

made extensive efforts to direct health education activities to promote positive

behavior change of populations especially in the Tobacco control program. Extensive

school health education programs such as IGROW (for adolescent girls) and

LIFESMIC (for encouraging healthy lifestyles) have been undertaken by the Ministry

of Health in conjunction with the Ministry of Education. During my tenure in the

Ministry of Health, I have also been involved in Global surveys for Family Health

and Child Health survey, World Bank situational analysis of the UAE to name a few.

G. PRIZES AND AWARDS

1 GCC Health Counsel Prize for UAE National Diabetes

Awareness Campaign.

2011

2 GCC Health Counsel Prize for Health Promotion for AIDS

Control and Prevention.

2010

3 GCC Health Counsel Prize for Health Promotion for UAE

National Campaign for Prevention of Obesity.

2009

4 UAE Health Foundation Prize by World Health Organization 2003

5 H. H. Sheikh Rashid Bin Saeed Al-Maktoum Honors Awards and

Certificates for Science

1990

G. TRAINING COURSES

Period Place Name and Place of the Course

1994 Saudi Arabia Course on Epidemiology of Diabetes Mellitus, King Saud

University,

1992 UAE Course on Decision Making for Managers, UAE

1985 Bahrain International Course on the Management and Control of

Diarrhoeal Diseases organized by the World Health

Organization, Eastern Mediterranean Region

1983 Oman International Course on the Management and Control of

Diarrhoeal Diseases organized by the World Health

Organization, Eastern Mediterranean Region

1983 Bahrain International Course on the Management of Expanded

Program of Immunization, organized by the World Health

Organization

1983 UAE Course on Response to Oil Pollution, organized by the

United States Coast Guard, Abu Dhabi

1980 Bahrain Course on the Expanded Program of Immunization,

organized by the World Health Organization

H. RESEARCH

Published Research

Title of article Journal and Year of Publishing

Incidence and Prevalence of HBV among

health workers in UAE,

Emirates Medical Journal 1986

Role of Micro-Organisms in the

pathogenesis of Seborrhic Dermatitis,

Egyptian Journal of Dermatology, 1995

Incidence and Prevalence of Smoking

among a certain age group-School

children

MOH-WHO, 2004

Global School Health Survey MOH-WHO-CDC Atlanta, 2005

Global School Health Survey MOH-WHO-CDC Atlanta, 2010

I. TO BE PUBLISHED RESEARCH

- Assessment of Community Awareness Towards Healthy Life Style – 2011.

- Assessment of Type 2 Diabetes Among Adults in UAE – 2010.

- Assessment of Iodine Deficiency Disease in UAE – 2009.

J. ON GOING RESEARCH

- Epidemiology and Diabetes Type 2: Associated Risk Factor Among Different Age

Groups (MOH, Baker Institute, University Of Sharjah and WHO) 2010-2012.

- Assessment of Diabetes Mellitus among School Children (MOH and RCDR)

2010-2011.

- National Nutritional Survey Among Different Public Age Groups (MOH, UAE

University and WHO) 2009-2011.

Other Research conducted:

1. Evaluation of oral Ketoconazole in the treatment of Tinea Versicolor, 1987

2. Role of immunity in the pathogenesis of Seborrheic Dermatitis, 1995 (Ph. D

thesis)

3. Project of Population- Human T-Lymphocytotropic Virus Type I (HTLV-I),

1994

4. Child Health Survey for GCC countries, 1985

5. Medical Herbs in the UAE, UAE University-Al Ain, 1993

6. Family Health Survey in the GCC countries, 1996

7. Incidence and Prevalence of Diabetes in the UAE, in collaboration with World

Health Organization and Centre for Disease Control, USA.

K. MANAGEMENT OF PROGRAMS AND TECHNICAL

COMITTEES

1989 to 2006 Manager of National AIDS Prevention Committee

1992 -2006 Manager of National Committee for Organ Transplantation, UAE

2000 to date Chairman of the National Vaccination Committee

1991 – 2006 Member of Staff Recruitment Board at Ministry of Health, UAE

1991 – 1996 Member of Executive National Health Planning Board, UAE

1996 – 2006 Vice Chairman of the National Drug Registration Committee

1996 – 2006 Manager of National Cancer control Program

1994 Member of the Committee for the Organizational Structure of the

Ministry of Public Health and Civil service

1989 to 2004 Member of Technicians Private Licensing Division Board

1989-1991 Member of Doctors Licensing and Degree Evaluation Committee,

UAE

1989-1990 Chairman of Medical Mission to Kingdom of Saudi Arabia during

the Pilgrimage Season, (40 medical staff)

1991 Chairman of Medical Team during Liberation of Kuwait state

1984 Chairman of Medical Mission to Yemen, during earthquake

1998- 2001 Member of Tropical Disease Research (TDR) Board, World

Health Organization, Geneva.

L. PROFESSIONAL SOCIETIES MEMBERSHIP

S No. Name of Organization/Society/Committee Place Since

1 International Epidemiology Association U.K 2008

2 Royal College of Physicians of United Kingdom U.K 2000

3 American College of Physicians USA 1999

4 Regional member of Advisory Board of the Bahrain

Branch of the UK Cochrane Center

Bahrain 2006

5 Administrative Board of the Pan Arab Leagues of

Dermatology

Arab

Countries

1989-1998

6 Leagues of Dermatology for Gulf Countries GCC 1989- to

date

7 Board of Emirates Medical Association UAE 1984-1988

8 Secretary General of Dermatology Division of the

Emirates Medical Association

UAE 1993 –

1996

9 Fathers Council of Sharjah City UAE 1986-1988

M. CIVIC ACTIVITIES AND COMMUNITY INVOLVEMENT

1 Secretary General for the 1st Gulf Organ Transplantation

Congress, Abu Dhabi

1997

2 Chairman of Ras Al Khaimah Social District Committee for

Development of Old People Geriatric Home(48 beds)

1990-1996

3 Secretary General for 4th Asian Congress of Dermatology, Dubai 1995-1996

4 Chairman of Sharjah District Committee for Establishment of

“Old People Home”(40 beds)

1996-1998

N. ACHIEVEMENTS

In Public Health Legislation:

1- Development of National Tobacco Control Laws and Implementation

Regulation (2011).

2- The Development and the update of the National Organ Transplantation

Law (1994-2011).

3- Development of HIV/AIDS People Rights and Responsibilities Regulation

(2010).

4- Development of National Public Health Law (ongoing 2010).

5- Modification and Update of other Laws; Birth and Death Law,

Communicable Disease Law, Non communicable Disease Law and Mental

Health law.

6- Development of National Tobacco Control Law (2009).

7- Development of National Radiation Protection Law (2002).


Gulf Chapter of the American Association of Clinical Endocrinologists (Bahrain, Kuwait, Oman, Qatar, Kingdom of Saudi Arabia, United Arab Emirates)


Attn: Gulf AACE Chapter Members, In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model, the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This meeting is open to all Gulf-AACE members and their invited guests. If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate statements are limited to one page. Please send your response to [email protected] or by fax at 904/404-4173. Name: AHMED A.K. HASSOUN Address: PODIUM VILLA D-101, EXECUTIVE TOWERS, BUSINESS BAY City: DUBAI Country: UNITED ARAB EMIRATES Email: [email protected] Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the purposes of Chapter business? YES Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)

President ___ Vice President ___ Secretary ___ Treasurer ___ Board of Director Member CV or bio-sketch included Candidate statement included

AHMED A.K. HASSOUN, MD, FACE, FACP Consultant Endocrinologist & Chairman of Research and Medical Education Dubai Diabetes Center - Dubai Health Authority Dr. Hassoun completed his residency training in Internal Medicine at Brown University - Rhode Island, USA. After 3 years of extensive clinical and research fellowship in Endocrinology, Diabetes & Metabolism at the Mayo Clinic in Rochester, Minnesota, he joined the Endocrinology staff at Mayo Clinic. He is American board certified in both Internal Medicine & Endocrinology, Diabetes, and Metabolism. Dr. Hassoun is a fellow of the American College of Physicians and the American College of Endocrinology. In addition, he is an active member of: American Diabetes Association (ADA), American Endocrine Society (ES), and the American Association of Clinical Endocrinologists (AACE). His previous appointments included: Chief of Endocrinology, Emirates Diabetes Society Board member, Clinical Assistant Professor at Wayne State University in Michigan and the Faculty of Medicine at the UAE University. He has been actively participating in: developing and updating the UAE Diabetes guidelines, educating & training doctors & other healthcare providers, as well as conducting research in the field of diabetes & endocrinology. Dr. Hassoun is a founding member and active coordinator of the monthly UAE Endocrinology meetings, which was established in the year 2000, to encourage up-to-date education and dialogue amongst endocrinologists in UAE. “After great anticipation, I was delighted to hear the news of the initiation of the Gulf Chapter of AACE. This is an exciting opportunity for Endocrinologists in the region to collaborate with one another and progress (as a group) within the scientific field. It would be a great honor and a stimulating challenge to be appointed as the President of the Gulf Chapter. With consultation and the support of the Chapter members, my efforts would be focused primarily on: implementing regional endocrinology guidelines, increasing scientific meetings in collaboration with AACE and its other Chapters, and educating healthcare providers with the ultimate aim of empowering our patients to achieve optimum endocrine health through our initiatives. In addition, I would like to establish collaborative research efforts between the Gulf member countries. I believe that I have the appropriate background, experience and rapport to assist the Gulf Chapter in its commencement, growth, and development. Having been an AACE member since 1995 and actively participating and presenting in its annual meetings, I have a definite understanding of the organization and its values. Also, the intensive clinical training I received at the Mayo Clinic provided me with exceptional knowledge and clinical skills. Furthermore, I have considerable experience in design, coordination and management of several scientific educational programs. If chosen to represent the Gulf Chapter, as President I will do my best to successfully accomplish the organization’s goals. I look forward to advocating the Gulf Chapter of AACE and its members. Finally, I would like to thank all the individuals who have been involved in initiating the AACE Gulf Chapter, and for giving us this wonderful opportunity.

gulf chapter sample ballot - american association of · pdf file · 2012-09-17aug...

Documents